{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a1"},"numbersOfAis":"1","activeIngredientName":["TROPICAMIDE"],"dose":["0.5"],"productID":{"$numberInt":"260"},"sanitizedRegiestrationNumber":"00000981","productName":"MYDRIACYL","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["TROPICAMIDE"],"atcCode":["S01FA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TROPICAMIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a2"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN (ERYTHROMYCIN LACTOBIONATE)"],"dose":["500"],"productID":{"$numberInt":"1169"},"sanitizedRegiestrationNumber":"00000175","productName":"ERYTHROCIN IV","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN (ERYTHROMYCIN LACTOBIONATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a3"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE (EPINEPHRINE BITARTRATE)"],"dose":["10","0.01"],"productID":{"$numberInt":"589"},"sanitizedRegiestrationNumber":"00001791","productName":"XYLOCAINE 1% W EPINEPHRINE 1:100000","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a4"},"numbersOfAis":"1","activeIngredientName":["FLUMETHASONE PIVALATE"],"dose":[".03"],"productID":{"$numberInt":"559"},"sanitizedRegiestrationNumber":"00005134","productName":"LOCACORTEN .03%","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["FLUMETASONE"],"atcCode":["D07AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUMETHASONE PIVALATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a5"},"numbersOfAis":"1","activeIngredientName":["ETHCHLORVYNOL"],"dose":["500"],"productID":{"$numberInt":"226"},"sanitizedRegiestrationNumber":"00000027","productName":"PLACIDYL CAP 500MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1952-12-31"],"sanitizedIndication":["ETHCHLORVYNOL"],"atcCode":["N05CM08"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHCHLORVYNOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a6"},"numbersOfAis":"1","activeIngredientName":["CLIOQUINOL"],"dose":["3"],"productID":{"$numberInt":"808"},"sanitizedRegiestrationNumber":"00005797","productName":"VIOFORM 3%","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2010-12-31"],"sanitizedIndication":["CLIOQUINOL"],"atcCode":["D08AH30"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLIOQUINOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a7"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN"],"dose":["30"],"productID":{"$numberInt":"769"},"sanitizedRegiestrationNumber":"00023442","productName":"DILANTIN-30 SUSPENSION","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a8"},"numbersOfAis":"1","activeIngredientName":["CHLORPHENIRAMINE MALEATE"],"dose":["4"],"productID":{"$numberInt":"579"},"sanitizedRegiestrationNumber":"00021288","productName":"TEVA-PHENIRAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["CHLORPHENIRAMINE"],"atcCode":["R06AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPHENIRAMINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9a9"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"309"},"sanitizedRegiestrationNumber":"00026093","productName":"BETADINE VAGINAL DOUCHE 10%","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Douche"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["G01AX11"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9aa"},"numbersOfAis":"1","activeIngredientName":["CHLORAMBUCIL"],"dose":["2"],"productID":{"$numberInt":"1193"},"sanitizedRegiestrationNumber":"00004626","productName":"LEUKERAN","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1957-12-31"],"sanitizedIndication":["CHLORAMBUCIL"],"atcCode":["L01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORAMBUCIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ab"},"numbersOfAis":"1","activeIngredientName":["HYPROMELLOSE"],"dose":["0.5"],"productID":{"$numberInt":"793"},"sanitizedRegiestrationNumber":"00000809","productName":"ISOPTO TEARS 0.5%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYPROMELLOSE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ac"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"2376"},"sanitizedRegiestrationNumber":"00000841","productName":"ISOPTO CARPINE","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1959-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ad"},"numbersOfAis":"1","activeIngredientName":["HYDRALAZINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"119"},"sanitizedRegiestrationNumber":"00005525","productName":"APRESOLINE TABLETS, 10MG","licenseHolderSponser":"STERIMAX INC","companyCode":[{"$numberInt":"8892"}],"facilityAddress":" 2770 Portland Drive Oakville Ontario Canada L6H 6R4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1952-12-31"],"sanitizedIndication":["HYDRALAZINE"],"atcCode":["C02DB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDRALAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ae"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"209"},"sanitizedRegiestrationNumber":"00001686","productName":"XYLOCAINE VISCOUS 2%","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Topical","Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9af"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN STEARATE"],"dose":["25"],"productID":{"$numberInt":"1101"},"sanitizedRegiestrationNumber":"00000302","productName":"ERYTHROCIN LIQUID 125","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN STEARATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b0"},"numbersOfAis":"1","activeIngredientName":["HYDRALAZINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"805"},"sanitizedRegiestrationNumber":"00005541","productName":"APRESOLINE TABLETS, 50MG","licenseHolderSponser":"STERIMAX INC","companyCode":[{"$numberInt":"8892"}],"facilityAddress":" 2770 Portland Drive Oakville Ontario Canada L6H 6R4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1952-12-31"],"sanitizedIndication":["HYDRALAZINE"],"atcCode":["C02DB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDRALAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b1"},"numbersOfAis":"1","activeIngredientName":["TETRACYCLINE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"315"},"sanitizedRegiestrationNumber":"00024422","productName":"TETRACYN CAP 250MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1952-12-31"],"sanitizedIndication":["TETRACYCLINE"],"atcCode":["J01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b2"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN (ERYTHROMYCIN LACTOBIONATE)"],"dose":["1"],"productID":{"$numberInt":"1168"},"sanitizedRegiestrationNumber":"00000183","productName":"ERYTHROCIN IV","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1954-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN (ERYTHROMYCIN LACTOBIONATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b3"},"numbersOfAis":"1","activeIngredientName":["METHYLTESTOSTERONE"],"dose":["25"],"productID":{"$numberInt":"13363"},"sanitizedRegiestrationNumber":"00005630","productName":"METANDREN 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["METHYLTESTOSTERONE"],"atcCode":["G03BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLTESTOSTERONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b4"},"numbersOfAis":"1","activeIngredientName":["IMIPRAMINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"2038"},"sanitizedRegiestrationNumber":"00010472","productName":"TOFRANIL 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1959-12-31"],"sanitizedIndication":["IMIPRAMINE"],"atcCode":["N06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IMIPRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b5"},"numbersOfAis":"1","activeIngredientName":["PHENTOLAMINE MESYLATE"],"dose":["5"],"productID":{"$numberInt":"802"},"sanitizedRegiestrationNumber":"00005193","productName":"ROGITINE 5MG/VIAL","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1953-12-31"],"sanitizedIndication":["PHENTOLAMINE"],"atcCode":["C04AB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENTOLAMINE MESYLATE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["AMP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b6"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"318"},"sanitizedRegiestrationNumber":"00024384","productName":"ATARAX CAP 25MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1956-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b7"},"numbersOfAis":"1","activeIngredientName":["QUININE SULFATE"],"dose":["300"],"productID":{"$numberInt":"290"},"sanitizedRegiestrationNumber":"00021016","productName":"TEVA-QUININE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1966-12-31"],"sanitizedIndication":["QUININE"],"atcCode":["P01BC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUININE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b8"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE"],"dose":["0.5"],"productID":{"$numberInt":"355"},"sanitizedRegiestrationNumber":"00028185","productName":"CELESTONE TAB 0.5MG","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["H02AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9b9"},"numbersOfAis":"1","activeIngredientName":["CARBACHOL"],"dose":["3"],"productID":{"$numberInt":"255"},"sanitizedRegiestrationNumber":"00000663","productName":"ISOPTO CARBACHOL 3%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["CARBACHOL"],"atcCode":["S01EB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBACHOL"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ba"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["250"],"productID":{"$numberInt":"2220"},"sanitizedRegiestrationNumber":"00030619","productName":"SOLU-CORTEF 250 MG ACT-O-VIAL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1962-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9bb"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"1125"},"sanitizedRegiestrationNumber":"00020877","productName":"TEVA-AMPICILLIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1971-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9bc"},"numbersOfAis":"1","activeIngredientName":["DESIPRAMINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"1098"},"sanitizedRegiestrationNumber":"00010448","productName":"PERTOFRANE 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["DESIPRAMINE"],"atcCode":["N06AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DESIPRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9bd"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"722"},"sanitizedRegiestrationNumber":"00024368","productName":"VIBRAMYCIN CAP 100MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1969-12-31"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9be"},"numbersOfAis":"1","activeIngredientName":["THROMBIN"],"dose":["5000"],"productID":{"$numberInt":"1046"},"sanitizedRegiestrationNumber":"00023094","productName":"THROMBOSTAT 5000UNITS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THROMBIN"],"atcCode":["B02BC06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THROMBIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9bf"},"numbersOfAis":"1","activeIngredientName":["PENTOBARBITAL SODIUM"],"dose":["50"],"productID":{"$numberInt":"2576"},"sanitizedRegiestrationNumber":"00000213","productName":"NEMBUTAL SODIUM INJ 50MG/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["PENTOBARBITAL"],"atcCode":["N05CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENTOBARBITAL SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c0"},"numbersOfAis":"2","activeIngredientName":["SENNOSIDES","DOCUSATE SODIUM"],"dose":["8.6","50"],"productID":{"$numberInt":"2133"},"sanitizedRegiestrationNumber":"00026123","productName":"SENOKOT S","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1975-12-31"],"sanitizedIndication":["SENNA GLYCOSIDES, COMBINATIONS"],"atcCode":["A06AB56"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SENNOSIDES","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c1"},"numbersOfAis":"1","activeIngredientName":["SULFINPYRAZONE"],"dose":["100"],"productID":{"$numberInt":"1149"},"sanitizedRegiestrationNumber":"00010510","productName":"ANTURAN 100MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1959-12-31"],"sanitizedIndication":["SULFINPYRAZONE"],"atcCode":["M04AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFINPYRAZONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c2"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["60"],"productID":{"$numberInt":"2377"},"sanitizedRegiestrationNumber":"00000892","productName":"ISOPTO CARPINE LIQ 6%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1959-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c3"},"numbersOfAis":"1","activeIngredientName":["ORCIPRENALINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"1551"},"sanitizedRegiestrationNumber":"00003859","productName":"ALUPENT LIQ 50MG/ML","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ORCIPRENALINE"],"atcCode":["R03AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ORCIPRENALINE SULFATE"],"sanitizedRouteOfAdministration":["Inhalation","Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c4"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"585"},"sanitizedRegiestrationNumber":"00001732","productName":"XYLOCAINE 1%","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c5"},"numbersOfAis":"1","activeIngredientName":["HYPROMELLOSE"],"dose":["1"],"productID":{"$numberInt":"794"},"sanitizedRegiestrationNumber":"00000817","productName":"ISOPTO TEARS 1%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYPROMELLOSE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c6"},"numbersOfAis":"1","activeIngredientName":["THIOTHIXENE"],"dose":["5"],"productID":{"$numberInt":"784"},"sanitizedRegiestrationNumber":"00024449","productName":"NAVANE","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1969-12-31"],"sanitizedIndication":["TIOTIXENE"],"atcCode":["N05AF04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOTHIXENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c7"},"numbersOfAis":"1","activeIngredientName":["THYROID"],"dose":["30"],"productID":{"$numberInt":"772"},"sanitizedRegiestrationNumber":"00023949","productName":"THYROID TAB 30MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THYROID GLAND PREPARATIONS"],"atcCode":["H03AA05"],"pharmaceuticalStd":["CSD"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THYROID"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c8"},"numbersOfAis":"1","activeIngredientName":["AZATHIOPRINE"],"dose":["50"],"productID":{"$numberInt":"1192"},"sanitizedRegiestrationNumber":"00004596","productName":"IMURAN","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1966-12-31"],"sanitizedIndication":["AZATHIOPRINE"],"atcCode":["L04AX01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AZATHIOPRINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9c9"},"numbersOfAis":"1","activeIngredientName":["ACENOCOUMAROL"],"dose":["1"],"productID":{"$numberInt":"1118"},"sanitizedRegiestrationNumber":"00010383","productName":"SINTROM","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1962-12-31"],"sanitizedIndication":["ACENOCOUMAROL"],"atcCode":["B01AA07"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACENOCOUMAROL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ca"},"numbersOfAis":"2","activeIngredientName":["DIPHENOXYLATE HYDROCHLORIDE","ATROPINE SULFATE"],"dose":["2.5",".025"],"productID":{"$numberInt":"937"},"sanitizedRegiestrationNumber":"00036323","productName":"LOMOTIL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1960-12-31"],"sanitizedIndication":["DIPHENOXYLATE"],"atcCode":["A07DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DIPHENOXYLATE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9cb"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["2"],"productID":{"$numberInt":"2375"},"sanitizedRegiestrationNumber":"00000868","productName":"ISOPTO CARPINE","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9cc"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["50"],"productID":{"$numberInt":"1735"},"sanitizedRegiestrationNumber":"00037850","productName":"SODIUM CHLORIDE INJECTION 5%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05XA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9cd"},"numbersOfAis":"1","activeIngredientName":["FERROUS GLUCONATE"],"dose":["300"],"productID":{"$numberInt":"1660"},"sanitizedRegiestrationNumber":"00162531","productName":"FERROUS GLUCONATE TAB 300MG","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["FERROUS GLUCONATE"],"atcCode":["B03AA03"],"pharmaceuticalStd":["NF"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FERROUS GLUCONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ce"},"numbersOfAis":"7","activeIngredientName":["PREDNISONE","PHENIRAMINE MALEATE","VITAMIN A","VITAMIN D2","VITAMIN E","INOSITOL","PHOSPHATIDYL CHOLINE"],"dose":["5","10","6000","125","5","2.5",".25"],"productID":{"$numberInt":"236"},"sanitizedRegiestrationNumber":"00154008","productName":"PREDNIDERM TAB","licenseHolderSponser":"ORMOND VETERINARY SUPPLY LTD.","companyCode":[{"$numberInt":"4863"}],"facilityAddress":" 574 Shaver Road Ancaster Ontario Canada L9G 3K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1966-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PREDNISONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","UNIT","UNIT","UNIT","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9cf"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["500"],"productID":{"$numberInt":"2221"},"sanitizedRegiestrationNumber":"00030627","productName":"SOLU-CORTEF 500 MG ACT-O-VIAL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1966-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d0"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["200"],"productID":{"$numberInt":"777"},"sanitizedRegiestrationNumber":"00010405","productName":"TEGRETOL 200MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d1"},"numbersOfAis":"1","activeIngredientName":["PERPHENAZINE"],"dose":["5"],"productID":{"$numberInt":"373"},"sanitizedRegiestrationNumber":"00028002","productName":"TRILAFON INJ 5MG/ML","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["PERPHENAZINE"],"atcCode":["N05AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERPHENAZINE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d2"},"numbersOfAis":"1","activeIngredientName":["METHSUXIMIDE"],"dose":["300"],"productID":{"$numberInt":"763"},"sanitizedRegiestrationNumber":"00022802","productName":"CELONTIN CAP 300MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1957-12-31"],"sanitizedIndication":["MESUXIMIDE"],"atcCode":["N03AD03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHSUXIMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d3"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"320"},"sanitizedRegiestrationNumber":"00024589","productName":"ATARAX IM SOL 50MG/ML","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1957-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d4"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"212"},"sanitizedRegiestrationNumber":"00001694","productName":"XYLOCAINE JELLY 2%","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d5"},"numbersOfAis":"1","activeIngredientName":["SULFACETAMIDE SODIUM"],"dose":["100"],"productID":{"$numberInt":"371"},"sanitizedRegiestrationNumber":"00028053","productName":"SODIUM SULAMYD 10%","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["SULFACETAMIDE"],"atcCode":["S01AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFACETAMIDE SODIUM"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d6"},"numbersOfAis":"1","activeIngredientName":["ATROPINE SULFATE"],"dose":["1"],"productID":{"$numberInt":"254"},"sanitizedRegiestrationNumber":"00035017","productName":"ISOPTO ATROPINE","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1964-12-31"],"sanitizedIndication":["ATROPINE"],"atcCode":["S01FA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATROPINE SULFATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d7"},"numbersOfAis":"1","activeIngredientName":["PERPHENAZINE"],"dose":["2"],"productID":{"$numberInt":"374"},"sanitizedRegiestrationNumber":"00028150","productName":"TRILAFON SYR 2MG/5ML","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["PERPHENAZINE"],"atcCode":["N05AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERPHENAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d9"},"numbersOfAis":"1","activeIngredientName":["HYDROCHLOROTHIAZIDE"],"dose":["25"],"productID":{"$numberInt":"778"},"sanitizedRegiestrationNumber":"00021474","productName":"TEVA-HYDROCHLOROTHIAZIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE"],"atcCode":["C03AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCHLOROTHIAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9da"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["100"],"productID":{"$numberInt":"2219"},"sanitizedRegiestrationNumber":"00030600","productName":"SOLU-CORTEF 100 MG ACT-O-VIAL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1958-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9db"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE)"],"dose":["200"],"productID":{"$numberInt":"3699"},"sanitizedRegiestrationNumber":"00000604","productName":"EES-200 CHEWABLE TBS (ERYPED)","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9dc"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE (EPINEPHRINE BITARTRATE)"],"dose":["10","5"],"productID":{"$numberInt":"590"},"sanitizedRegiestrationNumber":"00001805","productName":"XYLOCAINE 1% W EPINEPHRINE 1:200000","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9d8"},"numbersOfAis":"1","activeIngredientName":["SPIRONOLACTONE"],"dose":["25"],"productID":{"$numberInt":"1403"},"sanitizedRegiestrationNumber":"00028606","productName":"ALDACTONE 25 MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["SPIRONOLACTONE"],"atcCode":["C03DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SPIRONOLACTONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9de"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"587"},"sanitizedRegiestrationNumber":"00036641","productName":"XYLOCAINE 2%","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9df"},"numbersOfAis":"1","activeIngredientName":["FLUOROURACIL"],"dose":["50"],"productID":{"$numberInt":"10015"},"sanitizedRegiestrationNumber":"00012882","productName":"FLUOROURACIL INJECTION","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["FLUOROURACIL"],"atcCode":["L01BC02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOROURACIL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e0"},"numbersOfAis":"1","activeIngredientName":["ETHOSUXIMIDE"],"dose":["250"],"productID":{"$numberInt":"731"},"sanitizedRegiestrationNumber":"00023485","productName":"ZARONTIN SYR 250MG/5ML","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1964-12-31"],"sanitizedIndication":["ETHOSUXIMIDE"],"atcCode":["N03AD01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHOSUXIMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e1"},"numbersOfAis":"2","activeIngredientName":["BETAMETHASONE ACETATE","BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)"],"dose":["3","3"],"productID":{"$numberInt":"354"},"sanitizedRegiestrationNumber":"00028096","productName":"CELESTONE SOLUSPAN","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1965-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["H02AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BETAMETHASONE ACETATE","Combination"],"sanitizedRouteOfAdministration":["Intrabursal","Intra-Articular","Intramuscular","Intradermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e3"},"numbersOfAis":"1","activeIngredientName":["HYDROCHLOROTHIAZIDE"],"dose":["50"],"productID":{"$numberInt":"812"},"sanitizedRegiestrationNumber":"00021482","productName":"TEVA-HYDROCHLOROTHIAZIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE"],"atcCode":["C03AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCHLOROTHIAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e4"},"numbersOfAis":"1","activeIngredientName":["HOMATROPINE HYDROBROMIDE"],"dose":["5"],"productID":{"$numberInt":"258"},"sanitizedRegiestrationNumber":"00000787","productName":"ISOPTO HOMATROPINE 5%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["HOMATROPINE"],"atcCode":["S01FA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HOMATROPINE HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e5"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["4"],"productID":{"$numberInt":"2374"},"sanitizedRegiestrationNumber":"00000884","productName":"ISOPTO CARPINE","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e6"},"numbersOfAis":"1","activeIngredientName":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"dose":["25"],"productID":{"$numberInt":"52045"},"sanitizedRegiestrationNumber":"00027456","productName":"SERENTIL TAB 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1997-08-29"],"sanitizedIndication":["MESORIDAZINE"],"atcCode":["N05AC03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9dd"},"numbersOfAis":"1","activeIngredientName":["AMPHOTERICIN B"],"dose":["50"],"productID":{"$numberInt":"933"},"sanitizedRegiestrationNumber":"00029149","productName":"FUNGIZONE","licenseHolderSponser":"CHEPLAPHARM ARZNEIMITTEL GMBH","companyCode":[{"$numberInt":"15812"}],"facilityAddress":" Ziegelhof 24 Greifswald Mecklenburg-Vorpommern Germany 17489","countryOfOrigin":["Germany"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1958-12-31"],"sanitizedIndication":["AMPHOTERICIN B"],"atcCode":["J02AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPHOTERICIN B"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Label (Pharmaceutical)| Package (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e2"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE ACETATE"],"dose":["80"],"productID":{"$numberInt":"789"},"sanitizedRegiestrationNumber":"00030767","productName":"DEPO-MEDROL 80 MG/ML","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Intrasynovial","Intra-Articular","Intramuscular","Intralesional"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e8"},"numbersOfAis":"1","activeIngredientName":["ETHINYL ESTRADIOL"],"dose":[".5"],"productID":{"$numberInt":"358"},"sanitizedRegiestrationNumber":"00028231","productName":"ESTINYL TAB 0.5MG","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["ETHINYLESTRADIOL"],"atcCode":["G03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHINYL ESTRADIOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e9"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE ACETATE"],"dose":["2.5"],"productID":{"$numberInt":"1395"},"sanitizedRegiestrationNumber":"00031062","productName":"MEDROL TOPICAL 0.25%","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["D07AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ea"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"310"},"sanitizedRegiestrationNumber":"00026034","productName":"BETADINE VAGINAL GEL 10%","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["G01AX11"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9eb"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["9"],"productID":{"$numberInt":"3821"},"sanitizedRegiestrationNumber":"00037826","productName":"SODIUM CHLORIDE IR 9.0MG/ML UROSOL","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05CB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Irrigation","Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ed"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE)"],"dose":["500"],"productID":{"$numberInt":"1132"},"sanitizedRegiestrationNumber":"00030678","productName":"SOLU-MEDROL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution","Kit"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9e7"},"numbersOfAis":"1","activeIngredientName":["METHYLPHENIDATE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"801"},"sanitizedRegiestrationNumber":"00005614","productName":"RITALIN 20MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA III)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["METHYLPHENIDATE"],"atcCode":["N06BA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPHENIDATE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ee"},"numbersOfAis":"1","activeIngredientName":["SULFACETAMIDE SODIUM"],"dose":["300"],"productID":{"$numberInt":"370"},"sanitizedRegiestrationNumber":"00028061","productName":"SODIUM SULAMYD OPH DPS 30%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["SULFACETAMIDE"],"atcCode":["S01AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFACETAMIDE SODIUM"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ef"},"numbersOfAis":"1","activeIngredientName":["THIORIDAZINE"],"dose":["10"],"productID":{"$numberInt":"421"},"sanitizedRegiestrationNumber":"00027375","productName":"MELLARIL","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["THIORIDAZINE"],"atcCode":["N05AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIORIDAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9f0"},"numbersOfAis":"2","activeIngredientName":["NORETHINDRONE","MESTRANOL"],"dose":["1",".05"],"productID":{"$numberInt":"1853"},"sanitizedRegiestrationNumber":"00022608","productName":"ORTHO-NOVUM 1/50 TABLETS (21 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["NORETHISTERONE AND ESTROGEN"],"atcCode":["G03AA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NORETHINDRONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f2"},"numbersOfAis":"1","activeIngredientName":["DIMENHYDRINATE"],"dose":["50"],"productID":{"$numberInt":"577"},"sanitizedRegiestrationNumber":"00021423","productName":"TEVA-DIMENATE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIMENHYDRINATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f3"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["5"],"productID":{"$numberInt":"12170"},"sanitizedRegiestrationNumber":"00060445","productName":"SODIUM BICARBONATE 5% INJ 5GM/100ML USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SODIUM BICARBONATE"],"atcCode":["B05XA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f4"},"numbersOfAis":"1","activeIngredientName":["PHENOBARBITAL"],"dose":["30"],"productID":{"$numberInt":"1087"},"sanitizedRegiestrationNumber":"00023809","productName":"PHENOBARBITAL TAB 30MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PHENOBARBITAL","PHENOBARBITAL"],"atcCode":["N03AA02","N03AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENOBARBITAL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f5"},"numbersOfAis":"1","activeIngredientName":["WATER"],"dose":["30"],"productID":{"$numberInt":"117"},"sanitizedRegiestrationNumber":"00038202","productName":"BACTERIOSTATIC WATER FOR INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1952-12-31"],"sanitizedIndication":["SOLVENTS AND DILUTING AGENTS,INCL IRRIGAT SOLUT"],"atcCode":["V07AB"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WATER"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["ML"],"quantityNeedToTake":["30"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9ec"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.6"],"productID":{"$numberInt":"1253"},"sanitizedRegiestrationNumber":"00037621","productName":"NITROSTAT","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1972-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Sublingual"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f7"},"numbersOfAis":"8","activeIngredientName":["CALCIUM D-PANTOTHENATE","THIAMINE MONONITRATE","PYRIDOXINE HYDROCHLORIDE","VITAMIN B12","VITAMIN B2","IRON (FERROUS SULFATE)","NICOTINAMIDE","VITAMIN C"],"dose":["10","6","5","0.025","6","105","30","500"],"productID":{"$numberInt":"253"},"sanitizedRegiestrationNumber":"00039853","productName":"IBERET 500","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1965-12-31"],"sanitizedIndication":["IRON AND MULTIVITAMINS"],"atcCode":["B03AE03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM D-PANTOTHENATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["","","","","","","",""],"qunatityUnit":["","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f8"},"numbersOfAis":"1","activeIngredientName":["MEDROXYPROGESTERONE ACETATE"],"dose":["100"],"productID":{"$numberInt":"675"},"sanitizedRegiestrationNumber":"00030945","productName":"PROVERA 100MG TABLETS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1968-12-31"],"sanitizedIndication":["MEDROXYPROGESTERONE"],"atcCode":["G03DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEDROXYPROGESTERONE ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f9"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN (CLOXACILLIN SODIUM)"],"dose":["500"],"productID":{"$numberInt":"2234"},"sanitizedRegiestrationNumber":"00337773","productName":"TEVA-CLOXACILLIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1975-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN (CLOXACILLIN SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9fa"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["50"],"productID":{"$numberInt":"4043"},"sanitizedRegiestrationNumber":"00514012","productName":"VOLTAREN","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Delayed-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332d8a1cf2b8555cf9f1"},"numbersOfAis":"1","activeIngredientName":["MANNITOL"],"dose":["50"],"productID":{"$numberInt":"1742"},"sanitizedRegiestrationNumber":"00037982","productName":"MANNITOL INJ 5% ABBOVAC","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1963-12-31"],"sanitizedIndication":["MANNITOL"],"atcCode":["B05BC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MANNITOL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9fc"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["9"],"productID":{"$numberInt":"817"},"sanitizedRegiestrationNumber":"00037796","productName":"SODIUM CHLORIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05XA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intraperitoneal","Subcutaneous","Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9fd"},"numbersOfAis":"1","activeIngredientName":["DIAZEPAM"],"dose":["10"],"productID":{"$numberInt":"3179"},"sanitizedRegiestrationNumber":"00013293","productName":"VALIUM 10 TAB","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["DIAZEPAM"],"atcCode":["N05BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9fe"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN (ERYTHROMYCIN STEARATE)"],"dose":["250"],"productID":{"$numberInt":"705"},"sanitizedRegiestrationNumber":"00000434","productName":"ERYTHROCIN FILMTAB 250MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1955-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN (ERYTHROMYCIN STEARATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9ff"},"numbersOfAis":"1","activeIngredientName":["NORETHINDRONE ACETATE"],"dose":["5"],"productID":{"$numberInt":"1401"},"sanitizedRegiestrationNumber":"00023760","productName":"NORLUTATE","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1961-12-31"],"sanitizedIndication":["NORETHISTERONE"],"atcCode":["G03DC02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NORETHINDRONE ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9f6"},"numbersOfAis":"3","activeIngredientName":["SODIUM CHLORIDE","DEXTROSE","SODIUM LACTATE"],"dose":["300","2.5","310"],"productID":{"$numberInt":"10861"},"sanitizedRegiestrationNumber":"00060976","productName":"LACTATE CHLORIDE DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa01"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["1"],"productID":{"$numberInt":"2222"},"sanitizedRegiestrationNumber":"00030635","productName":"SOLU-CORTEF 1 GM ACT-O-VIAL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa02"},"numbersOfAis":"1","activeIngredientName":["THIORIDAZINE HYDROCHLORIDE"],"dose":["30"],"productID":{"$numberInt":"51885"},"sanitizedRegiestrationNumber":"00027359","productName":"MELLARIL","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1997-08-15"],"sanitizedIndication":["THIORIDAZINE"],"atcCode":["N05AC02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIORIDAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cf9fb"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN SODIUM"],"dose":["100"],"productID":{"$numberInt":"1037"},"sanitizedRegiestrationNumber":"00022780","productName":"DILANTIN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa03"},"numbersOfAis":"1","activeIngredientName":["HOMATROPINE HYDROBROMIDE"],"dose":["2"],"productID":{"$numberInt":"257"},"sanitizedRegiestrationNumber":"00000779","productName":"ISOPTO HOMATROPINE 2%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["HOMATROPINE"],"atcCode":["S01FA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HOMATROPINE HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa04"},"numbersOfAis":"1","activeIngredientName":["TETRACOSACTIDE"],"dose":["0.25"],"productID":{"$numberInt":"1954"},"sanitizedRegiestrationNumber":"00022381","productName":"CORTROSYN INJ 0.25MG","licenseHolderSponser":"AMPHASTAR PHARMACEUTICALS, INC.","companyCode":[{"$numberInt":"11482"}],"facilityAddress":" 11570 Sixth Street Rancho Cucamonga California United States 91730","countryOfOrigin":["United States"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1974-12-31"],"sanitizedIndication":["TETRACOSACTIDE","TETRACOSACTIDE"],"atcCode":["H01AA02","H01AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRACOSACTIDE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa00"},"numbersOfAis":"1","activeIngredientName":["DIHYDROERGOTAMINE MESYLATE"],"dose":["1"],"productID":{"$numberInt":"415"},"sanitizedRegiestrationNumber":"00027243","productName":"DIHYDROERGOTAMINE (DHE), 1MG/ML","licenseHolderSponser":"STERIMAX INC","companyCode":[{"$numberInt":"8892"}],"facilityAddress":" 2770 Portland Drive Oakville Ontario Canada L6H 6R4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["2046-12-31"],"sanitizedIndication":["DIHYDROERGOTAMINE"],"atcCode":["N02CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIHYDROERGOTAMINE MESYLATE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e38332e8a1cf2b8555cfa05"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE"],"dose":["16"],"productID":{"$numberInt":"1396"},"sanitizedRegiestrationNumber":"00036129","productName":"MEDROL 16 MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa06"},"numbersOfAis":"1","activeIngredientName":["BACITRACIN"],"dose":["50000"],"productID":{"$numberInt":"431"},"sanitizedRegiestrationNumber":"00030708","productName":"BACITRACIN USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["BACITRACIN","BACITRACIN"],"atcCode":["J01XX10","J01XX10"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BACITRACIN"],"sanitizedRouteOfAdministration":["Topical","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa07"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["5"],"productID":{"$numberInt":"11040"},"sanitizedRegiestrationNumber":"00060240","productName":"SODIUM CHLORIDE 5% INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05XA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa08"},"numbersOfAis":"1","activeIngredientName":["THYROID"],"dose":["125"],"productID":{"$numberInt":"774"},"sanitizedRegiestrationNumber":"00023965","productName":"THYROID TAB 125MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THYROID GLAND PREPARATIONS"],"atcCode":["H03AA05"],"pharmaceuticalStd":["CSD"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THYROID"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa09"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE"],"dose":["2.5","450"],"productID":{"$numberInt":"10925"},"sanitizedRegiestrationNumber":"00060720","productName":"DEXTROSE 2.5% AND SOD CHLORIDE 0.45% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0a"},"numbersOfAis":"1","activeIngredientName":["THIOPENTAL SODIUM"],"dose":["1"],"productID":{"$numberInt":"224"},"sanitizedRegiestrationNumber":"00038407","productName":"PENTOTHAL SODIUM INJ 1GM STERILE","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THIOPENTAL"],"atcCode":["N01AF03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOPENTAL SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0b"},"numbersOfAis":"2","activeIngredientName":["FLUMETHASONE PIVALATE","CLIOQUINOL"],"dose":["0.02","1"],"productID":{"$numberInt":"868"},"sanitizedRegiestrationNumber":"00074454","productName":"LOCACORTEN VIOFORM EARDROPS","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["FLUMETASONE AND ANTIINFECTIVES","FLUMETASONE AND ANTIINFECTIVES"],"atcCode":["S02CA02","S02CA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["FLUMETHASONE PIVALATE","Combination"],"sanitizedRouteOfAdministration":["Otic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0c"},"numbersOfAis":"1","activeIngredientName":["DEXTROSE"],"dose":["10"],"productID":{"$numberInt":"59976"},"sanitizedRegiestrationNumber":"00060364","productName":"10% DEXTROSE INJECTION, USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1997-08-13"],"sanitizedIndication":["CARBOHYDRATES"],"atcCode":["B05BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROSE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0d"},"numbersOfAis":"2","activeIngredientName":["SULFACETAMIDE SODIUM","PREDNISOLONE ACETATE"],"dose":["100","5"],"productID":{"$numberInt":"367"},"sanitizedRegiestrationNumber":"00177024","productName":"METIMYD OPH SUS","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1956-12-31"],"sanitizedIndication":["PREDNISOLONE AND ANTIINFECTIVES"],"atcCode":["S01CA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFACETAMIDE SODIUM","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0e"},"numbersOfAis":"1","activeIngredientName":["PROPYLTHIOURACIL"],"dose":["100"],"productID":{"$numberInt":"159"},"sanitizedRegiestrationNumber":"00010219","productName":"PROPYL-THYRACIL","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["2045-12-31"],"sanitizedIndication":["PROPYLTHIOURACIL"],"atcCode":["H03BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPYLTHIOURACIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa0f"},"numbersOfAis":"1","activeIngredientName":["CHLORPROPAMIDE"],"dose":["100"],"productID":{"$numberInt":"495"},"sanitizedRegiestrationNumber":"00024708","productName":"DIABINESE TAB 100MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["CHLORPROPAMIDE"],"atcCode":["A10BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROPAMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa10"},"numbersOfAis":"2","activeIngredientName":["HYDROCORTISONE","CLIOQUINOL"],"dose":["0.5","3"],"productID":{"$numberInt":"811"},"sanitizedRegiestrationNumber":"00074489","productName":"VIOFORM HYDROCORTISONE MILD","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["HYDROCORTISONE AND ANTIBIOTICS","HYDROCORTISONE AND ANTIBIOTICS"],"atcCode":["D07CA01","D07CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYDROCORTISONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa11"},"numbersOfAis":"1","activeIngredientName":["SULFAMETHAZINE SODIUM"],"dose":["12.5"],"productID":{"$numberInt":"133"},"sanitizedRegiestrationNumber":"00097187","productName":"SODIUM SULFAMETHAZINE SOLUTION 12.5%","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1955-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFAMETHAZINE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa12"},"numbersOfAis":"1","activeIngredientName":["DEXAMETHASONE"],"dose":["0.1"],"productID":{"$numberInt":"4591"},"sanitizedRegiestrationNumber":"00042579","productName":"MAXIDEX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1966-12-31"],"sanitizedIndication":["DEXAMETHASONE"],"atcCode":["S01BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXAMETHASONE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa13"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE"],"dose":["10","900"],"productID":{"$numberInt":"10441"},"sanitizedRegiestrationNumber":"00060755","productName":"DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES","ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02","B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa14"},"numbersOfAis":"1","activeIngredientName":["CARBACHOL"],"dose":[".01"],"productID":{"$numberInt":"3906"},"sanitizedRegiestrationNumber":"00042544","productName":"MIOSTAT OPHTHALMIC LIQ 0.01%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["CARBACHOL"],"atcCode":["S01EB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBACHOL"],"sanitizedRouteOfAdministration":["Intraocular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa15"},"numbersOfAis":"1","activeIngredientName":["ETHINYL ESTRADIOL"],"dose":[".02"],"productID":{"$numberInt":"357"},"sanitizedRegiestrationNumber":"00028215","productName":"ESTINYL TABLETS 0.02 MG.","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["ETHINYLESTRADIOL"],"atcCode":["G03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHINYL ESTRADIOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa16"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["300"],"productID":{"$numberInt":"425"},"sanitizedRegiestrationNumber":"00030732","productName":"LINCOCIN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["LINCOMYCIN"],"atcCode":["J01FF02"],"pharmaceuticalStd":["USP","PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa17"},"numbersOfAis":"1","activeIngredientName":["CADMIUM OXIDE"],"dose":["1.5"],"productID":{"$numberInt":"130"},"sanitizedRegiestrationNumber":"00097292","productName":"HOG DEWORMER 1.5%","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1955-12-31"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CADMIUM OXIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa18"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["100"],"productID":{"$numberInt":"4686"},"sanitizedRegiestrationNumber":"00162507","productName":"C ROLA TAB 100MG","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa19"},"numbersOfAis":"2","activeIngredientName":["TRIMEPRAZINE TARTRATE","PREDNISOLONE"],"dose":["5","2"],"productID":{"$numberInt":"1079"},"sanitizedRegiestrationNumber":"00170925","productName":"VANECTYL-P","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1965-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIMEPRAZINE TARTRATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1a"},"numbersOfAis":"1","activeIngredientName":["PREDNISONE"],"dose":["50"],"productID":{"$numberInt":"1286"},"sanitizedRegiestrationNumber":"00232378","productName":"TEVA-PREDNISONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1972-12-31"],"sanitizedIndication":["PREDNISONE"],"atcCode":["H02AB07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1b"},"numbersOfAis":"1","activeIngredientName":["NORETHINDRONE"],"dose":["0.35"],"productID":{"$numberInt":"1290"},"sanitizedRegiestrationNumber":"00037605","productName":"MICRONOR TABLETS 28-DAY","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1972-12-31"],"sanitizedIndication":["NORETHISTERONE"],"atcCode":["G03AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NORETHINDRONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1c"},"numbersOfAis":"2","activeIngredientName":["AMITRIPTYLINE HYDROCHLORIDE","PERPHENAZINE"],"dose":["25","4"],"productID":{"$numberInt":"362"},"sanitizedRegiestrationNumber":"00176974","productName":"ETRAFON F TAB","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1963-12-31"],"sanitizedIndication":["AMITRIPTYLINE AND PSYCHOLEPTICS","AMITRIPTYLINE AND PSYCHOLEPTICS"],"atcCode":["N06CA01","N06CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["AMITRIPTYLINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1d"},"numbersOfAis":"2","activeIngredientName":["VANILLYLNONAMIDE","NICOBOXIL"],"dose":["0.4","2.5"],"productID":{"$numberInt":"1556"},"sanitizedRegiestrationNumber":"00067423","productName":"FINALGON ONT","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1957-12-31"],"sanitizedIndication":["CAPSAICIN AND SIMILAR AGENTS"],"atcCode":["M02AB"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VANILLYLNONAMIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1e"},"numbersOfAis":"3","activeIngredientName":["RESERPINE","HYDROCHLOROTHIAZIDE","HYDRALAZINE HYDROCHLORIDE"],"dose":["0.1","15","25"],"productID":{"$numberInt":"118"},"sanitizedRegiestrationNumber":"00074608","productName":"SER-AP-ES TAB","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["RESERPINE  AND DIURETICS","RESERPINE  AND DIURETICS","RESERPINE  AND DIURETICS"],"atcCode":["C02LA01","C02LA01","C02LA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["RESERPINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa1f"},"numbersOfAis":"2","activeIngredientName":["PERPHENAZINE","AMITRIPTYLINE HYDROCHLORIDE"],"dose":["2","10"],"productID":{"$numberInt":"1490"},"sanitizedRegiestrationNumber":"00176931","productName":"ETRAFON 2 10","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["AMITRIPTYLINE AND PSYCHOLEPTICS","AMITRIPTYLINE AND PSYCHOLEPTICS"],"atcCode":["N06CA01","N06CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PERPHENAZINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa20"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE"],"dose":["20"],"productID":{"$numberInt":"433"},"sanitizedRegiestrationNumber":"00030929","productName":"CORTEF TABLETS 20 MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa21"},"numbersOfAis":"4","activeIngredientName":["CAFFEINE","ERGOTAMINE (ERGOTAMINE TARTRATE)","PENTOBARBITAL SODIUM","BELLADONNA"],"dose":["100","1","30","0.125"],"productID":{"$numberInt":"414"},"sanitizedRegiestrationNumber":"00176222","productName":"CAFERGOT PB TAB","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["ERGOTAMINE, COMBINATIONS WITH PSYCHOLEPTICS","ERGOTAMINE, COMBINATIONS WITH PSYCHOLEPTICS"],"atcCode":["N02CA72","N02CA72"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAFFEINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa22"},"numbersOfAis":"1","activeIngredientName":["GENTAMICIN SULFATE"],"dose":["40"],"productID":{"$numberInt":"1204"},"sanitizedRegiestrationNumber":"00223824","productName":"GARAMYCIN INJ 40MG/ML","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["GENTAMICIN"],"atcCode":["J01GB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GENTAMICIN SULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa23"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["5"],"productID":{"$numberInt":"514"},"sanitizedRegiestrationNumber":"00158305","productName":"BETADINE AEROSOL SPRAY 5%","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1967-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa24"},"numbersOfAis":"1","activeIngredientName":["TYLOSIN (TYLOSIN TARTRATE)"],"dose":["100"],"productID":{"$numberInt":"148"},"sanitizedRegiestrationNumber":"00103616","productName":"TYLAN SOLUBLE","licenseHolderSponser":"ELANCO CANADA LIMITED","companyCode":[{"$numberInt":"16571"}],"facilityAddress":"120 150 Research Lane Guelph Ontario Canada N1G 4T2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1962-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TYLOSIN (TYLOSIN TARTRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["JAR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa25"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["75"],"productID":{"$numberInt":"3837"},"sanitizedRegiestrationNumber":"00038083","productName":"SODIUM BICARBONATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["SODIUM BICARBONATE"],"atcCode":["B05XA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa26"},"numbersOfAis":"1","activeIngredientName":["EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"940"},"sanitizedRegiestrationNumber":"00155357","productName":"ADRENALIN CHLORIDE SOL 1:1000 AMP","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["EPINEPHRINE"],"atcCode":["C01CA24"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa27"},"numbersOfAis":"1","activeIngredientName":["KETAMINE (KETAMINE HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"1215"},"sanitizedRegiestrationNumber":"00224405","productName":"KETALAR","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1972-12-31"],"sanitizedIndication":["KETAMINE"],"atcCode":["N01AX03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["KETAMINE (KETAMINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa28"},"numbersOfAis":"2","activeIngredientName":["VITAMIN C","SODIUM ASCORBATE"],"dose":["40","67.5"],"productID":{"$numberInt":"1661"},"sanitizedRegiestrationNumber":"00266043","productName":"VITAMIN C TAB 100MG CHEWABLE","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN C","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa29"},"numbersOfAis":"1","activeIngredientName":["ORCIPRENALINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"1496"},"sanitizedRegiestrationNumber":"00249920","productName":"ALUPENT SYR 10MG/5.0ML","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1972-12-31"],"sanitizedIndication":["ORCIPRENALINE"],"atcCode":["R03CB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ORCIPRENALINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2a"},"numbersOfAis":"3","activeIngredientName":["CHLOROBUTANOL","SODIUM PHOSPHATE DIBASIC","POTASSIUM PHOSPHATE MONOBASIC"],"dose":["1.41875","35.69575","34.3905"],"productID":{"$numberInt":"1958"},"sanitizedRegiestrationNumber":"00313467","productName":"NEUTRALITE LIQ","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLOROBUTANOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["Kg","Kg","Kg"],"quantityNeedToTake":["576","576","576"],"qunatityUnit":["L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2b"},"numbersOfAis":"11","activeIngredientName":["PREDNISONE","PHENIRAMINE MALEATE","FATTY ACIDS UNSATURATED","RETINOL PALMITATE","VITAMIN D2","VITAMIN E","BIOTIN","INOSITOL","VITAMIN B2","NICOTINIC ACID","PHOSPHATIDYL CHOLINE"],"dose":["20","4","86","35000","500","35","10","10","10","20","1"],"productID":{"$numberInt":"562"},"sanitizedRegiestrationNumber":"00217468","productName":"STEROLIN LIQ","licenseHolderSponser":"ORMOND VETERINARY SUPPLY LTD.","companyCode":[{"$numberInt":"4863"}],"facilityAddress":" 574 Shaver Road Ancaster Ontario Canada L9G 3K9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PREDNISONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","%","UNIT","UNIT","UNIT","MCG","MG","MG","MG","MG"],"quantityNeedToTake":["30","30","30","30","30","30","30","30","30","30","30"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2c"},"numbersOfAis":"2","activeIngredientName":["NEOMYCIN SULFATE","HYDROCORTISONE ACETATE"],"dose":["0.5","1"],"productID":{"$numberInt":"429"},"sanitizedRegiestrationNumber":"00194913","productName":"NEO-CORTEF 1%  OINTMENT","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1954-12-31"],"sanitizedIndication":["HYDROCORTISONE AND ANTIBIOTICS","HYDROCORTISONE AND ANTIBIOTICS"],"atcCode":["D07CA01","D07CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NEOMYCIN SULFATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2d"},"numbersOfAis":"1","activeIngredientName":["ACETYLSALICYLIC ACID"],"dose":["650"],"productID":{"$numberInt":"2410"},"sanitizedRegiestrationNumber":"00229296","productName":"NOVASEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet (Delayed-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1976-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID"],"atcCode":["N02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETYLSALICYLIC ACID"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2e"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE (EPINEPHRINE BITARTRATE)"],"dose":["20","5"],"productID":{"$numberInt":"1830"},"sanitizedRegiestrationNumber":"00284106","productName":"XYLOCAINE 2% W EPINEPHRINE 1:200000","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1965-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Epidural"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa2f"},"numbersOfAis":"1","activeIngredientName":["CRYOFLUORANE"],"dose":["99.95"],"productID":{"$numberInt":"2774"},"sanitizedRegiestrationNumber":"00319244","productName":"PHARMAETHYL AER","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CRYOFLUORANE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa30"},"numbersOfAis":"2","activeIngredientName":["VITAMIN D","VITAMIN A"],"dose":["213","1500"],"productID":{"$numberInt":"1306"},"sanitizedRegiestrationNumber":"00233048","productName":"A AND D OINTMENT","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["COD-LIVER OIL OINTMENTS"],"atcCode":["D03AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa31"},"numbersOfAis":"3","activeIngredientName":["DEXAMETHASONE","NEOMYCIN (NEOMYCIN SULFATE)","POLYMYXIN B SULFATE"],"dose":["0.1","3.5","6000"],"productID":{"$numberInt":"2423"},"sanitizedRegiestrationNumber":"00358177","productName":"MAXITROL","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-31"],"sanitizedIndication":["DEXAMETHASONE AND ANTIINFECTIVES","DEXAMETHASONE AND ANTIINFECTIVES"],"atcCode":["S01CA01","S01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXAMETHASONE","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["","",""],"qunatityUnit":["W/W","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa32"},"numbersOfAis":"1","activeIngredientName":["HYDROCHLOROTHIAZIDE"],"dose":["25"],"productID":{"$numberInt":"1723"},"sanitizedRegiestrationNumber":"00263893","productName":"UROZIDE","licenseHolderSponser":"BIOMED PHARMA","companyCode":[{"$numberInt":"10997"}],"facilityAddress":" 9450  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1985-10-18"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE"],"atcCode":["C03AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCHLOROTHIAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa33"},"numbersOfAis":"2","activeIngredientName":["MENTHOL","EUCALYPTUS OIL"],"dose":[".4",".3"],"productID":{"$numberInt":"41474"},"sanitizedRegiestrationNumber":"00374571","productName":"MENTHOLATUM COUGH DROPS","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Lozenge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1974-12-31"],"sanitizedIndication":["Other cold preparations"],"atcCode":["R05X"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MENTHOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["1"],"qunatityUnit":["LOZ","LOZ"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa34"},"numbersOfAis":"2","activeIngredientName":["ETHYNODIOL DIACETATE","ETHINYL ESTRADIOL"],"dose":["1","50"],"productID":{"$numberInt":"2157"},"sanitizedRegiestrationNumber":"00343536","productName":"DEMULEN 50 (28 DAY PACK)","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ETYNODIOL AND ESTROGEN"],"atcCode":["G03AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ETHYNODIOL DIACETATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa35"},"numbersOfAis":"18","activeIngredientName":["HISTIDINE","GLYCINE","SODIUM ACETATE","LEUCINE","VALINE","ALANINE","TYROSINE","SODIUM CHLORIDE","METHIONINE","ISOLEUCINE","TRYPTOPHAN","PROLINE","L-LYSINE (L-LYSINE HYDROCHLORIDE)","THREONINE","ARGININE","MAGNESIUM CHLORIDE","POTASSIUM PHOSPHATE DIBASIC","PHENYLALANINE"],"dose":["440","2.08","680","620","460","2.08","40","117","580","480","180","420","580","420","1.04","102","522","620"],"productID":{"$numberInt":"1888"},"sanitizedRegiestrationNumber":"00285528","productName":"TRAVASOL E","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1974-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HISTIDINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa36"},"numbersOfAis":"1","activeIngredientName":["CLORAZEPATE DIPOTASSIUM"],"dose":["3.75"],"productID":{"$numberInt":"1655"},"sanitizedRegiestrationNumber":"00264938","productName":"TRANXENE CAP 3.75MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["CLORAZEPATE POTASSIUM"],"atcCode":["N05BA05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLORAZEPATE DIPOTASSIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa37"},"numbersOfAis":"2","activeIngredientName":["VITAMIN C","IRON (FERROUS SULFATE)"],"dose":["500","105"],"productID":{"$numberInt":"252"},"sanitizedRegiestrationNumber":"00039217","productName":"FERO GRAD 500","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["FERROUS SULPHATE"],"atcCode":["B03AD03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN C","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa38"},"numbersOfAis":"1","activeIngredientName":["TROMETAMOL"],"dose":["36"],"productID":{"$numberInt":"1731"},"sanitizedRegiestrationNumber":"00244287","productName":"THAM SOLUTION 36MG/ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1972-12-31"],"sanitizedIndication":["TROMETAMOL"],"atcCode":["B05XX02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TROMETAMOL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa39"},"numbersOfAis":"1","activeIngredientName":["CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"1295"},"sanitizedRegiestrationNumber":"00232831","productName":"TEVA-CHLORPROMAZINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["CHLORPROMAZINE"],"atcCode":["N05AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3a"},"numbersOfAis":"7","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","SODIUM ACETATE","POTASSIUM ACETATE","SODIUM BISULFITE"],"dose":["250","4.59","270","490","4.68","900","1.8"],"productID":{"$numberInt":"1615"},"sanitizedRegiestrationNumber":"00260118","productName":"SUPERDEX 50% INJ","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1953-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intraperitoneal","Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","MG","MG","G","MG","G"],"quantityNeedToTake":["500","500","500","500","500","500","500"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3b"},"numbersOfAis":"1","activeIngredientName":["PHENYLBUTAZONE"],"dose":["100"],"productID":{"$numberInt":"2407"},"sanitizedRegiestrationNumber":"00312789","productName":"APO PHENYLBUTAZONE TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["PHENYLBUTAZONE"],"atcCode":["M01AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYLBUTAZONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3c"},"numbersOfAis":"5","activeIngredientName":["POTASSIUM CHLORIDE","SODIUM LACTATE","POTASSIUM PHOSPHATE MONOBASIC","DEXTROSE","SODIUM CHLORIDE"],"dose":["205","220","100","5","120"],"productID":{"$numberInt":"11037"},"sanitizedRegiestrationNumber":"00261335","productName":"DEXTROSE 5% AND ELECTROLYTE NO75 INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","G","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3d"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["20"],"productID":{"$numberInt":"2798"},"sanitizedRegiestrationNumber":"00396788","productName":"APO FUROSEMIDE TAB 20MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1977-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3e"},"numbersOfAis":"1","activeIngredientName":["CHLORPROMAZINE HYDROCHLORIDE"],"dose":["111.4"],"productID":{"$numberInt":"2363"},"sanitizedRegiestrationNumber":"00312681","productName":"APO CHLORPROMAZINE","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["CHLORPROMAZINE"],"atcCode":["N05AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROMAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa3f"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["42"],"productID":{"$numberInt":"8350"},"sanitizedRegiestrationNumber":"00261971","productName":"SODIUM BICARBONATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["SODIUM BICARBONATE"],"atcCode":["B05XA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa40"},"numbersOfAis":"1","activeIngredientName":["SUCCINYLCHOLINE CHLORIDE"],"dose":["20"],"productID":{"$numberInt":"227"},"sanitizedRegiestrationNumber":"00038172","productName":"QUELICIN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1952-12-31"],"sanitizedIndication":["SUXAMETHONIUM"],"atcCode":["M03AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SUCCINYLCHOLINE CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa41"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE ACETATE"],"dose":["1"],"productID":{"$numberInt":"89"},"sanitizedRegiestrationNumber":"00053201","productName":"HIBITANE","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1955-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE ACETATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa42"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["450"],"productID":{"$numberInt":"10442"},"sanitizedRegiestrationNumber":"00060186","productName":"SODIUM CHLORIDE 0.45% INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05XA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa43"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["5"],"productID":{"$numberInt":"8171"},"sanitizedRegiestrationNumber":"00396834","productName":"APO-HALOPERIDOL TAB 5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa44"},"numbersOfAis":"1","activeIngredientName":["ZINC (ZINC GLUCONATE)"],"dose":["10"],"productID":{"$numberInt":"2729"},"sanitizedRegiestrationNumber":"00405094","productName":"ZINC GLUCONATE TAB 10MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["ZINC GLUCONATE"],"atcCode":["A12CB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZINC (ZINC GLUCONATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa45"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["20"],"productID":{"$numberInt":"2333"},"sanitizedRegiestrationNumber":"00337730","productName":"TEVA-FUROSEMIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1976-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa46"},"numbersOfAis":"2","activeIngredientName":["CARBIDOPA","LEVODOPA"],"dose":["25","250"],"productID":{"$numberInt":"2142"},"sanitizedRegiestrationNumber":"00328219","productName":"SINEMET 250/25","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1975-12-31"],"sanitizedIndication":["LEVODOPA AND DECARBOXYLASE INHIBITOR"],"atcCode":["N04BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBIDOPA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa47"},"numbersOfAis":"2","activeIngredientName":["TRIMETHOPRIM","SULFAMETHOXAZOLE"],"dose":["80","400"],"productID":{"$numberInt":"1804"},"sanitizedRegiestrationNumber":"00272469","productName":"BACTRIM ROCHE TAB","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["SULFAMETHOXAZOLE AND TRIMETHOPRIM"],"atcCode":["J01EE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIMETHOPRIM","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa48"},"numbersOfAis":"6","activeIngredientName":["VITAMIN B1","VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM)","PYRIDOXINE HYDROCHLORIDE","NICOTINAMIDE","DEXPANTHENOL","LIDOCAINE HYDROCHLORIDE"],"dose":["50","7.5","2","75","10","2.0"],"productID":{"$numberInt":"31"},"sanitizedRegiestrationNumber":"00147680","productName":"NEO-BEX INJECTABLE","licenseHolderSponser":"BROSTEL INC.","companyCode":[{"$numberInt":"14058"}],"facilityAddress":" 1688 - 50e Avenue Lachine Quebec Canada H8T 2V5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1951-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, OTHER COMBINATIONS"],"atcCode":["A11EX"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B1","Combination"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa49"},"numbersOfAis":"1","activeIngredientName":["CARBACHOL"],"dose":["1.5"],"productID":{"$numberInt":"575"},"sanitizedRegiestrationNumber":"00000655","productName":"ISOPTO CARBACHOL 1.5%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["CARBACHOL"],"atcCode":["S01EB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBACHOL"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4a"},"numbersOfAis":"1","activeIngredientName":["FERROUS FUMARATE"],"dose":["200"],"productID":{"$numberInt":"2875"},"sanitizedRegiestrationNumber":"00415030","productName":"FERROUS FUMARATE TAB 200MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["FERROUS FUMARATE"],"atcCode":["B03AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FERROUS FUMARATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4b"},"numbersOfAis":"1","activeIngredientName":["CHLORAMPHENICOL (CHLORAMPHENICOL SODIUM SUCCINATE)"],"dose":["1"],"productID":{"$numberInt":"2789"},"sanitizedRegiestrationNumber":"00312363","productName":"CHLOROMYCETIN SUCCINATE INJECTION 1GM","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["CHLORAMPHENICOL"],"atcCode":["J01BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORAMPHENICOL (CHLORAMPHENICOL SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4c"},"numbersOfAis":"1","activeIngredientName":["ATROPINE SULFATE"],"dose":["0.4"],"productID":{"$numberInt":"3554"},"sanitizedRegiestrationNumber":"00392782","productName":"ATROPINE SULFATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["ATROPINE"],"atcCode":["A03BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATROPINE SULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4d"},"numbersOfAis":"14","activeIngredientName":["GLYCINE","TYROSINE","METHIONINE","VALINE","TRYPTOPHAN","ARGININE","LEUCINE","L-LYSINE HYDROCHLORIDE","HISTIDINE","L-ALANINE","PROLINE","PHENYLALANINE","ISOLEUCINE","THREONINE"],"dose":["1.14","22","318","252","99","570","340","318","241","1.14","230","340","263","230"],"productID":{"$numberInt":"3131"},"sanitizedRegiestrationNumber":"00388742","productName":"TRAVASOL INJ WITHOUT ELECTROLYTES 5.5%","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLYCINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4e"},"numbersOfAis":"1","activeIngredientName":["ETHCHLORVYNOL"],"dose":["200"],"productID":{"$numberInt":"225"},"sanitizedRegiestrationNumber":"00000019","productName":"PLACIDYL CAP 200MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1956-12-31"],"sanitizedIndication":["ETHCHLORVYNOL"],"atcCode":["N05CM08"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHCHLORVYNOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa4f"},"numbersOfAis":"1","activeIngredientName":["PETROLATUM"],"dose":["100"],"productID":{"$numberInt":"2162"},"sanitizedRegiestrationNumber":"00336858","productName":"PETROLATUM BLANC U.S.P.","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1975-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PETROLATUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa50"},"numbersOfAis":"1","activeIngredientName":["OXAZEPAM"],"dose":["30"],"productID":{"$numberInt":"3464"},"sanitizedRegiestrationNumber":"00402737","productName":"APO OXAZEPAM TAB 30MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["OXAZEPAM"],"atcCode":["N05BA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa51"},"numbersOfAis":"1","activeIngredientName":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"5072"},"sanitizedRegiestrationNumber":"00342092","productName":"TEVA-CEPHALEXIN 250","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["CEFALEXIN"],"atcCode":["J01DB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa52"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"2272"},"sanitizedRegiestrationNumber":"00344923","productName":"DIPROSONE OINTMENT","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1976-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa53"},"numbersOfAis":"1","activeIngredientName":["CHLORTHALIDONE"],"dose":["100"],"productID":{"$numberInt":"2468"},"sanitizedRegiestrationNumber":"00360287","productName":"APO CHLORTHALIDONE TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["CHLORTALIDONE"],"atcCode":["C03BA04"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORTHALIDONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa54"},"numbersOfAis":"1","activeIngredientName":["MITOMYCIN"],"dose":["0.5"],"productID":{"$numberInt":"2628"},"sanitizedRegiestrationNumber":"00381799","productName":"MUTAMYCIN INJ 5MG/VIAL","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["MITOMYCIN"],"atcCode":["L01DC03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MITOMYCIN"],"sanitizedRouteOfAdministration":["Intravenous","Intravesical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa55"},"numbersOfAis":"5","activeIngredientName":["METHYL SALICYLATE","CLOVE OIL","CHLOROBUTANOL","CINNAMALDEHYDE","CINNAMON OIL"],"dose":["2.5","63.4","38.3","5","5"],"productID":{"$numberInt":"1291"},"sanitizedRegiestrationNumber":"00232661","productName":"DSO DRESSING","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1963-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["METHYL SALICYLATE","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["ML","ML","G","ML","ML"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa56"},"numbersOfAis":"4","activeIngredientName":["CAMPHOR","PARACHLOROPHENOL","PARAFORMALDEHYDE","LIDOCAINE"],"dose":["1.56",".96","2.16","4.32"],"productID":{"$numberInt":"1249"},"sanitizedRegiestrationNumber":"00229644","productName":"CAUSTINERF","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1972-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["A01AD11"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAMPHOR","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa57"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["2.5"],"productID":{"$numberInt":"2896"},"sanitizedRegiestrationNumber":"00406813","productName":"ACETOXYL 2.5 GEL","licenseHolderSponser":"VALEO PHARMA INC","companyCode":[{"$numberInt":"11211"}],"facilityAddress":" 16667 Hymus Blvd. Kirkland Quebec Canada H9H 4R9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa58"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM HYDROXIDE"],"dose":["400"],"productID":{"$numberInt":"4595"},"sanitizedRegiestrationNumber":"00417904","productName":"MILK OF MAGNESIA","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["MAGNESIUM HYDROXIDE","MAGNESIUM HYDROXIDE"],"atcCode":["A02AA04","A02AA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM HYDROXIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa59"},"numbersOfAis":"7","activeIngredientName":["VITAMIN B12","VITAMIN C","CALCIUM D-PANTOTHENATE","THIAMINE MONONITRATE","VITAMIN B2","NICOTINAMIDE","PYRIDOXINE HYDROCHLORIDE"],"dose":["10","300","20","35","15","50","5"],"productID":{"$numberInt":"6270"},"sanitizedRegiestrationNumber":"00414832","productName":"B COMPLEX W VITAMIN C FORTIS CAP","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX WITH VITAMIN C","VITAMIN B-COMPLEX WITH VITAMIN C"],"atcCode":["A11EB","A11EB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B12","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP","CAP","CAP","CAP","CAP","CAP","CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5a"},"numbersOfAis":"3","activeIngredientName":["GUAIACOL CARBONATE","DIPHENYLPYRALINE HYDROCHLORIDE","CAMPHOR"],"dose":["600","1.5","5"],"productID":{"$numberInt":"2148"},"sanitizedRegiestrationNumber":"00299561","productName":"CREO-RECTAL ADULTE","licenseHolderSponser":"LABORATOIRES CONFAB INC","companyCode":[{"$numberInt":"6837"}],"facilityAddress":" 4355 Boul. Sir Wilfrid Laurier St-Hubert Quebec Canada J3Y 3X3","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R05CA10"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GUAIACOL CARBONATE","Combination"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Label (Biological)| Import (Active Pharmaceutical Ingredients)| Fabricate (Biological)| Package (Pharmaceutical)| Package (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5b"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["100"],"productID":{"$numberInt":"6049"},"sanitizedRegiestrationNumber":"00369810","productName":"TEGRETOL CHEWTABS 100 MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Chewable)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5c"},"numbersOfAis":"2","activeIngredientName":["LEVODOPA","BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)"],"dose":["100","25"],"productID":{"$numberInt":"2723"},"sanitizedRegiestrationNumber":"00386464","productName":"PROLOPA CAP 100-25","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1977-12-31"],"sanitizedIndication":["LEVODOPA AND DECARBOXYLASE INHIBITOR"],"atcCode":["N04BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LEVODOPA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5d"},"numbersOfAis":"3","activeIngredientName":["VITAMIN A","CALCIUM (CALCIUM PHOSPHATE (DIBASIC))","VITAMIN D"],"dose":["2500","170","133"],"productID":{"$numberInt":"2887"},"sanitizedRegiestrationNumber":"00257834","productName":"AD & CALCIUM CAP","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN A","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5e"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["100"],"productID":{"$numberInt":"4286"},"sanitizedRegiestrationNumber":"00516848","productName":"MYCLO TAB 100MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["G01AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa5f"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"dose":["200"],"productID":{"$numberInt":"6649"},"sanitizedRegiestrationNumber":"00287938","productName":"VITAMIN E CAP USP 200IU","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["TOCOPHEROL (VIT E)"],"atcCode":["A11HA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa60"},"numbersOfAis":"1","activeIngredientName":["FLUPHENAZINE HYDROCHLORIDE"],"dose":["2.5"],"productID":{"$numberInt":"2859"},"sanitizedRegiestrationNumber":"00405353","productName":"APO FLUPHENAZINE TAB 2.5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["FLUPHENAZINE"],"atcCode":["N05AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUPHENAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa61"},"numbersOfAis":"1","activeIngredientName":["INSULIN (PORK)"],"dose":["100"],"productID":{"$numberInt":"4153"},"sanitizedRegiestrationNumber":"00513644","productName":"REGULAR PURIFIED PORK INSULIN INJ","licenseHolderSponser":"ELI LILLY AND COMPANY LIMITED","companyCode":[{"$numberInt":"4501"}],"facilityAddress":" Lilly Corporate Center, Building 100/328 Indianapolis Indiana United States 46285","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["INSULIN (PORK)"],"atcCode":["A10AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INSULIN (PORK)"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Fabricate (Pharmaceutical)| Label (Biological)| Label (Pharmaceutical)| Package (Biological)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa62"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"dose":["400"],"productID":{"$numberInt":"3541"},"sanitizedRegiestrationNumber":"00417580","productName":"VITAMIN E CAP 400UNIT","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["TOCOPHEROL (VIT E)"],"atcCode":["A11HA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa63"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["4"],"productID":{"$numberInt":"1436"},"sanitizedRegiestrationNumber":"00245097","productName":"HIBITANE SKIN CLEANSER","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1972-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa64"},"numbersOfAis":"1","activeIngredientName":["OXPRENOLOL HYDROCHLORIDE"],"dose":["40"],"productID":{"$numberInt":"3904"},"sanitizedRegiestrationNumber":"00402575","productName":"TRASICOR TAB 40MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["OXPRENOLOL"],"atcCode":["C07AA02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXPRENOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa65"},"numbersOfAis":"1","activeIngredientName":["DIMENHYDRINATE"],"dose":["50"],"productID":{"$numberInt":"3213"},"sanitizedRegiestrationNumber":"00415049","productName":"TRAVELMATE TAB 50MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["OTHER ANTIEMETICS"],"atcCode":["A04AD"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIMENHYDRINATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa66"},"numbersOfAis":"1","activeIngredientName":["BROMAZEPAM"],"dose":["3"],"productID":{"$numberInt":"4157"},"sanitizedRegiestrationNumber":"00518123","productName":"LECTOPAM TAB 3MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["BROMAZEPAM"],"atcCode":["N05BA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BROMAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa67"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B12"],"dose":["1000"],"productID":{"$numberInt":"4432"},"sanitizedRegiestrationNumber":"00521515","productName":"VITAMIN B12","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1978-12-31"],"sanitizedIndication":["CYANOCOBALAMIN"],"atcCode":["B03BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B12"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa68"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["250"],"productID":{"$numberInt":"2477"},"sanitizedRegiestrationNumber":"00375055","productName":"VIT C TAB 250MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa69"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","SODIUM GLUCONATE","MAGNESIUM CHLORIDE","DEXTROSE","SODIUM ACETATE","POTASSIUM CHLORIDE"],"dose":["526","502","30","5","368","37"],"productID":{"$numberInt":"1623"},"sanitizedRegiestrationNumber":"00260592","productName":"PLASMALYTE 148 IN 5% DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","G","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6a"},"numbersOfAis":"1","activeIngredientName":["FERROUS GLUCONATE"],"dose":["300"],"productID":{"$numberInt":"2804"},"sanitizedRegiestrationNumber":"00414913","productName":"FERROUS GLUCONATE TAB 300MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["FERROUS GLUCONATE"],"atcCode":["B03AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FERROUS GLUCONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6b"},"numbersOfAis":"2","activeIngredientName":["SPIRONOLACTONE","HYDROCHLOROTHIAZIDE"],"dose":["25","25"],"productID":{"$numberInt":"11941"},"sanitizedRegiestrationNumber":"00520802","productName":"APO-SPIROZIDE TAB","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SPIRONOLACTONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6c"},"numbersOfAis":"1","activeIngredientName":["FLURAZEPAM HYDROCHLORIDE"],"dose":["30"],"productID":{"$numberInt":"4546"},"sanitizedRegiestrationNumber":"00414239","productName":"SOM-PAM","licenseHolderSponser":"BIOMED PHARMA","companyCode":[{"$numberInt":"10997"}],"facilityAddress":" 9450  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Dormant"],"registrationDate":["1981-12-31"],"sanitizedIndication":["FLURAZEPAM"],"atcCode":["N05CD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLURAZEPAM HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6d"},"numbersOfAis":"1","activeIngredientName":["INSULIN"],"dose":["100"],"productID":{"$numberInt":"4154"},"sanitizedRegiestrationNumber":"00514535","productName":"LENTE PURIFIED PORK INSULIN INJ","licenseHolderSponser":"ELI LILLY AND COMPANY LIMITED","companyCode":[{"$numberInt":"4501"}],"facilityAddress":" Lilly Corporate Center, Building 100/328 Indianapolis Indiana United States 46285","countryOfOrigin":["United States"],"format":["Suspension (Lente)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["INSULIN (PORK)"],"atcCode":["A10AC03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INSULIN"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Fabricate (Pharmaceutical)| Label (Biological)| Label (Pharmaceutical)| Package (Biological)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6e"},"numbersOfAis":"1","activeIngredientName":["MINOXIDIL"],"dose":["10"],"productID":{"$numberInt":"4010"},"sanitizedRegiestrationNumber":"00514500","productName":"LONITEN 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["MINOXIDIL"],"atcCode":["C02DC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MINOXIDIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa6f"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN STEARATE"],"dose":["50"],"productID":{"$numberInt":"1727"},"sanitizedRegiestrationNumber":"00273023","productName":"ERYTHROCIN LIQ 250","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN STEARATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa70"},"numbersOfAis":"1","activeIngredientName":["NAPHAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"2634"},"sanitizedRegiestrationNumber":"00390283","productName":"NAPHCON FORTE","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["NAPHAZOLINE"],"atcCode":["S01GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPHAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa71"},"numbersOfAis":"1","activeIngredientName":["CLONIDINE HYDROCHLORIDE"],"dose":["0.2"],"productID":{"$numberInt":"1943"},"sanitizedRegiestrationNumber":"00291889","productName":"CATAPRES TAB 0.2MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1974-12-31"],"sanitizedIndication":["CLONIDINE"],"atcCode":["C02AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLONIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa72"},"numbersOfAis":"1","activeIngredientName":["CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)"],"dose":["150"],"productID":{"$numberInt":"1620"},"sanitizedRegiestrationNumber":"00260436","productName":"DALACIN C PHOSPHATE","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1973-12-31"],"sanitizedIndication":["CLINDAMYCIN"],"atcCode":["J01FF01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa73"},"numbersOfAis":"1","activeIngredientName":["AMITRIPTYLINE HYDROCHLORIDE"],"dose":["75"],"productID":{"$numberInt":"3413"},"sanitizedRegiestrationNumber":"00405612","productName":"LEVATE","licenseHolderSponser":"BIOMED PHARMA","companyCode":[{"$numberInt":"10997"}],"facilityAddress":" 9450  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["AMITRIPTYLINE"],"atcCode":["N06AA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMITRIPTYLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa74"},"numbersOfAis":"1","activeIngredientName":["ATROPINE SULFATE"],"dose":["1"],"productID":{"$numberInt":"1529"},"sanitizedRegiestrationNumber":"00252484","productName":"ATROPINE ONT 1%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1972-12-31"],"sanitizedIndication":["ATROPINE"],"atcCode":["S01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATROPINE SULFATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa75"},"numbersOfAis":"1","activeIngredientName":["INDOMETHACIN"],"dose":["25"],"productID":{"$numberInt":"4129"},"sanitizedRegiestrationNumber":"00337420","productName":"TEVA-INDOMETHACIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["INDOMETACIN"],"atcCode":["M01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INDOMETHACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa76"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["500"],"productID":{"$numberInt":"2032"},"sanitizedRegiestrationNumber":"00316873","productName":"VITAMIN C TAB 500MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1974-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa77"},"numbersOfAis":"5","activeIngredientName":["EUGENOL","ZINC ACETATE","BISMUTH SUBCARBONATE (OXYCARBONATE)","ZINC OXIDE","POLYSTYRENE"],"dose":["90","2.8","4.8","92.2","10"],"productID":{"$numberInt":"1279"},"sanitizedRegiestrationNumber":"00231827","productName":"TEMPRA CEMENT POWDER AND TEMPRA POLY LIQUID","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Powder","Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1971-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["EUGENOL","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["ML","G","G","G","ML"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["G","G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa78"},"numbersOfAis":"1","activeIngredientName":["SUCCINYLCHOLINE CHLORIDE"],"dose":["100"],"productID":{"$numberInt":"5295"},"sanitizedRegiestrationNumber":"00296163","productName":"QUELICIN CHLORIDE INJ 100MG/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["SUXAMETHONIUM"],"atcCode":["M03AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SUCCINYLCHOLINE CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa79"},"numbersOfAis":"1","activeIngredientName":["TRIAZOLAM"],"dose":["0.125"],"productID":{"$numberInt":"4065"},"sanitizedRegiestrationNumber":"00512559","productName":"HALCION","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["TRIAZOLAM"],"atcCode":["N05CD05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7a"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["4"],"productID":{"$numberInt":"5940"},"sanitizedRegiestrationNumber":"00125121","productName":"DILAUDID","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7b"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["50"],"productID":{"$numberInt":"4284"},"sanitizedRegiestrationNumber":"00516813","productName":"MYCLO CRM 50MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["G01AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7c"},"numbersOfAis":"1","activeIngredientName":["OXYCODONE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"3550"},"sanitizedRegiestrationNumber":"00392472","productName":"SUPEUDOL 20","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1973-12-31"],"sanitizedIndication":["OXYCODONE"],"atcCode":["N02AA05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYCODONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7d"},"numbersOfAis":"1","activeIngredientName":["DIAZEPAM"],"dose":["10"],"productID":{"$numberInt":"3721"},"sanitizedRegiestrationNumber":"00399728","productName":"DIAZEPAM INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["DIAZEPAM"],"atcCode":["N05BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIAZEPAM"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["2"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7e"},"numbersOfAis":"1","activeIngredientName":["BENZALKONIUM CHLORIDE"],"dose":[".1"],"productID":{"$numberInt":"2171"},"sanitizedRegiestrationNumber":"00319589","productName":"STING STOP 0.1%","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-11-04"],"sanitizedIndication":["BENZALKONIUM"],"atcCode":["D08AJ01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZALKONIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa7f"},"numbersOfAis":"1","activeIngredientName":["PHENYLBUTAZONE"],"dose":["1"],"productID":{"$numberInt":"1503"},"sanitizedRegiestrationNumber":"00250368","productName":"PHENYLBUTAZONE TAB 1000MG","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYLBUTAZONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa80"},"numbersOfAis":"1","activeIngredientName":["CALCIUM GLUCONATE"],"dose":["650"],"productID":{"$numberInt":"2944"},"sanitizedRegiestrationNumber":"00415103","productName":"CALCIUM GLUCONATE TAB 650MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["CALCIUM GLUCONATE"],"atcCode":["A12AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM GLUCONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa81"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"44402"},"sanitizedRegiestrationNumber":"00246026","productName":"VIBRAMYCIN INJ","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":["621027051334"],"unit":["Mg"],"type":["Vial"],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1997-07-25"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":["10"],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa82"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"dose":["36","18"],"productID":{"$numberInt":"2541"},"sanitizedRegiestrationNumber":"00375780","productName":"LIGNOSPAN STANDARD","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1976-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1.8","1.8"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa83"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["250"],"productID":{"$numberInt":"4100"},"sanitizedRegiestrationNumber":"00517070","productName":"CENTRAVITE C INJ 250MG/ML","licenseHolderSponser":"CENTRAL SALES LIMITED","companyCode":[{"$numberInt":"3976"}],"facilityAddress":"UNIT 1 14 Regan Road Brampton Ontario Canada L7A 1B9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa84"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["10"],"productID":{"$numberInt":"4285"},"sanitizedRegiestrationNumber":"00516821","productName":"MYCLO SOLUTION","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["D01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa85"},"numbersOfAis":"10","activeIngredientName":["RETINOL PALMITATE","VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)","THIAMINE MONONITRATE","NICOTINAMIDE","VITAMIN B12","VITAMIN D","VITAMIN C","VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","FOLIC ACID"],"dose":["5000","10","3","25","6","400","75","5","2",".1"],"productID":{"$numberInt":"4948"},"sanitizedRegiestrationNumber":"00561746","productName":"MULTIPLE VITAMINS TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["RETINOL PALMITATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT","MG","MG","MCG","UNIT","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa86"},"numbersOfAis":"1","activeIngredientName":["AMINOGLUTETHIMIDE"],"dose":["250"],"productID":{"$numberInt":"5198"},"sanitizedRegiestrationNumber":"00587729","productName":"CYTADREN TAB 250MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["AMINOGLUTHETIMIDE"],"atcCode":["L02BG01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMINOGLUTETHIMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa87"},"numbersOfAis":"3","activeIngredientName":["BUTALBITAL","CAFFEINE","ACETYLSALICYLIC ACID"],"dose":["50","40","330"],"productID":{"$numberInt":"6480"},"sanitizedRegiestrationNumber":"00608238","productName":"TEVA-TECNAL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS","ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS"],"atcCode":["N02BA71","N02BA71"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BUTALBITAL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa88"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["500"],"productID":{"$numberInt":"424"},"sanitizedRegiestrationNumber":"00030589","productName":"LINCOCIN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["LINCOMYCIN"],"atcCode":["J01FF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa89"},"numbersOfAis":"1","activeIngredientName":["GRISEOFULVIN"],"dose":["330"],"productID":{"$numberInt":"4712"},"sanitizedRegiestrationNumber":"00513237","productName":"FULVICIN PG TAB 330MG","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["GRISEOFULVIN"],"atcCode":["D01BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GRISEOFULVIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8a"},"numbersOfAis":"6","activeIngredientName":["SODIUM CITRATE DIHYDRATE","SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM ACETATE TRIHYDRATE"],"dose":["0.17","0.64","0.075","0.048","0.03","0.39"],"productID":{"$numberInt":"6366"},"sanitizedRegiestrationNumber":"00512990","productName":"BSS STERILE IRRIGATING SOLUTION","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["SOLVENTS AND DILUTING AGENTS,INCL IRRIGAT SOLUT"],"atcCode":["V07AB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CITRATE DIHYDRATE","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%","%","%"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8b"},"numbersOfAis":"2","activeIngredientName":["CARBIDOPA","LEVODOPA"],"dose":["25","100"],"productID":{"$numberInt":"4008"},"sanitizedRegiestrationNumber":"00513997","productName":"SINEMET 100/25","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1980-12-31"],"sanitizedIndication":["LEVODOPA AND DECARBOXYLASE INHIBITOR"],"atcCode":["N04BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBIDOPA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8c"},"numbersOfAis":"3","activeIngredientName":["SODIUM CACODYLATE","COPPER GLUCONATE","FERRIC CHLORIDE"],"dose":["32","1","5"],"productID":{"$numberInt":"4098"},"sanitizedRegiestrationNumber":"00517054","productName":"CENTRA COPPER INJ","licenseHolderSponser":"CENTRAL SALES LIMITED","companyCode":[{"$numberInt":"3976"}],"facilityAddress":"UNIT 1 14 Regan Road Brampton Ontario Canada L7A 1B9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CACODYLATE","Combination"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["5","5","5"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8d"},"numbersOfAis":"1","activeIngredientName":["FLURBIPROFEN"],"dose":["100"],"productID":{"$numberInt":"6276"},"sanitizedRegiestrationNumber":"00600792","productName":"ANSAID TABLETS 100 MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["FLURBIPROFEN"],"atcCode":["M01AE09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLURBIPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8e"},"numbersOfAis":"1","activeIngredientName":["GUAIFENESIN"],"dose":["100"],"productID":{"$numberInt":"41988"},"sanitizedRegiestrationNumber":"00608920","productName":"BALMINIL EXPECTORANT","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["GUAIFENESIN"],"atcCode":["R05CA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GUAIFENESIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa8f"},"numbersOfAis":"1","activeIngredientName":["PRILOCAINE HYDROCHLORIDE"],"dose":["40"],"productID":{"$numberInt":"4203"},"sanitizedRegiestrationNumber":"00519235","productName":"DENTSPLY 4% PRILOCAINE HYDROCHLORIDE DENTAL INJECTION","licenseHolderSponser":"DENTSPLY CANADA LIMITED","companyCode":[{"$numberInt":"3652"}],"facilityAddress":" 161 Vinyl Court Woodbridge Ontario Canada L4L 4A3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["PRILOCAINE"],"atcCode":["N01BB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRILOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa90"},"numbersOfAis":"1","activeIngredientName":["AMITRIPTYLINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"1690"},"sanitizedRegiestrationNumber":"00271152","productName":"LEVATE","licenseHolderSponser":"BIOMED PHARMA","companyCode":[{"$numberInt":"10997"}],"facilityAddress":" 9450  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1969-12-31"],"sanitizedIndication":["AMITRIPTYLINE"],"atcCode":["N06AA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMITRIPTYLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa91"},"numbersOfAis":"1","activeIngredientName":["INSULIN ISOPHANE NPH PORK"],"dose":["100"],"productID":{"$numberInt":"4090"},"sanitizedRegiestrationNumber":"00514551","productName":"NPH PURIFIED PORK INSULIN INJ","licenseHolderSponser":"ELI LILLY AND COMPANY LIMITED","companyCode":[{"$numberInt":"4501"}],"facilityAddress":" Lilly Corporate Center, Building 100/328 Indianapolis Indiana United States 46285","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["INSULIN (PORK)"],"atcCode":["A10AC03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INSULIN ISOPHANE NPH PORK"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Fabricate (Pharmaceutical)| Label (Biological)| Label (Pharmaceutical)| Package (Biological)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa92"},"numbersOfAis":"2","activeIngredientName":["PRILOCAINE HYDROCHLORIDE","EPINEPHRINE (EPINEPHRINE BITARTRATE)"],"dose":["40","5"],"productID":{"$numberInt":"4202"},"sanitizedRegiestrationNumber":"00519227","productName":"DENTSPLY 4% PRILOCAINE AND EPINEPHRINE INJECTION 1:200,000","licenseHolderSponser":"DENTSPLY CANADA LIMITED","companyCode":[{"$numberInt":"3652"}],"facilityAddress":" 161 Vinyl Court Woodbridge Ontario Canada L4L 4A3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1968-12-31"],"sanitizedIndication":["PRILOCAINE, COMBINATIONS"],"atcCode":["N01BB54"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PRILOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa93"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["50"],"productID":{"$numberInt":"2738"},"sanitizedRegiestrationNumber":"00397423","productName":"LOPRESOR 50MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa94"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["325"],"productID":{"$numberInt":"5035"},"sanitizedRegiestrationNumber":"00389218","productName":"NOVO-GESIC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa95"},"numbersOfAis":"2","activeIngredientName":["POLYMYXIN B (POLYMYXIN B SULFATE)","GRAMICIDIN"],"dose":["10000","0.25"],"productID":{"$numberInt":"50407"},"sanitizedRegiestrationNumber":"00422908","productName":"POLYTOPIC CREAM","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1997-01-27"],"sanitizedIndication":["COMBINATIONS OF ANTIBIOTICS"],"atcCode":["D06AX30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POLYMYXIN B (POLYMYXIN B SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa96"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["25"],"productID":{"$numberInt":"4042"},"sanitizedRegiestrationNumber":"00514004","productName":"VOLTAREN TAB 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Delayed-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa97"},"numbersOfAis":"1","activeIngredientName":["CLONIDINE HYDROCHLORIDE"],"dose":["0.025"],"productID":{"$numberInt":"4045"},"sanitizedRegiestrationNumber":"00519251","productName":"DIXARIT TAB 0.025MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CLONIDINE"],"atcCode":["N02CX02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLONIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa98"},"numbersOfAis":"2","activeIngredientName":["DEXTRAN","SODIUM CHLORIDE"],"dose":["10","0.9"],"productID":{"$numberInt":"1743"},"sanitizedRegiestrationNumber":"00224227","productName":"LMD 10% IN 0.9% SODIUM CHLORIDE","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["DEXTRAN,COMBINATIONS"],"atcCode":["B05AA55"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTRAN","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa99"},"numbersOfAis":"3","activeIngredientName":["CAFFEINE","ACETYLSALICYLIC ACID","BUTALBITAL"],"dose":["40","330","50"],"productID":{"$numberInt":"1852"},"sanitizedRegiestrationNumber":"00275328","productName":"FIORINAL TAB","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS","ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS"],"atcCode":["N02BA71","N02BA71"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAFFEINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9a"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["200"],"productID":{"$numberInt":"1070"},"sanitizedRegiestrationNumber":"00026050","productName":"BETADINE VAGINAL SUPPOSITORIES 200MG","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1971-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["G01AX11"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9b"},"numbersOfAis":"4","activeIngredientName":["BENZOIN","ALOE","STORAX","MYROXYLON BALSAMUM"],"dose":["10","2","8","4"],"productID":{"$numberInt":"41578"},"sanitizedRegiestrationNumber":"00545279","productName":"FRIAR'S BALSAM BENZOIN TINCTURE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tincture"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["Other cold preparations"],"atcCode":["R05X"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZOIN","Combination"],"sanitizedRouteOfAdministration":["Topical","Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G"],"quantityNeedToTake":["100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9c"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["20"],"productID":{"$numberInt":"4225"},"sanitizedRegiestrationNumber":"00525618","productName":"FELDENE CAP 20MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9d"},"numbersOfAis":"7","activeIngredientName":["D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","VITAMIN B1 (THIAMINE MONONITRATE)","NICOTINAMIDE","VITAMIN C","VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","VITAMIN B12"],"dose":["20","35","50","500","15","5","10"],"productID":{"$numberInt":"17760"},"sanitizedRegiestrationNumber":"00532045","productName":"B WITH C 500 CAP","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX WITH VITAMIN C"],"atcCode":["A11EB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP","CAP","CAP","CAP","CAP","CAP","CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9e"},"numbersOfAis":"1","activeIngredientName":["OXPRENOLOL HYDROCHLORIDE"],"dose":["160"],"productID":{"$numberInt":"4520"},"sanitizedRegiestrationNumber":"00534587","productName":"SLOW TRASICOR TAB 160MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["OXPRENOLOL"],"atcCode":["C07AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXPRENOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfa9f"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["10"],"productID":{"$numberInt":"4431"},"sanitizedRegiestrationNumber":"00527033","productName":"FUROSEMIDE INJ USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa0"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["100"],"productID":{"$numberInt":"2806"},"sanitizedRegiestrationNumber":"00415006","productName":"VITAMIN C TAB 100MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa1"},"numbersOfAis":"1","activeIngredientName":["BORIC ACID"],"dose":["2.5"],"productID":{"$numberInt":"41604"},"sanitizedRegiestrationNumber":"00524468","productName":"EYE WASH 2.5%","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["SODIUM BORATE"],"atcCode":["S01AX07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BORIC ACID"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa2"},"numbersOfAis":"2","activeIngredientName":["LEVODOPA","BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)"],"dose":["50","12.5"],"productID":{"$numberInt":"4459"},"sanitizedRegiestrationNumber":"00522597","productName":"PROLOPA CAP 50-12.5","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["LEVODOPA AND DECARBOXYLASE INHIBITOR"],"atcCode":["N04BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LEVODOPA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa3"},"numbersOfAis":"1","activeIngredientName":["OXYTETRACYCLINE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"4767"},"sanitizedRegiestrationNumber":"00518069","productName":"TERRAMYCIN CONCENTRATED SOL PWD","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYTETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa4"},"numbersOfAis":"1","activeIngredientName":["TOBRAMYCIN"],"dose":["0.3"],"productID":{"$numberInt":"4571"},"sanitizedRegiestrationNumber":"00513962","productName":"TOBREX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["TOBRAMYCIN"],"atcCode":["S01AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOBRAMYCIN"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa5"},"numbersOfAis":"1","activeIngredientName":["OXTRIPHYLLINE"],"dose":["600"],"productID":{"$numberInt":"4831"},"sanitizedRegiestrationNumber":"00536709","productName":"CHOLEDYL SA TABLETS 600MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["CHOLINE THEOPHYLLINATE"],"atcCode":["R03DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXTRIPHYLLINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa6"},"numbersOfAis":"1","activeIngredientName":["IODINE (NONYL PHENOXYPOLY ETHOXY ETHANOL-IODINE)"],"dose":["1.75"],"productID":{"$numberInt":"4073"},"sanitizedRegiestrationNumber":"00523712","productName":"DAIRY DINE","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (NONYL PHENOXYPOLY ETHOXY ETHANOL-IODINE)"],"sanitizedRouteOfAdministration":["Topical","Udder Wash"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa7"},"numbersOfAis":"1","activeIngredientName":["IODINE (ETHIODIZED OIL)"],"dose":["380"],"productID":{"$numberInt":"2570"},"sanitizedRegiestrationNumber":"00386685","productName":"LIPIODOL ULTRA FLUID","licenseHolderSponser":"GUERBET","companyCode":[{"$numberInt":"9113"}],"facilityAddress":" Bp 57400 Roissy Cdg Cedex Val-D'Oise France 95943","countryOfOrigin":["France"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1977-12-31"],"sanitizedIndication":["ETHYL ESTERS OF IODISED FATTY ACIDS"],"atcCode":["V08AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (ETHIODIZED OIL)"],"sanitizedRouteOfAdministration":["Intracavitary","Parenteral (Unspecified)"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa8"},"numbersOfAis":"4","activeIngredientName":["ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE"],"dose":[".035",".5",".035","1"],"productID":{"$numberInt":"4576"},"sanitizedRegiestrationNumber":"00538590","productName":"ORTHO 10/11 TABLETS (21 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["NORETHISTERONE AND ESTROGEN"],"atcCode":["G03AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ETHINYL ESTRADIOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaa9"},"numbersOfAis":"1","activeIngredientName":["MAPROTILINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"2350"},"sanitizedRegiestrationNumber":"00360481","productName":"LUDIOMIL TAB 25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1976-12-31"],"sanitizedIndication":["MAPROTILINE"],"atcCode":["N06AA21"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAPROTILINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaaa"},"numbersOfAis":"3","activeIngredientName":["INOSITOL (CALCIUM MAGNESIUM PHYTATE)","VITAMIN C","VITAMIN B1"],"dose":["18","500","2"],"productID":{"$numberInt":"5028"},"sanitizedRegiestrationNumber":"00517909","productName":"VITATHION","licenseHolderSponser":"SERVIER CANADA INC","companyCode":[{"$numberInt":"5096"}],"facilityAddress":" 235 Boul. Armand-Frappier  - Parc Scientif. Et De Haute Tech. De Laval Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1963-12-31"],"sanitizedIndication":["COMBINATIONS OF VITAMINS","COMBINATIONS OF VITAMINS"],"atcCode":["A11JA","A11JA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["INOSITOL (CALCIUM MAGNESIUM PHYTATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["SACHET","SACHET","SACHET"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaab"},"numbersOfAis":"7","activeIngredientName":["THIAMINE MONONITRATE","NICOTINAMIDE","CALCIUM D-PANTOTHENATE","VITAMIN B12","VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","VITAMIN C"],"dose":["15","100","20","10","10","5","500"],"productID":{"$numberInt":"4051"},"sanitizedRegiestrationNumber":"00520209","productName":"SURBEX 500 FILMTAB","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX WITH VITAMIN C","VITAMIN B-COMPLEX WITH VITAMIN C"],"atcCode":["A11EB","A11EB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["THIAMINE MONONITRATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MCG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaac"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["125"],"productID":{"$numberInt":"4981"},"sanitizedRegiestrationNumber":"00522678","productName":"APO NAPROXEN TAB 125MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaad"},"numbersOfAis":"2","activeIngredientName":["CALCIUM GLUCOHEPTONATE","CALCIUM GLUCONATE"],"dose":["132","112"],"productID":{"$numberInt":"4641"},"sanitizedRegiestrationNumber":"00548154","productName":"CALCIUM LIQUID","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CALCIUM (DIFFERENT SALTS IN COMBINATION)"],"atcCode":["A12AA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM GLUCOHEPTONATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaae"},"numbersOfAis":"1","activeIngredientName":["BROMAZEPAM"],"dose":["6"],"productID":{"$numberInt":"4158"},"sanitizedRegiestrationNumber":"00518131","productName":"LECTOPAM TAB 6MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["BROMAZEPAM"],"atcCode":["N05BA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BROMAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaaf"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["325"],"productID":{"$numberInt":"4733"},"sanitizedRegiestrationNumber":"00544981","productName":"APO ACETAMINOPHEN TAB 325MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab0"},"numbersOfAis":"1","activeIngredientName":["PROPRANOLOL HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"3812"},"sanitizedRegiestrationNumber":"00402788","productName":"APO PROPRANOLOL TAB 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1980-12-31"],"sanitizedIndication":["PROPRANOLOL"],"atcCode":["C07AA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPRANOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab1"},"numbersOfAis":"3","activeIngredientName":["CODEINE PHOSPHATE","DIPHENHYDRAMINE HYDROCHLORIDE","AMMONIUM CHLORIDE"],"dose":["3.33","12.5","125"],"productID":{"$numberInt":"4469"},"sanitizedRegiestrationNumber":"00535230","productName":"CALMYLIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CODEINE PHOSPHATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["5","5","5"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab2"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["10"],"productID":{"$numberInt":"4283"},"sanitizedRegiestrationNumber":"00516805","productName":"MYCLO CRM 10MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["D01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab3"},"numbersOfAis":"2","activeIngredientName":["TRIAMTERENE","HYDROCHLOROTHIAZIDE"],"dose":["50","25"],"productID":{"$numberInt":"4523"},"sanitizedRegiestrationNumber":"00532657","productName":"TEVA-TRIAMTERENE/HCTZ","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIAMTERENE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab4"},"numbersOfAis":"2","activeIngredientName":["PYRITHIONE DISULFIDE","TAR (POLYTAR)"],"dose":["1","1"],"productID":{"$numberInt":"5003"},"sanitizedRegiestrationNumber":"00550434","productName":"DAN-TAR PLUS SHAMPOO","licenseHolderSponser":"VALEO PHARMA INC","companyCode":[{"$numberInt":"11211"}],"facilityAddress":" 16667 Hymus Blvd. Kirkland Quebec Canada H9H 4R9","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["TARS","TARS"],"atcCode":["D05AA","D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PYRITHIONE DISULFIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab5"},"numbersOfAis":"1","activeIngredientName":["BISACODYL"],"dose":["5"],"productID":{"$numberInt":"4900"},"sanitizedRegiestrationNumber":"00545023","productName":"APO-BISACODYL","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet (Delayed-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["BISACODYL"],"atcCode":["A06AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BISACODYL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab6"},"numbersOfAis":"1","activeIngredientName":["ALPROSTADIL"],"dose":["500"],"productID":{"$numberInt":"4802"},"sanitizedRegiestrationNumber":"00559253","productName":"PROSTIN VR STERILE SOLUTION","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["ALPROSTADIL"],"atcCode":["C01EA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPROSTADIL"],"sanitizedRouteOfAdministration":["Intra-Arterial","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab7"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.05"],"productID":{"$numberInt":"4521"},"sanitizedRegiestrationNumber":"00535427","productName":"TEVA-ECTOSONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab8"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B12"],"dose":["5"],"productID":{"$numberInt":"4096"},"sanitizedRegiestrationNumber":"00516937","productName":"CENTRAVITE B12 5000INJ","licenseHolderSponser":"CENTRAL SALES LIMITED","companyCode":[{"$numberInt":"3976"}],"facilityAddress":"UNIT 1 14 Regan Road Brampton Ontario Canada L7A 1B9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B12"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfab9"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["500"],"productID":{"$numberInt":"4483"},"sanitizedRegiestrationNumber":"00537500","productName":"VITAMIN C 500MG CAPS TIME RELEASE","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule (Sustained-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaba"},"numbersOfAis":"2","activeIngredientName":["TRIMETHOPRIM","SULFAMETHOXAZOLE"],"dose":["16","80"],"productID":{"$numberInt":"4703"},"sanitizedRegiestrationNumber":"00550086","productName":"SEPTRA INJECTION","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["SULFAMETHOXAZOLE AND TRIMETHOPRIM"],"atcCode":["J01EE01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIMETHOPRIM","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfabb"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["100"],"productID":{"$numberInt":"4621"},"sanitizedRegiestrationNumber":"00546305","productName":"CAPOTEN TAB 100MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfabc"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"4522"},"sanitizedRegiestrationNumber":"00535435","productName":"TEVA-ECTOSONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfabd"},"numbersOfAis":"1","activeIngredientName":["OXYTETRACYCLINE HYDROCHLORIDE"],"dose":["220"],"productID":{"$numberInt":"5320"},"sanitizedRegiestrationNumber":"00546712","productName":"OXY TETRA FORTE","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYTETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfabe"},"numbersOfAis":"2","activeIngredientName":["AZATADINE MALEATE","PSEUDOEPHEDRINE SULFATE"],"dose":["1","120"],"productID":{"$numberInt":"5264"},"sanitizedRegiestrationNumber":"00517895","productName":"TRINALIN REPETABS","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["PSEUDOEPHEDRINE, COMBINATIONS","PSEUDOEPHEDRINE, COMBINATIONS"],"atcCode":["R01BA52","R01BA52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["AZATADINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfabf"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","CALCIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE","SODIUM CHLORIDE"],"dose":["3.92","0.26","25","0.15","5.62"],"productID":{"$numberInt":"4441"},"sanitizedRegiestrationNumber":"00530182","productName":"INPERSOL W DEXTROSE 2.5%","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac0"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["25"],"productID":{"$numberInt":"4619"},"sanitizedRegiestrationNumber":"00546283","productName":"CAPOTEN TAB 25MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac1"},"numbersOfAis":"2","activeIngredientName":["CETALKONIUM CHLORIDE","CHOLINE SALICYLATE"],"dose":["0.01","8.7"],"productID":{"$numberInt":"301"},"sanitizedRegiestrationNumber":"00026190","productName":"TEEJEL GEL","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1965-12-31"],"sanitizedIndication":["CHOLINE SALICYLATE, COMB. EXCL PSYCHOLEPTICS"],"atcCode":["N02BA53"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CETALKONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dental","Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac2"},"numbersOfAis":"1","activeIngredientName":["ALCOHOL ANHYDROUS"],"dose":["0.995"],"productID":{"$numberInt":"4442"},"sanitizedRegiestrationNumber":"00537640","productName":"DEHYDRATED ALCOHOL INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2048-12-31"],"sanitizedIndication":["OTHER THERAPEUTIC PRODUCTS"],"atcCode":["V03AX"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALCOHOL ANHYDROUS"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["ML"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac3"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["200"],"productID":{"$numberInt":"5091"},"sanitizedRegiestrationNumber":"00534560","productName":"LOPRESOR SR 200 MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac4"},"numbersOfAis":"1","activeIngredientName":["ACTH"],"dose":["40"],"productID":{"$numberInt":"5163"},"sanitizedRegiestrationNumber":"00561584","productName":"ACTH 40 INJ 40UNIT/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACTH"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac5"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["50"],"productID":{"$numberInt":"4620"},"sanitizedRegiestrationNumber":"00546291","productName":"CAPOTEN TAB 50MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac6"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["500"],"productID":{"$numberInt":"4734"},"sanitizedRegiestrationNumber":"00545007","productName":"APO ACETAMINOPHEN TAB 500MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac7"},"numbersOfAis":"1","activeIngredientName":["FENOTEROL HYDROBROMIDE"],"dose":["1"],"productID":{"$numberInt":"4606"},"sanitizedRegiestrationNumber":"00541389","productName":"BEROTEC 1MG/ML","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["FENOTEROL"],"atcCode":["R03AC04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENOTEROL HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac8"},"numbersOfAis":"4","activeIngredientName":["TRIAMCINOLONE ACETONIDE","NYSTATIN","NEOMYCIN (NEOMYCIN SULFATE)","GRAMICIDIN"],"dose":["1","100000","2.5","0.25"],"productID":{"$numberInt":"12862"},"sanitizedRegiestrationNumber":"00550507","productName":"TEVA-TRIACOMB","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TRIAMCINOLONE AND ANTIBIOTICS","TRIAMCINOLONE AND ANTIBIOTICS"],"atcCode":["D07CB01","D07CB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIAMCINOLONE ACETONIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfac9"},"numbersOfAis":"1","activeIngredientName":["BENZALKONIUM CHLORIDE"],"dose":[".4"],"productID":{"$numberInt":"5046"},"sanitizedRegiestrationNumber":"00555983","productName":"BENZALKONIUM CHLORIDE ANTISEPT TOWEL","licenseHolderSponser":"PROFESSIONAL DISPOSABLES INTERNATIONAL INC.","companyCode":[{"$numberInt":"4907"}],"facilityAddress":" 400 Chestnut Ridge Road Woodcliff Lake New Jersey United States 07677","countryOfOrigin":["United States"],"format":["Pad"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["BENZALKONIUM"],"atcCode":["D08AJ01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZALKONIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaca"},"numbersOfAis":"1","activeIngredientName":["PREDNISONE"],"dose":["50"],"productID":{"$numberInt":"4736"},"sanitizedRegiestrationNumber":"00550957","productName":"APO PREDNISONE TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["PREDNISONE"],"atcCode":["H02AB07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfacb"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["500"],"productID":{"$numberInt":"6272"},"sanitizedRegiestrationNumber":"00560235","productName":"LIFE VIT C TIMED RELEASE TAB 500MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfacc"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["120"],"productID":{"$numberInt":"4758"},"sanitizedRegiestrationNumber":"00554324","productName":"ISOPTIN TAB 120MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfacd"},"numbersOfAis":"1","activeIngredientName":["CALCIUM BOROGLUCONATE"],"dose":["23"],"productID":{"$numberInt":"4770"},"sanitizedRegiestrationNumber":"00553522","productName":"CALCIUM GLUCONATE 23% INJ","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM BOROGLUCONATE"],"sanitizedRouteOfAdministration":["Intraperitoneal","Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cface"},"numbersOfAis":"11","activeIngredientName":["VITAMIN A (RETINOL PALMITATE)","VITAMIN B2","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","FOLIC ACID","VITAMIN D","IRON (FERROUS FUMARATE)","VITAMIN B1 (THIAMINE MONONITRATE)","NICOTINAMIDE","VITAMIN B12","VITAMIN C","VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"dose":["5000","5","2",".1","400","4","3","25","6","75","10"],"productID":{"$numberInt":"4951"},"sanitizedRegiestrationNumber":"00567930","productName":"MULTIPLE VITAMINS PLUS IRON TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN A (RETINOL PALMITATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","MG","UNIT","MG","MG","MG","MCG","MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfacf"},"numbersOfAis":"1","activeIngredientName":["MEBENDAZOLE"],"dose":["100"],"productID":{"$numberInt":"4743"},"sanitizedRegiestrationNumber":"00556734","productName":"VERMOX","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["MEBENDAZOLE"],"atcCode":["P02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEBENDAZOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad0"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["500"],"productID":{"$numberInt":"5476"},"sanitizedRegiestrationNumber":"00549703","productName":"ACETAMINOPHEN 500 MG TABLETS USP EXTRA STRENGTH","licenseHolderSponser":"CELLCHEM PHARMACEUTICALS INC.","companyCode":[{"$numberInt":"16702"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad1"},"numbersOfAis":"1","activeIngredientName":["OXYMETAZOLINE HYDROCHLORIDE"],"dose":[".25"],"productID":{"$numberInt":"4713"},"sanitizedRegiestrationNumber":"00543454","productName":"OCUCLEAR OPH DPS 0.025%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["OXYMETAZOLINE"],"atcCode":["S01GA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad2"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["0.25"],"productID":{"$numberInt":"4471"},"sanitizedRegiestrationNumber":"00548359","productName":"XANAX","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad3"},"numbersOfAis":"2","activeIngredientName":["VITAMIN D","VITAMIN A"],"dose":["100","1250"],"productID":{"$numberInt":"41620"},"sanitizedRegiestrationNumber":"00572063","productName":"HUILE DE FOIE DE MORUE CAP 10MIN","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["VITAMIN A AND D IN COMBINATION"],"atcCode":["A11CB"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP","CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad4"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM CHLORIDE"],"dose":["600"],"productID":{"$numberInt":"4739"},"sanitizedRegiestrationNumber":"00554308","productName":"SLO-POT","licenseHolderSponser":"BIOMED PHARMA","companyCode":[{"$numberInt":"10997"}],"facilityAddress":" 9450  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"sanitizedIndication":["POTASSIUM CHLORIDE"],"atcCode":["A12BA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad5"},"numbersOfAis":"1","activeIngredientName":["IRON DEXTRAN COMPLEX"],"dose":["100"],"productID":{"$numberInt":"4720"},"sanitizedRegiestrationNumber":"00553018","productName":"UNI FERRON INJ 100MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IRON DEXTRAN COMPLEX"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad6"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["10"],"productID":{"$numberInt":"4224"},"sanitizedRegiestrationNumber":"00525596","productName":"FELDENE CAP 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad7"},"numbersOfAis":"19","activeIngredientName":["ARGININE","LEUCINE","METHIONINE","THREONINE","VALINE","SERINE","TYROSINE","POTASSIUM PHOSPHATE DIBASIC","SODIUM CHLORIDE","HISTIDINE","ISOLEUCINE","LYSINE ACETATE","PHENYLALANINE","TRYPTOPHAN","L-ALANINE","PROLINE","GLYCINE","MAGNESIUM CHLORIDE","SODIUM ACETATE"],"dose":["980","940","400","520","800","420","44","522","351","300","720","723","440","160","1.28","860","1.28","102","882"],"productID":{"$numberInt":"5597"},"sanitizedRegiestrationNumber":"00558966","productName":"AMINOSYN 10% W ELECTROLYTES","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ARGININE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","G","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad8"},"numbersOfAis":"1","activeIngredientName":["OXPRENOLOL HYDROCHLORIDE"],"dose":["80"],"productID":{"$numberInt":"4519"},"sanitizedRegiestrationNumber":"00534579","productName":"SLOW TRASICOR TAB 80MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["OXPRENOLOL"],"atcCode":["C07AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXPRENOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfad9"},"numbersOfAis":"4","activeIngredientName":["ETAFEDRIN HYDROCHLORIDE","SODIUM CITRATE","HYDROCODONE BITARTRATE","DOXYLAMINE SUCCINATE"],"dose":["3.33","40","0.33","1.2"],"productID":{"$numberInt":"4615"},"sanitizedRegiestrationNumber":"00550477","productName":"RATIO-CALMYDONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ETAFEDRIN HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfada"},"numbersOfAis":"1","activeIngredientName":["CODEINE PHOSPHATE"],"dose":["30"],"productID":{"$numberInt":"4806"},"sanitizedRegiestrationNumber":"00544884","productName":"CODEINE PHOSPHATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1978-12-31"],"sanitizedIndication":["CODEINE"],"atcCode":["R05DA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CODEINE PHOSPHATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfadb"},"numbersOfAis":"1","activeIngredientName":["EPINEPHRINE RACEMIC"],"dose":["2.25"],"productID":{"$numberInt":"39484"},"sanitizedRegiestrationNumber":"00525103","productName":"S2","licenseHolderSponser":"NEPHRON PHARMACEUTICALS CORPORATION","companyCode":[{"$numberInt":"9039"}],"facilityAddress":" 4500 12th Street Extension West Columbia South Carolina United States 29172","countryOfOrigin":["United States"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1998-10-02"],"sanitizedIndication":["EPINEPHRINE"],"atcCode":["R03AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPINEPHRINE RACEMIC"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfadc"},"numbersOfAis":"4","activeIngredientName":["IODOFORM","PENGHAWAR","BUTAMBEN","EUGENOL"],"dose":["15.8","3.5","25.7","13.7"],"productID":{"$numberInt":"4875"},"sanitizedRegiestrationNumber":"00555509","productName":"ALVOGYL","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Paste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["A01AD11"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IODOFORM","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G"],"quantityNeedToTake":["100","100","100","100"],"qunatityUnit":["G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfadd"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM SULFATE"],"dose":["500"],"productID":{"$numberInt":"4091"},"sanitizedRegiestrationNumber":"00328162","productName":"MAGNESIUM SULFATE INJ 500MG/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["MAGNESIUM SULPHATE"],"atcCode":["B05XA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfade"},"numbersOfAis":"1","activeIngredientName":["VITAMIN A (FISH LIVER OIL)"],"dose":["10000"],"productID":{"$numberInt":"41586"},"sanitizedRegiestrationNumber":"00560871","productName":"VITAMIN A CAP 10000UNIT","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["RETINOL (VIT A)"],"atcCode":["A11CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN A (FISH LIVER OIL)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfadf"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["50"],"productID":{"$numberInt":"4916"},"sanitizedRegiestrationNumber":"00571245","productName":"APO-DIPYRIDAMOLE-SC TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae0"},"numbersOfAis":"1","activeIngredientName":["INDAPAMIDE"],"dose":["2.5"],"productID":{"$numberInt":"4857"},"sanitizedRegiestrationNumber":"00564966","productName":"LOZIDE","licenseHolderSponser":"SERVIER CANADA INC","companyCode":[{"$numberInt":"5096"}],"facilityAddress":" 235 Boul. Armand-Frappier  - Parc Scientif. Et De Haute Tech. De Laval Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["INDAPAMIDE"],"atcCode":["C03BA11"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INDAPAMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae1"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["10"],"productID":{"$numberInt":"41607"},"sanitizedRegiestrationNumber":"00576026","productName":"TINACTIN SOL 10MG/ML","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae2"},"numbersOfAis":"1","activeIngredientName":["TESTOSTERONE PROPIONATE"],"dose":["100"],"productID":{"$numberInt":"4717"},"sanitizedRegiestrationNumber":"00552984","productName":"UNI-TEST INJ 100MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TESTOSTERONE PROPIONATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae3"},"numbersOfAis":"8","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM PHOSPHATE DIBASIC","SODIUM BICARBONATE","DEXTROSE","GLUTATHIONE DISULFIDE"],"dose":["0.714","0.038","0.0154","0.02","0.042","0.21","0.092","0.0184"],"productID":{"$numberInt":"4913"},"sanitizedRegiestrationNumber":"00568082","productName":"BSS PLUS","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Kit","Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["SOLVENTS AND DILUTING AGENTS,INCL IRRIGAT SOLUT"],"atcCode":["V07AB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intraocular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%","%","%","%","%"],"quantityNeedToTake":["","","","","","","",""],"qunatityUnit":["","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae4"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM CHLORIDE"],"dose":["1.784"],"productID":{"$numberInt":"1826"},"sanitizedRegiestrationNumber":"00283576","productName":"POTASSIUM CHLORIDE INJ 30MEQ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["POTASSIUM CHLORIDE"],"atcCode":["B05XA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae5"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["0.5"],"productID":{"$numberInt":"7128"},"sanitizedRegiestrationNumber":"00363685","productName":"TEVA-HALOPERIDOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae6"},"numbersOfAis":"2","activeIngredientName":["VITAMIN A (COD LIVER OIL)","VITAMIN D (COD LIVER OIL)"],"dose":["700","70"],"productID":{"$numberInt":"41594"},"sanitizedRegiestrationNumber":"00570869","productName":"HUILE DE FOIE DE MORUE","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["VITAMIN A AND D IN COMBINATION"],"atcCode":["A11CB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN A (COD LIVER OIL)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae7"},"numbersOfAis":"4","activeIngredientName":["ZINC CHLORIDE","CHROMIC CHLORIDE","CUPRIC CHLORIDE","MANGANESE CHLORIDE"],"dose":["1.67","6","0.42","0.37"],"productID":{"$numberInt":"5708"},"sanitizedRegiestrationNumber":"00569046","productName":"TRACE ELEMENTS INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ELECTROLYTES IN COMB WITH OTHER DRUGS"],"atcCode":["B05XA31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ZINC CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae8"},"numbersOfAis":"1","activeIngredientName":["NITROGEN"],"dose":["100"],"productID":{"$numberInt":"5683"},"sanitizedRegiestrationNumber":"00572829","productName":"NITROGEN 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["NITROGEN"],"atcCode":["V03AN04"],"pharmaceuticalStd":["NF"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGEN"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfae9"},"numbersOfAis":"17","activeIngredientName":["BIOTIN","COPPER (COPPER SULFATE)","D-ALPHA TOCOPHERYL ACETATE","IRON (FERROUS FUMARATE)","MAGNESIUM (MAGNESIUM SULFATE)","CALCIUM D-PANTOTHENATE","VITAMIN A (RETINOL PALMITATE)","VITAMIN B12","VITAMIN B2","NICOTINAMIDE","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","FOLIC ACID","VITAMIN D","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN C","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["50","2","10","10","50","10","6000","6","5","25","160","125",".1","400","3","75","2"],"productID":{"$numberInt":"4950"},"sanitizedRegiestrationNumber":"00566357","productName":"SUPER MULTIPLE VITAMINS AND MIN TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BIOTIN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MG","UNIT","MG","MG","MG","UNIT","MCG","MG","MG","MG","MG","MG","UNIT","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaea"},"numbersOfAis":"2","activeIngredientName":["VITAMIN D","CALCIUM (CALCIUM CARBONATE)"],"dose":["133","250"],"productID":{"$numberInt":"6899"},"sanitizedRegiestrationNumber":"00562548","productName":"CALCIUM TAB W VIT D","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaeb"},"numbersOfAis":"10","activeIngredientName":["THIAMINE MONONITRATE","NICOTINAMIDE","VITAMIN B12","VITAMIN C","VITAMIN D","IRON (FERROUS FUMARATE)","RETINOL PALMITATE","VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","FOLIC ACID"],"dose":["1.5","15","3","50","400","4","5000","1.5","1",".1"],"productID":{"$numberInt":"4946"},"sanitizedRegiestrationNumber":"00561711","productName":"CHILDREN'S CHEWABLE MULTI VIT W IRON","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["MULTIVITAMINS AND IRON"],"atcCode":["A11AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["THIAMINE MONONITRATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MCG","MG","UNIT","MG","UNIT","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaec"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["80"],"productID":{"$numberInt":"4757"},"sanitizedRegiestrationNumber":"00554316","productName":"ISOPTIN TAB 80MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaed"},"numbersOfAis":"2","activeIngredientName":["OXYQUINOLINE SULFATE","ALUMINUM CHLORIDE"],"dose":["100","25"],"productID":{"$numberInt":"2645"},"sanitizedRegiestrationNumber":"00379638","productName":"RACESTYPTINE SOL","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["OTHER AGENTS FOR LOCAL ORAL TREATMENT"],"atcCode":["A01AD"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYQUINOLINE SULFATE","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaee"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["50"],"productID":{"$numberInt":"6611"},"sanitizedRegiestrationNumber":"00648035","productName":"TEVA-METOPROLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaef"},"numbersOfAis":"4","activeIngredientName":["ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE"],"dose":[".035",".5",".035","1"],"productID":{"$numberInt":"4577"},"sanitizedRegiestrationNumber":"00538582","productName":"ORTHO 10/11 TABLETS (28 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["NORETHISTERONE AND ESTROGEN"],"atcCode":["G03AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ETHINYL ESTRADIOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf0"},"numbersOfAis":"1","activeIngredientName":["NADOLOL"],"dose":["160"],"productID":{"$numberInt":"4145"},"sanitizedRegiestrationNumber":"00523372","productName":"CORGARD TAB 160MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["NADOLOL"],"atcCode":["C07AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NADOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf1"},"numbersOfAis":"15","activeIngredientName":["L-ARGININE","L-ISOLEUCINE","L-PROLINE","L-TYROSINE","GLYCINE","L-LYSINE (L-LYSINE ACETATE)","SERINE","L-VALINE","L-ALANINE","L-LEUCINE","L-PHENYLALANINE","TRYPTOPHAN","HISTIDINE","METHIONINE","L-THREONINE"],"dose":["690","510","610","44","900","510","300","560","900","660","310","120","210","280","370"],"productID":{"$numberInt":"4560"},"sanitizedRegiestrationNumber":"00523232","productName":"AMINOSYN 7%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-ARGININE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf2"},"numbersOfAis":"1","activeIngredientName":["OXYGEN"],"dose":["100"],"productID":{"$numberInt":"5682"},"sanitizedRegiestrationNumber":"00572810","productName":"OXYGEN 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["OXYGEN"],"atcCode":["V03AN01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYGEN"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf3"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["1"],"productID":{"$numberInt":"5888"},"sanitizedRegiestrationNumber":"00560243","productName":"LIFE VIT C TIMED RELEASE TAB 1000MG","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf4"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"41612"},"sanitizedRegiestrationNumber":"00576050","productName":"TINACTIN AEROSOL POWDER","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Aerosol","Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf5"},"numbersOfAis":"1","activeIngredientName":["BROMOCRIPTINE (BROMOCRIPTINE MESYLATE)"],"dose":["5"],"productID":{"$numberInt":"5155"},"sanitizedRegiestrationNumber":"00568643","productName":"PARLODEL CAP 5MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["BROMOCRIPTINE"],"atcCode":["G02CB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BROMOCRIPTINE (BROMOCRIPTINE MESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf6"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["0.5"],"productID":{"$numberInt":"4472"},"sanitizedRegiestrationNumber":"00548367","productName":"XANAX TAB 0.5MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf7"},"numbersOfAis":"1","activeIngredientName":["TRAZODONE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"5118"},"sanitizedRegiestrationNumber":"00579351","productName":"DESYREL TAB 50MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["TRAZODONE"],"atcCode":["N06AX05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRAZODONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf8"},"numbersOfAis":"1","activeIngredientName":["SCOPOLAMINE HYDROBROMIDE"],"dose":["0.6"],"productID":{"$numberInt":"4788"},"sanitizedRegiestrationNumber":"00541877","productName":"SCOPOLAMINE HYDROBROMIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["SCOPOLAMINE"],"atcCode":["A04AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SCOPOLAMINE HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaf9"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM (MAGNESIUM OXIDE, MAGNESIUM SULFATE)"],"dose":["72.5"],"productID":{"$numberInt":"41589"},"sanitizedRegiestrationNumber":"00568260","productName":"MAGNESIUM CAP","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM (MAGNESIUM OXIDE, MAGNESIUM SULFATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfafa"},"numbersOfAis":"1","activeIngredientName":["SCOPOLAMINE HYDROBROMIDE"],"dose":["0.4"],"productID":{"$numberInt":"4787"},"sanitizedRegiestrationNumber":"00541869","productName":"SCOPOLAMINE HYDROBROMIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["SCOPOLAMINE"],"atcCode":["A04AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SCOPOLAMINE HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfafb"},"numbersOfAis":"2","activeIngredientName":["OXYGEN","CARBON DIOXIDE"],"dose":["95","5"],"productID":{"$numberInt":"5686"},"sanitizedRegiestrationNumber":"00572853","productName":"OXYGEN CARBON DIOXIDE MIXTURE","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYGEN","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfafc"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["25"],"productID":{"$numberInt":"4915"},"sanitizedRegiestrationNumber":"00571237","productName":"APO-DIPYRIDAMOLE-SC TAB 25MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfafd"},"numbersOfAis":"2","activeIngredientName":["HELIUM","OXYGEN"],"dose":["80","20"],"productID":{"$numberInt":"5689"},"sanitizedRegiestrationNumber":"00572896","productName":"HELIUM OXYGEN MIXTURE","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HELIUM","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfafe"},"numbersOfAis":"2","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","SALICYLIC ACID"],"dose":["0.5","30"],"productID":{"$numberInt":"5287"},"sanitizedRegiestrationNumber":"00578436","productName":"DIPROSALIC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["BETAMETHASONE","BETAMETHASONE"],"atcCode":["D07XC01","D07XC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfaff"},"numbersOfAis":"2","activeIngredientName":["VITAMIN A","VITAMIN D"],"dose":["2500","200"],"productID":{"$numberInt":"41600"},"sanitizedRegiestrationNumber":"00572055","productName":"HUILE DE FOIE DE MORUE CAP 20 MIN","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["VITAMIN A AND D IN COMBINATION"],"atcCode":["A11CB"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN A","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP","CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb00"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["250"],"productID":{"$numberInt":"5036"},"sanitizedRegiestrationNumber":"00565350","productName":"TEVA-NAPROXEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb01"},"numbersOfAis":"2","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","SALICYLIC ACID"],"dose":["0.5","20"],"productID":{"$numberInt":"5561"},"sanitizedRegiestrationNumber":"00578428","productName":"DIPROSALIC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["BETAMETHASONE","BETAMETHASONE"],"atcCode":["D07XC01","D07XC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb02"},"numbersOfAis":"2","activeIngredientName":["CHLORPHENIRAMINE MALEATE","PSEUDOEPHEDRINE SULFATE"],"dose":["12","120"],"productID":{"$numberInt":"5154"},"sanitizedRegiestrationNumber":"00576417","productName":"CHLOR-TRIPOLON DECON EXT STR REPETABS 12","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["PSEUDOEPHEDRINE, COMBINATIONS","PSEUDOEPHEDRINE, COMBINATIONS"],"atcCode":["R01BA52","R01BA52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORPHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb03"},"numbersOfAis":"1","activeIngredientName":["COPPER NAPHTHENATE"],"dose":["37.5"],"productID":{"$numberInt":"5165"},"sanitizedRegiestrationNumber":"00574996","productName":"COPPEROX LIQ 37.5%","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COPPER NAPHTHENATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb04"},"numbersOfAis":"1","activeIngredientName":["CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)"],"dose":["1"],"productID":{"$numberInt":"11260"},"sanitizedRegiestrationNumber":"00582301","productName":"DALACIN T 1%","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CLINDAMYCIN"],"atcCode":["D10AF01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb05"},"numbersOfAis":"5","activeIngredientName":["NEATSFOOT OIL","PINE TAR OIL","PHENOL","LANOLIN","OIL OF TURPENTINE"],"dose":["150.4","36","2.7","90","79.1"],"productID":{"$numberInt":"5167"},"sanitizedRegiestrationNumber":"00575038","productName":"HOOF SHIELD","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NEATSFOOT OIL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb06"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"41611"},"sanitizedRegiestrationNumber":"00576042","productName":"TINACTIN POWDER","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1965-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb07"},"numbersOfAis":"1","activeIngredientName":["AIR"],"dose":["100"],"productID":{"$numberInt":"5684"},"sanitizedRegiestrationNumber":"00572837","productName":"MEDICAL AIR 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["MEDICAL AIR"],"atcCode":["V03AN05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AIR"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb08"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"dose":["200"],"productID":{"$numberInt":"10430"},"sanitizedRegiestrationNumber":"00576964","productName":"VITAMINE E CAP 200UNIT","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["TOCOPHEROL (VIT E)"],"atcCode":["A11HA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb09"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"6795"},"sanitizedRegiestrationNumber":"00578452","productName":"VIBRA-TABS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0a"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["10000"],"productID":{"$numberInt":"8043"},"sanitizedRegiestrationNumber":"00579718","productName":"HEPARIN LEO INJ 10000UNIT/ML","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0b"},"numbersOfAis":"1","activeIngredientName":["CIMETIDINE"],"dose":["200"],"productID":{"$numberInt":"5151"},"sanitizedRegiestrationNumber":"00582409","productName":"NOVO-CIMETINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CIMETIDINE"],"atcCode":["A02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIMETIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0c"},"numbersOfAis":"1","activeIngredientName":["PIVAMPICILLIN"],"dose":["500"],"productID":{"$numberInt":"6553"},"sanitizedRegiestrationNumber":"00582247","productName":"PONDOCILLIN TAB 500MG","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["PIVAMPICILLIN"],"atcCode":["J01CA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIVAMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0d"},"numbersOfAis":"1","activeIngredientName":["TRAZODONE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"5119"},"sanitizedRegiestrationNumber":"00579378","productName":"DESYREL TAB 100MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["TRAZODONE"],"atcCode":["N06AX05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRAZODONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0e"},"numbersOfAis":"2","activeIngredientName":["SULFAMETHOXAZOLE","TRIMETHOPRIM"],"dose":["80","16"],"productID":{"$numberInt":"4607"},"sanitizedRegiestrationNumber":"00550078","productName":"BACTRIM ROCHE INJ","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["SULFAMETHOXAZOLE AND TRIMETHOPRIM"],"atcCode":["J01EE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFAMETHOXAZOLE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb0f"},"numbersOfAis":"1","activeIngredientName":["ISOTRETINOIN"],"dose":["40"],"productID":{"$numberInt":"5129"},"sanitizedRegiestrationNumber":"00582352","productName":"ACCUTANE ROCHE","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ISOTRETINOIN"],"atcCode":["D10BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOTRETINOIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb10"},"numbersOfAis":"2","activeIngredientName":["ACETYLSALICYLIC ACID","DIPYRIDAMOLE"],"dose":["330","75"],"productID":{"$numberInt":"5499"},"sanitizedRegiestrationNumber":"00579327","productName":"ASASANTINE CAP","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["B01AC30","B01AC30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETYLSALICYLIC ACID","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb11"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["500"],"productID":{"$numberInt":"3263"},"sanitizedRegiestrationNumber":"00406716","productName":"NOVAMOXIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb12"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["2"],"productID":{"$numberInt":"5197"},"sanitizedRegiestrationNumber":"00587702","productName":"APO HALOPERIDOL LIQ 2MG/ML","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb13"},"numbersOfAis":"1","activeIngredientName":["DINOPROSTONE"],"dose":["0.5"],"productID":{"$numberInt":"2684"},"sanitizedRegiestrationNumber":"00400688","productName":"PROSTIN E2 TABLETS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1977-12-31"],"sanitizedIndication":["DINOPROSTONE"],"atcCode":["G02AD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DINOPROSTONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb14"},"numbersOfAis":"1","activeIngredientName":["FUSIDATE SODIUM"],"dose":["2"],"productID":{"$numberInt":"5639"},"sanitizedRegiestrationNumber":"00586684","productName":"FUCIDIN INTERTULLE 2%","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Dressing"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["FUSIDIC ACID"],"atcCode":["D09AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUSIDATE SODIUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb15"},"numbersOfAis":"1","activeIngredientName":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"dose":["500"],"productID":{"$numberInt":"5182"},"sanitizedRegiestrationNumber":"00583421","productName":"TEVA-CEPHALEXIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CEFALEXIN"],"atcCode":["J01DB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb16"},"numbersOfAis":"3","activeIngredientName":["ACETYLSALICYLIC ACID","PHENYLPROPANOLAMINE HYDROCHLORIDE","CHLORPHENIRAMINE MALEATE"],"dose":["325","12.5","2"],"productID":{"$numberInt":"41613"},"sanitizedRegiestrationNumber":"00580503","productName":"CORICIDIN D TAB","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS","ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BA51","N02BA51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETYLSALICYLIC ACID","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb17"},"numbersOfAis":"11","activeIngredientName":["NICOTINAMIDE","PYRIDOXINE HYDROCHLORIDE","FOLIC ACID","VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)","VITAMIN D","THIAMINE MONONITRATE","VITAMIN B12","VITAMIN C","IRON (FERROUS FUMARATE)","RETINOL PALMITATE","VITAMIN B2"],"dose":["25","2",".1","10","400","3","6","75","15","5000","5"],"productID":{"$numberInt":"4947"},"sanitizedRegiestrationNumber":"00561738","productName":"MULTIPLE VIT PLUS IRON TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NICOTINAMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","UNIT","UNIT","MG","MCG","MG","MG","UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb18"},"numbersOfAis":"1","activeIngredientName":["DIMENHYDRINATE"],"dose":["50"],"productID":{"$numberInt":"3397"},"sanitizedRegiestrationNumber":"00392537","productName":"DIMENHYDRINATE INJ 50MG USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1973-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIMENHYDRINATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb19"},"numbersOfAis":"1","activeIngredientName":["CIMETIDINE"],"dose":["300"],"productID":{"$numberInt":"5152"},"sanitizedRegiestrationNumber":"00582417","productName":"NOVO-CIMETINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CIMETIDINE"],"atcCode":["A02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIMETIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1a"},"numbersOfAis":"2","activeIngredientName":["CHLORPHENIRAMINE MALEATE","ACETYLSALICYLIC ACID"],"dose":["2","325"],"productID":{"$numberInt":"41615"},"sanitizedRegiestrationNumber":"00580511","productName":"CORICIDIN TAB","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1981-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS","ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BA51","N02BA51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORPHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1b"},"numbersOfAis":"9","activeIngredientName":["RETINOL PALMITATE","VITAMIN B2","VITAMIN B12","VITAMIN C","NICOTINAMIDE","THIAMINE MONONITRATE","PYRIDOXINE HYDROCHLORIDE","FOLIC ACID","VITAMIN D"],"dose":["5000","2.5","3","50","20","3","1",".1","400"],"productID":{"$numberInt":"4945"},"sanitizedRegiestrationNumber":"00561703","productName":"CHILDREN'S CHEWABLE MULTI VITAMINS","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["RETINOL PALMITATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MCG","MG","MG","MG","MG","MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1c"},"numbersOfAis":"2","activeIngredientName":["GENTAMICIN (GENTAMICIN SULFATE)","BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)"],"dose":["3","1"],"productID":{"$numberInt":"5315"},"sanitizedRegiestrationNumber":"00586706","productName":"GARASONE OPHTHALMIC OINTMENT","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["BETAMETHASONE AND ANTIINFECTIVES","BETAMETHASONE AND ANTIINFECTIVES"],"atcCode":["S01CA05","S01CA05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GENTAMICIN (GENTAMICIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1d"},"numbersOfAis":"1","activeIngredientName":["MINOXIDIL"],"dose":["2.5"],"productID":{"$numberInt":"4011"},"sanitizedRegiestrationNumber":"00514497","productName":"LONITEN 2.5MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1980-12-31"],"sanitizedIndication":["MINOXIDIL"],"atcCode":["C02DC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MINOXIDIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1e"},"numbersOfAis":"1","activeIngredientName":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"5181"},"sanitizedRegiestrationNumber":"00583413","productName":"TEVA-CEPHALEXIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CEFALEXIN"],"atcCode":["J01DB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb1f"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["325"],"productID":{"$numberInt":"5584"},"sanitizedRegiestrationNumber":"00589241","productName":"ACETAMINOPHEN TAB 325MG","licenseHolderSponser":"DOMINION PHARMACAL","companyCode":[{"$numberInt":"4065"}],"facilityAddress":"SUITE 100 6111, Avenue Royalmount Montreal Quebec Canada H4P 2T4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb20"},"numbersOfAis":"1","activeIngredientName":["TENIPOSIDE"],"dose":["10"],"productID":{"$numberInt":"5995"},"sanitizedRegiestrationNumber":"00588989","productName":"VUMON","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["TENIPOSIDE"],"atcCode":["L01CB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TENIPOSIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb21"},"numbersOfAis":"1","activeIngredientName":["ISOTRETINOIN"],"dose":["10"],"productID":{"$numberInt":"5128"},"sanitizedRegiestrationNumber":"00582344","productName":"ACCUTANE ROCHE","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ISOTRETINOIN"],"atcCode":["D10BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOTRETINOIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb22"},"numbersOfAis":"1","activeIngredientName":["TRICLOCARBAN"],"dose":["1.5"],"productID":{"$numberInt":"41630"},"sanitizedRegiestrationNumber":"00596221","productName":"CLEARSKIN 2 CLEANSING CAKE 1.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Soap Bar"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["OTHER ANTISEPTICS AND DISINFECTANTS"],"atcCode":["D08AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRICLOCARBAN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb23"},"numbersOfAis":"1","activeIngredientName":["KETOTIFEN (KETOTIFEN FUMARATE)"],"dose":["1"],"productID":{"$numberInt":"10832"},"sanitizedRegiestrationNumber":"00577308","productName":"ZADITEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["KETOTIFEN"],"atcCode":["R06AX17"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["KETOTIFEN (KETOTIFEN FUMARATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb24"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["1"],"productID":{"$numberInt":"6134"},"sanitizedRegiestrationNumber":"00591467","productName":"STATEX SYRUP 1MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb25"},"numbersOfAis":"1","activeIngredientName":["FUSIDIC ACID"],"dose":["2"],"productID":{"$numberInt":"5637"},"sanitizedRegiestrationNumber":"00586668","productName":"FUCIDIN CREAM 2%","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["FUSIDIC ACID"],"atcCode":["D06AX01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUSIDIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb26"},"numbersOfAis":"1","activeIngredientName":["FUSIDATE SODIUM"],"dose":["2"],"productID":{"$numberInt":"5638"},"sanitizedRegiestrationNumber":"00586676","productName":"FUCIDIN OINTMENT 2%","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["FUSIDIC ACID"],"atcCode":["D06AX01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUSIDATE SODIUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb27"},"numbersOfAis":"1","activeIngredientName":["MITOMYCIN"],"dose":["20"],"productID":{"$numberInt":"5808"},"sanitizedRegiestrationNumber":"00587710","productName":"MUTAMYCIN INJ 20MG/VIAL","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MITOMYCIN"],"atcCode":["L01DC03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MITOMYCIN"],"sanitizedRouteOfAdministration":["Intravesical","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb28"},"numbersOfAis":"3","activeIngredientName":["CANTHARIDIN","PODOPHYLLIN","SALICYLIC ACID"],"dose":["1","5","30"],"productID":{"$numberInt":"5314"},"sanitizedRegiestrationNumber":"00589500","productName":"CANTHACUR-PS","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["WART AND ANTI-CORN PREPARATIONS"],"atcCode":["D11AF"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CANTHARIDIN","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb29"},"numbersOfAis":"1","activeIngredientName":["CODEINE PHOSPHATE"],"dose":["15"],"productID":{"$numberInt":"6415"},"sanitizedRegiestrationNumber":"00593435","productName":"TEVA-CODEINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CODEINE"],"atcCode":["R05DA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CODEINE PHOSPHATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2a"},"numbersOfAis":"3","activeIngredientName":["CAMPHOR","PHENOL","ZINC OXIDE"],"dose":["142","142","355"],"productID":{"$numberInt":"41632"},"sanitizedRegiestrationNumber":"00587605","productName":"MECCA OINTMENT","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["ZINC PRODUCTS"],"atcCode":["D02AB"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAMPHOR","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["28.4","28.4","28.4"],"qunatityUnit":["G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2b"},"numbersOfAis":"1","activeIngredientName":["AMSACRINE"],"dose":["50"],"productID":{"$numberInt":"5262"},"sanitizedRegiestrationNumber":"00582212","productName":"AMSA PD INJ 50MG/ML","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1983-12-31"],"sanitizedIndication":["AMSACRINE"],"atcCode":["L01XX01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMSACRINE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2c"},"numbersOfAis":"1","activeIngredientName":["GONADORELIN (GONADORELIN HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"5110"},"sanitizedRegiestrationNumber":"00573760","productName":"FACTREL","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GONADORELIN (GONADORELIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2d"},"numbersOfAis":"4","activeIngredientName":["CARBON MONOXIDE","NEON","OXYGEN","NITROGEN"],"dose":["0.3","0.5","21","78.2"],"productID":{"$numberInt":"8185"},"sanitizedRegiestrationNumber":"00588075","productName":"LUNG DIFFUSION TEST MIX NO NE CO","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBON MONOXIDE","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2e"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["150"],"productID":{"$numberInt":"5306"},"sanitizedRegiestrationNumber":"00584274","productName":"SINEQUAN CAP 150MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb2f"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"41608"},"sanitizedRegiestrationNumber":"00576034","productName":"TINACTIN","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1965-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb30"},"numbersOfAis":"1","activeIngredientName":["PLANTAGO SEED"],"dose":["600"],"productID":{"$numberInt":"6808"},"sanitizedRegiestrationNumber":"00584444","productName":"MUCILLOID CAP 600MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["ISPAGHULA (PSYLLA SEEDS)"],"atcCode":["A06AC01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PLANTAGO SEED"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb31"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["5"],"productID":{"$numberInt":"6133"},"sanitizedRegiestrationNumber":"00591475","productName":"STATEX SYRUP 5MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb32"},"numbersOfAis":"1","activeIngredientName":["NITROUS OXIDE"],"dose":["100"],"productID":{"$numberInt":"5685"},"sanitizedRegiestrationNumber":"00572845","productName":"NITROUS OXIDE 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["NITROUS OXIDE"],"atcCode":["N01AX13"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROUS OXIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb33"},"numbersOfAis":"1","activeIngredientName":["QUINIDINE GLUCONATE"],"dose":["325"],"productID":{"$numberInt":"6420"},"sanitizedRegiestrationNumber":"00595934","productName":"APO-QUIN-G TAB 325MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["QUINIDINE"],"atcCode":["C01BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb34"},"numbersOfAis":"1","activeIngredientName":["CARBON DIOXIDE"],"dose":["100"],"productID":{"$numberInt":"5687"},"sanitizedRegiestrationNumber":"00572861","productName":"CARBON DIOXIDE 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["CARBON DIOXIDE"],"atcCode":["V03AN02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBON DIOXIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb35"},"numbersOfAis":"1","activeIngredientName":["VALPROIC ACID (DIVALPROEX SODIUM)"],"dose":["125"],"productID":{"$numberInt":"5676"},"sanitizedRegiestrationNumber":"00596418","productName":"EPIVAL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["VALPROIC ACID"],"atcCode":["N03AG01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VALPROIC ACID (DIVALPROEX SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb36"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["100"],"productID":{"$numberInt":"6379"},"sanitizedRegiestrationNumber":"00590827","productName":"VOLTAREN SR","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb37"},"numbersOfAis":"5","activeIngredientName":["CALCIUM CHLORIDE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM ACETATE","SODIUM CHLORIDE"],"dose":["16.55","74.55","25.4","121","16.05"],"productID":{"$numberInt":"5535"},"sanitizedRegiestrationNumber":"00590215","productName":"TPN ELECTROLYTES","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["COMBINATIONS OF ELECTROLYTES"],"atcCode":["B05XA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb38"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["1"],"productID":{"$numberInt":"7357"},"sanitizedRegiestrationNumber":"00590819","productName":"LOPRESOR INJ 1.0MG/ML","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb39"},"numbersOfAis":"1","activeIngredientName":["CIMETIDINE"],"dose":["600"],"productID":{"$numberInt":"5362"},"sanitizedRegiestrationNumber":"00603686","productName":"NOVO-CIMETINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CIMETIDINE"],"atcCode":["A02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIMETIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3a"},"numbersOfAis":"1","activeIngredientName":["ISOPROPYL ALCOHOL"],"dose":["70"],"productID":{"$numberInt":"5794"},"sanitizedRegiestrationNumber":"00591556","productName":"BIOPROPYL LIQ 70%","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["ISOPROPANOL"],"atcCode":["D08AX05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOPROPYL ALCOHOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3b"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"6754"},"sanitizedRegiestrationNumber":"00594644","productName":"STATEX TAB 10MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3c"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["500"],"productID":{"$numberInt":"5183"},"sanitizedRegiestrationNumber":"00589861","productName":"TEVA-NAPROXEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3d"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["4"],"productID":{"$numberInt":"6053"},"sanitizedRegiestrationNumber":"00575240","productName":"PILOPINE HS 4%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3e"},"numbersOfAis":"1","activeIngredientName":["DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"5430"},"sanitizedRegiestrationNumber":"00596612","productName":"DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPHENHYDRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb3f"},"numbersOfAis":"1","activeIngredientName":["VALPROIC ACID (DIVALPROEX SODIUM)"],"dose":["250"],"productID":{"$numberInt":"5677"},"sanitizedRegiestrationNumber":"00596426","productName":"EPIVAL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["VALPROIC ACID"],"atcCode":["N03AG01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VALPROIC ACID (DIVALPROEX SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb40"},"numbersOfAis":"1","activeIngredientName":["MEDROXYPROGESTERONE ACETATE"],"dose":["150"],"productID":{"$numberInt":"19667"},"sanitizedRegiestrationNumber":"00585092","productName":"DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1995-12-31"],"sanitizedIndication":["MEDROXYPROGESTERONE"],"atcCode":["G03AC06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEDROXYPROGESTERONE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb41"},"numbersOfAis":"1","activeIngredientName":["PIVAMPICILLIN"],"dose":["175"],"productID":{"$numberInt":"10175"},"sanitizedRegiestrationNumber":"00582239","productName":"PONDOCILLIN PWS 175MG/5ML","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PIVAMPICILLIN"],"atcCode":["J01CA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIVAMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb42"},"numbersOfAis":"1","activeIngredientName":["HELIUM"],"dose":["100"],"productID":{"$numberInt":"5688"},"sanitizedRegiestrationNumber":"00572888","productName":"HELIUM 100%","licenseHolderSponser":"AIR LIQUIDE CANADA INC.","companyCode":[{"$numberInt":"8021"}],"facilityAddress":"SUITE 1700 1250 René-Lévesque Ouest Montréal Quebec Canada H3B 5E6","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["2011-12-31"],"sanitizedIndication":["HELIUM"],"atcCode":["V03AN03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HELIUM"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb43"},"numbersOfAis":"1","activeIngredientName":["VALPROIC ACID (DIVALPROEX SODIUM)"],"dose":["500"],"productID":{"$numberInt":"5678"},"sanitizedRegiestrationNumber":"00596434","productName":"EPIVAL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["VALPROIC ACID"],"atcCode":["N03AG01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VALPROIC ACID (DIVALPROEX SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb44"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN"],"dose":["250"],"productID":{"$numberInt":"5828"},"sanitizedRegiestrationNumber":"00603287","productName":"APO AMPI LIQ 250MG/5ML","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb45"},"numbersOfAis":"1","activeIngredientName":["LITHIUM CARBONATE"],"dose":["300"],"productID":{"$numberInt":"6041"},"sanitizedRegiestrationNumber":"00590665","productName":"DURALITH TAB 300MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LITHIUM"],"atcCode":["N05AN01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LITHIUM CARBONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb46"},"numbersOfAis":"2","activeIngredientName":["SPIRONOLACTONE","HYDROCHLOROTHIAZIDE"],"dose":["50","50"],"productID":{"$numberInt":"5316"},"sanitizedRegiestrationNumber":"00594377","productName":"ALDACTAZIDE 50","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SPIRONOLACTONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb47"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["25"],"productID":{"$numberInt":"6753"},"sanitizedRegiestrationNumber":"00594636","productName":"STATEX TABLET 25MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb48"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["500"],"productID":{"$numberInt":"5222"},"sanitizedRegiestrationNumber":"00592277","productName":"APO-NAPROXEN","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb49"},"numbersOfAis":"1","activeIngredientName":["CHLOROXYLENOL"],"dose":["1"],"productID":{"$numberInt":"5438"},"sanitizedRegiestrationNumber":"00592897","productName":"AK-1 1%","licenseHolderSponser":"STERIS CORPORATION","companyCode":[{"$numberInt":"5186"}],"facilityAddress":" 5960 Heisley Road Mentor Ohio United States 44060","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CHLOROXYLENOL"],"atcCode":["D08AE05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLOROXYLENOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4a"},"numbersOfAis":"1","activeIngredientName":["CODEINE PHOSPHATE"],"dose":["30"],"productID":{"$numberInt":"6416"},"sanitizedRegiestrationNumber":"00593451","productName":"TEVA-CODEINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CODEINE"],"atcCode":["R05DA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CODEINE PHOSPHATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4b"},"numbersOfAis":"2","activeIngredientName":["RESORCINOL","SULFUR"],"dose":["1","2"],"productID":{"$numberInt":"41650"},"sanitizedRegiestrationNumber":"00597716","productName":"CLEARSKIN 2 TINTED BLEMISH CRM","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["SULPHUR"],"atcCode":["D10AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["RESORCINOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4c"},"numbersOfAis":"1","activeIngredientName":["KETOTIFEN (KETOTIFEN FUMARATE)"],"dose":["1"],"productID":{"$numberInt":"10860"},"sanitizedRegiestrationNumber":"00600784","productName":"ZADITEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["KETOTIFEN"],"atcCode":["R06AX17"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["KETOTIFEN (KETOTIFEN FUMARATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4d"},"numbersOfAis":"2","activeIngredientName":["BENZYL ALCOHOL","BENZOCAINE"],"dose":["4","2"],"productID":{"$numberInt":"41523"},"sanitizedRegiestrationNumber":"00513857","productName":"FOILLE ONT","licenseHolderSponser":"BLISTEX CORPORATION","companyCode":[{"$numberInt":"3762"}],"facilityAddress":" 6790 Century Ave, Suite 300 Mississauga Ontario Canada L5N 2V8","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["BENZOCAINE","BENZOCAINE"],"atcCode":["D04AB04","D04AB04"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZYL ALCOHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4e"},"numbersOfAis":"1","activeIngredientName":["MORPHINE HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"6540"},"sanitizedRegiestrationNumber":"00607770","productName":"RATIO-MORPHINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb4f"},"numbersOfAis":"1","activeIngredientName":["BUSPIRONE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"10204"},"sanitizedRegiestrationNumber":"00603821","productName":"BUSPAR TAB 10MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["BUSPIRONE"],"atcCode":["N05BE01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUSPIRONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb50"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["250"],"productID":{"$numberInt":"4980"},"sanitizedRegiestrationNumber":"00522651","productName":"APO-NAPROXEN","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb51"},"numbersOfAis":"1","activeIngredientName":["MEXILETINE HYDROCHLORIDE"],"dose":["200"],"productID":{"$numberInt":"6175"},"sanitizedRegiestrationNumber":"00599964","productName":"MEXITIL CAP 200MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MEXILETINE"],"atcCode":["C01BB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEXILETINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb52"},"numbersOfAis":"2","activeIngredientName":["IOXAGLATE MEGLUMINE","IOXAGLATE SODIUM"],"dose":["393","196"],"productID":{"$numberInt":"5554"},"sanitizedRegiestrationNumber":"00603740","productName":"HEXABRIX 320","licenseHolderSponser":"GUERBET","companyCode":[{"$numberInt":"9113"}],"facilityAddress":" Bp 57400 Roissy Cdg Cedex Val-D'Oise France 95943","countryOfOrigin":["France"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["IOXAGLIC ACID"],"atcCode":["V08AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IOXAGLATE MEGLUMINE","Combination"],"sanitizedRouteOfAdministration":["Intravascular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb53"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL DECANOATE"],"dose":["100"],"productID":{"$numberInt":"5478"},"sanitizedRegiestrationNumber":"00599093","productName":"HALDOL LA INJ 100MG/ML","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL DECANOATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb54"},"numbersOfAis":"1","activeIngredientName":["IBUPROFEN"],"dose":["600"],"productID":{"$numberInt":"5917"},"sanitizedRegiestrationNumber":"00585114","productName":"APO IBUPROFEN TAB 600MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["IBUPROFEN"],"atcCode":["M01AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IBUPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb55"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM SULFATE"],"dose":["500"],"productID":{"$numberInt":"5614"},"sanitizedRegiestrationNumber":"00602264","productName":"MAGNESIUM SULFATE INJECTION 50% USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MAGNESIUM SULPHATE","MAGNESIUM SULPHATE"],"atcCode":["B05XA05","B05XA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb56"},"numbersOfAis":"1","activeIngredientName":["METHYLBENZETHONIUM CHLORIDE"],"dose":["0.5"],"productID":{"$numberInt":"41631"},"sanitizedRegiestrationNumber":"00596248","productName":"CLEARSKIN 2 CLEANSING CRM SCRUB 0.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["BENZETHONIUM CHLORIDE"],"atcCode":["D08AJ08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLBENZETHONIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb57"},"numbersOfAis":"2","activeIngredientName":["CALAMINE","DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["8","1"],"productID":{"$numberInt":"41558"},"sanitizedRegiestrationNumber":"00538493","productName":"CALAMINE LOTION WITH ANTIHISTAMINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1981-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["D04AA32"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALAMINE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb58"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL DECANOATE"],"dose":["50"],"productID":{"$numberInt":"5393"},"sanitizedRegiestrationNumber":"00599085","productName":"HALDOL LA INJ 50MG/ML","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL DECANOATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb59"},"numbersOfAis":"1","activeIngredientName":["PODOPHYLLIN"],"dose":["250"],"productID":{"$numberInt":"5764"},"sanitizedRegiestrationNumber":"00598208","productName":"PODOFILM LIQ 250MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["PODOPHYLLOTOXIN"],"atcCode":["D06BB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PODOPHYLLIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5a"},"numbersOfAis":"4","activeIngredientName":["BUTALBITAL","CAFFEINE","ACETYLSALICYLIC ACID","CODEINE PHOSPHATE"],"dose":["50","40","330","30"],"productID":{"$numberInt":"6419"},"sanitizedRegiestrationNumber":"00608181","productName":"TEVA-TECNAL C 1/2","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CODEIN, COMBINATIONS WITH PSYCHOLEPTICS","CODEIN, COMBINATIONS WITH PSYCHOLEPTICS"],"atcCode":["N02AA79","N02AA79"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BUTALBITAL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5b"},"numbersOfAis":"1","activeIngredientName":["PIRENZEPINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"5585"},"sanitizedRegiestrationNumber":"00608998","productName":"GASTROZEPIN TAB 50MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["PIRENZEPINE"],"atcCode":["A02BX03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIRENZEPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5c"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["20"],"productID":{"$numberInt":"6129"},"sanitizedRegiestrationNumber":"00596965","productName":"STATEX SUPPOSITORIES 20MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5d"},"numbersOfAis":"1","activeIngredientName":["INDOMETHACIN"],"dose":["50"],"productID":{"$numberInt":"5919"},"sanitizedRegiestrationNumber":"00611166","productName":"APO INDOMETHACIN CAP 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["INDOMETACIN"],"atcCode":["M01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INDOMETHACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5e"},"numbersOfAis":"1","activeIngredientName":["MEXILETINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"6174"},"sanitizedRegiestrationNumber":"00599956","productName":"MEXITIL CAP 100MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MEXILETINE"],"atcCode":["C01BB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEXILETINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb5f"},"numbersOfAis":"1","activeIngredientName":["CIMETIDINE"],"dose":["400"],"productID":{"$numberInt":"5361"},"sanitizedRegiestrationNumber":"00603678","productName":"NOVO-CIMETINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CIMETIDINE"],"atcCode":["A02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIMETIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb60"},"numbersOfAis":"1","activeIngredientName":["CYCLOPHOSPHAMIDE"],"dose":["1000"],"productID":{"$numberInt":"10385"},"sanitizedRegiestrationNumber":"00602833","productName":"CYTOXAN PWS FOR INJ 1000MG/VIAL","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CYCLOPHOSPHAMIDE"],"atcCode":["L01AA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYCLOPHOSPHAMIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb61"},"numbersOfAis":"1","activeIngredientName":["MORPHINE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"6539"},"sanitizedRegiestrationNumber":"00607762","productName":"RATIO-MORPHINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb62"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["5"],"productID":{"$numberInt":"6755"},"sanitizedRegiestrationNumber":"00594652","productName":"STATEX TAB 5MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb63"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN"],"dose":["125"],"productID":{"$numberInt":"5827"},"sanitizedRegiestrationNumber":"00603260","productName":"APO AMPI LIQ 125MG/5ML","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb64"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.2"],"productID":{"$numberInt":"9858"},"sanitizedRegiestrationNumber":"00584223","productName":"TRANSDERM-NITRO 0.2","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb65"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETAMINOPHEN"],"dose":["5","325"],"productID":{"$numberInt":"5778"},"sanitizedRegiestrationNumber":"00608165","productName":"TEVA-OXYCOCET","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["OXYCODONE AND PARACETAMOL","OXYCODONE AND PARACETAMOL"],"atcCode":["N02AJ17","N02AJ17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb66"},"numbersOfAis":"2","activeIngredientName":["HYDROCORTISONE ACETATE","ZINC SULFATE"],"dose":["10","10"],"productID":{"$numberInt":"6418"},"sanitizedRegiestrationNumber":"00607797","productName":"RATIO-HEMCORT-HC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["C05AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYDROCORTISONE ACETATE","Combination"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb67"},"numbersOfAis":"1","activeIngredientName":["MENADIONE SODIUM BISULFITE"],"dose":["25"],"productID":{"$numberInt":"5510"},"sanitizedRegiestrationNumber":"00600539","productName":"K3 VITE PWS 25MG/GM","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MENADIONE SODIUM BISULFITE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb68"},"numbersOfAis":"3","activeIngredientName":["BUTALBITAL","CAFFEINE","ACETYLSALICYLIC ACID"],"dose":["50","40","330"],"productID":{"$numberInt":"5779"},"sanitizedRegiestrationNumber":"00608211","productName":"TEVA-TECNAL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS"],"atcCode":["N02BA71"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BUTALBITAL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb69"},"numbersOfAis":"1","activeIngredientName":["HYDROQUINONE"],"dose":["2"],"productID":{"$numberInt":"41649"},"sanitizedRegiestrationNumber":"00602736","productName":"BANISHING CREAM","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["HYDROQUINONE"],"atcCode":["D11AX11"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROQUINONE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6a"},"numbersOfAis":"1","activeIngredientName":["DRONABINOL"],"dose":["2.5"],"productID":{"$numberInt":"17209"},"sanitizedRegiestrationNumber":"00611190","productName":"MARINOL","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["DRONABINOL"],"atcCode":["A04AD10"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DRONABINOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6b"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["250"],"productID":{"$numberInt":"5903"},"sanitizedRegiestrationNumber":"00611921","productName":"ASCORBIC ACID INJ 250MG/ML","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6c"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["75"],"productID":{"$numberInt":"5893"},"sanitizedRegiestrationNumber":"00601845","productName":"APO-DIPYRIDAMOLE-SC TAB 75MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6d"},"numbersOfAis":"4","activeIngredientName":["CAFFEINE","ACETYLSALICYLIC ACID","CODEINE PHOSPHATE","BUTALBITAL"],"dose":["40","330","15","50"],"productID":{"$numberInt":"6479"},"sanitizedRegiestrationNumber":"00608203","productName":"TEVA-TECNAL C 1/4","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CODEIN, COMBINATIONS WITH PSYCHOLEPTICS","CODEIN, COMBINATIONS WITH PSYCHOLEPTICS"],"atcCode":["N02AA79","N02AA79"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAFFEINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6e"},"numbersOfAis":"1","activeIngredientName":["SPIRONOLACTONE"],"dose":["25"],"productID":{"$numberInt":"5646"},"sanitizedRegiestrationNumber":"00613215","productName":"TEVA-SPIRONOLACTONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["SPIRONOLACTONE"],"atcCode":["C03DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SPIRONOLACTONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb6f"},"numbersOfAis":"1","activeIngredientName":["INDOMETHACIN"],"dose":["25"],"productID":{"$numberInt":"5918"},"sanitizedRegiestrationNumber":"00611158","productName":"APO INDOMETHACIN CAP 25MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["INDOMETACIN"],"atcCode":["M01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INDOMETHACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb70"},"numbersOfAis":"1","activeIngredientName":["SENNOSIDES"],"dose":["8.6"],"productID":{"$numberInt":"48363"},"sanitizedRegiestrationNumber":"00604402","productName":"GLYSENNID TAB 8.6MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-01-01"],"sanitizedIndication":["SENNA GLYCOSIDES"],"atcCode":["A06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SENNOSIDES"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb71"},"numbersOfAis":"3","activeIngredientName":["DIMETHICONE","MAGNESIUM HYDROXIDE","ALUMINUM HYDROXIDE-MAGNESIUM CARBONATE-CO DRIED GEL"],"dose":["25","100","300"],"productID":{"$numberInt":"5884"},"sanitizedRegiestrationNumber":"00608521","productName":"EMERJEL PLUS TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1966-12-31"],"sanitizedIndication":["ORDINARY SALT COMBINATIONS AND ANTIFLATULENTS"],"atcCode":["A02AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DIMETHICONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb72"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["2"],"productID":{"$numberInt":"41670"},"sanitizedRegiestrationNumber":"00618497","productName":"HEAD & SHOULDERS SHP CRM 2%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb73"},"numbersOfAis":"2","activeIngredientName":["VITAMIN A","VITAMIN D"],"dose":["500000","75000"],"productID":{"$numberInt":"5923"},"sanitizedRegiestrationNumber":"00611840","productName":"VITAMIN A & D INJ","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN A","Combination"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb74"},"numbersOfAis":"1","activeIngredientName":["CAMPHOR"],"dose":["200"],"productID":{"$numberInt":"5880"},"sanitizedRegiestrationNumber":"00613908","productName":"CAMPHOR INJ 200MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAMPHOR"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb75"},"numbersOfAis":"2","activeIngredientName":["CASCARA SAGRADA","PHENOLPHTHALEIN"],"dose":["10","100"],"productID":{"$numberInt":"5741"},"sanitizedRegiestrationNumber":"00595764","productName":"LE 100 B","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CONTACT LAXATIVES IN COMBINATION"],"atcCode":["A06AB20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CASCARA SAGRADA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb76"},"numbersOfAis":"1","activeIngredientName":["IRON (IRON DEXTRAN COMPLEX)"],"dose":["100"],"productID":{"$numberInt":"5924"},"sanitizedRegiestrationNumber":"00611891","productName":"IRON DEXTRAN INJ 100MG/ML","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IRON (IRON DEXTRAN COMPLEX)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb77"},"numbersOfAis":"1","activeIngredientName":["SODIUM ASCORBATE"],"dose":["250"],"productID":{"$numberInt":"5901"},"sanitizedRegiestrationNumber":"00611867","productName":"SODIUM ASCORBATE INJ 250MG/ML","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM ASCORBATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb78"},"numbersOfAis":"1","activeIngredientName":["CYCLOPHOSPHAMIDE"],"dose":["2000"],"productID":{"$numberInt":"10386"},"sanitizedRegiestrationNumber":"00602949","productName":"CYTOXAN PWS FOR INJ 2000MG/VIAL","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CYCLOPHOSPHAMIDE"],"atcCode":["L01AA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYCLOPHOSPHAMIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb79"},"numbersOfAis":"2","activeIngredientName":["HYDROCORTISONE ACETATE","ZINC SULFATE"],"dose":["0.5","0.5"],"productID":{"$numberInt":"6417"},"sanitizedRegiestrationNumber":"00607789","productName":"RATIO-HEMCORT-HC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["C05AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYDROCORTISONE ACETATE","Combination"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7a"},"numbersOfAis":"2","activeIngredientName":["SPIRONOLACTONE","HYDROCHLOROTHIAZIDE"],"dose":["25","25"],"productID":{"$numberInt":"5858"},"sanitizedRegiestrationNumber":"00613231","productName":"TEVA-SPIRONOLACTONE/HCTZ","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SPIRONOLACTONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7b"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"dose":["800"],"productID":{"$numberInt":"4949"},"sanitizedRegiestrationNumber":"00562815","productName":"VITAMIN E CAP 800UNIT","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["TOCOPHEROL (VIT E)"],"atcCode":["A11HA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7c"},"numbersOfAis":"1","activeIngredientName":["PROPAFENONE HYDROCHLORIDE"],"dose":["300"],"productID":{"$numberInt":"8465"},"sanitizedRegiestrationNumber":"00603716","productName":"RYTHMOL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PROPAFENONE"],"atcCode":["C01BC03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPAFENONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7d"},"numbersOfAis":"1","activeIngredientName":["DEXTROSE"],"dose":["50"],"productID":{"$numberInt":"5664"},"sanitizedRegiestrationNumber":"00611263","productName":"DEXTROSE 50% SOLN","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROSE"],"sanitizedRouteOfAdministration":["Intravenous","Intraperitoneal"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7e"},"numbersOfAis":"18","activeIngredientName":["TYROSINE","L-ALANINE","SODIUM CHLORIDE","HISTIDINE","TRYPTOPHAN","VALINE","SERINE","THREONINE","GLYCINE","POTASSIUM PHOSPHATE DIBASIC","METHIONINE","PHENYLALANINE","ARGININE","LYSINE (LYSINE ACETATE)","PROLINE","MAGNESIUM CHLORIDE","ISOLEUCINE","LEUCINE"],"dose":["44","1.1","410","260","150","680","370","460","1.1","522","340","380","850","624","750","102","620","810"],"productID":{"$numberInt":"5891"},"sanitizedRegiestrationNumber":"00613339","productName":"AMINOSYN 8.5% INJECTION WITH ELECTROLYTES","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TYROSINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb7f"},"numbersOfAis":"1","activeIngredientName":["SODIUM IODIDE"],"dose":["200"],"productID":{"$numberInt":"5621"},"sanitizedRegiestrationNumber":"00610569","productName":"SODIUM IODIDE 20% INJ","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM IODIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb80"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["100"],"productID":{"$numberInt":"5819"},"sanitizedRegiestrationNumber":"00618640","productName":"APO METOPROLOL TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb81"},"numbersOfAis":"15","activeIngredientName":["SERINE","L-VALINE","L-LYSINE (L-LYSINE ACETATE)","L-PROLINE","METHIONINE","L-ARGININE","L-PHENYLALANINE","L-TYROSINE","L-ALANINE","L-ISOLEUCINE","TRYPTOPHAN","L-LEUCINE","HISTIDINE","L-THREONINE","GLYCINE"],"dose":["370","680","624","750","340","850","380","44","1.1","620","150","810","260","460","1.1"],"productID":{"$numberInt":"5890"},"sanitizedRegiestrationNumber":"00613320","productName":"AMINOSYN 8.5%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SERINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","G"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb82"},"numbersOfAis":"18","activeIngredientName":["VITAMIN B2","VITAMIN D","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","IODINE (POTASSIUM IODIDE)","FOLIC ACID","NICOTINAMIDE","BIOTIN","IRON (FERROUS FUMARATE)","VITAMIN A (RETINOL PALMITATE)","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN B12","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","COPPER (COPPER SULFATE)","VITAMIN C","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","MAGNESIUM (MAGNESIUM OXIDE)","VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"dose":["2.6","400","125",".15",".1","20","45","10","5000","2.25","9","162","2","90","3","10","100","25"],"productID":{"$numberInt":"11335"},"sanitizedRegiestrationNumber":"00611727","productName":"VITOGEN SPECTRUM TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B2","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT","MG","MG","MG","MG","MCG","MG","UNIT","MG","MCG","MG","MG","MG","MG","MG","MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb83"},"numbersOfAis":"6","activeIngredientName":["NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL"],"dose":["0.5","0.035","0.75","0.035","1","0.035"],"productID":{"$numberInt":"5483"},"sanitizedRegiestrationNumber":"00602965","productName":"ORTHO 7/7/7 TABLETS (28 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["NORETHISTERONE AND ESTROGEN"],"atcCode":["G03AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NORETHINDRONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb84"},"numbersOfAis":"1","activeIngredientName":["DRONABINOL"],"dose":["5"],"productID":{"$numberInt":"17207"},"sanitizedRegiestrationNumber":"00611204","productName":"MARINOL","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["DRONABINOL"],"atcCode":["A04AD10"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DRONABINOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb85"},"numbersOfAis":"4","activeIngredientName":["CHLORTETRACYCLINE HYDROCHLORIDE","SULFAMETHAZINE","VITAMIN A (VITAMIN A ACETATE, RETINOL PALMITATE)","VITAMIN D3 (CHOLECALCIFEROL)"],"dose":["4.4","4.4","550000","55000"],"productID":{"$numberInt":"6216"},"sanitizedRegiestrationNumber":"00613983","productName":"AUREO S-700 BEEF CATTLE VITAMIN PREMIX CRUMBLES","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1967-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORTETRACYCLINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","UNIT","UNIT"],"quantityNeedToTake":["","","",""],"qunatityUnit":["Kg","Kg","Kg","Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb86"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["10"],"productID":{"$numberInt":"41636"},"sanitizedRegiestrationNumber":"00614238","productName":"TINACTIN JOCK ITCH TOP AER PWR 10MG/GM","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb87"},"numbersOfAis":"1","activeIngredientName":["TOBRAMYCIN"],"dose":["0.3"],"productID":{"$numberInt":"5707"},"sanitizedRegiestrationNumber":"00614254","productName":"TOBREX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["TOBRAMYCIN"],"atcCode":["S01AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOBRAMYCIN"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb88"},"numbersOfAis":"2","activeIngredientName":["DOPAMINE HYDROCHLORIDE","DEXTROSE"],"dose":["1.6","50"],"productID":{"$numberInt":"6768"},"sanitizedRegiestrationNumber":"00619698","productName":"DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOPAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb89"},"numbersOfAis":"6","activeIngredientName":["NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL","NORETHINDRONE","ETHINYL ESTRADIOL"],"dose":["0.5","0.035","0.75","0.035","1","0.035"],"productID":{"$numberInt":"5482"},"sanitizedRegiestrationNumber":"00602957","productName":"ORTHO 7/7/7 TABLETS (21 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["NORETHISTERONE AND ESTROGEN"],"atcCode":["G03AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NORETHINDRONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8a"},"numbersOfAis":"1","activeIngredientName":["PREDNISONE"],"dose":["1"],"productID":{"$numberInt":"5826"},"sanitizedRegiestrationNumber":"00598194","productName":"APO PREDNISONE TAB 1MG USP","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["PREDNISONE"],"atcCode":["H02AB07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8b"},"numbersOfAis":"1","activeIngredientName":["NADOLOL"],"dose":["40"],"productID":{"$numberInt":"5670"},"sanitizedRegiestrationNumber":"00607126","productName":"CORGARD TAB 40MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["NADOLOL"],"atcCode":["C07AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NADOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8c"},"numbersOfAis":"1","activeIngredientName":["PROMETHAZINE (PROMETHAZINE HYDROCHLORIDE)"],"dose":["25"],"productID":{"$numberInt":"5089"},"sanitizedRegiestrationNumber":"00567434","productName":"PROMETHAZINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["PROMETHAZINE"],"atcCode":["R06AD02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROMETHAZINE (PROMETHAZINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8d"},"numbersOfAis":"2","activeIngredientName":["ETHYL ETHER","IODINE"],"dose":["6","1.9"],"productID":{"$numberInt":"5879"},"sanitizedRegiestrationNumber":"00613045","productName":"UNI BLIS INJ","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ETHYL ETHER","Combination"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8e"},"numbersOfAis":"1","activeIngredientName":["THIAMINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"6277"},"sanitizedRegiestrationNumber":"00613924","productName":"VITAMIN B1 INJ 100MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb8f"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN"],"dose":["250"],"productID":{"$numberInt":"5595"},"sanitizedRegiestrationNumber":"00603279","productName":"APO AMPI CAPSULES 250MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb90"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["20"],"productID":{"$numberInt":"6131"},"sanitizedRegiestrationNumber":"00621935","productName":"STATEX DROPS 20MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb91"},"numbersOfAis":"3","activeIngredientName":["MENTHOL","EUCALYPTUS OIL","CAMPHOR"],"dose":["2.8","1.3","5"],"productID":{"$numberInt":"41651"},"sanitizedRegiestrationNumber":"00625965","productName":"MENTHOLATUM EXTRA STRENGTH ONT","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["Other cold preparations"],"atcCode":["R05X"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MENTHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb92"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN"],"dose":["500"],"productID":{"$numberInt":"5596"},"sanitizedRegiestrationNumber":"00603295","productName":"APO AMPI CAPSULES 500MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb93"},"numbersOfAis":"1","activeIngredientName":["LASALOCID SODIUM"],"dose":["150"],"productID":{"$numberInt":"5697"},"sanitizedRegiestrationNumber":"00598925","productName":"AVATEC PREMIX 150GM/KG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LASALOCID SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb94"},"numbersOfAis":"25","activeIngredientName":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)","FOLIC ACID","VITAMIN B2","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","VITAMIN D","BIOTIN","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","IRON (FERROUS FUMARATE)","MAGNESIUM (MAGNESIUM OXIDE)","COPPER (COPPER SULFATE)","MANGANESE (MANGANESE CHLORIDE)","POTASSIUM (POTASSIUM CHLORIDE)","CHROMIUM (CHROMIC CHLORIDE)","MOLYBDENUM (SODIUM MOLYBDATE)","VITAMIN A (RETINOL PALMITATE)","SELENIUM (YEAST)","ZINC (ZINC SULFATE)","IODINE (POTASSIUM IODIDE)","CHLORINE (POTASSIUM CHLORIDE)","VITAMIN C","VITAMIN B1 (THIAMINE MONONITRATE)","NICOTINAMIDE","VITAMIN B12"],"dose":["30",".4","2.6","3","400","45","10","162","125","10","100","2","5","30",".025",".025","5000",".025","15",".15","27.2","90","2.25","20","9"],"productID":{"$numberInt":"10812"},"sanitizedRegiestrationNumber":"00611735","productName":"VITOGEN SPECTRUM FORTE TAB","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","MG","UNIT","MCG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","UNIT","MG","MG","MG","MG","MG","MG","MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb95"},"numbersOfAis":"1","activeIngredientName":["TRIPELENNAMINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"6729"},"sanitizedRegiestrationNumber":"00623504","productName":"PYRIBENZAMINE TAB 50MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2047-12-31"],"sanitizedIndication":["TRIPELENNAMINE"],"atcCode":["R06AC04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIPELENNAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb96"},"numbersOfAis":"1","activeIngredientName":["STREPTOZOCIN"],"dose":["1"],"productID":{"$numberInt":"6166"},"sanitizedRegiestrationNumber":"00622141","productName":"ZANOSAR STERILE POWDER","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["STREPTOZOCIN"],"atcCode":["L01AD04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["STREPTOZOCIN"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb97"},"numbersOfAis":"2","activeIngredientName":["ACETAMINOPHEN","CODEINE PHOSPHATE"],"dose":["300","60"],"productID":{"$numberInt":"6824"},"sanitizedRegiestrationNumber":"00621463","productName":"TEVA-LENOLTEC NO. 4","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["CODEINE AND PARACETAMOL","CODEINE AND PARACETAMOL"],"atcCode":["N02AJ06","N02AJ06"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb98"},"numbersOfAis":"1","activeIngredientName":["DEXTROSE"],"dose":["13.3"],"productID":{"$numberInt":"5955"},"sanitizedRegiestrationNumber":"00613452","productName":"DEXTROSE INJ 13.3%","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CARBOHYDRATES"],"atcCode":["B05BA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROSE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb99"},"numbersOfAis":"2","activeIngredientName":["DOMIPHEN BROMIDE","DIBUCAINE"],"dose":["0.05","0.5"],"productID":{"$numberInt":"7153"},"sanitizedRegiestrationNumber":"00623407","productName":"NUPERCAINAL ANTISEPTIC CREAM","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1967-12-31"],"sanitizedIndication":["CINCHOCAINE"],"atcCode":["D04AB02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOMIPHEN BROMIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9a"},"numbersOfAis":"2","activeIngredientName":["SODIUM MONOFLUOROPHOSPHATE","POTASSIUM NITRATE"],"dose":[".8","5"],"productID":{"$numberInt":"41662"},"sanitizedRegiestrationNumber":"00624098","productName":"SENSODYNE-F FLUORIDE TOOTHPASTE","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Toothpaste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["SODIUM MONOFLUOROPHOSPHATE, COMBINATIONS"],"atcCode":["A01AA52"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM MONOFLUOROPHOSPHATE","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9b"},"numbersOfAis":"12","activeIngredientName":["VITAMIN C","NICOTINAMIDE","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","FOLIC ACID","VITAMIN B2","BIOTIN","ZINC (ZINC SULFATE)","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN B12","COPPER (CUPRIC OXIDE)"],"dose":["600","100","25","6","30",".4","10","45","23.9","22","12","3"],"productID":{"$numberInt":"6083"},"sanitizedRegiestrationNumber":"00630845","productName":"SUPRAVITE STRESS AVEC VIT E CUIVRE ET ZINC","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN C","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","UNIT","MG","MG","MCG","MG","MG","MCG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9c"},"numbersOfAis":"2","activeIngredientName":["DOPAMINE HYDROCHLORIDE","DEXTROSE"],"dose":["0.8","50"],"productID":{"$numberInt":"6769"},"sanitizedRegiestrationNumber":"00619701","productName":"DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOPAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9d"},"numbersOfAis":"4","activeIngredientName":["CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","SODIUM CHLORIDE"],"dose":["0.176","3.253","1.193","6.43"],"productID":{"$numberInt":"5950"},"sanitizedRegiestrationNumber":"00625663","productName":"PLEGISOL","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["ELECTROLYTES"],"atcCode":["B05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Instillation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9e"},"numbersOfAis":"1","activeIngredientName":["BETA-CAROTENE"],"dose":["10000"],"productID":{"$numberInt":"6759"},"sanitizedRegiestrationNumber":"00628840","productName":"BETA CAROTENE CAP 10000UNIT","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BETA-CAROTENE"],"atcCode":["A11CA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETA-CAROTENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfb9f"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["10"],"productID":{"$numberInt":"45892"},"sanitizedRegiestrationNumber":"00622354","productName":"HEPARIN SODIUM 5000UNIT/500ML IN SODIUM CHLORIDE 0.9%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1998-06-05"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba0"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETYLSALICYLIC ACID"],"dose":["5","325"],"productID":{"$numberInt":"5777"},"sanitizedRegiestrationNumber":"00608157","productName":"TEVA-OXYCODAN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["OXYCODONE AND ACETYLSALICYLIC ACID","OXYCODONE AND ACETYLSALICYLIC ACID"],"atcCode":["N02AJ18","N02AJ18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba1"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["10"],"productID":{"$numberInt":"4910"},"sanitizedRegiestrationNumber":"00565040","productName":"FUROSEMIDE INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba2"},"numbersOfAis":"1","activeIngredientName":["IBUPROFEN"],"dose":["400"],"productID":{"$numberInt":"6322"},"sanitizedRegiestrationNumber":"00629340","productName":"NOVO-PROFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["IBUPROFEN"],"atcCode":["M01AE01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IBUPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba3"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"7421"},"sanitizedRegiestrationNumber":"00617288","productName":"MORPHINE HP 50 - 50MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba4"},"numbersOfAis":"5","activeIngredientName":["PROPYLENE GLYCOL","CHOLINE CHLORIDE","POTASSIUM IODIDE","ETHYLENEDIAMINE DIHYDROIODIDE","COBALT SULFATE"],"dose":[".67","20","1.76",".44","1"],"productID":{"$numberInt":"5925"},"sanitizedRegiestrationNumber":"00616117","productName":"DOMCOL SOLUTION","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PROPYLENE GLYCOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["ML","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba5"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":[".05"],"productID":{"$numberInt":"6713"},"sanitizedRegiestrationNumber":"00623458","productName":"OTRIVIN PEDIATRIC DECONGESTANT NOSE DROPS","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba6"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["375"],"productID":{"$numberInt":"5860"},"sanitizedRegiestrationNumber":"00627097","productName":"TEVA-NAPROXEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba7"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM ACETATE"],"dose":["2"],"productID":{"$numberInt":"5817"},"sanitizedRegiestrationNumber":"00613444","productName":"POTASSIUM ACETATE INJ 2MEQ/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["POTASSIUM ACETATE"],"atcCode":["B05XA17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM ACETATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["mEq"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba8"},"numbersOfAis":"1","activeIngredientName":["PROPAFENONE HYDROCHLORIDE"],"dose":["150"],"productID":{"$numberInt":"8464"},"sanitizedRegiestrationNumber":"00603708","productName":"RYTHMOL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PROPAFENONE"],"atcCode":["C01BC03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPAFENONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfba9"},"numbersOfAis":"2","activeIngredientName":["PHENYLEPHRINE HYDROCHLORIDE","TROPICAMIDE"],"dose":["5.0","0.8"],"productID":{"$numberInt":"6057"},"sanitizedRegiestrationNumber":"00629693","productName":"PHENYLTROPE  OPH SOLN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["TROPICAMIDE, COMBINATIONS"],"atcCode":["S01FA56"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLEPHRINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbaa"},"numbersOfAis":"1","activeIngredientName":["DIBUCAINE"],"dose":["1"],"productID":{"$numberInt":"7287"},"sanitizedRegiestrationNumber":"00623385","productName":"NUPERCAINAL ANESTHETIC OINTMENT 1%","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2044-12-31"],"sanitizedIndication":["CINCHOCAINE"],"atcCode":["C05AD04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIBUCAINE"],"sanitizedRouteOfAdministration":["Topical","Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbab"},"numbersOfAis":"1","activeIngredientName":["GUAIFENESIN"],"dose":["100"],"productID":{"$numberInt":"41989"},"sanitizedRegiestrationNumber":"00609951","productName":"BALMINIL EXPECTORANT (SUCROSE FREE)","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["GUAIFENESIN"],"atcCode":["R05CA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GUAIFENESIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbac"},"numbersOfAis":"1","activeIngredientName":["IBUPROFEN"],"dose":["300"],"productID":{"$numberInt":"6321"},"sanitizedRegiestrationNumber":"00629332","productName":"NOVO-PROFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"sanitizedIndication":["IBUPROFEN"],"atcCode":["M01AE01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IBUPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbad"},"numbersOfAis":"11","activeIngredientName":["FOLIC ACID","NICOTINAMIDE","BIOTIN","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN B2","VITAMIN B12","IRON (FERROUS FUMARATE)","VITAMIN C","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)"],"dose":[".4","100","45","30","15","12","27","600","16","6","20"],"productID":{"$numberInt":"6084"},"sanitizedRegiestrationNumber":"00630853","productName":"SUPRAVITE STRESS AVEC VIT E ET FER","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["FOLIC ACID","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MCG","UNIT","MG","MCG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbae"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["125"],"productID":{"$numberInt":"5824"},"sanitizedRegiestrationNumber":"00628131","productName":"APO-AMOXI","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Powder For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbaf"},"numbersOfAis":"2","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","CLOTRIMAZOLE"],"dose":["0.05","1"],"productID":{"$numberInt":"10748"},"sanitizedRegiestrationNumber":"00611174","productName":"LOTRIDERM CREAM","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["IMIDAZOLES/TRIAZOLES IN COMBINATION WITH CORTICOSTEROIDS","IMIDAZOLES/TRIAZOLES IN COMBINATION WITH CORTICOSTEROIDS"],"atcCode":["D01AC20","D01AC20"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb0"},"numbersOfAis":"2","activeIngredientName":["ALUMINUM CHLORIDE","ALUMINUM CHLOROHYDRATE"],"dose":["2","20"],"productID":{"$numberInt":"41690"},"sanitizedRegiestrationNumber":"00629065","productName":"YOUTH DEW ROLL ON ANTIPERSP DEOD LOT","licenseHolderSponser":"ESTEE LAUDER DIST","companyCode":[{"$numberInt":"5490"}],"facilityAddress":" 550 Petrolia Road Toronto Ontario Canada M3J 2W3","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALUMINUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb1"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN SODIUM"],"dose":["500"],"productID":{"$numberInt":"5673"},"sanitizedRegiestrationNumber":"00618284","productName":"APO CLOXI CAP 500MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb2"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["500"],"productID":{"$numberInt":"5823"},"sanitizedRegiestrationNumber":"00628123","productName":"APO-AMOXI","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb3"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"5822"},"sanitizedRegiestrationNumber":"00628115","productName":"APO-AMOXI","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb4"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["2.5"],"productID":{"$numberInt":"6807"},"sanitizedRegiestrationNumber":"00630535","productName":"ISOPTIN INJ 2.5MG/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb5"},"numbersOfAis":"1","activeIngredientName":["MISOPROSTOL"],"dose":["200"],"productID":{"$numberInt":"6786"},"sanitizedRegiestrationNumber":"00632600","productName":"CYTOTEC 200 MCG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MISOPROSTOL"],"atcCode":["A02BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MISOPROSTOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb6"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B12"],"dose":["1"],"productID":{"$numberInt":"6563"},"sanitizedRegiestrationNumber":"00613940","productName":"VITAMIN B12 INJ 1000MCG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B12"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb7"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["1"],"productID":{"$numberInt":"6135"},"sanitizedRegiestrationNumber":"00637742","productName":"TEVA-LORAZEPAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb8"},"numbersOfAis":"1","activeIngredientName":["TOLMETIN (TOLMETIN SODIUM)"],"dose":["600"],"productID":{"$numberInt":"7516"},"sanitizedRegiestrationNumber":"00632740","productName":"TOLECTIN TAB 600MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["TOLMETIN"],"atcCode":["M01AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLMETIN (TOLMETIN SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbb9"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","DEXTROSE","CALCIUM CHLORIDE","SODIUM CHLORIDE","SODIUM LACTATE"],"dose":["5.08","4.25","25.7","538","448"],"productID":{"$numberInt":"7257"},"sanitizedRegiestrationNumber":"00634123","productName":"INPERSOL LM W 4.25% DEXTROSE","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbba"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["2"],"productID":{"$numberInt":"5937"},"sanitizedRegiestrationNumber":"00627100","productName":"DILAUDID","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbbb"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["20"],"productID":{"$numberInt":"6896"},"sanitizedRegiestrationNumber":"00632716","productName":"FELDENE SUP 20MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbbc"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["10"],"productID":{"$numberInt":"41635"},"sanitizedRegiestrationNumber":"00614211","productName":"TINACTIN JOCK ITCH CRM 10MG/GM","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbbd"},"numbersOfAis":"1","activeIngredientName":["PREDNISOLONE ACETATE"],"dose":["1"],"productID":{"$numberInt":"6362"},"sanitizedRegiestrationNumber":"00622931","productName":"AK TATE  OPH SUS 1%","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PREDNISOLONE"],"atcCode":["S01BA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbbe"},"numbersOfAis":"1","activeIngredientName":["PREDNISOLONE ACETATE"],"dose":["50"],"productID":{"$numberInt":"5744"},"sanitizedRegiestrationNumber":"00616923","productName":"UNI PRED 50 INJ 50MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intra-Articular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbbf"},"numbersOfAis":"1","activeIngredientName":["ISOPROPYL ALCOHOL"],"dose":["70"],"productID":{"$numberInt":"6181"},"sanitizedRegiestrationNumber":"00636835","productName":"ISOPROPYL RUBBING ALCOHOL 70% V/V","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["ISOPROPANOL"],"atcCode":["D08AX05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOPROPYL ALCOHOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc0"},"numbersOfAis":"10","activeIngredientName":["ISOLEUCINE","METHIONINE","THREONINE","VALINE","HISTIDINE","LEUCINE","PHENYLALANINE","TRYPTOPHAN","LYSINE (LYSINE ACETATE)","ARGININE"],"dose":["462","726","330","528","429","726","726","165","535","600"],"productID":{"$numberInt":"7163"},"sanitizedRegiestrationNumber":"00640131","productName":"AMINOSYN RF INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ISOLEUCINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc1"},"numbersOfAis":"1","activeIngredientName":["ETOPOSIDE"],"dose":["50"],"productID":{"$numberInt":"5963"},"sanitizedRegiestrationNumber":"00616192","productName":"VEPESID","licenseHolderSponser":"CHEPLAPHARM ARZNEIMITTEL GMBH","companyCode":[{"$numberInt":"15812"}],"facilityAddress":" Ziegelhof 24 Greifswald Mecklenburg-Vorpommern Germany 17489","countryOfOrigin":["Germany"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["ETOPOSIDE"],"atcCode":["L01CB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETOPOSIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Label (Pharmaceutical)| Package (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc2"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":[".05"],"productID":{"$numberInt":"6600"},"sanitizedRegiestrationNumber":"00623466","productName":"OTRIVIN PEDIATRIC NASAL SPRAY 0.05%","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc3"},"numbersOfAis":"1","activeIngredientName":["BACLOFEN"],"dose":["20"],"productID":{"$numberInt":"6244"},"sanitizedRegiestrationNumber":"00636576","productName":"LIORESAL D.S. TAB 20MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["BACLOFEN"],"atcCode":["M03BX01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BACLOFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc4"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","CALCIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["448","25.7","1.5","538","5.08"],"productID":{"$numberInt":"6870"},"sanitizedRegiestrationNumber":"00634115","productName":"INPERSOL LM W 1.5% DEXTROSE","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","G","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc5"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["50"],"productID":{"$numberInt":"6461"},"sanitizedRegiestrationNumber":"00632724","productName":"VOLTAREN","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc6"},"numbersOfAis":"2","activeIngredientName":["THEOPHYLLINE","DEXTROSE"],"dose":["0.8","5.0"],"productID":{"$numberInt":"6767"},"sanitizedRegiestrationNumber":"00640093","productName":"THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["THEOPHYLLINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["R03DA54"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["THEOPHYLLINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","%"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc7"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["10"],"productID":{"$numberInt":"6895"},"sanitizedRegiestrationNumber":"00632708","productName":"FELDENE SUP 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc8"},"numbersOfAis":"9","activeIngredientName":["D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE, RIBOFLAVIN-5-PHOSPHATE)","VITAMIN C","VITAMIN A","VITAMIN D","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN B1 (THIAMINE HYDROCHLORIDE)","VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE)","NICOTINAMIDE","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["2.6","100","1000","100","1","4.5","1","10","1.2"],"productID":{"$numberInt":"5613"},"sanitizedRegiestrationNumber":"00586315","productName":"MULTI 1000","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["MULTIVITAMINS, PLAIN"],"atcCode":["A11BA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE, RIBOFLAVIN-5-PHOSPHATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","UNIT","UNIT","UNIT","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbc9"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["500"],"productID":{"$numberInt":"5345"},"sanitizedRegiestrationNumber":"00589233","productName":"ACETAMINOPHEN EXTRA STRENGTH TAB 500MG","licenseHolderSponser":"DOMINION PHARMACAL","companyCode":[{"$numberInt":"4065"}],"facilityAddress":"SUITE 100 6111, Avenue Royalmount Montreal Quebec Canada H4P 2T4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbca"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["500"],"productID":{"$numberInt":"6086"},"sanitizedRegiestrationNumber":"00638676","productName":"PROCAN SR","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbcb"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"6088"},"sanitizedRegiestrationNumber":"00638692","productName":"PROCAN SR","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbcc"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["5"],"productID":{"$numberInt":"6720"},"sanitizedRegiestrationNumber":"00637734","productName":"PERSANTINE","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbcd"},"numbersOfAis":"1","activeIngredientName":["DEXTROSE"],"dose":["333"],"productID":{"$numberInt":"5474"},"sanitizedRegiestrationNumber":"00579440","productName":"DEXTROSE 33.3% IN WATER INJ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1983-12-31"],"sanitizedIndication":["CARBOHYDRATES"],"atcCode":["B05BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROSE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbce"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"8917"},"sanitizedRegiestrationNumber":"00647217","productName":"STATEX SYRUP 10MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbcf"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["10"],"productID":{"$numberInt":"6714"},"sanitizedRegiestrationNumber":"00642886","productName":"APO PIROXICAM CAP 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd0"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN SODIUM"],"dose":["250"],"productID":{"$numberInt":"5674"},"sanitizedRegiestrationNumber":"00618292","productName":"APO CLOXI CAP 250MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd1"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN V POTASSIUM"],"dose":["300"],"productID":{"$numberInt":"6423"},"sanitizedRegiestrationNumber":"00642231","productName":"APO PEN VK","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PHENOXYMETHYLPENICILLIN"],"atcCode":["J01CE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN V POTASSIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd2"},"numbersOfAis":"10","activeIngredientName":["VITAMIN B2","VITAMIN B12","VITAMIN C","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","FOLIC ACID","NICOTINAMIDE","BIOTIN","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"dose":["15","12","600","16","6","20",".4","100","45","30"],"productID":{"$numberInt":"6085"},"sanitizedRegiestrationNumber":"00630861","productName":"SUPRAVITE STRESS AVEC VIT E","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, OTHER COMBINATIONS","VITAMIN B-COMPLEX, OTHER COMBINATIONS"],"atcCode":["A11EX","A11EX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B2","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG","MG","MG","MG","MG","MG","MG","MCG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd3"},"numbersOfAis":"1","activeIngredientName":["IBUPROFEN"],"dose":["600"],"productID":{"$numberInt":"6323"},"sanitizedRegiestrationNumber":"00629359","productName":"TEVA-PROFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["IBUPROFEN"],"atcCode":["M01AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IBUPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd4"},"numbersOfAis":"1","activeIngredientName":["TUBOCURARINE CHLORIDE"],"dose":["3"],"productID":{"$numberInt":"6546"},"sanitizedRegiestrationNumber":"00640786","productName":"TUBOCURARINE CHLORIDE INJ 3MG/ML USP","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["TUBOCURARINE"],"atcCode":["M03AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TUBOCURARINE CHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd5"},"numbersOfAis":"11","activeIngredientName":["STREPTOMYCIN (STREPTOMYCIN SULFATE)","VITAMIN D3","VITAMIN B12","PYRIDOXINE HYDROCHLORIDE","VITAMIN B2","NICOTINIC ACID","MENADIONE","CALCIUM D-PANTOTHENATE","PENICILLIN G POTASSIUM","VITAMIN A","VITAMIN E"],"dose":["10.65","234300","227","298","312","2.343","710","710","5008340","710000","710"],"productID":{"$numberInt":"6289"},"sanitizedRegiestrationNumber":"00653195","productName":"COMBIOTIC VITAMIN BOOSTER PWS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1975-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["STREPTOMYCIN (STREPTOMYCIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","UNIT","MCG","MG","MG","G","MG","MG","UNIT","UNIT","UNIT"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["G","G","G","G","G","G","G","G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd6"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE"],"dose":["2.5","538","5.08","448","25.7"],"productID":{"$numberInt":"7258"},"sanitizedRegiestrationNumber":"00634131","productName":"INPERSOL LM W 2.5% DEXTROSE","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd7"},"numbersOfAis":"1","activeIngredientName":["METHYLPHENIDATE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"6067"},"sanitizedRegiestrationNumber":"00632775","productName":"RITALIN-SR TAB 20MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA III)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["METHYLPHENIDATE"],"atcCode":["N06BA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPHENIDATE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd8"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["100"],"productID":{"$numberInt":"6462"},"sanitizedRegiestrationNumber":"00632732","productName":"VOLTAREN","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbd9"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"41684"},"sanitizedRegiestrationNumber":"00653330","productName":"OTRIVIN MEDICATED COLD & ALLERGY RELIEF","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1961-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbda"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["30"],"productID":{"$numberInt":"51392"},"sanitizedRegiestrationNumber":"00639389","productName":"STATEX SUPPOSITORIES 30MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbdb"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"6620"},"sanitizedRegiestrationNumber":"00653217","productName":"TEVA-ECTOSONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbdc"},"numbersOfAis":"1","activeIngredientName":["FLURBIPROFEN"],"dose":["50"],"productID":{"$numberInt":"6167"},"sanitizedRegiestrationNumber":"00647942","productName":"ANSAID TABLETS 50 MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["FLURBIPROFEN"],"atcCode":["M01AE09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLURBIPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbdd"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN V POTASSIUM"],"dose":["125"],"productID":{"$numberInt":"6422"},"sanitizedRegiestrationNumber":"00642223","productName":"APO PEN VK","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PHENOXYMETHYLPENICILLIN"],"atcCode":["J01CE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN V POTASSIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbde"},"numbersOfAis":"1","activeIngredientName":["CYCLOSPORINE"],"dose":["50"],"productID":{"$numberInt":"5790"},"sanitizedRegiestrationNumber":"00593257","productName":"SANDIMMUNE IV 50MG/ML","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CICLOSPORIN"],"atcCode":["L04AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYCLOSPORINE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbdf"},"numbersOfAis":"3","activeIngredientName":["ACETAMINOPHEN","CAFFEINE","CODEINE PHOSPHATE"],"dose":["300","15","8"],"productID":{"$numberInt":"6763"},"sanitizedRegiestrationNumber":"00653233","productName":"TEVA-LENOLTEC NO. 1","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["CODEINE AND PARACETAMOL","CODEINE AND PARACETAMOL"],"atcCode":["N02AJ06","N02AJ06"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe0"},"numbersOfAis":"1","activeIngredientName":["GEMFIBROZIL"],"dose":["300"],"productID":{"$numberInt":"5759"},"sanitizedRegiestrationNumber":"00599026","productName":"LOPID CAP 300MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["GEMFIBROZIL"],"atcCode":["C10AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GEMFIBROZIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe1"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"3043"},"sanitizedRegiestrationNumber":"00392588","productName":"MORPHINE SULFATE INJ 10MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1978-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe2"},"numbersOfAis":"1","activeIngredientName":["COLESTIPOL HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"7199"},"sanitizedRegiestrationNumber":"00642975","productName":"COLESTID GRANULES","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Granules"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["COLESTIPOL"],"atcCode":["C10AC02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COLESTIPOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["SACHET"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe3"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["1"],"productID":{"$numberInt":"9869"},"sanitizedRegiestrationNumber":"00795291","productName":"VITAMIN C TIMED RELEASE TAB 1000MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe4"},"numbersOfAis":"1","activeIngredientName":["CONJUGATED ESTROGENS"],"dose":["0.3"],"productID":{"$numberInt":"15758"},"sanitizedRegiestrationNumber":"00798231","productName":"APO-CONEST TAB 0.3MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CONJUGATED ESTROGENS"],"atcCode":["G03CA57"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CONJUGATED ESTROGENS"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe5"},"numbersOfAis":"4","activeIngredientName":["HELIUM","NITROGEN","CARBON MONOXIDE","OXYGEN"],"dose":["10","68.9","0.1","21"],"productID":{"$numberInt":"44612"},"sanitizedRegiestrationNumber":"00823066","productName":"LUNG DIFFUSION TEST MIXTURE GAS","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HELIUM","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["%","%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe6"},"numbersOfAis":"1","activeIngredientName":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"dose":["10"],"productID":{"$numberInt":"10790"},"sanitizedRegiestrationNumber":"00851965","productName":"TEVA-TAMOXIFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["TAMOXIFEN"],"atcCode":["L02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe7"},"numbersOfAis":"23","activeIngredientName":["SERINE","DEXTROSE","POTASSIUM CHLORIDE","ACETYL-L-TYROSINE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","POTASSIUM PHOSPHATE DIBASIC","L-ISOLEUCINE","METHIONINE","L-PHENYLALANINE","L-THREONINE","TRYPTOPHAN","L-VALINE","L-ALANINE","L-ARGININE","L-ASPARTIC ACID","GLUTAMIC ACID","GLYCINE","HISTIDINE","L-PROLINE","L-LEUCINE","LYSINE (LYSINE ACETATE)"],"dose":["225","20","22","115","205","51","37","261","280","73","126","170","85","212","422","432","298","314","212","128","307","425","446"],"productID":{"$numberInt":"47126"},"sanitizedRegiestrationNumber":"00851574","productName":"AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1996-12-30"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SERINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe8"},"numbersOfAis":"2","activeIngredientName":["CARBON DIOXIDE","OXYGEN"],"dose":["50","50"],"productID":{"$numberInt":"11060"},"sanitizedRegiestrationNumber":"00882771","productName":"CARBON DIOXIDE 23.1% W OXYGEN","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBON DIOXIDE","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbe9"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["100"],"productID":{"$numberInt":"12346"},"sanitizedRegiestrationNumber":"00888230","productName":"A-HYDROCORT INJ 100MG/2ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbea"},"numbersOfAis":"1","activeIngredientName":["METRONIDAZOLE"],"dose":["5"],"productID":{"$numberInt":"7425"},"sanitizedRegiestrationNumber":"00649074","productName":"METRONIDAZOLE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["METRONIDAZOLE"],"atcCode":["J01XD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METRONIDAZOLE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbeb"},"numbersOfAis":"1","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)"],"dose":["500"],"productID":{"$numberInt":"48366"},"sanitizedRegiestrationNumber":"00648345","productName":"CALSAN CHEWABLE TAB 500MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-01-01"],"sanitizedIndication":["CALCIUM CARBONATE"],"atcCode":["A12AA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbec"},"numbersOfAis":"1","activeIngredientName":["MAPROTILINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"6256"},"sanitizedRegiestrationNumber":"00641855","productName":"LUDIOMIL TAB 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MAPROTILINE"],"atcCode":["N06AA21"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAPROTILINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbed"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN SODIUM"],"dose":["125"],"productID":{"$numberInt":"6424"},"sanitizedRegiestrationNumber":"00644633","productName":"APO CLOXI FOR ORAL SOLN 125MG/5ML","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbee"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.05"],"productID":{"$numberInt":"6822"},"sanitizedRegiestrationNumber":"00653209","productName":"TEVA-ECTOSONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbef"},"numbersOfAis":"3","activeIngredientName":["CAFFEINE","CODEINE PHOSPHATE","ACETAMINOPHEN"],"dose":["15","30","300"],"productID":{"$numberInt":"6346"},"sanitizedRegiestrationNumber":"00653276","productName":"TEVA-LENOLTEC NO. 3","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["CODEINE AND PARACETAMOL","CODEINE AND PARACETAMOL"],"atcCode":["N02AJ06","N02AJ06"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAFFEINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf0"},"numbersOfAis":"1","activeIngredientName":["TETRACYCLINE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"5733"},"sanitizedRegiestrationNumber":"00603252","productName":"APO TETRA TABS 250MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["TETRACYCLINE"],"atcCode":["J01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf1"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B12"],"dose":["25"],"productID":{"$numberInt":"7175"},"sanitizedRegiestrationNumber":"00653985","productName":"VITAMINE B12 TAB 25MCG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["CYANOCOBALAMIN"],"atcCode":["B03BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B12"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf2"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["4.5"],"productID":{"$numberInt":"6565"},"sanitizedRegiestrationNumber":"00652792","productName":"SALINE INJECTION 0.9% USP","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["500"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf3"},"numbersOfAis":"1","activeIngredientName":["HYDROCHLOROTHIAZIDE"],"dose":["100"],"productID":{"$numberInt":"8594"},"sanitizedRegiestrationNumber":"00644552","productName":"APO HYDRO TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE"],"atcCode":["C03AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCHLOROTHIAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf4"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"7176"},"sanitizedRegiestrationNumber":"00653993","productName":"VITAMINE B6 TAB 100MG USP","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PYRIDOXINE (VIT B6)"],"atcCode":["A11HA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf5"},"numbersOfAis":"7","activeIngredientName":["MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","SODIUM CHLORIDE","SODIUM ACETATE","NEOMYCIN (NEOMYCIN SULFATE)","SULFAMETHAZINE","POTASSIUM ACETATE"],"dose":["11","11","209","229","250","2","38"],"productID":{"$numberInt":"6202"},"sanitizedRegiestrationNumber":"00641618","productName":"NEO-SULFALYTE","licenseHolderSponser":"CAN-VET ANIMAL HEALTH SUPPLIES LTD.","companyCode":[{"$numberInt":"5793"}],"facilityAddress":"4 61 Malcolm Road Guelph Ontario Canada N1K 1A7","countryOfOrigin":["Canada"],"format":["Bolus"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","G","MG"],"quantityNeedToTake":["","","","","","",""],"qunatityUnit":["","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf6"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"5825"},"sanitizedRegiestrationNumber":"00628158","productName":"APO-AMOXI","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Powder For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf7"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["8.45"],"productID":{"$numberInt":"9330"},"sanitizedRegiestrationNumber":"00645389","productName":"FORMULE NO 202 PROFIL TAB 8.45GM","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["PYRIDOXINE (VIT B6)"],"atcCode":["A11HA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf8"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"41683"},"sanitizedRegiestrationNumber":"00650854","productName":"OTRIVIN COLD AND ALLERGY DECONGESTANT NOSE DROPS","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbf9"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN G PROCAINE"],"dose":["110"],"productID":{"$numberInt":"6213"},"sanitizedRegiestrationNumber":"00648191","productName":"PEN-P 110","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN G PROCAINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbfa"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["50"],"productID":{"$numberInt":"5818"},"sanitizedRegiestrationNumber":"00618632","productName":"APO METOPROLOL TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbfb"},"numbersOfAis":"3","activeIngredientName":["CAMPHOR","MENTHOL","CAPSICUM"],"dose":["5.124","5.124","336"],"productID":{"$numberInt":"6249"},"sanitizedRegiestrationNumber":"00651591","productName":"CHOATES VETERINARY HORSE LINIMENT","licenseHolderSponser":"HAWTHORNE PRODUCTS INC.","companyCode":[{"$numberInt":"4344"}],"facilityAddress":" 16828 N. State Road 167 N. Dunkirk Indiana United States 47336","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAMPHOR","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","MG"],"quantityNeedToTake":["470","470","470"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical - Veterinary)| Package (Pharmaceutical - Veterinary)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbfc"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["5"],"productID":{"$numberInt":"51391"},"sanitizedRegiestrationNumber":"00632228","productName":"STATEX SUPPOSITORIES 5MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbfd"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","BRETYLIUM TOSYLATE"],"dose":["50","4"],"productID":{"$numberInt":"9476"},"sanitizedRegiestrationNumber":"00655724","productName":"BRETYLIUM TOSYLATE 0.4% AND DEXTROSE 5% INJ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["BRETYLIUM TOSILATE"],"atcCode":["C01BD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbfe"},"numbersOfAis":"1","activeIngredientName":["VITAMIN B1 (THIAMINE HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"7177"},"sanitizedRegiestrationNumber":"00654000","productName":"VITAMINE B1 TAB 100MG USP","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["THIAMINE (VIT B1)"],"atcCode":["A11DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN B1 (THIAMINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfbff"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["750"],"productID":{"$numberInt":"6087"},"sanitizedRegiestrationNumber":"00638684","productName":"PROCAN SR","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc00"},"numbersOfAis":"1","activeIngredientName":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"dose":["1"],"productID":{"$numberInt":"8074"},"sanitizedRegiestrationNumber":"00657417","productName":"ROCEPHIN PWS 1GM/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CEFTRIAXONE"],"atcCode":["J01DD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc01"},"numbersOfAis":"1","activeIngredientName":["IVERMECTIN"],"dose":["68"],"productID":{"$numberInt":"8253"},"sanitizedRegiestrationNumber":"00651966","productName":"HEARTGARD-30 TABLETS FOR DOGS 68MCG","licenseHolderSponser":"MERIAL CANADA INC","companyCode":[{"$numberInt":"8208"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IVERMECTIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc02"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["20"],"productID":{"$numberInt":"6715"},"sanitizedRegiestrationNumber":"00642894","productName":"APO PIROXICAM CAP 20MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc03"},"numbersOfAis":"2","activeIngredientName":["ENALAPRIL SODIUM","HYDROCHLOROTHIAZIDE"],"dose":["8","25"],"productID":{"$numberInt":"10913"},"sanitizedRegiestrationNumber":"00657298","productName":"VASERETIC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ENALAPRIL AND DIURETICS","ENALAPRIL AND DIURETICS"],"atcCode":["C09BA02","C09BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ENALAPRIL SODIUM","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc04"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN"],"dose":["375"],"productID":{"$numberInt":"5508"},"sanitizedRegiestrationNumber":"00600806","productName":"APO-NAPROXEN","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc05"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","CALCIUM CHLORIDE","SODIUM ACETATE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["207.5","2.52","110.6","3.914","1.22"],"productID":{"$numberInt":"6606"},"sanitizedRegiestrationNumber":"00665444","productName":"D12006","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc06"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["1"],"productID":{"$numberInt":"6296"},"sanitizedRegiestrationNumber":"00655759","productName":"APO-LORAZEPAM TAB 1MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc07"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["2"],"productID":{"$numberInt":"6136"},"sanitizedRegiestrationNumber":"00637750","productName":"TEVA-LORAZEPAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc08"},"numbersOfAis":"5","activeIngredientName":["VITAMIN E","COBALT SULFATE","CALCIUM PHOSPHATE (DIBASIC)","SODIUM SELENITE","ETHOXYQUIN"],"dose":["35","35","11","85","353"],"productID":{"$numberInt":"6566"},"sanitizedRegiestrationNumber":"00652814","productName":"ULTRA-SEL","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN E","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MCG","MG","MCG","MCG"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["G","G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc09"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["650"],"productID":{"$numberInt":"8903"},"sanitizedRegiestrationNumber":"00648779","productName":"D12057","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0a"},"numbersOfAis":"1","activeIngredientName":["ANCROD"],"dose":["70"],"productID":{"$numberInt":"6682"},"sanitizedRegiestrationNumber":"00657271","productName":"VIPRINEX","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["ANCROD"],"atcCode":["B01AD09"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ANCROD"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0b"},"numbersOfAis":"2","activeIngredientName":["BRETYLIUM TOSYLATE","DEXTROSE"],"dose":["2","50"],"productID":{"$numberInt":"9477"},"sanitizedRegiestrationNumber":"00655716","productName":"BRETYLIUM TOSYLATE 0.2% AND DEXTROSE 5% INJ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["BRETYLIUM TOSILATE"],"atcCode":["C01BD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BRETYLIUM TOSYLATE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0c"},"numbersOfAis":"2","activeIngredientName":["CHLORTETRACYCLINE","SULFAMETHAZINE"],"dose":["77","77"],"productID":{"$numberInt":"6497"},"sanitizedRegiestrationNumber":"00655708","productName":"CHLOR-S-700","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORTETRACYCLINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["Kg","Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0d"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["0.5"],"productID":{"$numberInt":"6295"},"sanitizedRegiestrationNumber":"00655740","productName":"APO-LORAZEPAM TAB 0.5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0e"},"numbersOfAis":"1","activeIngredientName":["PIVMECILLINAM (PIVMECILLINAM HYDROCHLORIDE)"],"dose":["185"],"productID":{"$numberInt":"6471"},"sanitizedRegiestrationNumber":"00657212","productName":"SELEXID TAB 185MG","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PIVMECILLINAM"],"atcCode":["J01CA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIVMECILLINAM (PIVMECILLINAM HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc0f"},"numbersOfAis":"1","activeIngredientName":["BROMAZEPAM"],"dose":["1.5"],"productID":{"$numberInt":"7261"},"sanitizedRegiestrationNumber":"00682314","productName":"LECTOPAM TAB 1.5MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BROMAZEPAM"],"atcCode":["N05BA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BROMAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc10"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"6132"},"sanitizedRegiestrationNumber":"00632201","productName":"STATEX-SUPPOSITORIES 10MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc11"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"8190"},"sanitizedRegiestrationNumber":"00688622","productName":"DIPROLENE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc12"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":[".72"],"productID":{"$numberInt":"41682"},"sanitizedRegiestrationNumber":"00658731","productName":"TINACTIN LIQUID AEROSOL 0.72MG/GM","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc13"},"numbersOfAis":"5","activeIngredientName":["CALCIUM CHLORIDE","SODIUM CHLORIDE","ACETIC ACID","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["7.49","263","5.41","3.35","1.61"],"productID":{"$numberInt":"6836"},"sanitizedRegiestrationNumber":"00665681","productName":"ACID CONCENTRATE  D12095","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc14"},"numbersOfAis":"1","activeIngredientName":["IBUPROFEN"],"dose":["200"],"productID":{"$numberInt":"6320"},"sanitizedRegiestrationNumber":"00629324","productName":"NOVO-PROFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["IBUPROFEN"],"atcCode":["M01AE01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IBUPROFEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc15"},"numbersOfAis":"1","activeIngredientName":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"dose":["250"],"productID":{"$numberInt":"8037"},"sanitizedRegiestrationNumber":"00657387","productName":"ROCEPHIN PWS INJ 0.25GM/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CEFTRIAXONE"],"atcCode":["J01DD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc16"},"numbersOfAis":"2","activeIngredientName":["SULFADOXINE","PYRIMETHAMINE"],"dose":["500","25"],"productID":{"$numberInt":"9865"},"sanitizedRegiestrationNumber":"00692719","productName":"FANSIDAR TABLETS","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PYRIMETHAMINE, COMBINATIONS"],"atcCode":["P01BD51"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFADOXINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc17"},"numbersOfAis":"2","activeIngredientName":["CARBADOX","PYRANTEL TARTRATE"],"dose":["22","42.4"],"productID":{"$numberInt":"9739"},"sanitizedRegiestrationNumber":"00679976","productName":"MECADOX PLUS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBADOX","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["Kg","Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc18"},"numbersOfAis":"1","activeIngredientName":["ATRACURIUM BESYLATE"],"dose":["10"],"productID":{"$numberInt":"10998"},"sanitizedRegiestrationNumber":"00675210","productName":"TRACRIUM","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ATRACURIUM"],"atcCode":["M03AC04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATRACURIUM BESYLATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc19"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["1"],"productID":{"$numberInt":"41694"},"sanitizedRegiestrationNumber":"00679895","productName":"KEEP CLEAR ANTIDANDRUFF SHP 1%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1a"},"numbersOfAis":"1","activeIngredientName":["PROPRANOLOL HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"6685"},"sanitizedRegiestrationNumber":"00663719","productName":"APO-PROPRANOLOL TAB 20MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PROPRANOLOL"],"atcCode":["C07AA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPRANOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1b"},"numbersOfAis":"2","activeIngredientName":["SODIUM BICARBONATE","SODIUM CHLORIDE"],"dose":["66","23.5"],"productID":{"$numberInt":"6776"},"sanitizedRegiestrationNumber":"00691631","productName":"BICARBONATE CONCENTRATE D16001","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM BICARBONATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1c"},"numbersOfAis":"1","activeIngredientName":["GEMFIBROZIL"],"dose":["600"],"productID":{"$numberInt":"9259"},"sanitizedRegiestrationNumber":"00659606","productName":"LOPID 600MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["GEMFIBROZIL"],"atcCode":["C10AB04"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GEMFIBROZIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1d"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","CALCIUM CHLORIDE","ACETIC ACID","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["263","7.49","5.41","10.1","3.21"],"productID":{"$numberInt":"6609"},"sanitizedRegiestrationNumber":"00665665","productName":"ACID CONCENTRATE  D12093","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1e"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["25"],"productID":{"$numberInt":"6690"},"sanitizedRegiestrationNumber":"00676411","productName":"MORPHINE HP 25 - 25MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc1f"},"numbersOfAis":"1","activeIngredientName":["MORPHINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"6903"},"sanitizedRegiestrationNumber":"00690791","productName":"RATIO-MORPHINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc20"},"numbersOfAis":"1","activeIngredientName":["PETROLATUM"],"dose":["67"],"productID":{"$numberInt":"7127"},"sanitizedRegiestrationNumber":"00635189","productName":"PREVEX","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["SOFT PARAFFIN AND FAT PRODUCTS"],"atcCode":["D02AC"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PETROLATUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc21"},"numbersOfAis":"3","activeIngredientName":["VITAMIN C","POTASSIUM (POTASSIUM CHLORIDE)","IRON (FERROUS SULFATE)"],"dose":["83.45","35","9.5"],"productID":{"$numberInt":"9328"},"sanitizedRegiestrationNumber":"00675407","productName":"FORMULE NO 204 PROFIL TAB","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN C","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc22"},"numbersOfAis":"1","activeIngredientName":["DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)"],"dose":["4"],"productID":{"$numberInt":"6593"},"sanitizedRegiestrationNumber":"00664227","productName":"DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["DEXAMETHASONE"],"atcCode":["H02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intrasynovial","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc23"},"numbersOfAis":"1","activeIngredientName":["PLANTAGO SEED"],"dose":["750"],"productID":{"$numberInt":"6761"},"sanitizedRegiestrationNumber":"00686956","productName":"PSYLLIUM HYDROPHILIC MUCILLOID PWR 750MG/GM","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["ISPAGHULA (PSYLLA SEEDS)"],"atcCode":["A06AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PLANTAGO SEED"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc24"},"numbersOfAis":"7","activeIngredientName":["VITAMIN D","VITAMIN B6","VITAMIN B2","VITAMIN B1","VITAMIN C","VITAMIN A","NICOTINAMIDE"],"dose":["400","1","3","2","75","5000","20"],"productID":{"$numberInt":"7085"},"sanitizedRegiestrationNumber":"00666750","productName":"SUPRAVITE POUR ENFANTS","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","MG","MG","UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc25"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN"],"dose":["250"],"productID":{"$numberInt":"5599"},"sanitizedRegiestrationNumber":"00607142","productName":"ERYC DELAYED-RELEASE CAPSULES","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc26"},"numbersOfAis":"20","activeIngredientName":["PYRIDOXINE HYDROCHLORIDE","VITAMIN E (D-ALPHA TOCOPHERYL ACID SUCCINATE)","FOLIC ACID","IRON (FERROUS SULFATE)","MANGANESE (MANGANESE SULFATE)","INOSITOL","VITAMIN D","THIAMINE HYDROCHLORIDE","VITAMIN B2","VITAMIN C","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC))","COPPER (COPPER SULFATE)","CHOLINE BITARTRATE","VITAMIN B12","NICOTINAMIDE","CALCIUM (CALCIUM PHOSPHATE (DIBASIC))","IODINE (KELP)","ZINC (ZINC SULFATE)","VITAMIN A"],"dose":["3.35","3.35",".06","3.33","1","16.6","135","8","8","50","6.66","150",".34","15","3.35","50","250",".075","1.33","3333.3"],"productID":{"$numberInt":"9329"},"sanitizedRegiestrationNumber":"00666742","productName":"FORMULE NO 203 PROFIL TAB","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PYRIDOXINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT","MG","MG","MG","MG","UNIT","MG","MG","MG","MG","MG","MG","MG","MCG","MG","MG","MG","MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","","","","","","","","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc27"},"numbersOfAis":"2","activeIngredientName":["ACETAMINOPHEN","CODEINE PHOSPHATE"],"dose":["300","30"],"productID":{"$numberInt":"5780"},"sanitizedRegiestrationNumber":"00608882","productName":"TEVA-EMTEC-30","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["CODEINE AND PARACETAMOL","CODEINE AND PARACETAMOL"],"atcCode":["N02AJ06","N02AJ06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc28"},"numbersOfAis":"9","activeIngredientName":["VITAMIN B2","VITAMIN B1 (THIAMINE MONONITRATE)","FOLIC ACID","IRON (FERROUS SULFATE)","VITAMIN C","CALCIUM D-PANTOTHENATE","VITAMIN B12","NICOTINAMIDE","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["10","15",".4","27","500","20","10","100","5"],"productID":{"$numberInt":"7059"},"sanitizedRegiestrationNumber":"00690120","productName":"SURBEX-500 WITH IRON","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, OTHER COMBINATIONS","VITAMIN B-COMPLEX, OTHER COMBINATIONS"],"atcCode":["A11EX","A11EX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B2","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MCG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc29"},"numbersOfAis":"2","activeIngredientName":["SODIUM BICARBONATE","SODIUM CHLORIDE"],"dose":["66","30.6"],"productID":{"$numberInt":"6777"},"sanitizedRegiestrationNumber":"00691658","productName":"BICARBONATE CONCENTRATE D16000","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM BICARBONATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2a"},"numbersOfAis":"1","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)"],"dose":["500"],"productID":{"$numberInt":"6655"},"sanitizedRegiestrationNumber":"00672475","productName":"MOR-CAL TAB 500MG","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["CALCIUM CARBONATE"],"atcCode":["A12AA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2b"},"numbersOfAis":"4","activeIngredientName":["GLUTARAL","CETALKONIUM CHLORIDE","FORMALDEHYDE","BENZALKONIUM CHLORIDE"],"dose":["5","3","7.4","3"],"productID":{"$numberInt":"7438"},"sanitizedRegiestrationNumber":"00649260","productName":"TEGODOR","licenseHolderSponser":"CHARLES TENNANT & CO (CANADA) LTD.","companyCode":[{"$numberInt":"3977"}],"facilityAddress":" 34 Clayson Road Weston Ontario Canada M9M 2G8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLUTARAL","Combination"],"sanitizedRouteOfAdministration":["Disinfectant (Hospital/Hc Facilities)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["%","%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Active Pharmaceutical Ingredients)| Import (List A API for Veterinary Use)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2c"},"numbersOfAis":"3","activeIngredientName":["ACETAMINOPHEN","CAFFEINE","CODEINE PHOSPHATE"],"dose":["300","15","15"],"productID":{"$numberInt":"6764"},"sanitizedRegiestrationNumber":"00653241","productName":"TEVA-LENOLTEC NO. 2","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["CODEINE AND PARACETAMOL","CODEINE AND PARACETAMOL"],"atcCode":["N02AJ06","N02AJ06"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2d"},"numbersOfAis":"3","activeIngredientName":["BENZALKONIUM CHLORIDE","LIDOCAINE","CAMPHOR"],"dose":[".135","2",".2"],"productID":{"$numberInt":"7441"},"sanitizedRegiestrationNumber":"00697753","productName":"MEDI-QUIK FIRST AID SPRAY","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["LIDOCAINE","LIDOCAINE"],"atcCode":["D04AB01","D04AB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZALKONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2e"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","MAGNESIUM CHLORIDE","DEXTROSE","CALCIUM CHLORIDE","SODIUM CHLORIDE"],"dose":["392","15.2","500","25.7","562"],"productID":{"$numberInt":"9371"},"sanitizedRegiestrationNumber":"00678430","productName":"INPERSOL WITH DEXTROSE 0.5%","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc2f"},"numbersOfAis":"1","activeIngredientName":["TRICLOSAN"],"dose":[".25"],"productID":{"$numberInt":"6598"},"sanitizedRegiestrationNumber":"00655899","productName":"SEPTISOL SOLUTION","licenseHolderSponser":"STERIS CORPORATION","companyCode":[{"$numberInt":"5186"}],"facilityAddress":" 5960 Heisley Road Mentor Ohio United States 44060","countryOfOrigin":["United States"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["TRICLOSAN"],"atcCode":["D08AE04"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRICLOSAN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc30"},"numbersOfAis":"1","activeIngredientName":["NORFLOXACIN"],"dose":["400"],"productID":{"$numberInt":"6866"},"sanitizedRegiestrationNumber":"00643025","productName":"NOROXIN","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["NORFLOXACIN"],"atcCode":["J01MA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NORFLOXACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc31"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["10"],"productID":{"$numberInt":"6813"},"sanitizedRegiestrationNumber":"00695718","productName":"TEVA-PIROXICAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc32"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["100"],"productID":{"$numberInt":"6612"},"sanitizedRegiestrationNumber":"00648043","productName":"TEVA-METOPROLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc33"},"numbersOfAis":"1","activeIngredientName":["BETAXOLOL (BETAXOLOL HYDROCHLORIDE)"],"dose":["0.5"],"productID":{"$numberInt":"7208"},"sanitizedRegiestrationNumber":"00695688","productName":"BETOPTIC LIQ","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BETAXOLOL"],"atcCode":["S01ED02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAXOLOL (BETAXOLOL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc34"},"numbersOfAis":"1","activeIngredientName":["THIOPENTAL SODIUM"],"dose":["25"],"productID":{"$numberInt":"8600"},"sanitizedRegiestrationNumber":"00695017","productName":"PENTOTHAL INJ 25MG/ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["THIOPENTAL"],"atcCode":["N01AF03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOPENTAL SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc35"},"numbersOfAis":"2","activeIngredientName":["NITROUS OXIDE","OXYGEN"],"dose":["50","50"],"productID":{"$numberInt":"6850"},"sanitizedRegiestrationNumber":"00693596","productName":"LIQUI-MED ANALGESIC GAS","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-30"],"sanitizedIndication":["NITROUS OXIDE,COMBINATIONS"],"atcCode":["N01AX63"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NITROUS OXIDE","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc36"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"10485"},"sanitizedRegiestrationNumber":"00705799","productName":"STATEX DPS 50MG/ML","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc37"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN G PROCAINE"],"dose":["300000"],"productID":{"$numberInt":"8084"},"sanitizedRegiestrationNumber":"00712981","productName":"PEN AQUEOUS","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN G PROCAINE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc38"},"numbersOfAis":"1","activeIngredientName":["SPIRONOLACTONE"],"dose":["100"],"productID":{"$numberInt":"5647"},"sanitizedRegiestrationNumber":"00613223","productName":"TEVA-SPIRONOLACTONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["SPIRONOLACTONE"],"atcCode":["C03DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SPIRONOLACTONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc39"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","SODIUM CHLORIDE","SODIUM ACETATE","CALCIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["2.5","198.4","109.1","6.31","3.914"],"productID":{"$numberInt":"6774"},"sanitizedRegiestrationNumber":"00703397","productName":"D-12043 SOL CONC ELECTROLYT POUR DIALY","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3a"},"numbersOfAis":"3","activeIngredientName":["CODEINE PHOSPHATE","DIPHENHYDRAMINE HYDROCHLORIDE","AMMONIUM CHLORIDE"],"dose":["3.33","12.5","125"],"productID":{"$numberInt":"6844"},"sanitizedRegiestrationNumber":"00690074","productName":"COUGH SYRUP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS","OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02","R05FA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CODEINE PHOSPHATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["5","5","5"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3b"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["250"],"productID":{"$numberInt":"6693"},"sanitizedRegiestrationNumber":"00690473","productName":"ASCORBIC ACID INJ 250MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1986-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3c"},"numbersOfAis":"8","activeIngredientName":["VITAMIN B12","PYRIDOXINE HYDROCHLORIDE","THIAMINE MONONITRATE","VITAMIN C","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","NICOTINAMIDE","VITAMIN B2","ZINC (ZINC SULFATE)"],"dose":["0.01","5","15","500","18.3","100","10","22.5"],"productID":{"$numberInt":"7207"},"sanitizedRegiestrationNumber":"00685151","productName":"SURBEX-500 WITH ZINC","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, OTHER COMBINATIONS","VITAMIN B-COMPLEX, OTHER COMBINATIONS"],"atcCode":["A11EX","A11EX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B12","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3d"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["81.3"],"productID":{"$numberInt":"6775"},"sanitizedRegiestrationNumber":"00691623","productName":"BICARBONATE CONCENTRATE D17000","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3e"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["12.5"],"productID":{"$numberInt":"10487"},"sanitizedRegiestrationNumber":"00695661","productName":"CAPOTEN TAB 12.5MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc3f"},"numbersOfAis":"1","activeIngredientName":["MEDROXYPROGESTERONE ACETATE"],"dose":["2.5"],"productID":{"$numberInt":"13037"},"sanitizedRegiestrationNumber":"00708917","productName":"PROVERA 2.5MG TABLETS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MEDROXYPROGESTERONE"],"atcCode":["G03DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEDROXYPROGESTERONE ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc40"},"numbersOfAis":"1","activeIngredientName":["MORPHINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"7123"},"sanitizedRegiestrationNumber":"00690783","productName":"RATIO-MORPHINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc41"},"numbersOfAis":"2","activeIngredientName":["SODIUM HYDROXIDE","CALCIUM HYDROXIDE"],"dose":["46","18.4"],"productID":{"$numberInt":"9342"},"sanitizedRegiestrationNumber":"00654094","productName":"D-HORN PASTE","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Paste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM HYDROXIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["100","100"],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc42"},"numbersOfAis":"1","activeIngredientName":["CIMETIDINE"],"dose":["800"],"productID":{"$numberInt":"7312"},"sanitizedRegiestrationNumber":"00663727","productName":"NOVO-CIMETINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CIMETIDINE"],"atcCode":["A02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIMETIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc43"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["100"],"productID":{"$numberInt":"6311"},"sanitizedRegiestrationNumber":"00658855","productName":"LOPRESOR SR 100MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc44"},"numbersOfAis":"1","activeIngredientName":["CYPROTERONE ACETATE"],"dose":["100"],"productID":{"$numberInt":"11880"},"sanitizedRegiestrationNumber":"00704423","productName":"ANDROCUR DEPOT","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CYPROTERONE"],"atcCode":["G03HA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYPROTERONE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc45"},"numbersOfAis":"1","activeIngredientName":["TRAZODONE HYDROCHLORIDE"],"dose":["150"],"productID":{"$numberInt":"9503"},"sanitizedRegiestrationNumber":"00702277","productName":"DESYREL DIVIDOSE TABLET 150 MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TRAZODONE"],"atcCode":["N06AX05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRAZODONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc46"},"numbersOfAis":"2","activeIngredientName":["SPIRONOLACTONE","HYDROCHLOROTHIAZIDE"],"dose":["50","50"],"productID":{"$numberInt":"6892"},"sanitizedRegiestrationNumber":"00657182","productName":"TEVA-SPIRONOLACTONE/HCTZ","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SPIRONOLACTONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc47"},"numbersOfAis":"6","activeIngredientName":["LEVONORGESTREL","ETHINYL ESTRADIOL","ETHINYL ESTRADIOL","LEVONORGESTREL","ETHINYL ESTRADIOL","LEVONORGESTREL"],"dose":["125","30","40","50","30","75"],"productID":{"$numberInt":"8123"},"sanitizedRegiestrationNumber":"00707503","productName":"TRIQUILAR 28","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["LEVONORGESTREL AND ESTROGEN"],"atcCode":["G03AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LEVONORGESTREL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MCG","MCG","MCG","MCG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc48"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"6889"},"sanitizedRegiestrationNumber":"00705438","productName":"DILAUDID","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc49"},"numbersOfAis":"2","activeIngredientName":["BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)","GENTAMICIN (GENTAMICIN SULFATE)"],"dose":["1","3"],"productID":{"$numberInt":"7418"},"sanitizedRegiestrationNumber":"00682217","productName":"GARASONE OPHTHALMIC AND OTIC SOLUTION","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["BETAMETHASONE AND ANTIINFECTIVES","BETAMETHASONE AND ANTIINFECTIVES"],"atcCode":["S03CA06","S03CA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)","Combination"],"sanitizedRouteOfAdministration":["Otic","Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4a"},"numbersOfAis":"2","activeIngredientName":["ALUMINUM CHLORIDE","ALUMINUM CHLOROHYDRATE"],"dose":["2","20"],"productID":{"$numberInt":"8178"},"sanitizedRegiestrationNumber":"00705268","productName":"ANTI-PERSPIRANT ROLL-ON DEOD","licenseHolderSponser":"ESTEE LAUDER DIST","companyCode":[{"$numberInt":"5490"}],"facilityAddress":" 550 Petrolia Road Toronto Ontario Canada M3J 2W3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALUMINUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4b"},"numbersOfAis":"8","activeIngredientName":["POTASSIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CARBONATE","VITAMIN D","PROTEIN HYDROLYSATES","CALCIUM PHOSPHATE (DIBASIC)","VITAMIN A"],"dose":["1","2","250","750","5000","10","1","50000"],"productID":{"$numberInt":"6661"},"sanitizedRegiestrationNumber":"00609870","productName":"AMINOSOL BOLUS","licenseHolderSponser":"DISTRIVET INC.","companyCode":[{"$numberInt":"4094"}],"facilityAddress":" 279 St-Cyrille Upton Quebec Canada J0H 2E0","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","MG","MG","UNIT","G","G","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4c"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"7404"},"sanitizedRegiestrationNumber":"00712884","productName":"LIDOCAINE NEAT","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Epidural","Intramuscular","Subcutaneous","Block/Infiltration"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4d"},"numbersOfAis":"1","activeIngredientName":["ENALAPRIL SODIUM"],"dose":["4"],"productID":{"$numberInt":"8111"},"sanitizedRegiestrationNumber":"00708879","productName":"VASOTEC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ENALAPRIL"],"atcCode":["C09AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENALAPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4e"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["2"],"productID":{"$numberInt":"6297"},"sanitizedRegiestrationNumber":"00655767","productName":"APO-LORAZEPAM TAB 2MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc4f"},"numbersOfAis":"1","activeIngredientName":["ENALAPRIL SODIUM"],"dose":["8"],"productID":{"$numberInt":"8102"},"sanitizedRegiestrationNumber":"00670901","productName":"VASOTEC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ENALAPRIL"],"atcCode":["C09AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENALAPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc50"},"numbersOfAis":"1","activeIngredientName":["NITROSCANATE"],"dose":["500"],"productID":{"$numberInt":"8408"},"sanitizedRegiestrationNumber":"00623024","productName":"LOPATOL 500","licenseHolderSponser":"ELANCO CANADA LIMITED","companyCode":[{"$numberInt":"16571"}],"facilityAddress":"120 150 Research Lane Guelph Ontario Canada N1G 4T2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROSCANATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc51"},"numbersOfAis":"1","activeIngredientName":["FAMOTIDINE"],"dose":["40"],"productID":{"$numberInt":"7088"},"sanitizedRegiestrationNumber":"00710113","productName":"PEPCID TAB 40MG","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["FAMOTIDINE"],"atcCode":["A02BA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FAMOTIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc52"},"numbersOfAis":"1","activeIngredientName":["OXYTOCIN"],"dose":["20"],"productID":{"$numberInt":"7464"},"sanitizedRegiestrationNumber":"00713201","productName":"OXYTOCIN INJECTION","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYTOCIN"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc53"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"6757"},"sanitizedRegiestrationNumber":"00675962","productName":"STATEX TABLETS 50MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc54"},"numbersOfAis":"1","activeIngredientName":["ENALAPRIL SODIUM"],"dose":["16"],"productID":{"$numberInt":"8103"},"sanitizedRegiestrationNumber":"00670928","productName":"VASOTEC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ENALAPRIL"],"atcCode":["C09AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENALAPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc55"},"numbersOfAis":"5","activeIngredientName":["SODIUM BICARBONATE","MACROGOL","SODIUM SULFATE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["1.68","60","5.68","1.46",".75"],"productID":{"$numberInt":"9369"},"sanitizedRegiestrationNumber":"00709298","productName":"OCL SOLUTION","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["MINERAL SALTS IN COMBINATION"],"atcCode":["A06AD10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM BICARBONATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc56"},"numbersOfAis":"1","activeIngredientName":["MINOXIDIL"],"dose":["20"],"productID":{"$numberInt":"7084"},"sanitizedRegiestrationNumber":"00708925","productName":"MEN'S ROGAINE","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["MINOXIDIL, TOPICAL"],"atcCode":["D11AX01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MINOXIDIL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc57"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"6529"},"sanitizedRegiestrationNumber":"00629367","productName":"DIPROLENE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc58"},"numbersOfAis":"1","activeIngredientName":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"dose":["2"],"productID":{"$numberInt":"8038"},"sanitizedRegiestrationNumber":"00657409","productName":"ROCEPHIN PWS 2GM/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CEFTRIAXONE"],"atcCode":["J01DD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc59"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM PHOSPHATE MONOBASIC"],"dose":["176"],"productID":{"$numberInt":"8119"},"sanitizedRegiestrationNumber":"00711306","productName":"PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["POTASSIUM PHOS INCL COMB W/0TH POT. SALTS"],"atcCode":["B05XA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM PHOSPHATE MONOBASIC"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5a"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE SODIUM"],"dose":["100"],"productID":{"$numberInt":"8974"},"sanitizedRegiestrationNumber":"00716731","productName":"TARO-DOCUSATE","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5b"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE ACETONIDE"],"dose":["0.1"],"productID":{"$numberInt":"9280"},"sanitizedRegiestrationNumber":"00716987","productName":"TRIADERM ONT 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["D07AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5c"},"numbersOfAis":"1","activeIngredientName":["DEXAMETHASONE SODIUM PHOSPHATE"],"dose":["4"],"productID":{"$numberInt":"10814"},"sanitizedRegiestrationNumber":"00716715","productName":"DEXAMETHASONE SOD PHOS INJ 4MG/ML","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DEXAMETHASONE"],"atcCode":["H02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXAMETHASONE SODIUM PHOSPHATE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5d"},"numbersOfAis":"4","activeIngredientName":["MAGNESIUM CHLORIDE","SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE"],"dose":["0.03","0.64","0.075","0.048"],"productID":{"$numberInt":"7474"},"sanitizedRegiestrationNumber":"00707937","productName":"EYE STREAM","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["SOLVENTS AND DILUTING AGENTS,INCL IRRIGAT SOLUT"],"atcCode":["V07AB"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["","","",""],"qunatityUnit":["W/V","W/V","W/V","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5e"},"numbersOfAis":"4","activeIngredientName":["GRAMICIDIN","NYSTATIN","TRIAMCINOLONE ACETONIDE","NEOMYCIN (NEOMYCIN SULFATE)"],"dose":["0.25","100000","1","2.5"],"productID":{"$numberInt":"9449"},"sanitizedRegiestrationNumber":"00717029","productName":"VIADERM KC ONT","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["TRIAMCINOLONE AND ANTIBIOTICS","TRIAMCINOLONE AND ANTIBIOTICS"],"atcCode":["D07CB01","D07CB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GRAMICIDIN","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc5f"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"9269"},"sanitizedRegiestrationNumber":"00716634","productName":"BETADERM LOTION 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc60"},"numbersOfAis":"1","activeIngredientName":["FAMOTIDINE"],"dose":["20"],"productID":{"$numberInt":"7087"},"sanitizedRegiestrationNumber":"00710121","productName":"PEPCID TAB 20MG","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["FAMOTIDINE"],"atcCode":["A02BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FAMOTIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc61"},"numbersOfAis":"2","activeIngredientName":["GRAMICIDIN","POLYMYXIN B (POLYMYXIN B SULFATE)"],"dose":["0.025","10000"],"productID":{"$numberInt":"10025"},"sanitizedRegiestrationNumber":"00701785","productName":"OPTIMYXIN","licenseHolderSponser":"EURO-PHARM INTERNATIONAL CANADA INC","companyCode":[{"$numberInt":"7555"}],"facilityAddress":" 9400  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ANTIINFECTIVES, COMBINATIONS"],"atcCode":["S03AA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GRAMICIDIN","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic","Otic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc62"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"5936"},"sanitizedRegiestrationNumber":"00622133","productName":"DILAUDID HP","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc63"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["10"],"productID":{"$numberInt":"7131"},"sanitizedRegiestrationNumber":"00713449","productName":"TEVA-HALOPERIDOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc64"},"numbersOfAis":"1","activeIngredientName":["SENNOSIDES"],"dose":[".7"],"productID":{"$numberInt":"41729"},"sanitizedRegiestrationNumber":"00707643","productName":"CASTORIA LIQ 0.7MG/ML","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2019-12-31"],"sanitizedIndication":["SENNA GLYCOSIDES"],"atcCode":["A06AB06"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SENNOSIDES"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc65"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.05"],"productID":{"$numberInt":"8972"},"sanitizedRegiestrationNumber":"00716618","productName":"BETADERM CRM 0.05%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc66"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","6.70","7.49","1.61","5.41","90.0"],"productID":{"$numberInt":"6610"},"sanitizedRegiestrationNumber":"00665673","productName":"ACID CONCENTRATE D12094","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc67"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM CHLORIDE"],"dose":["1.5"],"productID":{"$numberInt":"9588"},"sanitizedRegiestrationNumber":"00713376","productName":"K-DUR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["POTASSIUM CHLORIDE"],"atcCode":["A12BA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc68"},"numbersOfAis":"2","activeIngredientName":["VITAMIN D","CALCIUM (CALCIUM CARBONATE)"],"dose":["125","600"],"productID":{"$numberInt":"8244"},"sanitizedRegiestrationNumber":"00722553","productName":"PREVENCAL + D A CROQUER 600MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc69"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["500"],"productID":{"$numberInt":"7149"},"sanitizedRegiestrationNumber":"00713341","productName":"APO-PROCAINAMIDE CAP 500MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6a"},"numbersOfAis":"1","activeIngredientName":["METHOCARBAMOL"],"dose":["100"],"productID":{"$numberInt":"8576"},"sanitizedRegiestrationNumber":"00731110","productName":"METHOCARBAMOL INJ 100MG/ML","licenseHolderSponser":"UNIVET PHARMACEUTICALS LTD.","companyCode":[{"$numberInt":"5339"}],"facilityAddress":"SUITE 11 4087 Harvester Rd Burlington Ontario Canada L7L 5M3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["METHOCARBAMOL"],"atcCode":["M03BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHOCARBAMOL"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6b"},"numbersOfAis":"1","activeIngredientName":["NYSTATIN"],"dose":["100000"],"productID":{"$numberInt":"8977"},"sanitizedRegiestrationNumber":"00716871","productName":"NYADERM CRM 100000UNIT/GM","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["NYSTATIN"],"atcCode":["D01AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NYSTATIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6c"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["375"],"productID":{"$numberInt":"7150"},"sanitizedRegiestrationNumber":"00713333","productName":"APO-PROCAINAMIDE CAP 375MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6d"},"numbersOfAis":"1","activeIngredientName":["NYSTATIN"],"dose":["25000"],"productID":{"$numberInt":"9277"},"sanitizedRegiestrationNumber":"00716901","productName":"NYADERM VAG CRM 25000UNIT/GM","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["NYSTATIN"],"atcCode":["G01AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NYSTATIN"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6e"},"numbersOfAis":"1","activeIngredientName":["FLUOCINOLONE ACETONIDE"],"dose":[".1"],"productID":{"$numberInt":"9274"},"sanitizedRegiestrationNumber":"00716804","productName":"FLUODERM ONT 0.01%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["FLUOCINOLONE ACETONIDE"],"atcCode":["D07AC04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc6f"},"numbersOfAis":"2","activeIngredientName":["SODIUM CHLORIDE","SODIUM BICARBONATE"],"dose":["223.5","626.4"],"productID":{"$numberInt":"7372"},"sanitizedRegiestrationNumber":"00732494","productName":"BICARBONATE CHLORIDE D12052","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["PCK","PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc70"},"numbersOfAis":"1","activeIngredientName":["LORAZEPAM"],"dose":["0.5"],"productID":{"$numberInt":"7314"},"sanitizedRegiestrationNumber":"00711101","productName":"TEVA-LORAZEPAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["LORAZEPAM"],"atcCode":["N05BA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc71"},"numbersOfAis":"1","activeIngredientName":["SODIUM HYPOCHLORITE"],"dose":["12"],"productID":{"$numberInt":"9158"},"sanitizedRegiestrationNumber":"00724939","productName":"DELLA-SAN LIQ 12%","licenseHolderSponser":"DELAVAL INC.","companyCode":[{"$numberInt":"10103"}],"facilityAddress":" 10900 Rue Secant Street Ville D'Anjou Quebec Canada H1J 1S5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM HYPOCHLORITE"],"sanitizedRouteOfAdministration":["Disinfectant (Food Premises)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc72"},"numbersOfAis":"18","activeIngredientName":["GLUTAMIC ACID","L-PROLINE","TAURINE","GLYCINE","L-LEUCINE","METHIONINE","L-THREONINE","L-VALINE","L-ARGININE","HISTIDINE","SERINE","L-TYROSINE","L-ISOLEUCINE","L-LYSINE (L-LYSINE ACETATE)","L-PHENYLALANINE","TRYPTOPHAN","L-ALANINE","L-ASPARTIC ACID"],"dose":["820","812","70","385","1.2","180","512","673","1.227","312","495","44","760","677","427","180","698","527"],"productID":{"$numberInt":"18606"},"sanitizedRegiestrationNumber":"00731366","productName":"AMINOSYN-PF 10%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLUTAMIC ACID","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","G","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc73"},"numbersOfAis":"4","activeIngredientName":["CALCIUM CARBONATE","MAGNESIUM OXIDE","VITAMIN D","FERROUS FUMARATE"],"dose":["1","82.9","125","24.4"],"productID":{"$numberInt":"15496"},"sanitizedRegiestrationNumber":"00718025","productName":"CALCIUM VITAMIN D IRON MAG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CARBONATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc74"},"numbersOfAis":"1","activeIngredientName":["NYSTATIN"],"dose":["100000"],"productID":{"$numberInt":"8978"},"sanitizedRegiestrationNumber":"00716898","productName":"NYADERM ONT 100000UNIT/GM","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["NYSTATIN"],"atcCode":["D01AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NYSTATIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc75"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["1"],"productID":{"$numberInt":"13685"},"sanitizedRegiestrationNumber":"00723770","productName":"XANAX TAB 1MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc76"},"numbersOfAis":"1","activeIngredientName":["CYPROTERONE ACETATE"],"dose":["50"],"productID":{"$numberInt":"7394"},"sanitizedRegiestrationNumber":"00704431","productName":"ANDROCUR","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CYPROTERONE"],"atcCode":["G03HA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYPROTERONE ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc77"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE ACETONIDE"],"dose":["0.25"],"productID":{"$numberInt":"9279"},"sanitizedRegiestrationNumber":"00716979","productName":"TRIADERM ONT 0.025%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1979-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["D07AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc78"},"numbersOfAis":"2","activeIngredientName":["CILASTATIN (CILASTATIN SODIUM)","IMIPENEM"],"dose":["250","250"],"productID":{"$numberInt":"8348"},"sanitizedRegiestrationNumber":"00717274","productName":"PRIMAXIN 250","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["IMIPENEM AND CILASTATIN"],"atcCode":["J01DH51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CILASTATIN (CILASTATIN SODIUM)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["VIAL","VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc79"},"numbersOfAis":"1","activeIngredientName":["PREDNISOLONE ACETATE"],"dose":["1"],"productID":{"$numberInt":"7042"},"sanitizedRegiestrationNumber":"00700401","productName":"TEVA-PREDNISOLONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PREDNISOLONE"],"atcCode":["S01BA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7a"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE ACETONIDE"],"dose":["0.1"],"productID":{"$numberInt":"8573"},"sanitizedRegiestrationNumber":"00716960","productName":"TRIADERM CRM 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["D07AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7b"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.05"],"productID":{"$numberInt":"9270"},"sanitizedRegiestrationNumber":"00716642","productName":"BETADERM ONT 0.05%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7c"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE ACETATE"],"dose":["2"],"productID":{"$numberInt":"10393"},"sanitizedRegiestrationNumber":"00749834","productName":"TOPIDERM HC 2%","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["D07AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE ACETATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7d"},"numbersOfAis":"1","activeIngredientName":["PROCAINAMIDE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"7151"},"sanitizedRegiestrationNumber":"00713325","productName":"APO-PROCAINAMIDE CAP 250MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PROCAINAMIDE"],"atcCode":["C01BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCAINAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7e"},"numbersOfAis":"1","activeIngredientName":["FLUTAMIDE"],"dose":["250"],"productID":{"$numberInt":"6035"},"sanitizedRegiestrationNumber":"00637726","productName":"EUFLEX","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1984-12-31"],"sanitizedIndication":["FLUTAMIDE"],"atcCode":["L02BB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUTAMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc7f"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"9719"},"sanitizedRegiestrationNumber":"00730726","productName":"ACETAMINOPHEN ORAL SOLUTION 80MG/ML USP","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc80"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"8973"},"sanitizedRegiestrationNumber":"00716650","productName":"BETADERM ONT 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc81"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["10000"],"productID":{"$numberInt":"9471"},"sanitizedRegiestrationNumber":"00740497","productName":"HEPALEAN 10,000 USP","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc82"},"numbersOfAis":"2","activeIngredientName":["PHENYLPROPANOLAMINE HYDROCHLORIDE","CHLORPHENIRAMINE MALEATE"],"dose":["50","8"],"productID":{"$numberInt":"41902"},"sanitizedRegiestrationNumber":"00723819","productName":"CORICIDIN D LONG ACTING TAB","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PHENYLPROPANOLAMINE, COMBINATIONS","PHENYLPROPANOLAMINE, COMBINATIONS"],"atcCode":["R01BA51","R01BA51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLPROPANOLAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc83"},"numbersOfAis":"1","activeIngredientName":["PROPRANOLOL HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"7349"},"sanitizedRegiestrationNumber":"00740675","productName":"TEVA-PROPRANOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["PROPRANOLOL"],"atcCode":["C07AA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPRANOLOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc84"},"numbersOfAis":"18","activeIngredientName":["L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID","L-PROLINE","DEXTROSE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","HISTIDINE","N-ACETYL-L-TYROSINE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","GLYCINE","SERINE"],"dose":["525","200","496","369","361","25","500","149","230","330","150","135","330","85","100","509","250","265"],"productID":{"$numberInt":"18699"},"sanitizedRegiestrationNumber":"00742783","productName":"AMINOSYN II IN DEXTROSE INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-LYSINE (L-LYSINE ACETATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc85"},"numbersOfAis":"1","activeIngredientName":["FAMOTIDINE"],"dose":["10"],"productID":{"$numberInt":"8290"},"sanitizedRegiestrationNumber":"00728128","productName":"PEPCID I.V. 10MG/ML","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["FAMOTIDINE"],"atcCode":["A02BA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FAMOTIDINE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc86"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","SODIUM CITRATE","CALCIUM CHLORIDE","SODIUM ACETATE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["6.4","1.49",".36","2.36",".75",".14"],"productID":{"$numberInt":"8169"},"sanitizedRegiestrationNumber":"00708127","productName":"BALANCED SALT SOLUTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05CB10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc87"},"numbersOfAis":"1","activeIngredientName":["PIROXICAM"],"dose":["20"],"productID":{"$numberInt":"6812"},"sanitizedRegiestrationNumber":"00695696","productName":"TEVA-PIROXICAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["PIROXICAM"],"atcCode":["M01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PIROXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc88"},"numbersOfAis":"5","activeIngredientName":["MACROGOL","SODIUM SULFATE","SODIUM BICARBONATE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["236","22.74","6.74","5.86","2.97"],"productID":{"$numberInt":"6370"},"sanitizedRegiestrationNumber":"00652512","productName":"GOLYTELY GI LAVAGE SOLUTION","licenseHolderSponser":"BRAINTREE LABORATORIES INC.","companyCode":[{"$numberInt":"3818"}],"facilityAddress":" 60 Columbian Street Braintree Massachusetts United States 02185-0929","countryOfOrigin":["United States"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["MINERAL SALTS IN COMBINATION"],"atcCode":["A06AD10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MACROGOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["4","4","4","4","4"],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc89"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["1"],"productID":{"$numberInt":"11350"},"sanitizedRegiestrationNumber":"00740055","productName":"DANDRUFF TREATMENT SHAMPOO REG 1%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8a"},"numbersOfAis":"4","activeIngredientName":["SODIUM CHLORIDE","DEXTROSE","SODIUM ACETATE","CALCIUM CHLORIDE"],"dose":["206.8","35","103.1","6.31"],"productID":{"$numberInt":"7370"},"sanitizedRegiestrationNumber":"00732699","productName":"D12034 CONC ELECTROLYTE RENAL DIALYSIS","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G"],"quantityNeedToTake":["","","",""],"qunatityUnit":["L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8b"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"dose":["400"],"productID":{"$numberInt":"8550"},"sanitizedRegiestrationNumber":"00758256","productName":"VITAMIN E 400UNIT CROQUABLES","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TOCOPHEROL (VIT E)"],"atcCode":["A11HA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8c"},"numbersOfAis":"1","activeIngredientName":["ISOSORBIDE DINITRATE"],"dose":["20"],"productID":{"$numberInt":"7350"},"sanitizedRegiestrationNumber":"00740721","productName":"CEDOCARD-SR SRT 20MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ISOSORBIDE DINITRATE"],"atcCode":["C01DA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOSORBIDE DINITRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8d"},"numbersOfAis":"1","activeIngredientName":["EPINEPHRINE"],"dose":["1"],"productID":{"$numberInt":"8352"},"sanitizedRegiestrationNumber":"00710814","productName":"EPINEPHRINE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["EPINEPHRINE"],"atcCode":["C01CA24"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPINEPHRINE"],"sanitizedRouteOfAdministration":["Intravenous","Intracardiac"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["10"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8e"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["10"],"productID":{"$numberInt":"9168"},"sanitizedRegiestrationNumber":"00755885","productName":"APO-PINDOL TAB 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc8f"},"numbersOfAis":"3","activeIngredientName":["VITAMIN D","CALCIUM (CALCIUM CARBONATE)","MAGNESIUM (MAGNESIUM OXIDE)"],"dose":["125","600","50"],"productID":{"$numberInt":"8245"},"sanitizedRegiestrationNumber":"00724750","productName":"PREVENCAL 600 + D ET MAGNESIUM","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc90"},"numbersOfAis":"1","activeIngredientName":["ESTRADIOL"],"dose":["8"],"productID":{"$numberInt":"8175"},"sanitizedRegiestrationNumber":"00756792","productName":"ESTRADERM-100","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ESTRADIOL"],"atcCode":["G03CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ESTRADIOL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc91"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"9268"},"sanitizedRegiestrationNumber":"00716626","productName":"BETADERM CRM 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc92"},"numbersOfAis":"2","activeIngredientName":["DOPAMINE HYDROCHLORIDE","DEXTROSE"],"dose":["1.6","50"],"productID":{"$numberInt":"11625"},"sanitizedRegiestrationNumber":"00761826","productName":"DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOPAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc93"},"numbersOfAis":"1","activeIngredientName":["IVERMECTIN"],"dose":["272"],"productID":{"$numberInt":"8255"},"sanitizedRegiestrationNumber":"00651990","productName":"HEARTGARD-30 TABLETS FOR DOGS 272MCG","licenseHolderSponser":"MERIAL CANADA INC","companyCode":[{"$numberInt":"8208"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IVERMECTIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc94"},"numbersOfAis":"1","activeIngredientName":["MEPIVACAINE HYDROCHLORIDE"],"dose":["30"],"productID":{"$numberInt":"10038"},"sanitizedRegiestrationNumber":"00753130","productName":"MEPIVICAINE HYDROCHLORIDE INJECTION, USP 3%","licenseHolderSponser":"DENTSPLY CANADA LIMITED","companyCode":[{"$numberInt":"3652"}],"facilityAddress":" 161 Vinyl Court Woodbridge Ontario Canada L4L 4A3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MEPIVACAINE"],"atcCode":["N01BB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEPIVACAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc95"},"numbersOfAis":"1","activeIngredientName":["TESTOSTERONE ENANTHATE"],"dose":["200"],"productID":{"$numberInt":"9450"},"sanitizedRegiestrationNumber":"00716936","productName":"TESTOSTERONE ENANTHATE INJ 200MG/ML","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TESTOSTERONE"],"atcCode":["G03BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TESTOSTERONE ENANTHATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc96"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["50"],"productID":{"$numberInt":"8603"},"sanitizedRegiestrationNumber":"00749354","productName":"APO METOPROLOL (TYPE L) TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc97"},"numbersOfAis":"1","activeIngredientName":["SUCCINYLCHOLINE CHLORIDE"],"dose":["20"],"productID":{"$numberInt":"6545"},"sanitizedRegiestrationNumber":"00640778","productName":"QUELICIN INJ 20MG/ML USP","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["SUXAMETHONIUM"],"atcCode":["M03AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SUCCINYLCHOLINE CHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc98"},"numbersOfAis":"1","activeIngredientName":["FLUOCINOLONE ACETONIDE"],"dose":[".01"],"productID":{"$numberInt":"9273"},"sanitizedRegiestrationNumber":"00716782","productName":"FLUODERM CRM 0.01%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["FLUOCINOLONE ACETONIDE"],"atcCode":["D07AC04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc99"},"numbersOfAis":"1","activeIngredientName":["FLUOCINOLONE ACETONIDE"],"dose":["0.25"],"productID":{"$numberInt":"9447"},"sanitizedRegiestrationNumber":"00716812","productName":"FLUODERM ONT 0.025%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["FLUOCINOLONE ACETONIDE"],"atcCode":["D07AC04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9a"},"numbersOfAis":"1","activeIngredientName":["FLUOCINOLONE ACETONIDE"],"dose":[".025"],"productID":{"$numberInt":"8975"},"sanitizedRegiestrationNumber":"00716790","productName":"FLUODERM CRM 0.025%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["FLUOCINOLONE ACETONIDE"],"atcCode":["D07AC04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9b"},"numbersOfAis":"4","activeIngredientName":["TRIAMCINOLONE ACETONIDE","NEOMYCIN (NEOMYCIN SULFATE)","GRAMICIDIN","NYSTATIN"],"dose":["1","2.5","0.25","100000"],"productID":{"$numberInt":"9448"},"sanitizedRegiestrationNumber":"00717002","productName":"VIADERM KC CRM","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1983-12-31"],"sanitizedIndication":["TRIAMCINOLONE AND ANTIBIOTICS","TRIAMCINOLONE AND ANTIBIOTICS"],"atcCode":["D07CB01","D07CB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIAMCINOLONE ACETONIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","UNIT"],"quantityNeedToTake":["","","",""],"qunatityUnit":["G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9c"},"numbersOfAis":"2","activeIngredientName":["IMIPENEM","CILASTATIN (CILASTATIN SODIUM)"],"dose":["500","500"],"productID":{"$numberInt":"8054"},"sanitizedRegiestrationNumber":"00717282","productName":"PRIMAXIN 500","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["IMIPENEM AND CILASTATIN"],"atcCode":["J01DH51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IMIPENEM","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["VIAL","VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9d"},"numbersOfAis":"18","activeIngredientName":["PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC))","CALCIUM (CALCIUM PHOSPHATE (DIBASIC))","MAGNESIUM (MAGNESIUM OXIDE)","IODINE (POTASSIUM IODIDE)","COPPER (COPPER SULFATE)","VITAMIN C","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","FOLIC ACID","BIOTIN","VITAMIN A (VITAMIN A ACETATE)","IRON (FERROUS FUMARATE)","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","VITAMIN D2","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN B2","VITAMIN B12","NICOTINAMIDE"],"dose":["154","200","100",".2","2","150","4.5","2.5",".3",".02","6000","20","10","400","25","3","7","30"],"productID":{"$numberInt":"8243"},"sanitizedRegiestrationNumber":"00718017","productName":"NOVIM 60","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC))","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","UNIT","MG","MG","UNIT","UNIT","MG","MCG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9e"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"8118"},"sanitizedRegiestrationNumber":"00742813","productName":"HYDROXYZINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfc9f"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"dose":["0.1"],"productID":{"$numberInt":"19225"},"sanitizedRegiestrationNumber":"00750050","productName":"TEVA-ECTOSONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE VALERATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca0"},"numbersOfAis":"1","activeIngredientName":["DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)"],"dose":["0.1"],"productID":{"$numberInt":"12640"},"sanitizedRegiestrationNumber":"00739839","productName":"SANDOZ DEXAMETHASONE","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DEXAMETHASONE"],"atcCode":["S03BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)"],"sanitizedRouteOfAdministration":["Ophthalmic","Otic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca1"},"numbersOfAis":"3","activeIngredientName":["SOYBEAN OIL","SAFFLOWER OIL","EGG PHOSPHOLIPIDS"],"dose":["10","10","1.2"],"productID":{"$numberInt":"8197"},"sanitizedRegiestrationNumber":"00720968","productName":"LIPOSYN II 20%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Emulsion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["FAT EMULSIONS"],"atcCode":["B05BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SOYBEAN OIL","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca2"},"numbersOfAis":"1","activeIngredientName":["MEPERIDINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"8121"},"sanitizedRegiestrationNumber":"00725765","productName":"MEPERIDINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["PETHIDINE"],"atcCode":["N02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEPERIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca3"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"7444"},"sanitizedRegiestrationNumber":"00738840","productName":"NOVO-HYDROXYZIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca4"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE ACETONIDE"],"dose":[".025"],"productID":{"$numberInt":"9278"},"sanitizedRegiestrationNumber":"00716952","productName":"TRIADERM CRM 0.025%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["D07AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca5"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C (ASCORBIC ACID, SODIUM ASCORBATE)"],"dose":["100"],"productID":{"$numberInt":"8077"},"sanitizedRegiestrationNumber":"00738719","productName":"VITAMINE-C 100MG - CROQUER (ORANGE)","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C (ASCORBIC ACID, SODIUM ASCORBATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca6"},"numbersOfAis":"18","activeIngredientName":["L-ARGININE","L-ASPARTIC ACID","GLUTAMIC ACID","GLYCINE","HISTIDINE","L-PROLINE","SERINE","N-ACETYL-L-TYROSINE","DEXTROSE","L-ISOLEUCINE","L-LEUCINE","L-LYSINE (L-LYSINE ACETATE)","METHIONINE","L-PHENYLALANINE","L-THREONINE","TRYPTOPHAN","L-VALINE","L-ALANINE"],"dose":["356","245","258","175","105","252","185","94","25","231","350","368","60","104","140","70","175","348"],"productID":{"$numberInt":"18645"},"sanitizedRegiestrationNumber":"00742759","productName":"AMINOSYN II 7% WITH 50% DEXTROSE","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-ARGININE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca7"},"numbersOfAis":"5","activeIngredientName":["VITAMIN B12","FERROUS FUMARATE","VITAMIN C","FOLIC ACID","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)"],"dose":["12","109.4","60",".4","6"],"productID":{"$numberInt":"10850"},"sanitizedRegiestrationNumber":"00718041","productName":"IRON VITAMINS B6,B12,C,FOLIC ACID TAB","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["IRON IN OTHER COMBINATIONS"],"atcCode":["B03AE"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B12","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca8"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["10"],"productID":{"$numberInt":"6627"},"sanitizedRegiestrationNumber":"00640468","productName":"HEPARIN LOCK FLUSH SOLUTION INJ 10UNIT/ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["BLOOD TRANSFUSION, AUXILIARY PRODUCTS"],"atcCode":["V07AC"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intraperitoneal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfca9"},"numbersOfAis":"15","activeIngredientName":["SULFAMETHAZINE SODIUM","SULFAMERAZINE SODIUM","SULFATHIAZOLE SODIUM","VITAMIN A","VITAMIN D3","VITAMIN B2","NICOTINIC ACID","CALCIUM D-PANTOTHENATE","VITAMIN B12","MENADIONE SODIUM BISULFITE","MAGNESIUM SULFATE","SODIUM ACETATE","SODIUM CHLORIDE","CALCIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["150","60","120","210000","70000","175","3","615","2","35","175","2.5","2.8","220","220"],"productID":{"$numberInt":"8101"},"sanitizedRegiestrationNumber":"00721069","productName":"SULFAVITE","licenseHolderSponser":"DOMINION VETERINARY LABORATORIES LTD.","companyCode":[{"$numberInt":"4091"}],"facilityAddress":" 1199 Sanford Street Winnipeg Manitoba Canada R3E 3A1","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFAMETHAZINE SODIUM","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","UNIT","UNIT","MG","G","MG","MG","MG","MG","G","G","MG","MG"],"quantityNeedToTake":["400","400","400","400","400","400","400","400","400","400","400","400","400","400","400"],"qunatityUnit":["G","G","G","G","G","G","G","G","G","G","G","G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcaa"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["80"],"productID":{"$numberInt":"9240"},"sanitizedRegiestrationNumber":"00765953","productName":"TEVA-FUROSEMIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcab"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE DIACETATE"],"dose":["40"],"productID":{"$numberInt":"12339"},"sanitizedRegiestrationNumber":"00716995","productName":"TRIAMCINOLONE DIACETATE SUS 40MG/ML","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["H02AB08"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE DIACETATE"],"sanitizedRouteOfAdministration":["Intralesional"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcac"},"numbersOfAis":"1","activeIngredientName":["TESTOSTERONE PROPIONATE"],"dose":["100"],"productID":{"$numberInt":"9805"},"sanitizedRegiestrationNumber":"00716944","productName":"TESTOSTERONE PROPIONATE INJ 100MG/ML","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1972-12-31"],"sanitizedIndication":["TESTOSTERONE"],"atcCode":["G03BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TESTOSTERONE PROPIONATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcad"},"numbersOfAis":"1","activeIngredientName":["FUROSEMIDE"],"dose":["80"],"productID":{"$numberInt":"6827"},"sanitizedRegiestrationNumber":"00707570","productName":"APO FUROSEMIDE TAB 80MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["FUROSEMIDE"],"atcCode":["C03CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUROSEMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcae"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["200"],"productID":{"$numberInt":"6463"},"sanitizedRegiestrationNumber":"00665088","productName":"TEGRETOL CHEWTABS 200 MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Chewable)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcaf"},"numbersOfAis":"6","activeIngredientName":["LEVONORGESTREL","ETHINYL ESTRADIOL","LEVONORGESTREL","ETHINYL ESTRADIOL","LEVONORGESTREL","ETHINYL ESTRADIOL"],"dose":["50","30","75","40","125","30"],"productID":{"$numberInt":"8124"},"sanitizedRegiestrationNumber":"00707600","productName":"TRIQUILAR 21","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["LEVONORGESTREL AND ESTROGEN"],"atcCode":["G03AB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LEVONORGESTREL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MCG","MCG","MCG","MCG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb0"},"numbersOfAis":"1","activeIngredientName":["EPINEPHRINE"],"dose":["1"],"productID":{"$numberInt":"9164"},"sanitizedRegiestrationNumber":"00721891","productName":"EPINEPHRINE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["EPINEPHRINE"],"atcCode":["C01CA24"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPINEPHRINE"],"sanitizedRouteOfAdministration":["Intratracheal","Intracardiac","Subcutaneous","Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb1"},"numbersOfAis":"3","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)","VITAMIN D","IRON (FERROUS FUMARATE)"],"dose":["600","125","20"],"productID":{"$numberInt":"8240"},"sanitizedRegiestrationNumber":"00718033","productName":"PREVENCAL 600 + D ET FER","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["VITAMINS WITH MINERALS"],"atcCode":["A11JB"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb2"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"11879"},"sanitizedRegiestrationNumber":"00716928","productName":"PITREX CRM 1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1979-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb3"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"7627"},"sanitizedRegiestrationNumber":"00740713","productName":"APO-DOXY CAP 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb4"},"numbersOfAis":"2","activeIngredientName":["EUCALYPTUS OIL","MENTHOL"],"dose":["4","4.7"],"productID":{"$numberInt":"10158"},"sanitizedRegiestrationNumber":"00762695","productName":"EMERTUSSIF LOZENGES","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Lozenge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["Other cold preparations"],"atcCode":["R05X"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["EUCALYPTUS OIL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["LOZ","LOZ"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb5"},"numbersOfAis":"5","activeIngredientName":["POTASSIUM CHLORIDE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM ACETATE","CALCIUM CHLORIDE"],"dose":["5.22","225","834","100.5","6.79"],"productID":{"$numberInt":"7371"},"sanitizedRegiestrationNumber":"00732745","productName":"D12046 CONC ELECTROLYTE RENAL DIALYSIS","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1986-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","MG","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb6"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["100"],"productID":{"$numberInt":"9791"},"sanitizedRegiestrationNumber":"00725315","productName":"HEPARIN LOCK FLUSH SOLUTION INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb7"},"numbersOfAis":"1","activeIngredientName":["FLAVOXATE HYDROCHLORIDE"],"dose":["200"],"productID":{"$numberInt":"7520"},"sanitizedRegiestrationNumber":"00728179","productName":"URISPAS TAB 200MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1987-12-31"],"sanitizedIndication":["FLAVOXATE"],"atcCode":["G04BD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLAVOXATE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb8"},"numbersOfAis":"3","activeIngredientName":["SOYBEAN OIL","SAFFLOWER OIL","EGG PHOSPHOLIPIDS"],"dose":["5","5","0.9"],"productID":{"$numberInt":"8198"},"sanitizedRegiestrationNumber":"00720976","productName":"LIPOSYN II 10%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Emulsion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["FAT EMULSIONS"],"atcCode":["B05BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SOYBEAN OIL","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcb9"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE CALCIUM"],"dose":["240"],"productID":{"$numberInt":"7467"},"sanitizedRegiestrationNumber":"00722855","productName":"DOCUSATE CALCIUM CAP 240MG USP","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE CALCIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcba"},"numbersOfAis":"2","activeIngredientName":["VITAMIN D","CALCIUM (CALCIUM PHOSPHATE (DIBASIC))"],"dose":["125","300"],"productID":{"$numberInt":"8242"},"sanitizedRegiestrationNumber":"00718106","productName":"PREVENCAL 300 + D A CROQUER","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcbb"},"numbersOfAis":"1","activeIngredientName":["CHLORTETRACYCLINE HYDROCHLORIDE"],"dose":["220"],"productID":{"$numberInt":"16979"},"sanitizedRegiestrationNumber":"00698210","productName":"CHLOR 100","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORTETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcbc"},"numbersOfAis":"16","activeIngredientName":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","IRON (FERROUS FUMARATE)","VITAMIN D2","VITAMIN C (SODIUM ASCORBATE)","VITAMIN B2","VITAMIN B12","COPPER (COPPER SULFATE)","FOLIC ACID","NICOTINAMIDE","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","CALCIUM (CALCIUM PHOSPHATE (DIBASIC))","PHOSPHORUS (CALCIUM PHOSPHATE (DIBASIC))","BIOTIN","VITAMIN A (VITAMIN A ACETATE)","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN B1 (THIAMINE MONONITRATE)"],"dose":["1.5","6","400","75","1.5","3","1",".1","15","10","200","154","15","5000","10","2"],"productID":{"$numberInt":"8241"},"sanitizedRegiestrationNumber":"00718084","productName":"NOVIM 60 JR CHEWABLE FOR CHILDREN","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","UNIT","MG","MG","MCG","MG","MG","MG","MG","MG","MG","MCG","UNIT","UNIT","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcbd"},"numbersOfAis":"1","activeIngredientName":["MEPERIDINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"8487"},"sanitizedRegiestrationNumber":"00725749","productName":"MEPERIDINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PETHIDINE"],"atcCode":["N02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEPERIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcbe"},"numbersOfAis":"1","activeIngredientName":["ESTRONE"],"dose":["0.1"],"productID":{"$numberInt":"7645"},"sanitizedRegiestrationNumber":"00727369","productName":"ESTRAGYN VAGINAL CREAM","licenseHolderSponser":"SEARCHLIGHT PHARMA INC","companyCode":[{"$numberInt":"16647"}],"facilityAddress":" 1600 Rue Notre Dame Ouest, Suite 312 Montreal Quebec Canada H3J 1M1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ESTRONE"],"atcCode":["G03CA07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ESTRONE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcbf"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["100"],"productID":{"$numberInt":"8042"},"sanitizedRegiestrationNumber":"00727520","productName":"HEPARIN LEO 100UNIT/ML","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["0-Unassigned"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc0"},"numbersOfAis":"1","activeIngredientName":["MEPERIDINE HYDROCHLORIDE"],"dose":["75"],"productID":{"$numberInt":"8120"},"sanitizedRegiestrationNumber":"00725757","productName":"MEPERIDINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1987-12-31"],"sanitizedIndication":["PETHIDINE"],"atcCode":["N02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEPERIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc1"},"numbersOfAis":"1","activeIngredientName":["LEUPROLIDE ACETATE"],"dose":["5"],"productID":{"$numberInt":"7367"},"sanitizedRegiestrationNumber":"00727695","productName":"LUPRON","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["LEUPRORELIN"],"atcCode":["L02AE02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEUPROLIDE ACETATE"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc2"},"numbersOfAis":"17","activeIngredientName":["L-LEUCINE","METHIONINE","L-THREONINE","L-VALINE","L-ARGININE","GLUTAMIC ACID","HISTIDINE","SERINE","L-ISOLEUCINE","L-LYSINE (L-LYSINE ACETATE)","L-PHENYLALANINE","TRYPTOPHAN","L-ALANINE","L-ASPARTIC ACID","GLYCINE","L-PROLINE","N-ACETYL-L-TYROSINE"],"dose":["850","146","340","425","865","627","255","450","561","893","253","170","844","595","425","614","230"],"productID":{"$numberInt":"18607"},"sanitizedRegiestrationNumber":"00742627","productName":"AMINOSYN II 8.5% INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-LEUCINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc3"},"numbersOfAis":"2","activeIngredientName":["PHOSPHORIC ACID","IODINE (NONYLPHENOXYPOLY(ETHYLENEOXY)ETHANOL IODINE COMPLEX)"],"dose":["11.5","1.75"],"productID":{"$numberInt":"9160"},"sanitizedRegiestrationNumber":"00724955","productName":"DELLA-WASH","licenseHolderSponser":"DELAVAL INC.","companyCode":[{"$numberInt":"10103"}],"facilityAddress":" 10900 Rue Secant Street Ville D'Anjou Quebec Canada H1J 1S5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1987-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHOSPHORIC ACID","Combination"],"sanitizedRouteOfAdministration":["Udder Wash"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc4"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C (ASCORBIC ACID, SODIUM ASCORBATE)"],"dose":["300"],"productID":{"$numberInt":"9255"},"sanitizedRegiestrationNumber":"00746258","productName":"SODIUM ASCORBATE AND ASCORBIC ACID PWR","licenseHolderSponser":"NISSAN CHEMICAL INDUSTRIES LTD.","companyCode":[{"$numberInt":"4746"}],"facilityAddress":"7-1, 3-CHOME, Kanda-Nashiki-Cho, Chiyoda-Ku Tokyo Saone Et Loire Japan 101-0054","countryOfOrigin":["Japan"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C (ASCORBIC ACID, SODIUM ASCORBATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Active Pharmaceutical Ingredients)| Label (Active Pharmaceutical Ingredients)| Package (Active Pharmaceutical Ingredients)| Test (Active Pharmaceutical Ingredients)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc5"},"numbersOfAis":"1","activeIngredientName":["HYDRALAZINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"12237"},"sanitizedRegiestrationNumber":"00723754","productName":"APRESOLINE","licenseHolderSponser":"STERIMAX INC","companyCode":[{"$numberInt":"8892"}],"facilityAddress":" 2770 Portland Drive Oakville Ontario Canada L6H 6R4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDRALAZINE"],"atcCode":["C02DB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDRALAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc6"},"numbersOfAis":"18","activeIngredientName":["TAURINE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","HISTIDINE","L-PROLINE","L-TYROSINE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","SERINE","GLYCINE","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID"],"dose":["50","534","125","125","861","220","570","44","831","300","452","370","347","270","475","360","490","576"],"productID":{"$numberInt":"18646"},"sanitizedRegiestrationNumber":"00731358","productName":"AMINOSYN-PF 7%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TAURINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc7"},"numbersOfAis":"2","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)","VITAMIN D"],"dose":["500","125"],"productID":{"$numberInt":"7430"},"sanitizedRegiestrationNumber":"00718092","productName":"PREVENCAL 500 +D","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc8"},"numbersOfAis":"2","activeIngredientName":["SULFAMETHOXAZOLE","TRIMETHOPRIM"],"dose":["40","8"],"productID":{"$numberInt":"7313"},"sanitizedRegiestrationNumber":"00726540","productName":"TEVA-TRIMEL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["SULFAMETHOXAZOLE AND TRIMETHOPRIM"],"atcCode":["J01EE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFAMETHOXAZOLE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcc9"},"numbersOfAis":"1","activeIngredientName":["CHLORPHENIRAMINE MALEATE"],"dose":["4"],"productID":{"$numberInt":"41738"},"sanitizedRegiestrationNumber":"00738972","productName":"CHLOR-TRIPOLON","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CHLORPHENIRAMINE"],"atcCode":["R06AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPHENIRAMINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcca"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["10"],"productID":{"$numberInt":"9790"},"sanitizedRegiestrationNumber":"00725323","productName":"HEPARIN LOCK FLUSH SOLUTION INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfccb"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["1000"],"productID":{"$numberInt":"9470"},"sanitizedRegiestrationNumber":"00740519","productName":"HEPALEAN 1000 USP","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfccc"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":[".1"],"productID":{"$numberInt":"41723"},"sanitizedRegiestrationNumber":"00741043","productName":"OTRIVIN WITH M-D PUMP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfccd"},"numbersOfAis":"1","activeIngredientName":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"dose":["300"],"productID":{"$numberInt":"7427"},"sanitizedRegiestrationNumber":"00733067","productName":"APO-RANITIDINE TABLET 300MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["RANITIDINE"],"atcCode":["A02BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcce"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"10117"},"sanitizedRegiestrationNumber":"00725250","productName":"TEVA-DOXYCYCLINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfccf"},"numbersOfAis":"17","activeIngredientName":["L-LYSINE (L-LYSINE ACETATE)","L-PHENYLALANINE","TRYPTOPHAN","L-ALANINE","L-ASPARTIC ACID","GLYCINE","L-PROLINE","N-ACETYL-L-TYROSINE","L-LEUCINE","METHIONINE","L-THREONINE","L-VALINE","L-ARGININE","GLUTAMIC ACID","HISTIDINE","SERINE","L-ISOLEUCINE"],"dose":["735","209","140","695","490","350","505","189","700","120","280","350","713","517","210","371","462"],"productID":{"$numberInt":"18608"},"sanitizedRegiestrationNumber":"00742635","productName":"AMINOSYN II 7% INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-LYSINE (L-LYSINE ACETATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd0"},"numbersOfAis":"1","activeIngredientName":["BUMETANIDE"],"dose":["5"],"productID":{"$numberInt":"14322"},"sanitizedRegiestrationNumber":"00728276","productName":"BURINEX","licenseHolderSponser":"KNIGHT THERAPEUTICS INC.","companyCode":[{"$numberInt":"16816"}],"facilityAddress":"1055 3400 De Maisonneuve Blvd W Montreal Quebec Canada H3Z 3B8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BUMETANIDE"],"atcCode":["C03CA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUMETANIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd1"},"numbersOfAis":"17","activeIngredientName":["GLYCINE","PROLINE","SERINE","ISOLEUCINE","LYSINE ACETATE","PHENYLALANINE","TRYPTOPHAN","L-ALANINE","GLUTAMIC ACID","HISTIDINE","L-ASPARTIC ACID","N-ACETYL-L-TYROSINE","LEUCINE","METHIONINE","THREONINE","VALINE","ARGININE"],"dose":["250","361","265","330","525","149","100","497","369","150","350","135","500","86","200","250","509"],"productID":{"$numberInt":"9163"},"sanitizedRegiestrationNumber":"00742643","productName":"AMINOSYN II 5% INJ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLYCINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd2"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"7442"},"sanitizedRegiestrationNumber":"00738824","productName":"NOVO-HYDROXYZIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd3"},"numbersOfAis":"2","activeIngredientName":["BENZALKONIUM CHLORIDE","LIDOCAINE"],"dose":[".13","2"],"productID":{"$numberInt":"8552"},"sanitizedRegiestrationNumber":"00728624","productName":"MEDI-QUIK FIRST AID SPRAY","licenseHolderSponser":"THE MENTHOLATUM COMPANY OF CANADA LTD","companyCode":[{"$numberInt":"4675"}],"facilityAddress":"UNIT 2 45 Hannover Dr. St. Catharines Ontario Canada L2W 1A3","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["LIDOCAINE","LIDOCAINE"],"atcCode":["D04AB01","D04AB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZALKONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd4"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"9718"},"sanitizedRegiestrationNumber":"00730742","productName":"CHILDRENS CHEWABLE ACETAMINOPHEN TAB 80MG USP","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd5"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["25000"],"productID":{"$numberInt":"18721"},"sanitizedRegiestrationNumber":"00740535","productName":"HEPALEAN 25,000 USP","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd6"},"numbersOfAis":"1","activeIngredientName":["MEDROXYPROGESTERONE ACETATE"],"dose":["10"],"productID":{"$numberInt":"7480"},"sanitizedRegiestrationNumber":"00729973","productName":"PROVERA 10MG TABLETS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MEDROXYPROGESTERONE"],"atcCode":["G03DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEDROXYPROGESTERONE ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd7"},"numbersOfAis":"22","activeIngredientName":["SODIUM CHLORIDE","SODIUM PHOSPHATE DIBASIC","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID","L-PROLINE","DEXTROSE","MAGNESIUM CHLORIDE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","HISTIDINE","N-ACETYL-L-TYROSINE","POTASSIUM CHLORIDE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","GLYCINE","SERINE"],"dose":["120","49","368","140","348","258","252","5","30","350","104","175","245","105","94","97","231","60","70","356","175","186"],"productID":{"$numberInt":"18698"},"sanitizedRegiestrationNumber":"00742724","productName":"AMINOSYN II 7% M IN 10% DEXTROSE(DUAL CHAMBER)","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd8"},"numbersOfAis":"21","activeIngredientName":["POTASSIUM PHOSPHATE DIBASIC","L-LEUCINE","L-LYSINE (L-LYSINE ACETATE)","METHIONINE","L-PHENYLALANINE","L-THREONINE","TRYPTOPHAN","L-VALINE","L-ALANINE","L-ARGININE","L-ASPARTIC ACID","GLUTAMIC ACID","GLYCINE","HISTIDINE","L-PROLINE","SERINE","N-ACETYL-L-TYROSINE","SODIUM CHLORIDE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","L-ISOLEUCINE"],"dose":["522","1","1.05","172","298","400","200","500","993","1.018","700","738","500","300","722","530","270","410","45","102","660"],"productID":{"$numberInt":"18628"},"sanitizedRegiestrationNumber":"00742651","productName":"AMINOSYN II 10% WITH ELECTROLYTES","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM PHOSPHATE DIBASIC","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","G","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcd9"},"numbersOfAis":"1","activeIngredientName":["PETROLATUM"],"dose":["100"],"productID":{"$numberInt":"9587"},"sanitizedRegiestrationNumber":"00741515","productName":"WHITE PETROLEUM JELLY USP OINTMENT","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SOFT PARAFFIN AND FAT PRODUCTS"],"atcCode":["D02AC"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PETROLATUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcda"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE"],"dose":["172.2","2.63","5.49","8.85","6.33","36.8"],"productID":{"$numberInt":"8035"},"sanitizedRegiestrationNumber":"00742171","productName":"ACID CONCENTRATE D12112","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcdb"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["240"],"productID":{"$numberInt":"9264"},"sanitizedRegiestrationNumber":"00742554","productName":"ISOPTIN SR","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcdc"},"numbersOfAis":"1","activeIngredientName":["IPRATROPIUM BROMIDE"],"dose":["250"],"productID":{"$numberInt":"8525"},"sanitizedRegiestrationNumber":"00731439","productName":"ATROVENT","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["IPRATROPIUM BROMIDE"],"atcCode":["R03BB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IPRATROPIUM BROMIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcdd"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)"],"dose":["0.5"],"productID":{"$numberInt":"8959"},"sanitizedRegiestrationNumber":"00755834","productName":"APO-TIMOP","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["S01ED01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcde"},"numbersOfAis":"1","activeIngredientName":["PETROLATUM"],"dose":["100"],"productID":{"$numberInt":"10314"},"sanitizedRegiestrationNumber":"00745790","productName":"WHITE PETROLEUM JELLY 100% BP","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SOFT PARAFFIN AND FAT PRODUCTS"],"atcCode":["D02AC"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PETROLATUM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcdf"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["15"],"productID":{"$numberInt":"9169"},"sanitizedRegiestrationNumber":"00755893","productName":"APO-PINDOL TAB 15MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce0"},"numbersOfAis":"18","activeIngredientName":["L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","GLYCINE","SERINE","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID","L-PROLINE","DEXTROSE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","HISTIDINE","N-ACETYL-L-TYROSINE"],"dose":["231","60","70","356","175","185","368","140","348","258","252","5","350","104","175","245","105","94"],"productID":{"$numberInt":"18703"},"sanitizedRegiestrationNumber":"00742740","productName":"AMINOSYN II 7% WITH 10% DEXTROSE","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-ISOLEUCINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce1"},"numbersOfAis":"4","activeIngredientName":["PHENYLPROPANOLAMINE HYDROCHLORIDE","ACETAMINOPHEN","CAFFEINE","DIPHENYLPYRALINE HYDROCHLORIDE"],"dose":["25","325","30","2"],"productID":{"$numberInt":"10161"},"sanitizedRegiestrationNumber":"00763519","productName":"EMERCIDIN D TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLPROPANOLAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce2"},"numbersOfAis":"1","activeIngredientName":["BUMETANIDE"],"dose":["1"],"productID":{"$numberInt":"14334"},"sanitizedRegiestrationNumber":"00728284","productName":"BURINEX","licenseHolderSponser":"KNIGHT THERAPEUTICS INC.","companyCode":[{"$numberInt":"16816"}],"facilityAddress":"1055 3400 De Maisonneuve Blvd W Montreal Quebec Canada H3Z 3B8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BUMETANIDE"],"atcCode":["C03CA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUMETANIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce3"},"numbersOfAis":"1","activeIngredientName":["ESTRADIOL"],"dose":["2"],"productID":{"$numberInt":"8386"},"sanitizedRegiestrationNumber":"00756849","productName":"ESTRADERM-25","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ESTRADIOL"],"atcCode":["G03CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ESTRADIOL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce4"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["100"],"productID":{"$numberInt":"8602"},"sanitizedRegiestrationNumber":"00751170","productName":"APO-METOPROLOL (TYPE L) TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce5"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","ACETIC ACID"],"dose":["1.61","7.49","67.54","263","10.8"],"productID":{"$numberInt":"8583"},"sanitizedRegiestrationNumber":"00774243","productName":"ACID CONCENTRATE 2100","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce6"},"numbersOfAis":"1","activeIngredientName":["ALFACALCIDOL"],"dose":[".2"],"productID":{"$numberInt":"9870"},"sanitizedRegiestrationNumber":"00759546","productName":"ONE-ALPHA SOL 0.2MCG/ML","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ALFACALCIDOL"],"atcCode":["A11CC03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALFACALCIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce7"},"numbersOfAis":"1","activeIngredientName":["OXYMETAZOLINE HYDROCHLORIDE"],"dose":["0.05"],"productID":{"$numberInt":"41903"},"sanitizedRegiestrationNumber":"00740861","productName":"DRIXORAL DECONGESTANT NASAL SPRAY","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["OXYMETAZOLINE"],"atcCode":["R01AA05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce8"},"numbersOfAis":"2","activeIngredientName":["DOPAMINE HYDROCHLORIDE","DEXTROSE"],"dose":["3.2","50"],"productID":{"$numberInt":"11624"},"sanitizedRegiestrationNumber":"00761834","productName":"DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOPAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfce9"},"numbersOfAis":"1","activeIngredientName":["CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE)"],"dose":["25"],"productID":{"$numberInt":"8488"},"sanitizedRegiestrationNumber":"00743518","productName":"CHLORPROMAZINE HYDROCHLORIDE INJECTION","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CHLORPROMAZINE"],"atcCode":["N05AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROMAZINE (CHLORPROMAZINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcea"},"numbersOfAis":"4","activeIngredientName":["CAFFEINE","PHENYLPROPANOLAMINE HYDROCHLORIDE","ACETAMINOPHEN","DIPHENYLPYRALINE HYDROCHLORIDE"],"dose":["32.4","25","325","2"],"productID":{"$numberInt":"10159"},"sanitizedRegiestrationNumber":"00763519","productName":"ORADRINE-2 TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CAFFEINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfceb"},"numbersOfAis":"1","activeIngredientName":["HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)"],"dose":["10"],"productID":{"$numberInt":"7510"},"sanitizedRegiestrationNumber":"00749486","productName":"RECOMBIVAX HB (WITH PRESERVATIVE)","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HEPATITIS B, PURIFIED ANTIGEN"],"atcCode":["J07BC01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcec"},"numbersOfAis":"1","activeIngredientName":["FLUPHENAZINE DECANOATE"],"dose":["100"],"productID":{"$numberInt":"10488"},"sanitizedRegiestrationNumber":"00755575","productName":"MODECATE CONCENTRATE","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["FLUPHENAZINE"],"atcCode":["N05AB02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUPHENAZINE DECANOATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfced"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["400"],"productID":{"$numberInt":"8374"},"sanitizedRegiestrationNumber":"00755583","productName":"TEGRETOL CR TAB 400MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcee"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["2"],"productID":{"$numberInt":"13327"},"sanitizedRegiestrationNumber":"00758485","productName":"SPECTRO GRAM 2 SKIN CLEANSER","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcef"},"numbersOfAis":"6","activeIngredientName":["POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","CALCIUM CHLORIDE","ACETIC ACID"],"dose":["3.35","1.61","89.99","262.98","7.49","5.4"],"productID":{"$numberInt":"14727"},"sanitizedRegiestrationNumber":"00774839","productName":"ACID CONCENTRATE 2105","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf0"},"numbersOfAis":"1","activeIngredientName":["FLUOROMETHOLONE ACETATE"],"dose":["0.1"],"productID":{"$numberInt":"8229"},"sanitizedRegiestrationNumber":"00756784","productName":"FLAREX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["FLUOROMETHOLONE"],"atcCode":["S01BA07"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOROMETHOLONE ACETATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf1"},"numbersOfAis":"1","activeIngredientName":["DILTIAZEM HYDROCHLORIDE"],"dose":["30"],"productID":{"$numberInt":"9172"},"sanitizedRegiestrationNumber":"00771376","productName":"APO-DILTIAZ","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["DILTIAZEM"],"atcCode":["C08DB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DILTIAZEM HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf3"},"numbersOfAis":"2","activeIngredientName":["SODIUM PHOSPHATE MONOBASIC","SODIUM PHOSPHATE DIBASIC"],"dose":["2.4","900"],"productID":{"$numberInt":"13578"},"sanitizedRegiestrationNumber":"00771678","productName":"PHOSPHO-SODA BUFFERED SALINE LAXATIVE","licenseHolderSponser":"C.B. FLEET COMPANY INC.","companyCode":[{"$numberInt":"4189"}],"facilityAddress":" 4615 Murray Place Lynchburg Virginia United States 24506-1349","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["SODIUM PHOSPHATE"],"atcCode":["A06AD17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM PHOSPHATE MONOBASIC","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["5","5"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf2"},"numbersOfAis":"1","activeIngredientName":["ENFLURANE"],"dose":["99.9"],"productID":{"$numberInt":"14790"},"sanitizedRegiestrationNumber":"00778370","productName":"ENFLURANE","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ENFLURANE"],"atcCode":["N01AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENFLURANE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf4"},"numbersOfAis":"1","activeIngredientName":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"9171"},"sanitizedRegiestrationNumber":"00768723","productName":"APO-CEPHALEX","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CEFALEXIN"],"atcCode":["J01DB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf5"},"numbersOfAis":"1","activeIngredientName":["AMMONIA"],"dose":["3.61"],"productID":{"$numberInt":"41767"},"sanitizedRegiestrationNumber":"00766097","productName":"AFTER BITE LIQUID 3.61%","licenseHolderSponser":"TENDER CORPORATION","companyCode":[{"$numberInt":"5251"}],"facilityAddress":" 944 Industrial Park Road Littleton New Hampshire United States 03561","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["OTHER ANTIPRURITICS"],"atcCode":["D04AX"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMMONIA"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf6"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["325"],"productID":{"$numberInt":"14475"},"sanitizedRegiestrationNumber":"00743542","productName":"ACETAMINOPHEN 325 MG USP REGULAR STRENGTH","licenseHolderSponser":"CELLCHEM PHARMACEUTICALS INC.","companyCode":[{"$numberInt":"16702"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf7"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE","CALCIUM CHLORIDE"],"dose":["263","1.61","10.8","67.54","6.24"],"productID":{"$numberInt":"10114"},"sanitizedRegiestrationNumber":"00774936","productName":"ACID CONCENTRATE 2116","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf9"},"numbersOfAis":"1","activeIngredientName":["DILTIAZEM HYDROCHLORIDE"],"dose":["60"],"productID":{"$numberInt":"9173"},"sanitizedRegiestrationNumber":"00771384","productName":"APO-DILTIAZ","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["DILTIAZEM"],"atcCode":["C08DB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DILTIAZEM HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcfa"},"numbersOfAis":"1","activeIngredientName":["SULINDAC"],"dose":["200"],"productID":{"$numberInt":"9239"},"sanitizedRegiestrationNumber":"00745596","productName":"TEVA-SULINDAC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SULINDAC"],"atcCode":["M01AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULINDAC"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcf8"},"numbersOfAis":"6","activeIngredientName":["POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["5.49","8.85","7.16","73.6","172.2","1.75"],"productID":{"$numberInt":"8904"},"sanitizedRegiestrationNumber":"00770280","productName":"ACID CONCENTRATE D12117","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcfb"},"numbersOfAis":"1","activeIngredientName":["SULINDAC"],"dose":["150"],"productID":{"$numberInt":"9238"},"sanitizedRegiestrationNumber":"00745588","productName":"TEVA-SULINDAC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SULINDAC"],"atcCode":["M01AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULINDAC"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcfc"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"8399"},"sanitizedRegiestrationNumber":"00775029","productName":"XYLOCAINE MPF 1%","licenseHolderSponser":"ASTRAZENECA L.P.","companyCode":[{"$numberInt":"9394"}],"facilityAddress":"DCC-1 1800 Concord Pike Wilmington Delaware United States 19850-5437","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcfd"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["2"],"productID":{"$numberInt":"10489"},"sanitizedRegiestrationNumber":"00752177","productName":"ZNP BAR 2%","licenseHolderSponser":"VALEO PHARMA INC","companyCode":[{"$numberInt":"11211"}],"facilityAddress":" 16667 Hymus Blvd. Kirkland Quebec Canada H9H 4R9","countryOfOrigin":["Canada"],"format":["Soap Bar"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcfe"},"numbersOfAis":"2","activeIngredientName":["TOBRAMYCIN","DEXAMETHASONE"],"dose":["0.3","0.1"],"productID":{"$numberInt":"10971"},"sanitizedRegiestrationNumber":"00778915","productName":"TOBRADEX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DEXAMETHASONE AND ANTIINFECTIVES","DEXAMETHASONE AND ANTIINFECTIVES"],"atcCode":["S01CA01","S01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TOBRAMYCIN","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfcff"},"numbersOfAis":"1","activeIngredientName":["ALTEPLASE"],"dose":["29"],"productID":{"$numberInt":"8379"},"sanitizedRegiestrationNumber":"00771473","productName":"ACTIVASE RT-PA INJ","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ALTEPLASE"],"atcCode":["B01AD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALTEPLASE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["M"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd00"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM SALICYLATE"],"dose":["325"],"productID":{"$numberInt":"9113"},"sanitizedRegiestrationNumber":"00760420","productName":"DOAN'S BACKACHE PILLS 325MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SALICYLIC ACID AND DERIVATIVES"],"atcCode":["N02BA"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM SALICYLATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd01"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE SODIUM"],"dose":["20"],"productID":{"$numberInt":"9812"},"sanitizedRegiestrationNumber":"00779105","productName":"DOCUSATE SODIUM SYRUP 4MG/ML","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd02"},"numbersOfAis":"8","activeIngredientName":["THIAMINE MONONITRATE","VITAMIN B2","NICOTINAMIDE","D-PANTOTHENIC ACID","PYRIDOXINE HYDROCHLORIDE","VITAMIN B12","BIOTIN","FOLIC ACID"],"dose":["75","75","75","75","75","75","75","1"],"productID":{"$numberInt":"16789"},"sanitizedRegiestrationNumber":"00753947","productName":"COMPLEXE B 75MG","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, PLAIN"],"atcCode":["A11EA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["THIAMINE MONONITRATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MCG","MCG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd03"},"numbersOfAis":"1","activeIngredientName":["ALFENTANIL (ALFENTANIL HYDROCHLORIDE)"],"dose":["500"],"productID":{"$numberInt":"8206"},"sanitizedRegiestrationNumber":"00755818","productName":"ALFENTA INJ 500MCG/ML","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ALFENTANIL"],"atcCode":["N01AH02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALFENTANIL (ALFENTANIL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd04"},"numbersOfAis":"2","activeIngredientName":["DOPAMINE HYDROCHLORIDE","DEXTROSE"],"dose":[".8","50"],"productID":{"$numberInt":"12256"},"sanitizedRegiestrationNumber":"00761850","productName":"DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOPAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd05"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["200"],"productID":{"$numberInt":"8373"},"sanitizedRegiestrationNumber":"00773611","productName":"TEGRETOL CR TAB 200MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd06"},"numbersOfAis":"1","activeIngredientName":["HEPATITIS B IMMUNOGLOBULIN (HUMAN)"],"dose":["1.5"],"productID":{"$numberInt":"9370"},"sanitizedRegiestrationNumber":"00780251","productName":"H-BIG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEPATITIS B IMMUNOGLOBULIN"],"atcCode":["J06BB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPATITIS B IMMUNOGLOBULIN (HUMAN)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd07"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","ACETIC ACID","POTASSIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE"],"dose":["268.24","8.11","10.06","89.99","3.21","7.74"],"productID":{"$numberInt":"9131"},"sanitizedRegiestrationNumber":"00771279","productName":"ACID CONCENTRATE 2139","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd08"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE","POTASSIUM CHLORIDE"],"dose":["263","7.49","1.61","10.8","67.54","6.71"],"productID":{"$numberInt":"8585"},"sanitizedRegiestrationNumber":"00774804","productName":"ACID CONCENTRATE 2102","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0a"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE"],"dose":["268.24","3.21","6.71","8.11","7.74","89.99"],"productID":{"$numberInt":"9130"},"sanitizedRegiestrationNumber":"00771244","productName":"ACID CONCENTRATE 2135","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0b"},"numbersOfAis":"1","activeIngredientName":["IODINE (IODOPHOR)"],"dose":[".092"],"productID":{"$numberInt":"10118"},"sanitizedRegiestrationNumber":"00780189","productName":"IOBAN 2 PAD","licenseHolderSponser":"3M CANADA COMPANY","companyCode":[{"$numberInt":"4550"}],"facilityAddress":" 300 Tartan Dr. London Ontario Canada N5V 4M9","countryOfOrigin":["Canada"],"format":["Pad"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["IODINE"],"atcCode":["D08AG03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (IODOPHOR)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SQ CM"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0c"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM ACETATE"],"dose":["392"],"productID":{"$numberInt":"9429"},"sanitizedRegiestrationNumber":"00780650","productName":"POTASSIUM ACETATE","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["POTASSIUM ACETATE"],"atcCode":["B05XA17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM ACETATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0d"},"numbersOfAis":"1","activeIngredientName":["CHLORPHENIRAMINE MALEATE"],"dose":["12"],"productID":{"$numberInt":"41734"},"sanitizedRegiestrationNumber":"00738964","productName":"CHLOR-TRIPOLON 12 HOUR","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CHLORPHENIRAMINE"],"atcCode":["R06AB04"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPHENIRAMINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0f"},"numbersOfAis":"1","activeIngredientName":["CALCIUM GLUCONATE"],"dose":["94"],"productID":{"$numberInt":"10911"},"sanitizedRegiestrationNumber":"00780618","productName":"CALCIUM GLUCONATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CALCIUM GLUCONATE"],"atcCode":["A12AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM GLUCONATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd10"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["80.68"],"productID":{"$numberInt":"8504"},"sanitizedRegiestrationNumber":"00771295","productName":"BICARBONATE CONCENTRATE 4105","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd11"},"numbersOfAis":"3","activeIngredientName":["SALICYLIC ACID","PODOPHYLLIN","CANTHARIDIN"],"dose":["30","2","1"],"productID":{"$numberInt":"9361"},"sanitizedRegiestrationNumber":"00772011","productName":"CANTHARONE PLUS","licenseHolderSponser":"DORMER LABORATORIES INC.","companyCode":[{"$numberInt":"4056"}],"facilityAddress":"5 91 Kelfield Street Toronto Ontario Canada M9W 5A3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1984-12-31"],"sanitizedIndication":["WART AND ANTI-CORN PREPARATIONS"],"atcCode":["D11AF"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SALICYLIC ACID","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Label (Biological)| Import (Biological)| Package (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd12"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","POTASSIUM CHLORIDE","ACETIC ACID"],"dose":["263","1.61","7.49","67.5","10.06","10.8"],"productID":{"$numberInt":"8586"},"sanitizedRegiestrationNumber":"00774960","productName":"ACID CONCENTRATE 2120","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd14"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["1.6"],"productID":{"$numberInt":"12169"},"sanitizedRegiestrationNumber":"00783633","productName":"1.6% SODIUM CHLORDIE PROCESSING SOLUTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05CB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd15"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["500"],"productID":{"$numberInt":"9868"},"sanitizedRegiestrationNumber":"00783773","productName":"VITAMINE C TIMED RELEASE TAB 500MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd16"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["80"],"productID":{"$numberInt":"10034"},"sanitizedRegiestrationNumber":"00782483","productName":"APO-VERAP TAB 80MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd17"},"numbersOfAis":"1","activeIngredientName":["SULINDAC"],"dose":["200"],"productID":{"$numberInt":"8593"},"sanitizedRegiestrationNumber":"00778362","productName":"APO-SULIN TAB 200MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SULINDAC"],"atcCode":["M01AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULINDAC"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd09"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["650"],"productID":{"$numberInt":"8587"},"sanitizedRegiestrationNumber":"00774995","productName":"800 SODIUM BICARBONATE POWDER","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["8"],"qunatityUnit":["L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd0e"},"numbersOfAis":"2","activeIngredientName":["TOBRAMYCIN","DEXAMETHASONE"],"dose":["0.3","0.1"],"productID":{"$numberInt":"11068"},"sanitizedRegiestrationNumber":"00778907","productName":"TOBRADEX","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DEXAMETHASONE AND ANTIINFECTIVES","DEXAMETHASONE AND ANTIINFECTIVES"],"atcCode":["S01CA01","S01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TOBRAMYCIN","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["",""],"qunatityUnit":["W/V","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd13"},"numbersOfAis":"1","activeIngredientName":["SULINDAC"],"dose":["150"],"productID":{"$numberInt":"8592"},"sanitizedRegiestrationNumber":"00778354","productName":"APO-SULIN TAB 150MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["SULINDAC"],"atcCode":["M01AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULINDAC"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd18"},"numbersOfAis":"1","activeIngredientName":["NYSTATIN"],"dose":["100000"],"productID":{"$numberInt":"10435"},"sanitizedRegiestrationNumber":"00779121","productName":"NYADERM ORAL SUS 100000UNIT/ML USP","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["NYSTATIN"],"atcCode":["A07AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NYSTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd19"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["120"],"productID":{"$numberInt":"9940"},"sanitizedRegiestrationNumber":"00782491","productName":"APO-VERAP TABLET 120MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1a"},"numbersOfAis":"1","activeIngredientName":["MEGESTROL ACETATE"],"dose":["160"],"productID":{"$numberInt":"7634"},"sanitizedRegiestrationNumber":"00731323","productName":"MEGACE","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["MEGESTROL"],"atcCode":["L02AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEGESTROL ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1b"},"numbersOfAis":"2","activeIngredientName":["ERGOTAMINE TARTRATE","CAFFEINE"],"dose":["2","100"],"productID":{"$numberInt":"10600"},"sanitizedRegiestrationNumber":"00782920","productName":"CAFERGOT SUP","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ERGOTAMINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["N02CA52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ERGOTAMINE TARTRATE","Combination"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["SUP","SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1c"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE"],"dose":["200","900"],"productID":{"$numberInt":"12171"},"sanitizedRegiestrationNumber":"00783641","productName":"DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SODIUM CHLORIDE, COMBINATIONS"],"atcCode":["B05CB51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1d"},"numbersOfAis":"3","activeIngredientName":["MACROGOL","PROPYLENE GLYCOL","SODIUM CHLORIDE"],"dose":["152","200","9"],"productID":{"$numberInt":"10299"},"sanitizedRegiestrationNumber":"00779296","productName":"SALINEX NASAL LUBRICANT GEL","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R01AX30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MACROGOL","Combination"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1e"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)"],"dose":["0.25"],"productID":{"$numberInt":"8958"},"sanitizedRegiestrationNumber":"00755826","productName":"APO-TIMOP","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["S01ED01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd1f"},"numbersOfAis":"1","activeIngredientName":["ATENOLOL"],"dose":["100"],"productID":{"$numberInt":"9175"},"sanitizedRegiestrationNumber":"00773697","productName":"APO-ATENOL TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ATENOLOL"],"atcCode":["C07AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATENOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd20"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN SODIUM"],"dose":["275"],"productID":{"$numberInt":"9241"},"sanitizedRegiestrationNumber":"00778389","productName":"TEVA-NAPROXEN SODIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd21"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["900"],"productID":{"$numberInt":"9825"},"sanitizedRegiestrationNumber":"00786160","productName":"0.9% SODIUM CHLORIDE IRRIGATION, USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05CB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd22"},"numbersOfAis":"1","activeIngredientName":["TETRACYCLINE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"14167"},"sanitizedRegiestrationNumber":"00780863","productName":"TETRAMED 250","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd23"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","DOPAMINE HYDROCHLORIDE"],"dose":["50","3.2"],"productID":{"$numberInt":"12681"},"sanitizedRegiestrationNumber":"00782394","productName":"DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd24"},"numbersOfAis":"3","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["5","200","75"],"productID":{"$numberInt":"10929"},"sanitizedRegiestrationNumber":"00786225","productName":"POTASS CHLOR 10MEQ 5% DEX AND 0.2% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd25"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","POTASSIUM CHLORIDE"],"dose":["5","75"],"productID":{"$numberInt":"10927"},"sanitizedRegiestrationNumber":"00786187","productName":"POTASS CHLORIDE 10MEQ IN 5% DEXTROSE INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd26"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE"],"dose":["5","330"],"productID":{"$numberInt":"10926"},"sanitizedRegiestrationNumber":"00786179","productName":"DEXTROSE 5% AND SOD CHLORIDE 0.33% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd27"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","POTASSIUM CHLORIDE"],"dose":["5","224"],"productID":{"$numberInt":"10928"},"sanitizedRegiestrationNumber":"00786195","productName":"POTASS CHLORIDE 30MEQ IN 5% DEXTROSE INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd28"},"numbersOfAis":"1","activeIngredientName":["CODEINE PHOSPHATE"],"dose":["5"],"productID":{"$numberInt":"8616"},"sanitizedRegiestrationNumber":"00779474","productName":"RATIO-CODEINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["CODEINE"],"atcCode":["R05DA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CODEINE PHOSPHATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd29"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["75"],"productID":{"$numberInt":"9943"},"sanitizedRegiestrationNumber":"00782459","productName":"VOLTAREN SR","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2a"},"numbersOfAis":"1","activeIngredientName":["VITAMIN K1"],"dose":["2"],"productID":{"$numberInt":"9993"},"sanitizedRegiestrationNumber":"00781878","productName":"VITAMIN K1 INJ 1MG/0.5ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Emulsion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PHYTOMENADIONE"],"atcCode":["B02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN K1"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2b"},"numbersOfAis":"1","activeIngredientName":["SODIUM CHLORIDE"],"dose":["12"],"productID":{"$numberInt":"12168"},"sanitizedRegiestrationNumber":"00783625","productName":"12% SODIUM CHLORDIE PROCESSING SOLUTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SODIUM CHLORIDE"],"atcCode":["B05CB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2c"},"numbersOfAis":"1","activeIngredientName":["CYCLOBENZAPRINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"8605"},"sanitizedRegiestrationNumber":"00782742","productName":"FLEXERIL   -(10MG)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["CYCLOBENZAPRINE"],"atcCode":["M03BX08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CYCLOBENZAPRINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2d"},"numbersOfAis":"1","activeIngredientName":["OXYTETRACYCLINE HYDROCHLORIDE"],"dose":["250"],"productID":{"$numberInt":"14103"},"sanitizedRegiestrationNumber":"00780782","productName":"OXY - 250","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1993-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYTETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2e"},"numbersOfAis":"1","activeIngredientName":["TESTOSTERONE UNDECANOATE"],"dose":["40"],"productID":{"$numberInt":"13411"},"sanitizedRegiestrationNumber":"00782327","productName":"ANDRIOL","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TESTOSTERONE"],"atcCode":["G03BA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TESTOSTERONE UNDECANOATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd2f"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN SODIUM"],"dose":["275"],"productID":{"$numberInt":"10035"},"sanitizedRegiestrationNumber":"00784354","productName":"APO-NAPRO-NA","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd30"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C (SODIUM ASCORBATE)"],"dose":["250"],"productID":{"$numberInt":"9992"},"sanitizedRegiestrationNumber":"00780634","productName":"VITAMIN C","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ASCORBIC ACID (VIT C)"],"atcCode":["A11GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C (SODIUM ASCORBATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd31"},"numbersOfAis":"1","activeIngredientName":["CARBAMAZEPINE"],"dose":["200"],"productID":{"$numberInt":"9242"},"sanitizedRegiestrationNumber":"00782718","productName":"TEVA-CARBAMAZEPINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CARBAMAZEPINE"],"atcCode":["N03AF01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBAMAZEPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd36"},"numbersOfAis":"1","activeIngredientName":["CHROMIUM (CHROMIC CHLORIDE)"],"dose":["4"],"productID":{"$numberInt":"13523"},"sanitizedRegiestrationNumber":"00786985","productName":"MICRO CR","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OTHER MINERAL PRODUCTS"],"atcCode":["A12CX"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHROMIUM (CHROMIC CHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd32"},"numbersOfAis":"1","activeIngredientName":["ZINC (ZINC SULFATE)"],"dose":["1"],"productID":{"$numberInt":"13451"},"sanitizedRegiestrationNumber":"00787019","productName":"MICRO ZN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ZINC SULPHATE"],"atcCode":["A12CB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZINC (ZINC SULFATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd34"},"numbersOfAis":"2","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["900","150"],"productID":{"$numberInt":"9826"},"sanitizedRegiestrationNumber":"00786209","productName":"(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ELECTROLYTES"],"atcCode":["B05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd33"},"numbersOfAis":"2","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["900","300"],"productID":{"$numberInt":"9827"},"sanitizedRegiestrationNumber":"00786217","productName":"(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ELECTROLYTES"],"atcCode":["B05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd35"},"numbersOfAis":"3","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["5","900","300"],"productID":{"$numberInt":"10867"},"sanitizedRegiestrationNumber":"00786306","productName":"POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3b"},"numbersOfAis":"3","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["5","900","150"],"productID":{"$numberInt":"10866"},"sanitizedRegiestrationNumber":"00786292","productName":"(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd37"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"9778"},"sanitizedRegiestrationNumber":"00794511","productName":"E-Z SPONGE 251 10%","licenseHolderSponser":"BECTON DICKINSON","companyCode":[{"$numberInt":"3812"}],"facilityAddress":" 1 Becton Drive Franklin Lakes New Jersey United States 07417","countryOfOrigin":["United States"],"format":["Sponge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd39"},"numbersOfAis":"1","activeIngredientName":["UREA HYDROGEN PEROXIDE"],"dose":["100"],"productID":{"$numberInt":"9128"},"sanitizedRegiestrationNumber":"00794163","productName":"ENDOPEROX 100%","licenseHolderSponser":"SEPTODONT","companyCode":[{"$numberInt":"5192"}],"facilityAddress":" 58 Rue Du Pont De Creteil St-Maur-Des-Fosses Val-De-Marne France 94107","countryOfOrigin":["France"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["A01AB11"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["UREA HYDROGEN PEROXIDE"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd38"},"numbersOfAis":"1","activeIngredientName":["MANGANESE (MANGANESE SULFATE)"],"dose":["0.1"],"productID":{"$numberInt":"13486"},"sanitizedRegiestrationNumber":"00786942","productName":"MICRO MN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OTHER MINERAL PRODUCTS"],"atcCode":["A12CX"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MANGANESE (MANGANESE SULFATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3a"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"10173"},"sanitizedRegiestrationNumber":"00786535","productName":"DILAUDID","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd40"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","POTASSIUM CHLORIDE","ACETIC ACID"],"dose":["263","1.61","7.49","67.54","3.35","10.8"],"productID":{"$numberInt":"8584"},"sanitizedRegiestrationNumber":"00774790","productName":"ACID CONCENTRATE 2101","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-30"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3e"},"numbersOfAis":"1","activeIngredientName":["MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"9584"},"sanitizedRegiestrationNumber":"00784516","productName":"VERSED INJ 1MG/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MIDAZOLAM"],"atcCode":["N05CD08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3c"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN SODIUM"],"dose":["50"],"productID":{"$numberInt":"9398"},"sanitizedRegiestrationNumber":"00780626","productName":"PHENYTOIN SODIUM INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3d"},"numbersOfAis":"2","activeIngredientName":["IOXAGLATE SODIUM","IOXAGLATE MEGLUMINE"],"dose":["123","246"],"productID":{"$numberInt":"9362"},"sanitizedRegiestrationNumber":"00788805","productName":"HEXABRIX 200","licenseHolderSponser":"GUERBET","companyCode":[{"$numberInt":"9113"}],"facilityAddress":" Bp 57400 Roissy Cdg Cedex Val-D'Oise France 95943","countryOfOrigin":["France"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["IOXAGLIC ACID"],"atcCode":["V08AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IOXAGLATE SODIUM","Combination"],"sanitizedRouteOfAdministration":["Intravascular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd3f"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM LACTATE","CALCIUM CHLORIDE","SODIUM CHLORIDE","POTASSIUM CHLORIDE"],"dose":["5","310","20","600","328"],"productID":{"$numberInt":"10937"},"sanitizedRegiestrationNumber":"00786322","productName":"POTASSIUM CHLOR 40MEQ 5% DEX & LAC RING","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd45"},"numbersOfAis":"1","activeIngredientName":["MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)"],"dose":["5"],"productID":{"$numberInt":"8457"},"sanitizedRegiestrationNumber":"00766011","productName":"VERSED INJ 5MG/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["MIDAZOLAM"],"atcCode":["N05CD08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd43"},"numbersOfAis":"1","activeIngredientName":["CARBOPLATIN"],"dose":["10"],"productID":{"$numberInt":"9576"},"sanitizedRegiestrationNumber":"00788759","productName":"PARAPLATIN-AQ INJ 10MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CARBOPLATIN"],"atcCode":["L01XA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CARBOPLATIN"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd41"},"numbersOfAis":"1","activeIngredientName":["BRETYLIUM TOSYLATE"],"dose":["50"],"productID":{"$numberInt":"12680"},"sanitizedRegiestrationNumber":"00786594","productName":"BRETYLIUM TOSYLATE INJ 50MG/ML","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["BRETYLIUM TOSILATE"],"atcCode":["C01BD02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BRETYLIUM TOSYLATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd42"},"numbersOfAis":"2","activeIngredientName":["SULFADIMETHOXINE","ORMETOPRIM"],"dose":["250","50"],"productID":{"$numberInt":"11295"},"sanitizedRegiestrationNumber":"00797162","productName":"ROMET-30 PREMIX","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFADIMETHOXINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["Kg","Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd44"},"numbersOfAis":"1","activeIngredientName":["ZINC (ZINC SULFATE)"],"dose":["5"],"productID":{"$numberInt":"13416"},"sanitizedRegiestrationNumber":"00787000","productName":"MICRO ZN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ZINC SULPHATE"],"atcCode":["A12CB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZINC (ZINC SULFATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4a"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41748"},"sanitizedRegiestrationNumber":"00790737","productName":"AVON COOL CONFIDENCE ROLL ON LIQ 17.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd48"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","CALCIUM CHLORIDE","POTASSIUM CHLORIDE","SODIUM CHLORIDE","DEXTROSE"],"dose":["310","20","179","600","5"],"productID":{"$numberInt":"10936"},"sanitizedRegiestrationNumber":"00786314","productName":"POTAS CHLOR 20MEQ 5% DEX AND LACTATE RINGER","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","G"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd46"},"numbersOfAis":"1","activeIngredientName":["HYDROMORPHONE HYDROCHLORIDE"],"dose":["8"],"productID":{"$numberInt":"9509"},"sanitizedRegiestrationNumber":"00786543","productName":"DILAUDID","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HYDROMORPHONE"],"atcCode":["N02AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd47"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"9779"},"sanitizedRegiestrationNumber":"00794511","productName":"E-Z SCRUB 241 SPG 10%","licenseHolderSponser":"BECTON DICKINSON","companyCode":[{"$numberInt":"3812"}],"facilityAddress":" 1 Becton Drive Franklin Lakes New Jersey United States 07417","countryOfOrigin":["United States"],"format":["Sponge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd49"},"numbersOfAis":"1","activeIngredientName":["LORATADINE"],"dose":["10"],"productID":{"$numberInt":"10533"},"sanitizedRegiestrationNumber":"00782696","productName":"CLARITIN ALLERGY","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-18"],"sanitizedIndication":["LORATADINE"],"atcCode":["R06AX13"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LORATADINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4f"},"numbersOfAis":"1","activeIngredientName":["CONJUGATED ESTROGENS"],"dose":["0.9"],"productID":{"$numberInt":"15760"},"sanitizedRegiestrationNumber":"00798215","productName":"APO-CONEST TAB 0.9MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CONJUGATED ESTROGENS"],"atcCode":["G03CA57"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CONJUGATED ESTROGENS"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4d"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"11887"},"sanitizedRegiestrationNumber":"00788503","productName":"VAPORISATEUR NASAL DECONGESTIONNANT","licenseHolderSponser":"LABORATOIRES CONFAB INC","companyCode":[{"$numberInt":"6837"}],"facilityAddress":" 4355 Boul. Sir Wilfrid Laurier St-Hubert Quebec Canada J3Y 3X3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Label (Biological)| Import (Active Pharmaceutical Ingredients)| Fabricate (Biological)| Package (Pharmaceutical)| Package (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4b"},"numbersOfAis":"4","activeIngredientName":["ACETAMINOPHEN","VITAMIN C","PHENYLEPHRINE HYDROCHLORIDE","PYRILAMINE MALEATE"],"dose":["325","50","5","20"],"productID":{"$numberInt":"41780"},"sanitizedRegiestrationNumber":"00791911","productName":"LEMON TIME","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["PCK","PCK","PCK","PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4e"},"numbersOfAis":"1","activeIngredientName":["OXYCODONE HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"10433"},"sanitizedRegiestrationNumber":"00789739","productName":"SUPEUDOL 5","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["OXYCODONE"],"atcCode":["N02AA05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYCODONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd4c"},"numbersOfAis":"1","activeIngredientName":["MANGANESE (MANGANESE SULFATE)"],"dose":["0.5"],"productID":{"$numberInt":"13489"},"sanitizedRegiestrationNumber":"00786950","productName":"MICRO MN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OTHER MINERAL PRODUCTS"],"atcCode":["A12CX"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MANGANESE (MANGANESE SULFATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd54"},"numbersOfAis":"1","activeIngredientName":["ACTH"],"dose":["40"],"productID":{"$numberInt":"10958"},"sanitizedRegiestrationNumber":"00786381","productName":"BEXCO ACTH","licenseHolderSponser":"CENTRAL SALES LIMITED","companyCode":[{"$numberInt":"3976"}],"facilityAddress":"UNIT 1 14 Regan Road Brampton Ontario Canada L7A 1B9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACTH"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd52"},"numbersOfAis":"2","activeIngredientName":["ISOPROPYL ALCOHOL","CHLORHEXIDINE GLUCONATE"],"dose":["70",".5"],"productID":{"$numberInt":"10047"},"sanitizedRegiestrationNumber":"00804622","productName":"CHLORHEXIDINE 0.5% LIQ","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CHLORHEXIDINE, COMBINATIONS"],"atcCode":["D08AC52"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ISOPROPYL ALCOHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd50"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"51892"},"sanitizedRegiestrationNumber":"00791172","productName":"BALMINIL NASAL DECONGESTANT","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1991-01-30"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd53"},"numbersOfAis":"3","activeIngredientName":["PHENYLPROPANOLAMINE HYDROCHLORIDE","ACETAMINOPHEN","CAFFEINE"],"dose":["16.2","325","16.2"],"productID":{"$numberInt":"10162"},"sanitizedRegiestrationNumber":"00789305","productName":"EMERTABS TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLPROPANOLAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd51"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["500","567","392","23.9","15.2"],"productID":{"$numberInt":"10512"},"sanitizedRegiestrationNumber":"00799793","productName":"DIANEAL PD 101 CAPD SOLUTION W 0.5% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd59"},"numbersOfAis":"4","activeIngredientName":["SODIUM CHLORIDE","SODIUM LACTATE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE"],"dose":["600","310","30","20"],"productID":{"$numberInt":"9830"},"sanitizedRegiestrationNumber":"00799971","productName":"LACTATED RINGER'S IRRIGATION SOL","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05CB10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd57"},"numbersOfAis":"1","activeIngredientName":["WATER"],"dose":["100"],"productID":{"$numberInt":"9831"},"sanitizedRegiestrationNumber":"00799998","productName":"STERILE WATER FOR IRRIGATION, USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SOLVENTS AND DILUTING AGENTS,INCL IRRIGAT SOLUT"],"atcCode":["V07AB"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WATER"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd55"},"numbersOfAis":"1","activeIngredientName":["CONJUGATED ESTROGENS"],"dose":["0.625"],"productID":{"$numberInt":"15759"},"sanitizedRegiestrationNumber":"00798223","productName":"APO-CONEST TAB 0.625MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CONJUGATED ESTROGENS"],"atcCode":["G03CA57"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CONJUGATED ESTROGENS"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd58"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"10054"},"sanitizedRegiestrationNumber":"00800813","productName":"DM SYRUP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd56"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"13888"},"sanitizedRegiestrationNumber":"00805009","productName":"TEVA-TOPISONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5e"},"numbersOfAis":"1","activeIngredientName":["TRIMEBUTINE MALEATE"],"dose":["200"],"productID":{"$numberInt":"11743"},"sanitizedRegiestrationNumber":"00803499","productName":"MODULON","licenseHolderSponser":"APTALIS PHARMA CANADA ULC","companyCode":[{"$numberInt":"15086"}],"facilityAddress":"500 85 Enterprise Blvd Markham Ontario Canada L6G 0B5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TRIMEBUTINE","TRIMEBUTINE"],"atcCode":["A03AA05","A03AA05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIMEBUTINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Wholesale (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5c"},"numbersOfAis":"1","activeIngredientName":["CONJUGATED ESTROGENS"],"dose":["2.5"],"productID":{"$numberInt":"15762"},"sanitizedRegiestrationNumber":"00798193","productName":"APO-CONEST TAB 2.5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CONJUGATED ESTROGENS"],"atcCode":["G03CA57"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CONJUGATED ESTROGENS"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5a"},"numbersOfAis":"1","activeIngredientName":["VITAMIN K1"],"dose":["10"],"productID":{"$numberInt":"9994"},"sanitizedRegiestrationNumber":"00804312","productName":"VITAMIN K1 INJ 10MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Emulsion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PHYTOMENADIONE"],"atcCode":["B02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN K1"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5d"},"numbersOfAis":"1","activeIngredientName":["PROCHLORPERAZINE"],"dose":["10"],"productID":{"$numberInt":"9919"},"sanitizedRegiestrationNumber":"00789720","productName":"SANDOZ PROCHLORPERAZINE","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PROCHLORPERAZINE"],"atcCode":["N05AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCHLORPERAZINE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5b"},"numbersOfAis":"3","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","DEXTROSE"],"dose":["330","150","5"],"productID":{"$numberInt":"10932"},"sanitizedRegiestrationNumber":"00786241","productName":"POTASSIUM 20MEQ 5% DEXTROSE AND 0.33% SODIUM CHLORIDE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","G"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd63"},"numbersOfAis":"2","activeIngredientName":["MAGNESIUM (MAGNESIUM CARBONATE)","CALCIUM (CALCIUM CARBONATE)"],"dose":["80","160"],"productID":{"$numberInt":"12641"},"sanitizedRegiestrationNumber":"00794341","productName":"CALCIUM ET MAGNESIUM TAB","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS"],"atcCode":["A12AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM (MAGNESIUM CARBONATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd61"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","SODIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE"],"dose":["387","589","26","500","15"],"productID":{"$numberInt":"10513"},"sanitizedRegiestrationNumber":"00799890","productName":"DIANEAL PD 104 CAPD SOLUTION W 0.5% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd62"},"numbersOfAis":"1","activeIngredientName":["DICHLORVOS (D.D.V.P.)"],"dose":["9.6"],"productID":{"$numberInt":"12682"},"sanitizedRegiestrationNumber":"00797197","productName":"ATGARD C SWINE WORMER","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICHLORVOS (D.D.V.P.)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd5f"},"numbersOfAis":"1","activeIngredientName":["PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)"],"dose":["5"],"productID":{"$numberInt":"9920"},"sanitizedRegiestrationNumber":"00789747","productName":"PROCHLORPERAZINE MESYLATE INJ 5MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["PROCHLORPERAZINE"],"atcCode":["N05AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd60"},"numbersOfAis":"1","activeIngredientName":["COPPER (COPPER SULFATE)"],"dose":["0.4"],"productID":{"$numberInt":"13563"},"sanitizedRegiestrationNumber":"00786969","productName":"MICRO CU","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OTHER MINERAL PRODUCTS"],"atcCode":["A12CX"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COPPER (COPPER SULFATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd68"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","SODIUM CHLORIDE","SODIUM LACTATE"],"dose":["4.25","15.2","25.7","538","448"],"productID":{"$numberInt":"10870"},"sanitizedRegiestrationNumber":"00799858","productName":"DIANEAL PD 102 CAPD SOLUTION W 4.25% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd66"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41782"},"sanitizedRegiestrationNumber":"00803650","productName":"AVON ROLL ON ANTIPERSP DEOD","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd67"},"numbersOfAis":"3","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","DEXTROSE"],"dose":["450","75","5"],"productID":{"$numberInt":"10938"},"sanitizedRegiestrationNumber":"00790109","productName":"POTASS CHLORIDE 5% DEXTR 0.45% SOD CHLOR INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","G"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd64"},"numbersOfAis":"1","activeIngredientName":["FLUNISOLIDE"],"dose":["250"],"productID":{"$numberInt":"9181"},"sanitizedRegiestrationNumber":"00790486","productName":"BRONALIDE INHAL 250MCG/AEM","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Metered-Dose Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["FLUNISOLIDE"],"atcCode":["R03BA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUNISOLIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["ACT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6d"},"numbersOfAis":"3","activeIngredientName":["POTASSIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE"],"dose":["224","5","330"],"productID":{"$numberInt":"10933"},"sanitizedRegiestrationNumber":"00786268","productName":"POTASS CHLOR 30MEQ 5% DEX AND 0.33% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd65"},"numbersOfAis":"3","activeIngredientName":["POTASSIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE"],"dose":["224","5","200"],"productID":{"$numberInt":"10930"},"sanitizedRegiestrationNumber":"00786233","productName":"POTAS CHLOR 30MEQ 5% DEX AND 0.2% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6b"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["25"],"productID":{"$numberInt":"41749"},"sanitizedRegiestrationNumber":"00800473","productName":"AVON ON DUTY 24 PLUS","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6c"},"numbersOfAis":"4","activeIngredientName":["CALCIUM CHLORIDE","SODIUM CHLORIDE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["6.13","86.1","185.8","1.75"],"productID":{"$numberInt":"9318"},"sanitizedRegiestrationNumber":"00798258","productName":"K+36.8","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G"],"quantityNeedToTake":["","","",""],"qunatityUnit":["L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd69"},"numbersOfAis":"1","activeIngredientName":["LOVASTATIN"],"dose":["40"],"productID":{"$numberInt":"11100"},"sanitizedRegiestrationNumber":"00795852","productName":"MEVACOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LOVASTATIN"],"atcCode":["C10AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LOVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd72"},"numbersOfAis":"1","activeIngredientName":["LOVASTATIN"],"dose":["20"],"productID":{"$numberInt":"9253"},"sanitizedRegiestrationNumber":"00795860","productName":"MEVACOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["LOVASTATIN"],"atcCode":["C10AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LOVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6a"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE"],"dose":["15.2","2.5","567","392","23.9"],"productID":{"$numberInt":"10009"},"sanitizedRegiestrationNumber":"00799823","productName":"DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd71"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["5"],"productID":{"$numberInt":"10026"},"sanitizedRegiestrationNumber":"00808652","productName":"HALOPERIDOL INJ 5MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd70"},"numbersOfAis":"4","activeIngredientName":["SODIUM LACTATE","SODIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["462","723","27.6","19.1"],"productID":{"$numberInt":"10514"},"sanitizedRegiestrationNumber":"00799947","productName":"DIANEAL PD109 CAPD SOLUTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6e"},"numbersOfAis":"2","activeIngredientName":["SORBITOL","MANNITOL"],"dose":["2.5","500"],"productID":{"$numberInt":"9829"},"sanitizedRegiestrationNumber":"00799963","productName":"CYSTOSOL W 3% HEXITOLS","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05CX10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SORBITOL","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd77"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","POTASSIUM CHLORIDE","ACETIC ACID"],"dose":["263","2.14","7.49","45","5.02","5.41"],"productID":{"$numberInt":"9184"},"sanitizedRegiestrationNumber":"00798304","productName":"ACID CONCENTRATE D12143","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd6f"},"numbersOfAis":"1","activeIngredientName":["DEXTROSE"],"dose":["173.2"],"productID":{"$numberInt":"9341"},"sanitizedRegiestrationNumber":"00798908","productName":"DEXTROSE-35 5.55 - 4.5","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROSE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd75"},"numbersOfAis":"2","activeIngredientName":["POTASSIUM PHOSPHATE MONOBASIC","POTASSIUM PHOSPHATE DIBASIC"],"dose":["224","236"],"productID":{"$numberInt":"10509"},"sanitizedRegiestrationNumber":"00804789","productName":"POTASSIUM PHOSPHATES","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["POTASSIUM PHOS INCL COMB W/0TH POT. SALTS"],"atcCode":["B05XA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM PHOSPHATE MONOBASIC","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd76"},"numbersOfAis":"5","activeIngredientName":["SODIUM ACETATE","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM CHLORIDE","CALCIUM CHLORIDE"],"dose":["13.6","7.46","4.07","7.31","1.84"],"productID":{"$numberInt":"9833"},"sanitizedRegiestrationNumber":"00809551","productName":"MULTIPLE ELECTROLYTE ADDITIVE LIQ FORMULA 1","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ELECTROLYTES"],"atcCode":["B05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM ACETATE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd73"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41883"},"sanitizedRegiestrationNumber":"00812536","productName":"SECRET BABY PWR SCENT ANTIPERSP SOLID 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7c"},"numbersOfAis":"1","activeIngredientName":["GLYCINE"],"dose":["1.5"],"productID":{"$numberInt":"9828"},"sanitizedRegiestrationNumber":"00799955","productName":"GLYCINE 1.5% IRRIGATION USP SOL","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["GLYCINE"],"atcCode":["B05CX03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYCINE"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd74"},"numbersOfAis":"1","activeIngredientName":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"dose":["10"],"productID":{"$numberInt":"10664"},"sanitizedRegiestrationNumber":"00812404","productName":"APO-TAMOX TAB 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TAMOXIFEN"],"atcCode":["L02BA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7a"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"13889"},"sanitizedRegiestrationNumber":"00804991","productName":"TEVA-TOPISONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7b"},"numbersOfAis":"2","activeIngredientName":["PHENYLPROPANOLAMINE HYDROCHLORIDE","ACETYLSALICYLIC ACID"],"dose":["12.5","325"],"productID":{"$numberInt":"11433"},"sanitizedRegiestrationNumber":"00811351","productName":"CORICIDIN ND TAB","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS","ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BA51","N02BA51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLPROPANOLAMINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd78"},"numbersOfAis":"1","activeIngredientName":["GUAIFENESIN"],"dose":["100"],"productID":{"$numberInt":"11001"},"sanitizedRegiestrationNumber":"00800821","productName":"EXPECTORANT SYRUP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["GUAIFENESIN"],"atcCode":["R05CA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GUAIFENESIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd81"},"numbersOfAis":"1","activeIngredientName":["CALCIUM CHLORIDE"],"dose":["5.8"],"productID":{"$numberInt":"9185"},"sanitizedRegiestrationNumber":"00798711","productName":"CALCIUM-35 0.25 - 4.5","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd79"},"numbersOfAis":"1","activeIngredientName":["BETA-CAROTENE"],"dose":["10000"],"productID":{"$numberInt":"10174"},"sanitizedRegiestrationNumber":"00807559","productName":"BETA CAROTENE GELULE CAP 10000UNIT","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["BETA-CAROTENE"],"atcCode":["A11CA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETA-CAROTENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7f"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["2"],"productID":{"$numberInt":"9927"},"sanitizedRegiestrationNumber":"00812374","productName":"CLOTRIMADERM VAG CREAM 2%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["G01AF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd80"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["5"],"productID":{"$numberInt":"11472"},"sanitizedRegiestrationNumber":"00808741","productName":"MYLAN-GLYBE","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7d"},"numbersOfAis":"1","activeIngredientName":["CONJUGATED ESTROGENS"],"dose":["1.25"],"productID":{"$numberInt":"15761"},"sanitizedRegiestrationNumber":"00798207","productName":"APO-CONEST TAB 1.25MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CONJUGATED ESTROGENS"],"atcCode":["G03CA57"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CONJUGATED ESTROGENS"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd86"},"numbersOfAis":"3","activeIngredientName":["SODIUM CHLORIDE","DEXTROSE","POTASSIUM CHLORIDE"],"dose":["330","5","300"],"productID":{"$numberInt":"10934"},"sanitizedRegiestrationNumber":"00786276","productName":"POTASS CHLOR 40MEQ 5% DEX AND 0.33% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd7e"},"numbersOfAis":"3","activeIngredientName":["POLYMYXIN B (POLYMYXIN B SULFATE)","GRAMICIDIN","NEOMYCIN (NEOMYCIN SULFATE)"],"dose":["10000","0.025","1.75"],"productID":{"$numberInt":"10062"},"sanitizedRegiestrationNumber":"00807435","productName":"OPTIMYXIN PLUS","licenseHolderSponser":"EURO-PHARM INTERNATIONAL CANADA INC","companyCode":[{"$numberInt":"7555"}],"facilityAddress":" 9400  Boul. Langelier Montreal Quebec Canada H1P 3H8","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ANTIINFECTIVES, COMBINATIONS"],"atcCode":["S03AA30"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POLYMYXIN B (POLYMYXIN B SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Otic","Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd84"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":[".05"],"productID":{"$numberInt":"10145"},"sanitizedRegiestrationNumber":"00804614","productName":"CHLORHEXIDINE LIQ 0.05%","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd85"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["1"],"productID":{"$numberInt":"11893"},"sanitizedRegiestrationNumber":"00812382","productName":"CLOTRIMADERM CREAM 1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["D01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd82"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41882"},"sanitizedRegiestrationNumber":"00812544","productName":"SECRET UNSCENTED ANTIPERSP SOLID 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8b"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE CALCIUM"],"dose":["240"],"productID":{"$numberInt":"10316"},"sanitizedRegiestrationNumber":"00809055","productName":"TEVA-DOCUSATE CALCIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE CALCIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd83"},"numbersOfAis":"1","activeIngredientName":["ANTIHEMOPHILIC FACTOR (HUMAN)"],"dose":["1700"],"productID":{"$numberInt":"9794"},"sanitizedRegiestrationNumber":"00808709","productName":"HEMOFIL M","licenseHolderSponser":"BAXTER HEALTHCARE CORPORATION","companyCode":[{"$numberInt":"7682"}],"facilityAddress":" One Baxter Parkway Deerfield Illinois United States 60015","countryOfOrigin":["United States"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["COAGULATION FACTOR VIII"],"atcCode":["B02BD02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ANTIHEMOPHILIC FACTOR (HUMAN)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd89"},"numbersOfAis":"1","activeIngredientName":["FOLIC ACID (SODIUM FOLATE)"],"dose":["5"],"productID":{"$numberInt":"10312"},"sanitizedRegiestrationNumber":"00816086","productName":"FOLIC ACID INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["FOLIC ACID"],"atcCode":["B03BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FOLIC ACID (SODIUM FOLATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8a"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41881"},"sanitizedRegiestrationNumber":"00812560","productName":"SECRET REG SCENT ANTIPERSP SOLID 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd87"},"numbersOfAis":"1","activeIngredientName":["VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE)"],"dose":["250"],"productID":{"$numberInt":"9593"},"sanitizedRegiestrationNumber":"00788716","productName":"VANCOCIN","licenseHolderSponser":"SEARCHLIGHT PHARMA INC","companyCode":[{"$numberInt":"16647"}],"facilityAddress":" 1600 Rue Notre Dame Ouest, Suite 312 Montreal Quebec Canada H3J 1M1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VANCOMYCIN"],"atcCode":["A07AA09"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd90"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["25"],"productID":{"$numberInt":"9888"},"sanitizedRegiestrationNumber":"00808539","productName":"TEVA-DICLOFENAC EC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd88"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["2"],"productID":{"$numberInt":"13686"},"sanitizedRegiestrationNumber":"00813958","productName":"XANAX TS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8e"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","LIDOCAINE HYDROCHLORIDE"],"dose":["50","2"],"productID":{"$numberInt":"10518"},"sanitizedRegiestrationNumber":"00828599","productName":"LIDOCAINE HCL 0.2% AND DEXTROSE 5% INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["C01BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8f"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["110"],"productID":{"$numberInt":"10166"},"sanitizedRegiestrationNumber":"00813648","productName":"LINCOMIX 110","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8c"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"10224"},"sanitizedRegiestrationNumber":"00813745","productName":"LINCOMIX 100","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd95"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","DEXTROSE"],"dose":["8","50"],"productID":{"$numberInt":"10520"},"sanitizedRegiestrationNumber":"00828610","productName":"LIDOCAINE HCL 0.8% AND 5% DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["C01BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd8d"},"numbersOfAis":"1","activeIngredientName":["IVERMECTIN"],"dose":["136"],"productID":{"$numberInt":"10529"},"sanitizedRegiestrationNumber":"00812323","productName":"HEARTGARD-30 CHEWABLES FOR DOGS 136MCG","licenseHolderSponser":"MERIAL CANADA INC","companyCode":[{"$numberInt":"8208"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":["Tablet"],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IVERMECTIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":["6"],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd93"},"numbersOfAis":"1","activeIngredientName":["SALBUTAMOL"],"dose":["100"],"productID":{"$numberInt":"9941"},"sanitizedRegiestrationNumber":"00790419","productName":"APO-SALVENT AEM 100MCG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Metered-Dose Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SALBUTAMOL"],"atcCode":["R03AC02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALBUTAMOL"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["ACT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd94"},"numbersOfAis":"1","activeIngredientName":["VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE)"],"dose":["125"],"productID":{"$numberInt":"9594"},"sanitizedRegiestrationNumber":"00800430","productName":"VANCOCIN","licenseHolderSponser":"SEARCHLIGHT PHARMA INC","companyCode":[{"$numberInt":"16647"}],"facilityAddress":" 1600 Rue Notre Dame Ouest, Suite 312 Montreal Quebec Canada H3J 1M1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VANCOMYCIN"],"atcCode":["A07AA09"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd91"},"numbersOfAis":"1","activeIngredientName":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"dose":["150"],"productID":{"$numberInt":"9891"},"sanitizedRegiestrationNumber":"00828564","productName":"TEVA-RANITIDINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["RANITIDINE"],"atcCode":["A02BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9a"},"numbersOfAis":"3","activeIngredientName":["CHLORZOXAZONE","ACETAMINOPHEN","CODEINE PHOSPHATE"],"dose":["250","300","8"],"productID":{"$numberInt":"11339"},"sanitizedRegiestrationNumber":"00834319","productName":"ACETAZONE FORTE C8","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLORZOXAZONE, COMBINATIONS EXCL PSYCHOLEPTICS","CHLORZOXAZONE, COMBINATIONS EXCL PSYCHOLEPTICS"],"atcCode":["M03BB53","M03BB53"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORZOXAZONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd92"},"numbersOfAis":"3","activeIngredientName":["LIPASE","AMYLASE","PROTEASE"],"dose":["25000","100000","100000"],"productID":{"$numberInt":"9892"},"sanitizedRegiestrationNumber":"00821373","productName":"COTAZYM ECS 20","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Capsule (Delayed Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MULTIENZYMES (LIPASE, PROTEASE ETC)"],"atcCode":["A09AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIPASE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT","UNIT"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd98"},"numbersOfAis":"1","activeIngredientName":["MISOPROSTOL"],"dose":["100"],"productID":{"$numberInt":"9529"},"sanitizedRegiestrationNumber":"00813966","productName":"CYTOTEC 100 MCG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MISOPROSTOL"],"atcCode":["A02BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MISOPROSTOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd99"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41884"},"sanitizedRegiestrationNumber":"00812552","productName":"SECRET SPRING BREEZE ANTIPERS SOLID 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd96"},"numbersOfAis":"1","activeIngredientName":["TERAZOSIN HYDROCHLORIDE"],"dose":["2"],"productID":{"$numberInt":"9619"},"sanitizedRegiestrationNumber":"00818682","productName":"HYTRIN","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TERAZOSIN"],"atcCode":["G04CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERAZOSIN HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9f"},"numbersOfAis":"1","activeIngredientName":["IPRATROPIUM BROMIDE"],"dose":["20"],"productID":{"$numberInt":"10296"},"sanitizedRegiestrationNumber":"00824216","productName":"ATROVENT NASAL AEROSOL 20MCG/AEM","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":["Ml"],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["IPRATROPIUM BROMIDE"],"atcCode":["R03BB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IPRATROPIUM BROMIDE"],"sanitizedRouteOfAdministration":["Inhalation","Nasal"],"className":"Human","primaryPackageQuantity":["10"],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["ACT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd97"},"numbersOfAis":"1","activeIngredientName":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"dose":["20"],"productID":{"$numberInt":"10762"},"sanitizedRegiestrationNumber":"00812390","productName":"APO-TAMOX TAB 20MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TAMOXIFEN"],"atcCode":["L02BA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9d"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","THEOPHYLLINE"],"dose":["50","4"],"productID":{"$numberInt":"18671"},"sanitizedRegiestrationNumber":"00828742","productName":"THEOPHYLLINE 4MG AND 5% DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["THEOPHYLLINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["R03DA54"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9e"},"numbersOfAis":"1","activeIngredientName":["LISINOPRIL"],"dose":["10"],"productID":{"$numberInt":"11102"},"sanitizedRegiestrationNumber":"00839396","productName":"PRINIVIL","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LISINOPRIL"],"atcCode":["C09AA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LISINOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9b"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"12702"},"sanitizedRegiestrationNumber":"00869325","productName":"MORPHINE EXTRA-FORTE","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda4"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["4.25","567","392","23.9","15.2"],"productID":{"$numberInt":"10143"},"sanitizedRegiestrationNumber":"00799807","productName":"DIANEAL PD 101 CAPD SOLUTION W 4.25% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfd9c"},"numbersOfAis":"1","activeIngredientName":["LISINOPRIL"],"dose":["5"],"productID":{"$numberInt":"11101"},"sanitizedRegiestrationNumber":"00839388","productName":"PRINIVIL","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LISINOPRIL"],"atcCode":["C09AA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LISINOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda2"},"numbersOfAis":"1","activeIngredientName":["DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["12.5"],"productID":{"$numberInt":"11772"},"sanitizedRegiestrationNumber":"00804193","productName":"ALLERNIX ELIXIR","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPHENHYDRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda3"},"numbersOfAis":"1","activeIngredientName":["BETA-CAROTENE"],"dose":["10000"],"productID":{"$numberInt":"14619"},"sanitizedRegiestrationNumber":"00854603","productName":"BETA-CAROTENE CAPSULES 10000UNIT","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BETA-CAROTENE"],"atcCode":["A11CA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETA-CAROTENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda0"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["44"],"productID":{"$numberInt":"10165"},"sanitizedRegiestrationNumber":"00813559","productName":"LINCOMIX 44","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda9"},"numbersOfAis":"1","activeIngredientName":["BUTORPHANOL (BUTORPHANOL TARTRATE)"],"dose":["5"],"productID":{"$numberInt":"11822"},"sanitizedRegiestrationNumber":"00844985","productName":"TORBUTROL","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUTORPHANOL (BUTORPHANOL TARTRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda1"},"numbersOfAis":"3","activeIngredientName":["DEXTROSE","POTASSIUM CHLORIDE","SODIUM CHLORIDE"],"dose":["5","224","450"],"productID":{"$numberInt":"10935"},"sanitizedRegiestrationNumber":"00786284","productName":"POTASS CHLOR 30MEQ 5% DEX AND 0.45% SOD CHLOR","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ELECTROLYTES WITH CARBOHYDRATES"],"atcCode":["B05BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda7"},"numbersOfAis":"1","activeIngredientName":["DOMPERIDONE (DOMPERIDONE MALEATE)"],"dose":["10"],"productID":{"$numberInt":"10691"},"sanitizedRegiestrationNumber":"00855820","productName":"MOTILIUM TAB 10MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOMPERIDONE"],"atcCode":["A03FA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOMPERIDONE (DOMPERIDONE MALEATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda8"},"numbersOfAis":"1","activeIngredientName":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"dose":["20"],"productID":{"$numberInt":"10791"},"sanitizedRegiestrationNumber":"00851973","productName":"TEVA-TAMOXIFEN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["TAMOXIFEN"],"atcCode":["L02BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TAMOXIFEN (TAMOXIFEN CITRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda5"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["80"],"productID":{"$numberInt":"9731"},"sanitizedRegiestrationNumber":"00812331","productName":"NOVO-VERAMIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdae"},"numbersOfAis":"1","activeIngredientName":["AUROTHIOGLUCOSE"],"dose":["50"],"productID":{"$numberInt":"10311"},"sanitizedRegiestrationNumber":"00855774","productName":"SOLGANAL INJ 50MG/ML","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["2040-12-31"],"sanitizedIndication":["AUROTHIOGLUCOSE"],"atcCode":["M01CB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AUROTHIOGLUCOSE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfda6"},"numbersOfAis":"1","activeIngredientName":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"dose":["500"],"productID":{"$numberInt":"9917"},"sanitizedRegiestrationNumber":"00839213","productName":"SANDOSTATIN 500MCG/ML","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["OCTREOTIDE"],"atcCode":["H01CB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdac"},"numbersOfAis":"1","activeIngredientName":["LISINOPRIL"],"dose":["20"],"productID":{"$numberInt":"11103"},"sanitizedRegiestrationNumber":"00839418","productName":"PRINIVIL","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LISINOPRIL"],"atcCode":["C09AA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LISINOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdad"},"numbersOfAis":"1","activeIngredientName":["CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)"],"dose":["25"],"productID":{"$numberInt":"10456"},"sanitizedRegiestrationNumber":"00813575","productName":"ANTIROBE AQUADROPS","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdaa"},"numbersOfAis":"1","activeIngredientName":["TRICLOSAN"],"dose":[".07"],"productID":{"$numberInt":"9787"},"sanitizedRegiestrationNumber":"00817627","productName":"BORAXO TILE AND PORCELAIN CLEANER LIQ 0.07%","licenseHolderSponser":"THE DIAL CORPORATION","companyCode":[{"$numberInt":"4045"}],"facilityAddress":" 19001 North Scottsdale Road Scottsdale Arizona United States 85255","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRICLOSAN"],"sanitizedRouteOfAdministration":["Disinfectant (Hospital/Hc Facilities)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb3"},"numbersOfAis":"1","activeIngredientName":["METHYLENE BLUE"],"dose":["10"],"productID":{"$numberInt":"10064"},"sanitizedRegiestrationNumber":"00816108","productName":"METHYLENE BLUE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["METHYLTHIONINIUM CHLORIDE"],"atcCode":["V03AB17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLENE BLUE"],"sanitizedRouteOfAdministration":["Parenteral (Unspecified)"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdab"},"numbersOfAis":"1","activeIngredientName":["CALCITRIOL"],"dose":["1"],"productID":{"$numberInt":"12885"},"sanitizedRegiestrationNumber":"00824291","productName":"ROCALTROL ORAL SOLUTION 1MCG/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CALCITRIOL"],"atcCode":["A11CC04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCITRIOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb1"},"numbersOfAis":"2","activeIngredientName":["CHLORZOXAZONE","ACETAMINOPHEN"],"dose":["250","300"],"productID":{"$numberInt":"11427"},"sanitizedRegiestrationNumber":"00834300","productName":"ACETAZONE FORTE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLORZOXAZONE, COMBINATIONS EXCL PSYCHOLEPTICS","CHLORZOXAZONE, COMBINATIONS EXCL PSYCHOLEPTICS"],"atcCode":["M03BB53","M03BB53"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORZOXAZONE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb2"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["1.5","538","448","18.3","5.08"],"productID":{"$numberInt":"10863"},"sanitizedRegiestrationNumber":"00865095","productName":"DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdaf"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["25"],"productID":{"$numberInt":"10036"},"sanitizedRegiestrationNumber":"00839175","productName":"APO-DICLO","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb8"},"numbersOfAis":"1","activeIngredientName":["TERAZOSIN HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"12778"},"sanitizedRegiestrationNumber":"00818674","productName":"HYTRIN","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TERAZOSIN"],"atcCode":["G04CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERAZOSIN HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb0"},"numbersOfAis":"5","activeIngredientName":["CALCIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE","SODIUM CHLORIDE","ACETIC ACID"],"dose":["4.99","67.5","2.14","263","10.8"],"productID":{"$numberInt":"9845"},"sanitizedRegiestrationNumber":"00860425","productName":"ACID CONCENTRATE D12186","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb6"},"numbersOfAis":"1","activeIngredientName":["METOCLOPRAMIDE HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"10495"},"sanitizedRegiestrationNumber":"00842826","productName":"APO-METOCLOP TAB 5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["METOCLOPRAMIDE"],"atcCode":["A03FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOCLOPRAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb7"},"numbersOfAis":"23","activeIngredientName":["L-ALANINE","GLUTAMIC ACID","L-PROLINE","DEXTROSE","MAGNESIUM CHLORIDE","L-LEUCINE","L-THREONINE","L-ASPARTIC ACID","HISTIDINE","ACETYL-L-TYROSINE","POTASSIUM CHLORIDE","POTASSIUM PHOSPHATE DIBASIC","METHIONINE","L-ISOLEUCINE","L-PHENYLALANINE","L-VALINE","L-ARGININE","GLYCINE","SERINE","SODIUM CHLORIDE","CALCIUM CHLORIDE","L-LYSINE (LYSINE ACETATE)","TRYPTOPHAN"],"dose":["422","314","307","25","51","425","170","298","128","115","22","261","73","280","126","212","432","212","225","205","37","446","85"],"productID":{"$numberInt":"18701"},"sanitizedRegiestrationNumber":"00851531","productName":"AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-ALANINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb4"},"numbersOfAis":"1","activeIngredientName":["METOCLOPRAMIDE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"10496"},"sanitizedRegiestrationNumber":"00842834","productName":"APO-METOCLOP TAB 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["METOCLOPRAMIDE"],"atcCode":["A03FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOCLOPRAMIDE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdbd"},"numbersOfAis":"6","activeIngredientName":["PENICILLIN G PROCAINE","DIHYDROSTREPTOMYCIN (DIHYDROSTREPTOMYCIN SULFATE)","NOVOBIOCIN (NOVOBIOCIN SODIUM)","POLYMYXIN B SULFATE","HYDROCORTISONE ACETATE","HYDROCORTISONE SODIUM SUCCINATE"],"dose":["100000","100","150","50000","20","12.5"],"productID":{"$numberInt":"10817"},"sanitizedRegiestrationNumber":"00813877","productName":"SPECIAL FORMULA 17900-FORTE","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PENICILLIN G PROCAINE","Combination"],"sanitizedRouteOfAdministration":["Intramammary"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","UNIT","MG","MG"],"quantityNeedToTake":["10","10","10","10","10","10"],"qunatityUnit":["ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdbb"},"numbersOfAis":"5","activeIngredientName":["ACETIC ACID","MAGNESIUM CHLORIDE","SODIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE"],"dose":["5.41","2.14","263","7.49","45"],"productID":{"$numberInt":"9433"},"sanitizedRegiestrationNumber":"00804673","productName":"ACID CONCENTRATE D12146","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETIC ACID","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb5"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE"],"dose":["263","1.61","3.35","5.41","6.24","45"],"productID":{"$numberInt":"9851"},"sanitizedRegiestrationNumber":"00860549","productName":"ACID CONCENTRATE D12204","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdb9"},"numbersOfAis":"3","activeIngredientName":["EGG PHOSPHOLIPIDS","SOYBEAN OIL","SAFFLOWER OIL"],"dose":["700","5.0","5.0"],"productID":{"$numberInt":"47094"},"sanitizedRegiestrationNumber":"00818712","productName":"LIPOSYN II INJ 10%","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Emulsion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-01-01"],"sanitizedIndication":["FAT EMULSIONS"],"atcCode":["B05BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["EGG PHOSPHOLIPIDS","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","G"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdbc"},"numbersOfAis":"1","activeIngredientName":["MOMETASONE FUROATE"],"dose":["0.1"],"productID":{"$numberInt":"11444"},"sanitizedRegiestrationNumber":"00851736","productName":"ELOCOM OINTMENT","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["MOMETASONE"],"atcCode":["D07AC13"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MOMETASONE FUROATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc2"},"numbersOfAis":"18","activeIngredientName":["L-PROLINE","HISTIDINE","SERINE","DEXTROSE","L-LEUCINE","METHIONINE","L-THREONINE","L-VALINE","L-ALANINE","L-ARGININE","L-ASPARTIC ACID","GLYCINE","N-ACETYL-L-TYROSINE","L-ISOLEUCINE","L-LYSINE (L-LYSINE ACETATE)","L-PHENYLALANINE","TRYPTOPHAN","GLUTAMIC ACID"],"dose":["307","128","225","20","425","73","170","212","422","432","298","212","115","280","446","126","85","314"],"productID":{"$numberInt":"18729"},"sanitizedRegiestrationNumber":"00839310","productName":"AMINOSYN II IN DEXTROSE INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["L-PROLINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc0"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE"],"dose":["538","1.5","15.2","448","25.7"],"productID":{"$numberInt":"10869"},"sanitizedRegiestrationNumber":"00799831","productName":"DIANEAL PD 102 CAPD SOLUTION W 1.5% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","G","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdba"},"numbersOfAis":"2","activeIngredientName":["EUCALYPTUS OIL","MENTHOL"],"dose":["7.2","8.4"],"productID":{"$numberInt":"10401"},"sanitizedRegiestrationNumber":"00860662","productName":"HONEY LEMON MENTHOL EUCALYPTUS COUGH DPS","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Lozenge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["Other cold preparations"],"atcCode":["R05X"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["EUCALYPTUS OIL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["LOZ","LOZ"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdbe"},"numbersOfAis":"1","activeIngredientName":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"dose":["10"],"productID":{"$numberInt":"10475"},"sanitizedRegiestrationNumber":"00851957","productName":"ROCEPHIN INJ 10GM/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CEFTRIAXONE"],"atcCode":["J01DD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc1"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"10211"},"sanitizedRegiestrationNumber":"00862975","productName":"DIPROLENE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc7"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["5"],"productID":{"$numberInt":"10949"},"sanitizedRegiestrationNumber":"00869007","productName":"TEVA-PINDOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdbf"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["2.5"],"productID":{"$numberInt":"17234"},"sanitizedRegiestrationNumber":"00839299","productName":"VERAPAMIL HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc5"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"12991"},"sanitizedRegiestrationNumber":"00850322","productName":"MORPHINE SULFATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc3"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.4"],"productID":{"$numberInt":"10116"},"sanitizedRegiestrationNumber":"00852384","productName":"TRANSDERM-NITRO 0.4","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdcc"},"numbersOfAis":"23","activeIngredientName":["HISTIDINE","ACETYL-L-TYROSINE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","MAGNESIUM CHLORIDE","GLYCINE","SERINE","SODIUM CHLORIDE","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","POTASSIUM CHLORIDE","POTASSIUM PHOSPHATE DIBASIC","GLUTAMIC ACID","L-PROLINE","DEXTROSE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","CALCIUM CHLORIDE"],"dose":["105","94","231","60","70","356","51","175","185","205","368","140","348","22","261","258","252","25","350","104","175","245","37"],"productID":{"$numberInt":"18700"},"sanitizedRegiestrationNumber":"00851566","productName":"AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HISTIDINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc6"},"numbersOfAis":"1","activeIngredientName":["BUTORPHANOL (BUTORPHANOL TARTRATE)"],"dose":["10"],"productID":{"$numberInt":"10672"},"sanitizedRegiestrationNumber":"00845000","productName":"TORBUGESIC","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUTORPHANOL (BUTORPHANOL TARTRATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc4"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","THEOPHYLLINE"],"dose":["50",".8"],"productID":{"$numberInt":"9970"},"sanitizedRegiestrationNumber":"00828718","productName":"THEOPHYLLINE 0.8MG AND 5% DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["THEOPHYLLINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["R03DA54"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc8"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","3.35","4.99","2.14","10.8","67.5"],"productID":{"$numberInt":"9854"},"sanitizedRegiestrationNumber":"00860611","productName":"ACID CONCENTRATE D12188","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdca"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":[".5"],"productID":{"$numberInt":"10905"},"sanitizedRegiestrationNumber":"00865400","productName":"APO-ALPRAZ","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdcb"},"numbersOfAis":"6","activeIngredientName":["CALCIUM CHLORIDE","DEXTROSE","MAGNESIUM CHLORIDE","SODIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID"],"dose":["7.16","36.8","2.63","172.2","2.75","8.85"],"productID":{"$numberInt":"9843"},"sanitizedRegiestrationNumber":"00850446","productName":"ACID CONCENTRATE D12135","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd1"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["50"],"productID":{"$numberInt":"16848"},"sanitizedRegiestrationNumber":"00860778","productName":"NITROGLYCERIN INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["10"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdc9"},"numbersOfAis":"1","activeIngredientName":["TERAZOSIN HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"9618"},"sanitizedRegiestrationNumber":"00818658","productName":"HYTRIN","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TERAZOSIN"],"atcCode":["G04CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERAZOSIN HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdcd"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["25"],"productID":{"$numberInt":"41785"},"sanitizedRegiestrationNumber":"00861057","productName":"AVON COOL CONFIDENCE SOLID STK 25%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdcf"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["10"],"productID":{"$numberInt":"10950"},"sanitizedRegiestrationNumber":"00869015","productName":"TEVA-PINDOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd0"},"numbersOfAis":"1","activeIngredientName":["DILTIAZEM HYDROCHLORIDE"],"dose":["60"],"productID":{"$numberInt":"10395"},"sanitizedRegiestrationNumber":"00862932","productName":"TEVA-DILTIAZEM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DILTIAZEM"],"atcCode":["C08DB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DILTIAZEM HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd6"},"numbersOfAis":"1","activeIngredientName":["FLUOCINONIDE"],"dose":["0.05"],"productID":{"$numberInt":"11682"},"sanitizedRegiestrationNumber":"00816132","productName":"TOPACTIN CREAM 0.05% U.S.P.","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1991-12-31"],"sanitizedIndication":["FLUOCINONIDE"],"atcCode":["D07AC08"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUOCINONIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdce"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE CALCIUM"],"dose":["240"],"productID":{"$numberInt":"10569"},"sanitizedRegiestrationNumber":"00842044","productName":"NOVO-DOCUSATE CALCIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE CALCIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd2"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"dose":["15","5"],"productID":{"$numberInt":"10943"},"sanitizedRegiestrationNumber":"00875813","productName":"XYLOCAINE MPF 1.5% WITH EPINEPHRINE","licenseHolderSponser":"ASTRAZENECA L.P.","companyCode":[{"$numberInt":"9394"}],"facilityAddress":"DCC-1 1800 Concord Pike Wilmington Delaware United States 19850-5437","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Epidural"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd4"},"numbersOfAis":"2","activeIngredientName":["PYRITHIONE ZINC","MENTHOL"],"dose":["2","0.3"],"productID":{"$numberInt":"10999"},"sanitizedRegiestrationNumber":"00800686","productName":"Z-PLUS SHAMPOO","licenseHolderSponser":"DORMER LABORATORIES INC.","companyCode":[{"$numberInt":"4056"}],"facilityAddress":"5 91 Kelfield Street Toronto Ontario Canada M9W 5A3","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PYRITHIONE ZINC","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Label (Biological)| Import (Biological)| Package (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd5"},"numbersOfAis":"1","activeIngredientName":["VITAMIN C"],"dose":["500"],"productID":{"$numberInt":"19297"},"sanitizedRegiestrationNumber":"00873896","productName":"VITAMINE C CAP 500MG","licenseHolderSponser":"PHARMALAB INC.","companyCode":[{"$numberInt":"4878"}],"facilityAddress":" 8750 Boul Guillaume-Couture Levis Quebec Canada G6V 9G9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN C"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfddb"},"numbersOfAis":"2","activeIngredientName":["CHLORHEXIDINE GLUCONATE","CETRIMONIUM BROMIDE"],"dose":["1.5","15"],"productID":{"$numberInt":"9842"},"sanitizedRegiestrationNumber":"00806269","productName":"CHLORHEXIDINE-CETRIMIDE SOLTN CONC","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CHLORHEXIDINE, COMBINATIONS"],"atcCode":["D08AC52"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORHEXIDINE GLUCONATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd3"},"numbersOfAis":"1","activeIngredientName":["PEPPERMINT OIL"],"dose":["187"],"productID":{"$numberInt":"12663"},"sanitizedRegiestrationNumber":"00875872","productName":"COLPERMIN ENTERIC COATED CAP 187MG","licenseHolderSponser":"TILLOTTS PHARMA AG","companyCode":[{"$numberInt":"5267"}],"facilityAddress":" Baslerstrasse 15 Rheinfelden Aargau Switzerland 4310","countryOfOrigin":["Switzerland"],"format":["Capsule (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIFLATULENTS"],"atcCode":["A02DA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PEPPERMINT OIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd7"},"numbersOfAis":"2","activeIngredientName":["CORBADRINE","MEPIVACAINE HYDROCHLORIDE"],"dose":["0.05","20"],"productID":{"$numberInt":"11114"},"sanitizedRegiestrationNumber":"00874639","productName":"2% POLOCAINE DENTAL WITH LEVONORDEFRIN 1:20,000","licenseHolderSponser":"DENTSPLY CANADA LIMITED","companyCode":[{"$numberInt":"3652"}],"facilityAddress":" 161 Vinyl Court Woodbridge Ontario Canada L4L 4A3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["MEPIVACAINE, COMBINATIONS"],"atcCode":["N01BB53"],"pharmaceuticalStd":["MFR","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CORBADRINE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd9"},"numbersOfAis":"1","activeIngredientName":["MELENGESTROL ACETATE"],"dose":["220"],"productID":{"$numberInt":"10001"},"sanitizedRegiestrationNumber":"00813826","productName":"MGA 100 PREMIX","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MELENGESTROL ACETATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdda"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["3000000"],"productID":{"$numberInt":"9866"},"sanitizedRegiestrationNumber":"00812501","productName":"ROFERON-A SOL INJ 3MILLION IU/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D","Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde0"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["250"],"productID":{"$numberInt":"15607"},"sanitizedRegiestrationNumber":"00872539","productName":"HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-04-21"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdd8"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","10.1","6.24","1.61","10.8","45.0"],"productID":{"$numberInt":"9852"},"sanitizedRegiestrationNumber":"00860565","productName":"ACID CONCENTRATE D12201","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfddc"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["12"],"productID":{"$numberInt":"41772"},"sanitizedRegiestrationNumber":"00852546","productName":"SECRET CLEAN ANTIPERSP AER 12%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdde"},"numbersOfAis":"3","activeIngredientName":["PADIMATE O","OXYBENZONE","CAMPHOR"],"dose":["7.5","3.5",".28"],"productID":{"$numberInt":"41895"},"sanitizedRegiestrationNumber":"00864129","productName":"BLISTEX MED LIP CONDITIONER SPF15 ONT","licenseHolderSponser":"BLISTEX CORPORATION","companyCode":[{"$numberInt":"3762"}],"facilityAddress":" 6790 Century Ave, Suite 300 Mississauga Ontario Canada L5N 2V8","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE"],"atcCode":["D02BA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PADIMATE O","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfddf"},"numbersOfAis":"2","activeIngredientName":["LEVODOPA","CARBIDOPA"],"dose":["200","50"],"productID":{"$numberInt":"11481"},"sanitizedRegiestrationNumber":"00870935","productName":"SINEMET CR 200/50","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["LEVODOPA AND DECARBOXYLASE INHIBITOR"],"atcCode":["N04BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LEVODOPA","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde5"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN SODIUM)"],"dose":["250"],"productID":{"$numberInt":"12261"},"sanitizedRegiestrationNumber":"00872644","productName":"AMPICILLIN SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN SODIUM)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfddd"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["100"],"productID":{"$numberInt":"15608"},"sanitizedRegiestrationNumber":"00872520","productName":"HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde1"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE SODIUM"],"dose":["10"],"productID":{"$numberInt":"11521"},"sanitizedRegiestrationNumber":"00870218","productName":"DOCUSATE SODIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde4"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["1"],"productID":{"$numberInt":"41797"},"sanitizedRegiestrationNumber":"00860832","productName":"DAN CON PERT PLUS EXTRA BODY FINE OILY HAIR","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde3"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["2.5","538","448","18.3","5.08"],"productID":{"$numberInt":"10864"},"sanitizedRegiestrationNumber":"00865109","productName":"DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["USP","MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdea"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["2.5"],"productID":{"$numberInt":"11473"},"sanitizedRegiestrationNumber":"00808733","productName":"MYLAN-GLYBE","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde6"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"10941"},"sanitizedRegiestrationNumber":"00809187","productName":"TEVA-TOPISONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde2"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","THEOPHYLLINE"],"dose":["50","1.6"],"productID":{"$numberInt":"9969"},"sanitizedRegiestrationNumber":"00828726","productName":"THEOPHYLLINE 1.6MG AND 5% DEXTROSE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["THEOPHYLLINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["R03DA54"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde8"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","POLYMYXIN B SULFATE"],"dose":["50","10000"],"productID":{"$numberInt":"10912"},"sanitizedRegiestrationNumber":"00874949","productName":"LIDOMYXIN","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIINFECTIVES, COMBINATIONS"],"atcCode":["S02AA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Otic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde9"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"10940"},"sanitizedRegiestrationNumber":"00849669","productName":"TEVA-TOPILENE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdeb"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["1"],"productID":{"$numberInt":"15605"},"sanitizedRegiestrationNumber":"00878626","productName":"HYDROCORTISONE SODIUM SUCCINATE INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfde7"},"numbersOfAis":"1","activeIngredientName":["CLONIDINE HYDROCHLORIDE"],"dose":[".2"],"productID":{"$numberInt":"10910"},"sanitizedRegiestrationNumber":"00868957","productName":"APO-CLONIDINE TAB 0.2MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CLONIDINE"],"atcCode":["C02AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLONIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfded"},"numbersOfAis":"1","activeIngredientName":["DEXAMETHASONE (DEXAMETHASONE SODIUM PHOSPHATE)"],"dose":["10"],"productID":{"$numberInt":"12208"},"sanitizedRegiestrationNumber":"00874582","productName":"DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DEXAMETHASONE"],"atcCode":["H02AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXAMETHASONE (DEXAMETHASONE SODIUM PHOSPHATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intrasynovial","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdec"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["50"],"productID":{"$numberInt":"9886"},"sanitizedRegiestrationNumber":"00842648","productName":"TEVA-METOPROLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdee"},"numbersOfAis":"1","activeIngredientName":["CLOTRIMAZOLE"],"dose":["1"],"productID":{"$numberInt":"9926"},"sanitizedRegiestrationNumber":"00812366","productName":"CLOTRIMADERM VAG CREAM 1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CLOTRIMAZOLE"],"atcCode":["G01AF02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOTRIMAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdef"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["25"],"productID":{"$numberInt":"12701"},"sanitizedRegiestrationNumber":"00869317","productName":"MORPHINE FORTE","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf0"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["120"],"productID":{"$numberInt":"9732"},"sanitizedRegiestrationNumber":"00812358","productName":"NOVO-VERAMIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf1"},"numbersOfAis":"1","activeIngredientName":["AMLODIPINE (AMLODIPINE BESYLATE)"],"dose":["10"],"productID":{"$numberInt":"12939"},"sanitizedRegiestrationNumber":"00878936","productName":"NORVASC TAB 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMLODIPINE"],"atcCode":["C08CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMLODIPINE (AMLODIPINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf3"},"numbersOfAis":"1","activeIngredientName":["CETRIMONIUM BROMIDE"],"dose":[".5"],"productID":{"$numberInt":"12864"},"sanitizedRegiestrationNumber":"00874426","productName":"CETRIMIDE CREAM 0.5%","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CETRIMONIUM"],"atcCode":["D08AJ02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CETRIMONIUM BROMIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf4"},"numbersOfAis":"2","activeIngredientName":["IODINE (POLYETHOXY POLYPROPOXY POLYETHOXY ETHANOL - IODINE COMPLEX)","GLYCERINE"],"dose":["0.25","2.000"],"productID":{"$numberInt":"12540"},"sanitizedRegiestrationNumber":"00878766","productName":"DELLA-PRETECH PLUS","licenseHolderSponser":"DELAVAL INC.","companyCode":[{"$numberInt":"10103"}],"facilityAddress":" 10900 Rue Secant Street Ville D'Anjou Quebec Canada H1J 1S5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IODINE (POLYETHOXY POLYPROPOXY POLYETHOXY ETHANOL - IODINE COMPLEX)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["",""],"qunatityUnit":["W/V","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf2"},"numbersOfAis":"1","activeIngredientName":["THIAMINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"10063"},"sanitizedRegiestrationNumber":"00816078","productName":"VITAMIN B1","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["THIAMINE (VIT B1)"],"atcCode":["A11DA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf5"},"numbersOfAis":"1","activeIngredientName":["MINOXIDIL"],"dose":["20"],"productID":{"$numberInt":"12757"},"sanitizedRegiestrationNumber":"00885754","productName":"APO-GAIN LIQ 20MG/ML","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MINOXIDIL, TOPICAL"],"atcCode":["D11AX01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MINOXIDIL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf6"},"numbersOfAis":"1","activeIngredientName":["FLUORIDE (SODIUM FLUORIDE)"],"dose":["1.23"],"productID":{"$numberInt":"16703"},"sanitizedRegiestrationNumber":"00874698","productName":"FLOAM AER 1.23%","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["SODIUM FLUORIDE"],"atcCode":["A01AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUORIDE (SODIUM FLUORIDE)"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf8"},"numbersOfAis":"29","activeIngredientName":["SELENIUM (SODIUM SELENATE)","VITAMIN A (VITAMIN A ACETATE)","VITAMIN B12","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","MAGNESIUM (MAGNESIUM OXIDE)","CHLORINE (POTASSIUM CHLORIDE)","VITAMIN B2","NICOTINAMIDE","BIOTIN","IODINE (POTASSIUM IODIDE)","MANGANESE (MANGANESE SULFATE)","MOLYBDENUM (SODIUM MOLYBDATE)","CHROMIUM (CHROMIC CHLORIDE)","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","IRON (FERROUS FUMARATE)","POTASSIUM (POTASSIUM CHLORIDE)","ZINC (ZINC SULFATE)","NICKEL (NICKEL SULFATE)","TIN (STANNOUS CHLORIDE)","VANADIUM (SODIUM VANADATE)","SILICON (SODIUM METASILICATE)","VITAMIN C","FOLIC ACID","VITAMIN B1 (THIAMINE MONONITRATE)","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN D","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","COPPER (CUPRIC OXIDE)"],"dose":["25","5000","9","162","100","27.2","2.6","20","45",".15","5","25","25","3","10","10","30","15","5","10","10","10","90",".4","2.25","30","400","125","2"],"productID":{"$numberInt":"18915"},"sanitizedRegiestrationNumber":"00839132","productName":"MULTIVITAMIN-MULTIMINERAL FORMULA TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SELENIUM (SODIUM SELENATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","UNIT","MCG","MG","MG","MG","MG","MG","MCG","MG","MG","MCG","MCG","MG","MG","MG","MG","MG","MCG","MCG","MCG","MCG","MG","MG","MG","UNIT","UNIT","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdfa"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE"],"dose":["263","1.61","3.35","5.41","6.24","90"],"productID":{"$numberInt":"9847"},"sanitizedRegiestrationNumber":"00860441","productName":"D12230 LIQ","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf9"},"numbersOfAis":"5","activeIngredientName":["DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["1.5","567","392","23.9","15.2"],"productID":{"$numberInt":"10144"},"sanitizedRegiestrationNumber":"00799815","productName":"DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdfb"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"dose":["10"],"productID":{"$numberInt":"10510"},"sanitizedRegiestrationNumber":"00857629","productName":"POLYFLEX","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Powder For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdfd"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN"],"dose":["333"],"productID":{"$numberInt":"10707"},"sanitizedRegiestrationNumber":"00873454","productName":"ERYC DELAYED-RELEASE CAPSULES","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdfe"},"numbersOfAis":"1","activeIngredientName":["LEVAMISOLE (LEVAMISOLE HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"10831"},"sanitizedRegiestrationNumber":"00846368","productName":"ERGAMISOL TAB 50MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LEVAMISOLE"],"atcCode":["P02CE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEVAMISOLE (LEVAMISOLE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdf7"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE"],"dose":["172.2","2.63","5.49","8.85","5.11","55.2"],"productID":{"$numberInt":"9849"},"sanitizedRegiestrationNumber":"00860522","productName":"ACID CONCENTRATE D12167","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdff"},"numbersOfAis":"1","activeIngredientName":["DILTIAZEM HYDROCHLORIDE"],"dose":["30"],"productID":{"$numberInt":"10394"},"sanitizedRegiestrationNumber":"00862924","productName":"TEVA-DILTIAZEM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DILTIAZEM"],"atcCode":["C08DB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DILTIAZEM HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfdfc"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["15"],"productID":{"$numberInt":"12992"},"sanitizedRegiestrationNumber":"00850330","productName":"MORPHINE SULFATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe00"},"numbersOfAis":"6","activeIngredientName":["POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["3.35","10.8","6.24","67.5","263","2.14"],"productID":{"$numberInt":"9844"},"sanitizedRegiestrationNumber":"00860417","productName":"ACID CONCENTRATE D12185","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe02"},"numbersOfAis":"1","activeIngredientName":["METRONIDAZOLE"],"dose":["5"],"productID":{"$numberInt":"10871"},"sanitizedRegiestrationNumber":"00870420","productName":"METRONIDAZOLE INJECTION, USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["METRONIDAZOLE"],"atcCode":["J01XD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METRONIDAZOLE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe03"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE SODIUM"],"dose":["100"],"productID":{"$numberInt":"10986"},"sanitizedRegiestrationNumber":"00870196","productName":"TEVA-DOCUSATE SODIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe04"},"numbersOfAis":"1","activeIngredientName":["CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)"],"dose":["25"],"productID":{"$numberInt":"11365"},"sanitizedRegiestrationNumber":"00813532","productName":"ANTIROBE","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe05"},"numbersOfAis":"1","activeIngredientName":["CETRIMONIUM BROMIDE"],"dose":[".5"],"productID":{"$numberInt":"10565"},"sanitizedRegiestrationNumber":"00873195","productName":"CETRIMIDE TINCTURE 0.5%","licenseHolderSponser":"CANADIAN CUSTOM PACKAGING COMPANY","companyCode":[{"$numberInt":"3857"}],"facilityAddress":" 333 Rimrock Road Toronto Ontario Canada M3J 3J9","countryOfOrigin":["Canada"],"format":["Tincture"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CETRIMONIUM"],"atcCode":["D08AJ02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CETRIMONIUM BROMIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe01"},"numbersOfAis":"1","activeIngredientName":["MOMETASONE FUROATE"],"dose":["0.1"],"productID":{"$numberInt":"11443"},"sanitizedRegiestrationNumber":"00871095","productName":"ELOCOM LOTION","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["MOMETASONE"],"atcCode":["D07AC13"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MOMETASONE FUROATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe06"},"numbersOfAis":"1","activeIngredientName":["SIMVASTATIN"],"dose":["20"],"productID":{"$numberInt":"16473"},"sanitizedRegiestrationNumber":"00884340","productName":"ZOCOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["SIMVASTATIN"],"atcCode":["C10AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe07"},"numbersOfAis":"2","activeIngredientName":["LISINOPRIL","HYDROCHLOROTHIAZIDE"],"dose":["20","25"],"productID":{"$numberInt":"13432"},"sanitizedRegiestrationNumber":"00884421","productName":"PRINZIDE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LISINOPRIL AND DIURETICS","LISINOPRIL AND DIURETICS"],"atcCode":["C09BA03","C09BA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LISINOPRIL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe08"},"numbersOfAis":"2","activeIngredientName":["CARBON DIOXIDE","OXYGEN"],"dose":["12","88"],"productID":{"$numberInt":"11058"},"sanitizedRegiestrationNumber":"00882755","productName":"CARBON DIOXIDE 7.1% W OXYGEN","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBON DIOXIDE","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe09"},"numbersOfAis":"2","activeIngredientName":["PENICILLIN G PROCAINE","NOVOBIOCIN (NOVOBIOCIN SODIUM)"],"dose":["200000","400"],"productID":{"$numberInt":"14036"},"sanitizedRegiestrationNumber":"00813850","productName":"NOVODRY PLUS","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PENICILLIN G PROCAINE","Combination"],"sanitizedRouteOfAdministration":["Intramammary"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG"],"quantityNeedToTake":["10","10"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0a"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN SODIUM)"],"dose":["500"],"productID":{"$numberInt":"12262"},"sanitizedRegiestrationNumber":"00872652","productName":"AMPICILLIN SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN SODIUM)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0b"},"numbersOfAis":"1","activeIngredientName":["SIMVASTATIN"],"dose":["40"],"productID":{"$numberInt":"46718"},"sanitizedRegiestrationNumber":"00884359","productName":"ZOCOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1996-08-14"],"sanitizedIndication":["SIMVASTATIN"],"atcCode":["C10AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0c"},"numbersOfAis":"1","activeIngredientName":["SODIUM BICARBONATE"],"dose":["650"],"productID":{"$numberInt":"13018"},"sanitizedRegiestrationNumber":"00882666","productName":"BICART","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM BICARBONATE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["CARTRIDGE"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0d"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"12645"},"sanitizedRegiestrationNumber":"00884154","productName":"LIDOCAINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0e"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["500"],"productID":{"$numberInt":"12703"},"sanitizedRegiestrationNumber":"00888214","productName":"A-HYDROCORT INJ 500MG/4ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe0f"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["25"],"productID":{"$numberInt":"41781"},"sanitizedRegiestrationNumber":"00861081","productName":"AVON ON DUTY 24 PLUS SOLID ANTIPERSP STK 25%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe10"},"numbersOfAis":"1","activeIngredientName":["ALCOHOL ANHYDROUS"],"dose":["62"],"productID":{"$numberInt":"10915"},"sanitizedRegiestrationNumber":"00831123","productName":"PUREL HAND SANITIZER","licenseHolderSponser":"GOJO INDUSTRIES, INC.","companyCode":[{"$numberInt":"4264"}],"facilityAddress":"500 One Gojo Plaza Akron Ohio United States 44311","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ETHANOL"],"atcCode":["D08AX08"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALCOHOL ANHYDROUS"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe11"},"numbersOfAis":"1","activeIngredientName":["EPHEDRINE SULFATE"],"dose":["50"],"productID":{"$numberInt":"11096"},"sanitizedRegiestrationNumber":"00876534","productName":"EPHEDRINE SULFATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["EPHEDRINE"],"atcCode":["C01CA26"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPHEDRINE SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe12"},"numbersOfAis":"1","activeIngredientName":["TYPHOID VACCINE (SALMONELLA TYPHI TY21A)"],"dose":["10"],"productID":{"$numberInt":"13630"},"sanitizedRegiestrationNumber":"00885975","productName":"VIVOTIF","licenseHolderSponser":"PAXVAX BERNA GMBH","companyCode":[{"$numberInt":"16526"}],"facilityAddress":" Oberriedstrasse 68 Thorishaus Bern Switzerland 3174","countryOfOrigin":["Switzerland"],"format":["Capsule (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Marketed"],"registrationDate":["1993-01-01"],"sanitizedIndication":["TYPHOID, ORAL, LIVE ATTENUATED"],"atcCode":["J07AP01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TYPHOID VACCINE (SALMONELLA TYPHI TY21A)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["B"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Fabricate (Pharmaceutical)| Label (Biological)| Label (Pharmaceutical)| Package (Biological)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe13"},"numbersOfAis":"1","activeIngredientName":["SIMVASTATIN"],"dose":["5"],"productID":{"$numberInt":"11337"},"sanitizedRegiestrationNumber":"00884324","productName":"ZOCOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SIMVASTATIN"],"atcCode":["C10AA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe14"},"numbersOfAis":"2","activeIngredientName":["SODIUM CHLORIDE","HEPARIN (HEPARIN SODIUM)"],"dose":["9","2"],"productID":{"$numberInt":"10521"},"sanitizedRegiestrationNumber":"00828750","productName":"HEPARIN SOD AND 0.9% SOD CHLORIDE INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEPARIN, COMBINATIONS"],"atcCode":["B01AB51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe15"},"numbersOfAis":"1","activeIngredientName":["AMLODIPINE (AMLODIPINE BESYLATE)"],"dose":["2.5"],"productID":{"$numberInt":"43612"},"sanitizedRegiestrationNumber":"00878901","productName":"NORVASC TAB 2.5MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Approved"],"registrationDate":[null],"sanitizedIndication":["AMLODIPINE"],"atcCode":["C08CA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMLODIPINE (AMLODIPINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe16"},"numbersOfAis":"1","activeIngredientName":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"dose":["50"],"productID":{"$numberInt":"9915"},"sanitizedRegiestrationNumber":"00839191","productName":"SANDOSTATIN 50MCG/ML","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["OCTREOTIDE"],"atcCode":["H01CB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe17"},"numbersOfAis":"1","activeIngredientName":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"dose":["100"],"productID":{"$numberInt":"9916"},"sanitizedRegiestrationNumber":"00839205","productName":"SANDOSTATIN 100MCG/ML","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["OCTREOTIDE"],"atcCode":["H01CB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OCTREOTIDE (OCTREOTIDE ACETATE)"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe18"},"numbersOfAis":"18","activeIngredientName":["HISTIDINE","N-ACETYL-L-TYROSINE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","SERINE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","GLYCINE","L-PROLINE","DEXTROSE","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID"],"dose":["128","115","425","126","212","298","225","280","73","85","432","212","307","10","446","170","422","314"],"productID":{"$numberInt":"18702"},"sanitizedRegiestrationNumber":"00839302","productName":"AMINOSYN II IN DEXTROSE INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HISTIDINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe19"},"numbersOfAis":"2","activeIngredientName":["PHENYLEPHRINE HYDROCHLORIDE","ACETAMINOPHEN"],"dose":["10","650"],"productID":{"$numberInt":"10188"},"sanitizedRegiestrationNumber":"00843792","productName":"NEOCITRAN EXTRA STRENGTH COLD & CONGESTION","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLEPHRINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["SACHET","SACHET"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1a"},"numbersOfAis":"2","activeIngredientName":["SULFAMETHOXAZOLE","TRIMETHOPRIM"],"dose":["40","8"],"productID":{"$numberInt":"10535"},"sanitizedRegiestrationNumber":"00846465","productName":"APO-SULFATRIM ORAL SUSPENSION","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SULFAMETHOXAZOLE AND TRIMETHOPRIM"],"atcCode":["J01EE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SULFAMETHOXAZOLE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["5","5"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1b"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["6000000"],"productID":{"$numberInt":"9813"},"sanitizedRegiestrationNumber":"00812498","productName":"ROFERON A SOLN INJ 6 MILLION","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1c"},"numbersOfAis":"1","activeIngredientName":["DINOPROST (DINOPROST TROMETHAMINE)"],"dose":["5"],"productID":{"$numberInt":"10457"},"sanitizedRegiestrationNumber":"00813605","productName":"LUTALYSE","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DINOPROST (DINOPROST TROMETHAMINE)"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1d"},"numbersOfAis":"1","activeIngredientName":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["400"],"productID":{"$numberInt":"10000"},"sanitizedRegiestrationNumber":"00813761","productName":"LINCOMIX","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1e"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"14445"},"sanitizedRegiestrationNumber":"00849650","productName":"TEVA-TOPILENE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe1f"},"numbersOfAis":"2","activeIngredientName":["CHLORHEXIDINE GLUCONATE","ISOPROPYL ALCOHOL"],"dose":[".5","70"],"productID":{"$numberInt":"10683"},"sanitizedRegiestrationNumber":"00887935","productName":"IC-GEL","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["CHLORHEXIDINE, COMBINATIONS"],"atcCode":["D08AC52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORHEXIDINE GLUCONATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe20"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","DEXTROSE"],"dose":["4","50"],"productID":{"$numberInt":"10519"},"sanitizedRegiestrationNumber":"00828602","productName":"0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["C01BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe21"},"numbersOfAis":"1","activeIngredientName":["BENZALKONIUM CHLORIDE"],"dose":["5"],"productID":{"$numberInt":"10686"},"sanitizedRegiestrationNumber":"00888001","productName":"PINE-A-BAC LIQUID","licenseHolderSponser":"ZEP MANUFACTURING COMPANY OF CANADA","companyCode":[{"$numberInt":"5477"}],"facilityAddress":" 11627-178 Street Edmonton Alberta Canada T5S 1N6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZALKONIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Disinfectant (Food Premises)","Disinfectant (Hospital/Hc Facilities)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe22"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["50"],"productID":{"$numberInt":"9889"},"sanitizedRegiestrationNumber":"00808547","productName":"TEVA-DICLOFENAC EC","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe23"},"numbersOfAis":"1","activeIngredientName":["BENAZEPRIL HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"14276"},"sanitizedRegiestrationNumber":"00885851","productName":"LOTENSIN 20MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BENAZEPRIL"],"atcCode":["C09AA07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENAZEPRIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe24"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["5"],"productID":{"$numberInt":"10830"},"sanitizedRegiestrationNumber":"00882836","productName":"APO-PRAZO TAB 5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe25"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["50"],"productID":{"$numberInt":"10037"},"sanitizedRegiestrationNumber":"00839183","productName":"APO-DICLO","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet (Enteric-Coated)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe26"},"numbersOfAis":"3","activeIngredientName":["SODIUM CHLORIDE","SODIUM BICARBONATE","MAGNESIUM CHLORIDE"],"dose":["84.6","37.8","1"],"productID":{"$numberInt":"10050"},"sanitizedRegiestrationNumber":"00821616","productName":"BICARBONATE CONCENTRATE D20000","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G"],"quantityNeedToTake":["","",""],"qunatityUnit":["L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe27"},"numbersOfAis":"1","activeIngredientName":["METOPROLOL TARTRATE"],"dose":["100"],"productID":{"$numberInt":"9887"},"sanitizedRegiestrationNumber":"00842656","productName":"TEVA-METOPROLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["METOPROLOL"],"atcCode":["C07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METOPROLOL TARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe28"},"numbersOfAis":"1","activeIngredientName":["CLOMIPHENE CITRATE"],"dose":["50"],"productID":{"$numberInt":"11805"},"sanitizedRegiestrationNumber":"00893722","productName":"SEROPHENE TAB 50MG","licenseHolderSponser":"EMD SERONO A DIVISION OF EMD INC CANADA","companyCode":[{"$numberInt":"5181"}],"facilityAddress":" 2695 North Sheridan Way, Suite 200 Mississauga Ontario Canada L5K 2N6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CLOMIFENE"],"atcCode":["G03GB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOMIPHENE CITRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe29"},"numbersOfAis":"4","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","1.61","10.8","45"],"productID":{"$numberInt":"9848"},"sanitizedRegiestrationNumber":"00860468","productName":"ACID CONCENTRATE D12203","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G"],"quantityNeedToTake":["","","",""],"qunatityUnit":["L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2a"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["100"],"productID":{"$numberInt":"10900"},"sanitizedRegiestrationNumber":"00893625","productName":"APO-CAPTO TAB 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2b"},"numbersOfAis":"2","activeIngredientName":["HYDROCHLOROTHIAZIDE","LISINOPRIL"],"dose":["12.5","20"],"productID":{"$numberInt":"13431"},"sanitizedRegiestrationNumber":"00884413","productName":"PRINZIDE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LISINOPRIL AND DIURETICS","LISINOPRIL AND DIURETICS"],"atcCode":["C09BA03","C09BA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYDROCHLOROTHIAZIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2c"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"10828"},"sanitizedRegiestrationNumber":"00882801","productName":"APO-PRAZO TAB 1MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2d"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","6.7","7.49","3.21","10.8","45"],"productID":{"$numberInt":"10821"},"sanitizedRegiestrationNumber":"00890200","productName":"ACID CONCENTRATE D12209","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2e"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","10.05","7.49","2.14","10.8","45"],"productID":{"$numberInt":"10820"},"sanitizedRegiestrationNumber":"00890197","productName":"ACID CONCENTRATE D12207","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe2f"},"numbersOfAis":"1","activeIngredientName":["DINOPROSTONE"],"dose":["0.5"],"productID":{"$numberInt":"10492"},"sanitizedRegiestrationNumber":"00860786","productName":"PREPIDIL GEL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DINOPROSTONE"],"atcCode":["G02AD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DINOPROSTONE"],"sanitizedRouteOfAdministration":["Intracervical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["2.5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe30"},"numbersOfAis":"1","activeIngredientName":["ENALAPRIL SODIUM"],"dose":["2"],"productID":{"$numberInt":"11136"},"sanitizedRegiestrationNumber":"00851795","productName":"VASOTEC","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ENALAPRIL"],"atcCode":["C09AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENALAPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe31"},"numbersOfAis":"1","activeIngredientName":["NEOSTIGMINE METHYLSULFATE"],"dose":["1"],"productID":{"$numberInt":"11131"},"sanitizedRegiestrationNumber":"00885282","productName":"NEOSTIGMINE METHYLSULFATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["NEOSTIGMINE"],"atcCode":["N07AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NEOSTIGMINE METHYLSULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe32"},"numbersOfAis":"1","activeIngredientName":["NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)"],"dose":["1"],"productID":{"$numberInt":"11641"},"sanitizedRegiestrationNumber":"00893285","productName":"NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["NOREPINEPHRINE"],"atcCode":["C01CA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe33"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41951"},"sanitizedRegiestrationNumber":"00895202","productName":"LIFE BRAND WOMEN'S STK A/P UNSCENTED 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe34"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":["0.1"],"productID":{"$numberInt":"11904"},"sanitizedRegiestrationNumber":"00851256","productName":"DECONGESTANT NOSE DROPS 0.1%","licenseHolderSponser":"LABORATOIRES CONFAB INC","companyCode":[{"$numberInt":"6837"}],"facilityAddress":" 4355 Boul. Sir Wilfrid Laurier St-Hubert Quebec Canada J3Y 3X3","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Label (Biological)| Import (Active Pharmaceutical Ingredients)| Fabricate (Biological)| Package (Pharmaceutical)| Package (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe35"},"numbersOfAis":"1","activeIngredientName":["MOMETASONE FUROATE"],"dose":["0.1"],"productID":{"$numberInt":"11196"},"sanitizedRegiestrationNumber":"00851744","productName":"ELOCOM CREAM","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["MOMETASONE"],"atcCode":["D07AC13"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MOMETASONE FUROATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe36"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41771"},"sanitizedRegiestrationNumber":"00852511","productName":"SECRET SPORTY CLEAN ANTIPER SOLID STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe37"},"numbersOfAis":"1","activeIngredientName":["CALCITRIOL"],"dose":["1"],"productID":{"$numberInt":"11150"},"sanitizedRegiestrationNumber":"00891738","productName":"CALCIJEX","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CALCITRIOL"],"atcCode":["A11CC04"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCITRIOL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe38"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["0.25"],"productID":{"$numberInt":"10904"},"sanitizedRegiestrationNumber":"00865397","productName":"APO-ALPRAZ","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe39"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41776"},"sanitizedRegiestrationNumber":"00861065","productName":"AVON ROLL ON ANTIPERS DEOD SERENAD LOT 17.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3a"},"numbersOfAis":"1","activeIngredientName":["FLUCONAZOLE"],"dose":["50"],"productID":{"$numberInt":"10952"},"sanitizedRegiestrationNumber":"00891800","productName":"DIFLUCAN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["FLUCONAZOLE"],"atcCode":["J02AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUCONAZOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3b"},"numbersOfAis":"1","activeIngredientName":["FENTANYL (FENTANYL CITRATE)"],"dose":["50"],"productID":{"$numberInt":"12664"},"sanitizedRegiestrationNumber":"00888346","productName":"FENTANYL CITRATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["FENTANYL"],"atcCode":["N01AH01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENTANYL (FENTANYL CITRATE)"],"sanitizedRouteOfAdministration":["Intramuscular","Epidural","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3c"},"numbersOfAis":"1","activeIngredientName":["SALICYLIC ACID"],"dose":["40"],"productID":{"$numberInt":"41816"},"sanitizedRegiestrationNumber":"00895091","productName":"DR. SCHOLL'S SOFT CORN REMOVERS","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Plaster"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["WART AND ANTI-CORN PREPARATIONS"],"atcCode":["D11AF"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALICYLIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3d"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["2"],"productID":{"$numberInt":"10829"},"sanitizedRegiestrationNumber":"00882828","productName":"APO-PRAZO TAB 2MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3e"},"numbersOfAis":"1","activeIngredientName":["ACETYLSALICYLIC ACID"],"dose":["15.5"],"productID":{"$numberInt":"9561"},"sanitizedRegiestrationNumber":"00812080","productName":"CENTRA ASA 240 BOLUS 15.5GM","licenseHolderSponser":"CENTRAL SALES LIMITED","companyCode":[{"$numberInt":"3976"}],"facilityAddress":"UNIT 1 14 Regan Road Brampton Ontario Canada L7A 1B9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETYLSALICYLIC ACID"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe3f"},"numbersOfAis":"1","activeIngredientName":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"dose":["300"],"productID":{"$numberInt":"9890"},"sanitizedRegiestrationNumber":"00828556","productName":"TEVA-RANITIDINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["RANITIDINE"],"atcCode":["A02BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe40"},"numbersOfAis":"1","activeIngredientName":["BENAZEPRIL HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"14274"},"sanitizedRegiestrationNumber":"00885843","productName":"LOTENSIN 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BENAZEPRIL"],"atcCode":["C09AA07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENAZEPRIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe41"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"41867"},"sanitizedRegiestrationNumber":"00884553","productName":"TEMPRA CHILDREN'S SYRUP","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe42"},"numbersOfAis":"1","activeIngredientName":["TERCONAZOLE"],"dose":["4"],"productID":{"$numberInt":"11460"},"sanitizedRegiestrationNumber":"00894729","productName":"TERAZOL 7 VAGINAL CREAM 0.4%","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TERCONAZOLE"],"atcCode":["G01AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERCONAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe43"},"numbersOfAis":"6","activeIngredientName":["POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","CALCIUM CHLORIDE","ACETIC ACID"],"dose":["5.49","1.75","73.66","172.19","6.13","8.85"],"productID":{"$numberInt":"14728"},"sanitizedRegiestrationNumber":"00883530","productName":"ACID CONCENTRATE 3186","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe44"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["50"],"productID":{"$numberInt":"12646"},"sanitizedRegiestrationNumber":"00894605","productName":"HEPARIN SODIUM 25000UNIT/500ML IN 5% DEXTR INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe45"},"numbersOfAis":"6","activeIngredientName":["ACETIC ACID","POTASSIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE","CALCIUM CHLORIDE","SODIUM CHLORIDE"],"dose":["8.85","8.24","1.75","73.66","6.13","172.19"],"productID":{"$numberInt":"14726"},"sanitizedRegiestrationNumber":"00883549","productName":"ACID CONCENTRATE 3187","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETIC ACID","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe46"},"numbersOfAis":"5","activeIngredientName":["CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","SODIUM LACTATE"],"dose":["18.3","5.08","4.25","538","448"],"productID":{"$numberInt":"10865"},"sanitizedRegiestrationNumber":"00865117","productName":"DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CALCIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","G","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe47"},"numbersOfAis":"1","activeIngredientName":["APRACLONIDINE (APRACLONIDINE HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"12993"},"sanitizedRegiestrationNumber":"00888354","productName":"IOPIDINE","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["APRACLONIDINE"],"atcCode":["S01EA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["APRACLONIDINE (APRACLONIDINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe48"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["50"],"productID":{"$numberInt":"10908"},"sanitizedRegiestrationNumber":"00893617","productName":"APO-CAPTO TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe49"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC POTASSIUM"],"dose":["50"],"productID":{"$numberInt":"13805"},"sanitizedRegiestrationNumber":"00881635","productName":"VOLTAREN RAPIDE TABLETS 50MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["M01AB05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC POTASSIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4a"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["1"],"productID":{"$numberInt":"14755"},"sanitizedRegiestrationNumber":"00888222","productName":"A-HYDROCORT INJ 1000MG/8ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4b"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)"],"dose":["0.25"],"productID":{"$numberInt":"13177"},"sanitizedRegiestrationNumber":"00893773","productName":"MYLAN-TIMOLOL","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["S01ED01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4c"},"numbersOfAis":"1","activeIngredientName":["PRAVASTATIN SODIUM"],"dose":["10"],"productID":{"$numberInt":"11029"},"sanitizedRegiestrationNumber":"00893749","productName":"PRAVACHOL - TAB 10MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PRAVASTATIN"],"atcCode":["C10AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAVASTATIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4d"},"numbersOfAis":"1","activeIngredientName":["AMLODIPINE (AMLODIPINE BESYLATE)"],"dose":["5"],"productID":{"$numberInt":"12938"},"sanitizedRegiestrationNumber":"00878928","productName":"NORVASC TAB 5MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMLODIPINE"],"atcCode":["C08CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMLODIPINE (AMLODIPINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4e"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"42061"},"sanitizedRegiestrationNumber":"00895326","productName":"PERSONNELLE A/P STK UNSCENTED 22%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe4f"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["25"],"productID":{"$numberInt":"10907"},"sanitizedRegiestrationNumber":"00893609","productName":"APO-CAPTO TAB 25MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe50"},"numbersOfAis":"1","activeIngredientName":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"dose":["1"],"productID":{"$numberInt":"11463"},"sanitizedRegiestrationNumber":"00894699","productName":"ROCEPHIN PWS INJ 1GM/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CEFTRIAXONE"],"atcCode":["J01DD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEFTRIAXONE (CEFTRIAXONE SODIUM)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe51"},"numbersOfAis":"1","activeIngredientName":["LODOXAMIDE (LODOXAMIDE TROMETHAMINE)"],"dose":["0.1"],"productID":{"$numberInt":"13591"},"sanitizedRegiestrationNumber":"00893560","productName":"ALOMIDE","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LODOXAMIDE"],"atcCode":["S01GX05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LODOXAMIDE (LODOXAMIDE TROMETHAMINE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe52"},"numbersOfAis":"4","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","PHENIRAMINE MALEATE","PHENYLEPHRINE HYDROCHLORIDE","VITAMIN C"],"dose":["30","20","10","50"],"productID":{"$numberInt":"19088"},"sanitizedRegiestrationNumber":"00893463","productName":"HOT LEMON RELIEF FOR SYMPTOMS OF COUGH AND COLD","licenseHolderSponser":"CELLCHEM PHARMACEUTICALS INC.","companyCode":[{"$numberInt":"16702"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1995-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["SACHET","SACHET","SACHET","SACHET"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe53"},"numbersOfAis":"5","activeIngredientName":["PHENIRAMINE MALEATE","GUAIFENESIN","PHENYLPROPANOLAMINE HYDROCHLORIDE","PYRILAMINE MALEATE","HYDROCODONE BITARTRATE"],"dose":["6.25","100","12.5","6.25","1.67"],"productID":{"$numberInt":"15203"},"sanitizedRegiestrationNumber":"01906615","productName":"TRIAMINIC EXPECTORANT DH SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["5","5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe54"},"numbersOfAis":"2","activeIngredientName":["BENZALKONIUM CHLORIDE","SALICYLIC ACID"],"dose":[".2","2"],"productID":{"$numberInt":"11716"},"sanitizedRegiestrationNumber":"00899690","productName":"IONIL SHAMPOO","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["OTHERS"],"atcCode":["D11AC30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZALKONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe55"},"numbersOfAis":"1","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)"],"dose":["500"],"productID":{"$numberInt":"8966"},"sanitizedRegiestrationNumber":"00744182","productName":"PREVENCAL TAB 500MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CALCIUM CARBONATE"],"atcCode":["A12AA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe56"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":["3","7.5"],"productID":{"$numberInt":"41990"},"sanitizedRegiestrationNumber":"00891045","productName":"AVON SUNSEEKERS SUNBLOCK LOT SPF15","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe57"},"numbersOfAis":"3","activeIngredientName":["OXYBENZONE","OCTISALATE","OCTINOXATE"],"dose":["6","5","7.5"],"productID":{"$numberInt":"41810"},"sanitizedRegiestrationNumber":"00889318","productName":"AVON SUN SEEKERS FACE SUNBLOCK CRM SPF30","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe58"},"numbersOfAis":"2","activeIngredientName":["SODIUM PHOSPHATE MONOBASIC","SODIUM PHOSPHATE DIBASIC"],"dose":["276","268"],"productID":{"$numberInt":"11258"},"sanitizedRegiestrationNumber":"00896187","productName":"SODIUM PHOSPHATES INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SODIUM PHOSPHATE"],"atcCode":["B05XA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM PHOSPHATE MONOBASIC","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe59"},"numbersOfAis":"6","activeIngredientName":["MAGNESIUM CHLORIDE","POTASSIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","SODIUM CHLORIDE","DEXTROSE"],"dose":["3.21","3.35","8.11","7.74","268.24","89.99"],"productID":{"$numberInt":"9129"},"sanitizedRegiestrationNumber":"00770213","productName":"ACID CONCENTRATE 2125","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5a"},"numbersOfAis":"1","activeIngredientName":["TERCONAZOLE"],"dose":["80"],"productID":{"$numberInt":"11462"},"sanitizedRegiestrationNumber":"00894710","productName":"TERAZOL 3 VAGINAL OVULES 80MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Ovule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TERCONAZOLE"],"atcCode":["G01AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERCONAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5b"},"numbersOfAis":"1","activeIngredientName":["FLUCONAZOLE"],"dose":["2"],"productID":{"$numberInt":"10954"},"sanitizedRegiestrationNumber":"00891835","productName":"DIFLUCAN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["FLUCONAZOLE"],"atcCode":["J02AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUCONAZOLE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5c"},"numbersOfAis":"1","activeIngredientName":["PYRITHIONE ZINC"],"dose":["1"],"productID":{"$numberInt":"41798"},"sanitizedRegiestrationNumber":"00860875","productName":"DANDRUFF CONTROL PERT PLUSNORMAL OR DRY HAIR","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PYRITHIONE ZINC"],"atcCode":["D11AX12"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PYRITHIONE ZINC"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5d"},"numbersOfAis":"1","activeIngredientName":["SIMVASTATIN"],"dose":["10"],"productID":{"$numberInt":"10947"},"sanitizedRegiestrationNumber":"00884332","productName":"ZOCOR","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["SIMVASTATIN"],"atcCode":["C10AA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMVASTATIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5e"},"numbersOfAis":"3","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","PSEUDOEPHEDRINE HYDROCHLORIDE","CHLORPHENIRAMINE MALEATE"],"dose":["7.5","15","1"],"productID":{"$numberInt":"13361"},"sanitizedRegiestrationNumber":"00896179","productName":"TRIAMINIC COLD & NIGHTTIME COUGH","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["5","5","5"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe5f"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["50"],"productID":{"$numberInt":"11035"},"sanitizedRegiestrationNumber":"00895652","productName":"APO-DIPYRIDAMOLE-FC TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe60"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"41869"},"sanitizedRegiestrationNumber":"00875988","productName":"TEMPRA INFANT DROPS","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe61"},"numbersOfAis":"1","activeIngredientName":["NEOSTIGMINE METHYLSULFATE"],"dose":["0.5"],"productID":{"$numberInt":"11095"},"sanitizedRegiestrationNumber":"00874957","productName":"NEOSTIGMINE METHYLSULFATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["NEOSTIGMINE"],"atcCode":["N07AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NEOSTIGMINE METHYLSULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe62"},"numbersOfAis":"1","activeIngredientName":["HALOPERIDOL"],"dose":["20"],"productID":{"$numberInt":"8477"},"sanitizedRegiestrationNumber":"00768820","productName":"TEVA-HALOPERIDOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HALOPERIDOL"],"atcCode":["N05AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HALOPERIDOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe63"},"numbersOfAis":"2","activeIngredientName":["SPECTINOMYCIN (SPECTINOMYCIN SULFATE)","LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)"],"dose":["22","22"],"productID":{"$numberInt":"10168"},"sanitizedRegiestrationNumber":"00813907","productName":"L-S 20","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SPECTINOMYCIN (SPECTINOMYCIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G"],"quantityNeedToTake":["",""],"qunatityUnit":["Kg","Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe64"},"numbersOfAis":"1","activeIngredientName":["HYPROMELLOSE"],"dose":["0.5"],"productID":{"$numberInt":"11709"},"sanitizedRegiestrationNumber":"00889806","productName":"SANDOZ EYELUBE 0.5%","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYPROMELLOSE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe65"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":[".5","4"],"productID":{"$numberInt":"41992"},"sanitizedRegiestrationNumber":"01905244","productName":"SUN SEEKERS SUNTANNING LOTION SPF4","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe66"},"numbersOfAis":"1","activeIngredientName":["ISOPROPYL ALCOHOL"],"dose":["60"],"productID":{"$numberInt":"17952"},"sanitizedRegiestrationNumber":"00767964","productName":"CAL STAT","licenseHolderSponser":"STERIS CORPORATION","companyCode":[{"$numberInt":"5186"}],"facilityAddress":" 5960 Heisley Road Mentor Ohio United States 44060","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ISOPROPANOL"],"atcCode":["D08AX05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOPROPYL ALCOHOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe67"},"numbersOfAis":"1","activeIngredientName":["ZIDOVUDINE"],"dose":["10"],"productID":{"$numberInt":"11342"},"sanitizedRegiestrationNumber":"01902644","productName":"RETROVIR (AZT)","licenseHolderSponser":"VIIV HEALTHCARE ULC","companyCode":[{"$numberInt":"14255"}],"facilityAddress":" 245 Boulevard Armand-Frappier Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ZIDOVUDINE"],"atcCode":["J05AF01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZIDOVUDINE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe68"},"numbersOfAis":"3","activeIngredientName":["VALINE","LEUCINE","ISOLEUCINE"],"dose":["1.24","1.38","1.38"],"productID":{"$numberInt":"12758"},"sanitizedRegiestrationNumber":"00890901","productName":"BCAA 4% INJ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VALINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe69"},"numbersOfAis":"1","activeIngredientName":["FLUMAZENIL"],"dose":["0.1"],"productID":{"$numberInt":"11944"},"sanitizedRegiestrationNumber":"00874019","productName":"ANEXATE INJ 0.1MG/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["FLUMAZENIL"],"atcCode":["V03AB25"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUMAZENIL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6a"},"numbersOfAis":"1","activeIngredientName":["OXIBENDAZOLE"],"dose":["5.45"],"productID":{"$numberInt":"11544"},"sanitizedRegiestrationNumber":"01904787","productName":"ANTHELCIDE EQ","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Paste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXIBENDAZOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["SYR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6b"},"numbersOfAis":"1","activeIngredientName":["COAL TAR"],"dose":["1.5"],"productID":{"$numberInt":"13131"},"sanitizedRegiestrationNumber":"00899712","productName":"PSORIGEL GEL 1.5%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1978-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COAL TAR"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6c"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41853"},"sanitizedRegiestrationNumber":"00895342","productName":"PERSONNELLE LADIES A/P STK POWDER FRESH 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6d"},"numbersOfAis":"3","activeIngredientName":["MENTHOL","SALICYLIC ACID","COAL TAR"],"dose":["1.2","2.1","8.0"],"productID":{"$numberInt":"10473"},"sanitizedRegiestrationNumber":"00800694","productName":"X-TAR SHAMPOO","licenseHolderSponser":"DORMER LABORATORIES INC.","companyCode":[{"$numberInt":"4056"}],"facilityAddress":"5 91 Kelfield Street Toronto Ontario Canada M9W 5A3","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TARS","TARS"],"atcCode":["D05AA","D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MENTHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Label (Biological)| Import (Biological)| Package (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6e"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41921"},"sanitizedRegiestrationNumber":"00895369","productName":"PERSONNELLE ULTRA A/P STICK SCENTED 22%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe6f"},"numbersOfAis":"2","activeIngredientName":["ALCOHOL ANHYDROUS","ERYTHROMYCIN"],"dose":["44","2"],"productID":{"$numberInt":"11861"},"sanitizedRegiestrationNumber":"01902628","productName":"SANS-ACNE SOLUTION","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ERYTHROMYCIN, COMBINATIONS"],"atcCode":["D10AF52"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALCOHOL ANHYDROUS","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe70"},"numbersOfAis":"1","activeIngredientName":["CLONIDINE HYDROCHLORIDE"],"dose":[".1"],"productID":{"$numberInt":"10909"},"sanitizedRegiestrationNumber":"00868949","productName":"APO-CLONIDINE TAB 0.1MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CLONIDINE"],"atcCode":["C02AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLONIDINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe71"},"numbersOfAis":"1","activeIngredientName":["CLOZAPINE"],"dose":["100"],"productID":{"$numberInt":"11421"},"sanitizedRegiestrationNumber":"00894745","productName":"CLOZARIL","licenseHolderSponser":"HLS THERAPEUTICS INC","companyCode":[{"$numberInt":"16998"}],"facilityAddress":" 10 Carlson Court, Suite 701 Etobicoke Ontario Canada M9W 6L2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CLOZAPINE"],"atcCode":["N05AH02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOZAPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe72"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["36000000"],"productID":{"$numberInt":"12940"},"sanitizedRegiestrationNumber":"00891002","productName":"ROFERON-A SOLUTION INJ 36000000UNIT/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D","Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe73"},"numbersOfAis":"7","activeIngredientName":["GLYCINE","POTASSIUM CHLORIDE","SODIUM ACETATE ANHYDROUS","POTASSIUM PHOSPHATE DIBASIC","DEXTROSE","SODIUM CHLORIDE","CITRIC ACID"],"dose":["6.006","1.491","13.125","1.742","152","4.675","1"],"productID":{"$numberInt":"11333"},"sanitizedRegiestrationNumber":"00890006","productName":"REVIBE H.E.","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLYCINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G","G"],"quantityNeedToTake":["184","184","184","184","184","184","184"],"qunatityUnit":["G","G","G","G","G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe74"},"numbersOfAis":"2","activeIngredientName":["PRILOCAINE","LIDOCAINE"],"dose":["2.5","2.5"],"productID":{"$numberInt":"11440"},"sanitizedRegiestrationNumber":"00886858","productName":"EMLA CREAM","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TOPICAL ANESTHETICS, COMBINATIONS"],"atcCode":["D04AB30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PRILOCAINE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe75"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)"],"dose":["0.5"],"productID":{"$numberInt":"13095"},"sanitizedRegiestrationNumber":"00893781","productName":"MYLAN-TIMOLOL","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["S01ED01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe76"},"numbersOfAis":"1","activeIngredientName":["SALINOMYCIN SODIUM"],"dose":["60"],"productID":{"$numberInt":"11451"},"sanitizedRegiestrationNumber":"00884545","productName":"COXISTAC 6%","licenseHolderSponser":"PHIBRO ANIMAL HEALTH CORPORATION","companyCode":[{"$numberInt":"14250"}],"facilityAddress":" Glenpoint Centre East, 3rd Floor, 300 Frank W Burr Blvd., Ste. 21 Teaneck New Jersey United States 07666","countryOfOrigin":["United States"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALINOMYCIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe77"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41865"},"sanitizedRegiestrationNumber":"00895334","productName":"PERSONNELLE LADIES SCENT A/P STK 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe78"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["40"],"productID":{"$numberInt":"12647"},"sanitizedRegiestrationNumber":"00894648","productName":"HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe79"},"numbersOfAis":"1","activeIngredientName":["LACTULOSE"],"dose":["667"],"productID":{"$numberInt":"12699"},"sanitizedRegiestrationNumber":"00854409","productName":"RATIO-LACTULOSE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1986-12-31"],"sanitizedIndication":["LACTULOSE"],"atcCode":["A06AD11"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LACTULOSE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7a"},"numbersOfAis":"1","activeIngredientName":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"dose":["100"],"productID":{"$numberInt":"10383"},"sanitizedRegiestrationNumber":"00874256","productName":"APO-DOXY TABS 100MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DOXYCYCLINE"],"atcCode":["J01AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYCYCLINE (DOXYCYCLINE HYCLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7b"},"numbersOfAis":"1","activeIngredientName":["PRAVASTATIN SODIUM"],"dose":["20"],"productID":{"$numberInt":"11030"},"sanitizedRegiestrationNumber":"00893757","productName":"PRAVACHOL - TAB 20MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PRAVASTATIN"],"atcCode":["C10AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAVASTATIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7c"},"numbersOfAis":"1","activeIngredientName":["ISOPROTERENOL HYDROCHLORIDE"],"dose":["0.2"],"productID":{"$numberInt":"11642"},"sanitizedRegiestrationNumber":"00897639","productName":"ISOPROTERENOL HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ISOPRENALINE"],"atcCode":["C01CA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOPROTERENOL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7d"},"numbersOfAis":"1","activeIngredientName":["HYPROMELLOSE"],"dose":["10"],"productID":{"$numberInt":"11898"},"sanitizedRegiestrationNumber":"00874965","productName":"SANDOZ EYELUBE 1%","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYPROMELLOSE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7e"},"numbersOfAis":"1","activeIngredientName":["DOCUSATE SODIUM"],"dose":["20"],"productID":{"$numberInt":"11520"},"sanitizedRegiestrationNumber":"00870226","productName":"RATIO-DOCUSATE SODIUM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DOCUSATE SODIUM"],"atcCode":["A06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOCUSATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe7f"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41847"},"sanitizedRegiestrationNumber":"00895350","productName":"PERSONNELLE LADIES A/P STK UNSCENTED 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe80"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41860"},"sanitizedRegiestrationNumber":"00895393","productName":"ZEL STK A/P LADIES SCENTED 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe81"},"numbersOfAis":"1","activeIngredientName":["ZIDOVUDINE"],"dose":["50"],"productID":{"$numberInt":"11942"},"sanitizedRegiestrationNumber":"01902652","productName":"RETROVIR (AZT)","licenseHolderSponser":"VIIV HEALTHCARE ULC","companyCode":[{"$numberInt":"14255"}],"facilityAddress":" 245 Boulevard Armand-Frappier Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ZIDOVUDINE"],"atcCode":["J05AF01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZIDOVUDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe82"},"numbersOfAis":"1","activeIngredientName":["CHLOROXYLENOL"],"dose":[".6"],"productID":{"$numberInt":"11786"},"sanitizedRegiestrationNumber":"01901443","productName":"DERMAPRO ANTIMICROB LOT SOP 0.6%","licenseHolderSponser":"GOJO INDUSTRIES, INC.","companyCode":[{"$numberInt":"4264"}],"facilityAddress":"500 One Gojo Plaza Akron Ohio United States 44311","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLOROXYLENOL"],"atcCode":["D08AE05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLOROXYLENOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe83"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41784"},"sanitizedRegiestrationNumber":"00871168","productName":"AVON ROLL ON ANTIPERSP DEOD DESTINY 17.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe84"},"numbersOfAis":"1","activeIngredientName":["PENTASTARCH"],"dose":["10"],"productID":{"$numberInt":"13582"},"sanitizedRegiestrationNumber":"00887110","productName":"PENTASPAN","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription Recommended"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-01-27"],"sanitizedIndication":["HYDROXYETHYLSTARCH"],"atcCode":["B05AA07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENTASTARCH"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["100"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe85"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["5"],"productID":{"$numberInt":"14500"},"sanitizedRegiestrationNumber":"00896276","productName":"BENZAC W WASH LOT 5%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe86"},"numbersOfAis":"3","activeIngredientName":["PHENIRAMINE MALEATE","PHENYLPROPANOLAMINE HYDROCHLORIDE","PYRILAMINE MALEATE"],"dose":["25","50","25"],"productID":{"$numberInt":"13222"},"sanitizedRegiestrationNumber":"01906593","productName":"TRIAMINIC TIME RELEASE TAB","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PHENYLPROPANOLAMINE, COMBINATIONS","PHENYLPROPANOLAMINE, COMBINATIONS","PHENYLPROPANOLAMINE, COMBINATIONS"],"atcCode":["R01BA51","R01BA51","R01BA51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe87"},"numbersOfAis":"1","activeIngredientName":["SIMETHICONE"],"dose":["125"],"productID":{"$numberInt":"13362"},"sanitizedRegiestrationNumber":"00896675","productName":"GAS-X EXTRA STRENGTH","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Tablet (Chewable)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SILICONES"],"atcCode":["A03AX13"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMETHICONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe88"},"numbersOfAis":"2","activeIngredientName":["OXYGEN","HELIUM"],"dose":["50","50"],"productID":{"$numberInt":"46353"},"sanitizedRegiestrationNumber":"01906801","productName":"HELIUM-OXYGEN MIX GAS","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYGEN","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe89"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41861"},"sanitizedRegiestrationNumber":"00895148","productName":"BIG V STK A/P SCENTED 22%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8a"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41907"},"sanitizedRegiestrationNumber":"00895199","productName":"LIFE BRAND STK ULTRA A/P SCENTED 22%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8b"},"numbersOfAis":"1","activeIngredientName":["BENAZEPRIL HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"14273"},"sanitizedRegiestrationNumber":"00885835","productName":"LOTENSIN 5MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BENAZEPRIL"],"atcCode":["C09AA07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENAZEPRIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8c"},"numbersOfAis":"2","activeIngredientName":["ALCOHOL ANHYDROUS","CHLOROXYLENOL"],"dose":["40",".5"],"productID":{"$numberInt":"15829"},"sanitizedRegiestrationNumber":"00880019","productName":"SANI-DEX ANTIMICROBIAL HAND WIPES","licenseHolderSponser":"PROFESSIONAL DISPOSABLES INTERNATIONAL INC.","companyCode":[{"$numberInt":"4907"}],"facilityAddress":" 400 Chestnut Ridge Road Woodcliff Lake New Jersey United States 07677","countryOfOrigin":["United States"],"format":["Pad"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CHLOROXYLENOL, COMBINATIONS"],"atcCode":["D08AE55"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALCOHOL ANHYDROUS","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8d"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","HEPARIN SODIUM"],"dose":["5","5000"],"productID":{"$numberInt":"11945"},"sanitizedRegiestrationNumber":"01900757","productName":"HEPARIN SODIUM & DEXTROSE 5% IN VIAFLEX LIQ","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["HEPARIN, COMBINATIONS"],"atcCode":["B01AB51"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","UNIT"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8e"},"numbersOfAis":"3","activeIngredientName":["PHENIRAMINE MALEATE","PHENYLEPHRINE HYDROCHLORIDE","VITAMIN C"],"dose":["20","10","50"],"productID":{"$numberInt":"41841"},"sanitizedRegiestrationNumber":"01905376","productName":"NEO CITRAN A POWDER","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PHENYLEPHRINE, COMBINATIONS","PHENYLEPHRINE, COMBINATIONS"],"atcCode":["R01BA53","R01BA53"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["PCK","PCK","PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe8f"},"numbersOfAis":"1","activeIngredientName":["MAGNESIUM CHLORIDE"],"dose":["16"],"productID":{"$numberInt":"10855"},"sanitizedRegiestrationNumber":"00890170","productName":"MAGNESIUM-35  0.5 - 4.5","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MAGNESIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe90"},"numbersOfAis":"1","activeIngredientName":["TERAZOSIN HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"9542"},"sanitizedRegiestrationNumber":"00818666","productName":"HYTRIN","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TERAZOSIN"],"atcCode":["G04CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERAZOSIN HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe91"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["12.5"],"productID":{"$numberInt":"10906"},"sanitizedRegiestrationNumber":"00893595","productName":"APO-CAPTO TAB 12.5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe92"},"numbersOfAis":"4","activeIngredientName":["PHENIRAMINE MALEATE","CODEINE PHOSPHATE","PYRILAMINE MALEATE","PHENYLPROPANOLAMINE HYDROCHLORIDE"],"dose":["6.25","5","6.25","12.5"],"productID":{"$numberInt":"14038"},"sanitizedRegiestrationNumber":"01906682","productName":"TUSSAMINIC C PEDIATRIC SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe93"},"numbersOfAis":"2","activeIngredientName":["DOCUSATE SODIUM","YELLOW PHENOLPHTHALEIN"],"dose":["75","65"],"productID":{"$numberInt":"41819"},"sanitizedRegiestrationNumber":"01907859","productName":"EX-LAX LIGHT FORMULA LAX W STOOL SOFTEN TAB","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PHENOLPHTHALEIN, COMBINATIONS"],"atcCode":["A06AB54"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DOCUSATE SODIUM","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe94"},"numbersOfAis":"6","activeIngredientName":["POTASSIUM CHLORIDE","CALCIUM CHLORIDE","SODIUM CHLORIDE","ACETIC ACID","DEXTROSE","MAGNESIUM CHLORIDE"],"dose":["2.75","5.11","172.2","8.85","36.8","876"],"productID":{"$numberInt":"11340"},"sanitizedRegiestrationNumber":"01908758","productName":"ACID CONCENTRATE D 12219 LIQ","licenseHolderSponser":"BIO-PHARM INC.","companyCode":[{"$numberInt":"3789"}],"facilityAddress":" 2091 Hartel Street Levittown Pennsylvania United States 19057-4506","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POTASSIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","MG"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe95"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM CHLORIDE"],"dose":["251.6"],"productID":{"$numberInt":"13833"},"sanitizedRegiestrationNumber":"01905740","productName":"K + 45","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe96"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["15"],"productID":{"$numberInt":"10951"},"sanitizedRegiestrationNumber":"00869023","productName":"TEVA-PINDOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe97"},"numbersOfAis":"4","activeIngredientName":["PHENYLEPHRINE HYDROCHLORIDE","PHENIRAMINE MALEATE","VITAMIN C","ACETAMINOPHEN"],"dose":["10","20","50","325"],"productID":{"$numberInt":"41822"},"sanitizedRegiestrationNumber":"01905368","productName":"NEO CITRAN POWDER","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLEPHRINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["","","",""],"qunatityUnit":["SACHET","SACHET","SACHET","SACHET"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe98"},"numbersOfAis":"1","activeIngredientName":["TETRACYCLINE HYDROCHLORIDE"],"dose":["1000"],"productID":{"$numberInt":"14102"},"sanitizedRegiestrationNumber":"00894486","productName":"TETRAMED 1000","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRACYCLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe99"},"numbersOfAis":"1","activeIngredientName":["FOSINOPRIL SODIUM"],"dose":["10"],"productID":{"$numberInt":"12759"},"sanitizedRegiestrationNumber":"01907107","productName":"MONOPRIL TAB 10MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FOSINOPRIL"],"atcCode":["C09AA09"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FOSINOPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9a"},"numbersOfAis":"3","activeIngredientName":["COAL TAR","SALICYLIC ACID","BENZALKONIUM CHLORIDE"],"dose":["4.25","2","0.2"],"productID":{"$numberInt":"41889"},"sanitizedRegiestrationNumber":"00888591","productName":"MEDI-DAN SHAMPOO","licenseHolderSponser":"MAHDEEN MEDICEUTICALS LTD","companyCode":[{"$numberInt":"14883"}],"facilityAddress":" 2079 Markle Drive Oakville Ontario Canada L6H 3N6","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TARS","TARS"],"atcCode":["D05AA","D05AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["COAL TAR","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9b"},"numbersOfAis":"1","activeIngredientName":["SIMETHICONE"],"dose":["80"],"productID":{"$numberInt":"41821"},"sanitizedRegiestrationNumber":"01907875","productName":"GAS-X REGULAR STRENGTH","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SILICONES"],"atcCode":["A03AX13"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMETHICONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9c"},"numbersOfAis":"15","activeIngredientName":["PHENYLALANINE","METHIONINE","L-LYSINE (L-LYSINE HYDROCHLORIDE)","ISOLEUCINE","VALINE","HISTIDINE","THREONINE","TRYPTOPHAN","L-ALANINE","GLYCINE","ARGININE","PROLINE","TYROSINE","SERINE","LEUCINE"],"dose":["560","400","580","600","580","480","420","180","2.07","1.03","1.15","680","40","500","730"],"productID":{"$numberInt":"11329"},"sanitizedRegiestrationNumber":"00872296","productName":"TRAVASOL","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["AMINO ACIDS"],"atcCode":["B05BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLALANINE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","G","G","G","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9d"},"numbersOfAis":"1","activeIngredientName":["NORFLOXACIN"],"dose":["3"],"productID":{"$numberInt":"12194"},"sanitizedRegiestrationNumber":"01908294","productName":"NOROXIN","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["NORFLOXACIN"],"atcCode":["S01AX12"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NORFLOXACIN"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9e"},"numbersOfAis":"2","activeIngredientName":["OPIUM","BELLADONNA"],"dose":["65","15"],"productID":{"$numberInt":"11257"},"sanitizedRegiestrationNumber":"01901869","productName":"SANDOZ OPIUM & BELLADONNA","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["OPIUM","OPIUM"],"atcCode":["N02AA02","N02AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OPIUM","Combination"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfe9f"},"numbersOfAis":"2","activeIngredientName":["PETROLATUM","DIMETHICONE"],"dose":["6","3"],"productID":{"$numberInt":"11430"},"sanitizedRegiestrationNumber":"01909169","productName":"MOISTUREL SENSITIVE SKIN LOTION","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SILICONE PRODUCTS"],"atcCode":["D02AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PETROLATUM","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea0"},"numbersOfAis":"3","activeIngredientName":["SODIUM CARBONATE (ANHYDROUS)","MAGNESIUM OXIDE","CITRIC ACID"],"dose":["430","380","3.24"],"productID":{"$numberInt":"9832"},"sanitizedRegiestrationNumber":"00800015","productName":"UROLOGIC SOLUTION G","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05CB10"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CARBONATE (ANHYDROUS)","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","G"],"quantityNeedToTake":["100","100","100"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea1"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["5"],"productID":{"$numberInt":"11658"},"sanitizedRegiestrationNumber":"00899453","productName":"BENZAC AC 5 GEL 5%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea2"},"numbersOfAis":"4","activeIngredientName":["PHENIRAMINE MALEATE","HYDROCODONE BITARTRATE","PHENYLPROPANOLAMINE HYDROCHLORIDE","PYRILAMINE MALEATE"],"dose":["6.25","1.667","12.5","6.25"],"productID":{"$numberInt":"15490"},"sanitizedRegiestrationNumber":"01906690","productName":"TUSSAMINIC DH PEDIATRIC SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea3"},"numbersOfAis":"2","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)","PILOCARPINE HYDROCHLORIDE"],"dose":["0.5","4"],"productID":{"$numberInt":"13238"},"sanitizedRegiestrationNumber":"01905090","productName":"TIMPILO 4","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL, COMBINATIONS","TIMOLOL, COMBINATIONS"],"atcCode":["S01ED51","S01ED51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea4"},"numbersOfAis":"2","activeIngredientName":["TIMOLOL (TIMOLOL MALEATE)","PILOCARPINE HYDROCHLORIDE"],"dose":["0.5","2"],"productID":{"$numberInt":"13237"},"sanitizedRegiestrationNumber":"01905082","productName":"TIMPILO 2","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL, COMBINATIONS","TIMOLOL, COMBINATIONS"],"atcCode":["S01ED51","S01ED51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TIMOLOL (TIMOLOL MALEATE)","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea5"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["2"],"productID":{"$numberInt":"12990"},"sanitizedRegiestrationNumber":"00850314","productName":"MORPHINE SULFATE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Pre Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea6"},"numbersOfAis":"2","activeIngredientName":["PETROLATUM","DIMETHICONE"],"dose":["30","1"],"productID":{"$numberInt":"11936"},"sanitizedRegiestrationNumber":"01909142","productName":"MOISTUREL CREAM","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SILICONE PRODUCTS"],"atcCode":["D02AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PETROLATUM","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea7"},"numbersOfAis":"1","activeIngredientName":["YELLOW PHENOLPHTHALEIN"],"dose":["95"],"productID":{"$numberInt":"41820"},"sanitizedRegiestrationNumber":"01907840","productName":"EX-LAX CHOCOLATED TAB 95MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PHENOLPHTHALEIN"],"atcCode":["A06AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["YELLOW PHENOLPHTHALEIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea8"},"numbersOfAis":"2","activeIngredientName":["CARBON DIOXIDE","OXYGEN"],"dose":["23","77"],"productID":{"$numberInt":"11059"},"sanitizedRegiestrationNumber":"00882763","productName":"CARBON DIOXIDE 12.1% W OXYGEN","licenseHolderSponser":"PRAXAIR CANADA INC","companyCode":[{"$numberInt":"4976"}],"facilityAddress":"SUITE 1200 1 City Centre Drive Mississauga Ontario Canada L5B 1M2","countryOfOrigin":["Canada"],"format":["Gas"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1970-12-30"],"sanitizedIndication":["MEDICAL GASES"],"atcCode":["V03AN"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CARBON DIOXIDE","Combination"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfea9"},"numbersOfAis":"1","activeIngredientName":["ZIDOVUDINE"],"dose":["100"],"productID":{"$numberInt":"11300"},"sanitizedRegiestrationNumber":"01902660","productName":"RETROVIR (AZT)","licenseHolderSponser":"VIIV HEALTHCARE ULC","companyCode":[{"$numberInt":"14255"}],"facilityAddress":" 245 Boulevard Armand-Frappier Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["ZIDOVUDINE"],"atcCode":["J05AF01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZIDOVUDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeaa"},"numbersOfAis":"3","activeIngredientName":["MACROGOL","SODIUM CHLORIDE","PROPYLENE GLYCOL"],"dose":["160","9","50"],"productID":{"$numberInt":"11232"},"sanitizedRegiestrationNumber":"01910701","productName":"SALINEX NASAL LUBRICANT","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R01AX30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MACROGOL","Combination"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeab"},"numbersOfAis":"1","activeIngredientName":["TENOXICAM"],"dose":["20"],"productID":{"$numberInt":"11732"},"sanitizedRegiestrationNumber":"00884367","productName":"MOBIFLEX TAB 20MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["TENOXICAM"],"atcCode":["M01AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TENOXICAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeac"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"dose":["10","0.01"],"productID":{"$numberInt":"12649"},"sanitizedRegiestrationNumber":"01901958","productName":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfead"},"numbersOfAis":"1","activeIngredientName":["CILAZAPRIL"],"dose":["1"],"productID":{"$numberInt":"13836"},"sanitizedRegiestrationNumber":"01911465","productName":"INHIBACE TAB 1MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["CILAZAPRIL"],"atcCode":["C09AA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CILAZAPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeae"},"numbersOfAis":"1","activeIngredientName":["CALCIUM (CALCIUM CARBONATE)"],"dose":["500"],"productID":{"$numberInt":"12578"},"sanitizedRegiestrationNumber":"01910876","productName":"WEBBER CALCIUM TAB 500MG","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["CALCIUM CARBONATE"],"atcCode":["A12AA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM (CALCIUM CARBONATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeaf"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["250"],"productID":{"$numberInt":"12229"},"sanitizedRegiestrationNumber":"00888206","productName":"A-HYDROCORT INJ 250MG/2ML","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb0"},"numbersOfAis":"1","activeIngredientName":["FOSINOPRIL SODIUM"],"dose":["20"],"productID":{"$numberInt":"12760"},"sanitizedRegiestrationNumber":"01907115","productName":"MONOPRIL TAB 20MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FOSINOPRIL"],"atcCode":["C09AA09"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FOSINOPRIL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb1"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"dose":["20","0.01"],"productID":{"$numberInt":"12648"},"sanitizedRegiestrationNumber":"01901915","productName":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb2"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["75"],"productID":{"$numberInt":"11036"},"sanitizedRegiestrationNumber":"00895660","productName":"APO-DIPYRIDAMOLE-FC TAB 75MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb3"},"numbersOfAis":"2","activeIngredientName":["OCTINOXATE","OXYBENZONE"],"dose":["6.5","2.5"],"productID":{"$numberInt":"41991"},"sanitizedRegiestrationNumber":"01905236","productName":"SUN SEEKERS TANNING LOTION SPF8","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OCTINOXATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb4"},"numbersOfAis":"2","activeIngredientName":["CHLORPHENIRAMINE MALEATE","PHENYLPROPANOLAMINE HYDROCHLORIDE"],"dose":["2","12.5"],"productID":{"$numberInt":"41890"},"sanitizedRegiestrationNumber":"01907883","productName":"TRIAMINIC COLD AND ALLERGY SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PHENYLPROPANOLAMINE, COMBINATIONS","PHENYLPROPANOLAMINE, COMBINATIONS"],"atcCode":["R01BA51","R01BA51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHLORPHENIRAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["5","5"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb5"},"numbersOfAis":"4","activeIngredientName":["POVIDONE-IODINE","DEXTROSE","LIDOCAINE HYDROCHLORIDE","TETRACAINE (TETRACAINE HYDROCHLORIDE)"],"dose":["10","10","1","1"],"productID":{"$numberInt":"12165"},"sanitizedRegiestrationNumber":"01901826","productName":"SPINAL ANAESTHESIA TRAY","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POVIDONE-IODINE","Combination"],"sanitizedRouteOfAdministration":["Topical","Block/Infiltration","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["KIT","KIT","KIT","KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb6"},"numbersOfAis":"1","activeIngredientName":["CALCITRIOL"],"dose":["2"],"productID":{"$numberInt":"11291"},"sanitizedRegiestrationNumber":"00891746","productName":"CALCIJEX","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["CALCITRIOL"],"atcCode":["A11CC04"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCITRIOL"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb7"},"numbersOfAis":"1","activeIngredientName":["CILAZAPRIL (CILAZAPRIL MONOHYDRATE)"],"dose":["2.5"],"productID":{"$numberInt":"13835"},"sanitizedRegiestrationNumber":"01911473","productName":"INHIBACE","licenseHolderSponser":"CHEPLAPHARM ARZNEIMITTEL GMBH","companyCode":[{"$numberInt":"15812"}],"facilityAddress":" Ziegelhof 24 Greifswald Mecklenburg-Vorpommern Germany 17489","countryOfOrigin":["Germany"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["CILAZAPRIL"],"atcCode":["C09AA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CILAZAPRIL (CILAZAPRIL MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Label (Pharmaceutical)| Package (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb8"},"numbersOfAis":"5","activeIngredientName":["PYRILAMINE MALEATE","ACETAMINOPHEN","CAFFEINE","PHENYLPROPANOLAMINE HYDROCHLORIDE","PHENIRAMINE MALEATE"],"dose":["12.5","325","30","25","12.5"],"productID":{"$numberInt":"12542"},"sanitizedRegiestrationNumber":"01906658","productName":"TRIAMINICIN COLDS & FLU CAPLETS","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PYRILAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeb9"},"numbersOfAis":"1","activeIngredientName":["GLYCERINE"],"dose":["23"],"productID":{"$numberInt":"14499"},"sanitizedRegiestrationNumber":"01900471","productName":"WIBI LOTION 23%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OTHER EMOLLIENTS AND PROTECTIVES"],"atcCode":["D02AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYCERINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeba"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.6"],"productID":{"$numberInt":"11226"},"sanitizedRegiestrationNumber":"01911929","productName":"NITRO-DUR 0.6","licenseHolderSponser":"USPHARMA LTD","companyCode":[{"$numberInt":"17456"}],"facilityAddress":" 13900 Nw 57th Court Miami Florida United States 33014","countryOfOrigin":["United States"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfebb"},"numbersOfAis":"22","activeIngredientName":["DEXTROSE","MAGNESIUM CHLORIDE","L-LEUCINE","L-PHENYLALANINE","L-VALINE","L-ASPARTIC ACID","HISTIDINE","N-ACETYL-L-TYROSINE","POTASSIUM CHLORIDE","L-ISOLEUCINE","METHIONINE","TRYPTOPHAN","L-ARGININE","GLYCINE","SERINE","SODIUM CHLORIDE","SODIUM PHOSPHATE DIBASIC","L-LYSINE (L-LYSINE ACETATE)","L-THREONINE","L-ALANINE","GLUTAMIC ACID","L-PROLINE"],"dose":["10","30","425","126","212","298","128","115","97","280","73","85","432","212","225","120","49","446","170","422","314","307"],"productID":{"$numberInt":"18697"},"sanitizedRegiestrationNumber":"00742716","productName":"AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER)","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfebc"},"numbersOfAis":"1","activeIngredientName":["MENTHOL"],"dose":["17.3"],"productID":{"$numberInt":"41879"},"sanitizedRegiestrationNumber":"01909762","productName":"MEGGEZONES MENTHOL PASTILLES","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Lozenge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["R02AA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MENTHOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfebd"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"18012"},"sanitizedRegiestrationNumber":"01901982","productName":"LIDOCAINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfebe"},"numbersOfAis":"2","activeIngredientName":["IMIPENEM","CILASTATIN (CILASTATIN SODIUM)"],"dose":["500","500"],"productID":{"$numberInt":"11379"},"sanitizedRegiestrationNumber":"01911449","productName":"PRIMAXIN IV 500","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["IMIPENEM AND CILASTATIN"],"atcCode":["J01DH51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IMIPENEM","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["VIAL","VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfebf"},"numbersOfAis":"3","activeIngredientName":["PHENYLEPHRINE HYDROCHLORIDE","PHENIRAMINE MALEATE","DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["10","20","30"],"productID":{"$numberInt":"11901"},"sanitizedRegiestrationNumber":"01906704","productName":"NEOCITRAN COLD & COUGH NIGHT","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PHENYLEPHRINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["PCK","PCK","PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec0"},"numbersOfAis":"18","activeIngredientName":["GLUTAMIC ACID","GLYCINE","HISTIDINE","L-PROLINE","TRYPTOPHAN","L-VALINE","L-ALANINE","L-ARGININE","L-ASPARTIC ACID","N-ACETYL-L-TYROSINE","L-ISOLEUCINE","L-LYSINE (L-LYSINE ACETATE)","L-PHENYLALANINE","SERINE","DEXTROSE","L-LEUCINE","METHIONINE","L-THREONINE"],"dose":["314","212","128","307","85","212","422","432","298","115","280","446","126","225","25","425","73","170"],"productID":{"$numberInt":"18727"},"sanitizedRegiestrationNumber":"00742767","productName":"AMINOSYN II 8.5% WITH 50% DEXTROSE","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05BA10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GLUTAMIC ACID","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","MG","G","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec1"},"numbersOfAis":"2","activeIngredientName":["DEXTROSE","HEPARIN SODIUM"],"dose":["5","4000"],"productID":{"$numberInt":"11757"},"sanitizedRegiestrationNumber":"01913255","productName":"HEPARIN SODIUM AND DEXTROSE 5% INJ USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["HEPARIN, COMBINATIONS"],"atcCode":["B01AB51"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROSE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","UNIT"],"quantityNeedToTake":["100","100"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec2"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN G SODIUM"],"dose":["5000000"],"productID":{"$numberInt":"12343"},"sanitizedRegiestrationNumber":"00883751","productName":"PENICILLIN G SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BENZYLPENICILLIN"],"atcCode":["J01CE01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN G SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec3"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["120"],"productID":{"$numberInt":"11534"},"sanitizedRegiestrationNumber":"01907123","productName":"ISOPTIN SR","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec4"},"numbersOfAis":"1","activeIngredientName":["FLUCONAZOLE"],"dose":["100"],"productID":{"$numberInt":"10953"},"sanitizedRegiestrationNumber":"00891819","productName":"DIFLUCAN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1990-12-31"],"sanitizedIndication":["FLUCONAZOLE"],"atcCode":["J02AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUCONAZOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec5"},"numbersOfAis":"1","activeIngredientName":["CLOBETASOL PROPIONATE"],"dose":["0.05"],"productID":{"$numberInt":"13438"},"sanitizedRegiestrationNumber":"01910299","productName":"TEVA-CLOBETASOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CLOBETASOL"],"atcCode":["D07AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOBETASOL PROPIONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec6"},"numbersOfAis":"1","activeIngredientName":["CLOBETASOL PROPIONATE"],"dose":["0.05"],"productID":{"$numberInt":"13439"},"sanitizedRegiestrationNumber":"01910280","productName":"TEVA-CLOBETASOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CLOBETASOL"],"atcCode":["D07AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOBETASOL PROPIONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec7"},"numbersOfAis":"3","activeIngredientName":["ACETAMINOPHEN","PHENIRAMINE MALEATE","PHENYLEPHRINE HYDROCHLORIDE"],"dose":["325","20","10"],"productID":{"$numberInt":"12226"},"sanitizedRegiestrationNumber":"01906720","productName":"NEO CITRAN NUTRASWEET","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":["058478082035"],"unit":[""],"type":["Box"],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS","ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51","N02BE51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETAMINOPHEN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":["10"],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["","",""],"qunatityUnit":["PCK","PCK","PCK"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec8"},"numbersOfAis":"1","activeIngredientName":["VIRGINIAMYCIN"],"dose":["22"],"productID":{"$numberInt":"11525"},"sanitizedRegiestrationNumber":"01908359","productName":"STAFAC 22","licenseHolderSponser":"PHIBRO ANIMAL HEALTH CORPORATION","companyCode":[{"$numberInt":"14250"}],"facilityAddress":" Glenpoint Centre East, 3rd Floor, 300 Frank W Burr Blvd., Ste. 21 Teaneck New Jersey United States 07666","countryOfOrigin":["United States"],"format":["Drug Premix"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VIRGINIAMYCIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["Kg"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfec9"},"numbersOfAis":"1","activeIngredientName":["SALBUTAMOL (SALBUTAMOL SULFATE)"],"dose":["5"],"productID":{"$numberInt":"10391"},"sanitizedRegiestrationNumber":"00860808","productName":"RATIO-SALBUTAMOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["SALBUTAMOL"],"atcCode":["R03AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALBUTAMOL (SALBUTAMOL SULFATE)"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeca"},"numbersOfAis":"1","activeIngredientName":["DOMPERIDONE (DOMPERIDONE MALEATE)"],"dose":["10"],"productID":{"$numberInt":"13180"},"sanitizedRegiestrationNumber":"01912070","productName":"TEVA-DOMPERIDONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["DOMPERIDONE"],"atcCode":["A03FA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOMPERIDONE (DOMPERIDONE MALEATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfecb"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.2"],"productID":{"$numberInt":"11227"},"sanitizedRegiestrationNumber":"01911910","productName":"NITRO-DUR 0.2","licenseHolderSponser":"USPHARMA LTD","companyCode":[{"$numberInt":"17456"}],"facilityAddress":" 13900 Nw 57th Court Miami Florida United States 33014","countryOfOrigin":["United States"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfecc"},"numbersOfAis":"4","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","TETRACAINE HYDROCHLORIDE","DEXTROSE","EPHEDRINE SULFATE"],"dose":["1","1","10","5"],"productID":{"$numberInt":"12588"},"sanitizedRegiestrationNumber":"01909509","productName":"SPINAL ANESTHESIA TRAY","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Block/Infiltration","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["KIT","KIT","KIT","KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfecd"},"numbersOfAis":"1","activeIngredientName":["SULFAMETHAZINE"],"dose":["8"],"productID":{"$numberInt":"11850"},"sanitizedRegiestrationNumber":"01908375","productName":"CALFSPAN TABLETS","licenseHolderSponser":"CAN-VET ANIMAL HEALTH SUPPLIES LTD.","companyCode":[{"$numberInt":"5793"}],"facilityAddress":"4 61 Malcolm Road Guelph Ontario Canada N1K 1A7","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFAMETHAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfece"},"numbersOfAis":"1","activeIngredientName":["CETIRIZINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"11590"},"sanitizedRegiestrationNumber":"01900986","productName":"REACTINE TAB 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CETIRIZINE"],"atcCode":["R06AE07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CETIRIZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfecf"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["9000000"],"productID":{"$numberInt":"11522"},"sanitizedRegiestrationNumber":"01911996","productName":"ROFERON A STERILE PWS 9M UNIT/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D","Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed0"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["0.5"],"productID":{"$numberInt":"11804"},"sanitizedRegiestrationNumber":"01913492","productName":"TEVA-ALPRAZOLAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1993-09-23"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed1"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["160"],"productID":{"$numberInt":"16988"},"sanitizedRegiestrationNumber":"01901389","productName":"CHILDREN'S ACETAMINOPHEN ORAL SOLN 160MG/5ML","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed2"},"numbersOfAis":"3","activeIngredientName":["OXYBENZONE","PADIMATE O","DIMETHICONE"],"dose":["3","7","1.5"],"productID":{"$numberInt":"41920"},"sanitizedRegiestrationNumber":"01914650","productName":"BLISTEX SUNBLOCK STK SPF15","licenseHolderSponser":"BLISTEX CORPORATION","companyCode":[{"$numberInt":"3762"}],"facilityAddress":" 6790 Century Ave, Suite 300 Mississauga Ontario Canada L5N 2V8","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE"],"atcCode":["D02BA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed3"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["75"],"productID":{"$numberInt":"12671"},"sanitizedRegiestrationNumber":"01913441","productName":"NOVO-DOXEPIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed4"},"numbersOfAis":"10","activeIngredientName":["VITAMIN D3","VITAMIN C","THIAMINE MONONITRATE","PYRIDOXINE HYDROCHLORIDE","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","VITAMIN A (VITAMIN A ACETATE)","VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)","VITAMIN B12","VITAMIN B2","NICOTINAMIDE"],"dose":["400","75","1.5","1","10","5000","5","10","1.5","10"],"productID":{"$numberInt":"14474"},"sanitizedRegiestrationNumber":"01911244","productName":"CHILDRENS CHEWABLE VITAMIN TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["MULTIVITAMINS, PLAIN"],"atcCode":["A11BA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D3","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","MG","MG","UNIT","UNIT","MCG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed5"},"numbersOfAis":"1","activeIngredientName":["NALOXONE HYDROCHLORIDE"],"dose":["0.02"],"productID":{"$numberInt":"13997"},"sanitizedRegiestrationNumber":"01913948","productName":"NARCAN INJECTION 0.02MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NALOXONE"],"atcCode":["V03AB15"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NALOXONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed6"},"numbersOfAis":"1","activeIngredientName":["HYDROCODONE BITARTRATE"],"dose":["5"],"productID":{"$numberInt":"13314"},"sanitizedRegiestrationNumber":"01916599","productName":"HYCODAN TABLETS","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCODONE"],"atcCode":["R05DA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCODONE BITARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed7"},"numbersOfAis":"7","activeIngredientName":["NICOTINAMIDE","VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","IRON (FERRONYL)","THIAMINE MONONITRATE","VITAMIN C","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)"],"dose":["30","5","1","15","3","75","5"],"productID":{"$numberInt":"42378"},"sanitizedRegiestrationNumber":"01914715","productName":"GERITOL TABLETS","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX, OTHER COMBINATIONS"],"atcCode":["A11EX"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NICOTINAMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed8"},"numbersOfAis":"2","activeIngredientName":["GENTAMICIN (GENTAMICIN SULFATE)","SODIUM CHLORIDE"],"dose":["0.8","9"],"productID":{"$numberInt":"12675"},"sanitizedRegiestrationNumber":"01913549","productName":"GENTAMICIN SULFATE IN NACL O.9% INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GENTAMICIN"],"atcCode":["J01GB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GENTAMICIN (GENTAMICIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfed9"},"numbersOfAis":"1","activeIngredientName":["GLICLAZIDE"],"dose":["80"],"productID":{"$numberInt":"10918"},"sanitizedRegiestrationNumber":"00765996","productName":"DIAMICRON","licenseHolderSponser":"SERVIER CANADA INC","companyCode":[{"$numberInt":"5096"}],"facilityAddress":" 235 Boul. Armand-Frappier  - Parc Scientif. Et De Haute Tech. De Laval Laval Quebec Canada H7V 4A7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["GLICLAZIDE"],"atcCode":["A10BB09"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLICLAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeda"},"numbersOfAis":"3","activeIngredientName":["OXYBENZONE","OCTISALATE","OCTINOXATE"],"dose":["3","5","7.5"],"productID":{"$numberInt":"41809"},"sanitizedRegiestrationNumber":"01902806","productName":"SUN SEEKERS SUN BLOCKING LOTION SPF 30 LOT","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["%","%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfedb"},"numbersOfAis":"18","activeIngredientName":["IRON (FERROUS FUMARATE)","MAGNESIUM (MAGNESIUM OXIDE)","COPPER (CUPRIC OXIDE)","VITAMIN A (VITAMIN A ACETATE)","VITAMIN C","VITAMIN B1 (THIAMINE MONONITRATE)","NICOTINAMIDE","IODINE (POTASSIUM IODIDE)","VITAMIN E (D-ALPHA TOCOPHERYL ACID SUCCINATE)","FOLIC ACID","VITAMIN B2","VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE)","BIOTIN","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","VITAMIN D3","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","VITAMIN B12","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)"],"dose":["10","100","2","5000","90","2.25","20",".15","25",".1","2.6","3","45","125","400","162","9","10"],"productID":{"$numberInt":"15582"},"sanitizedRegiestrationNumber":"01902555","productName":"MULTIVITAMIN-MULTIMINERAL FORMULA REG TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IRON (FERROUS FUMARATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","UNIT","MG","MG","MG","MG","UNIT","MG","MG","MG","MCG","MG","UNIT","MG","MCG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB","TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfedc"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN SODIUM"],"dose":["500"],"productID":{"$numberInt":"12435"},"sanitizedRegiestrationNumber":"01912429","productName":"CLOXACILLIN SODIUM FOR INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfedd"},"numbersOfAis":"1","activeIngredientName":["ALPRAZOLAM"],"dose":["0.25"],"productID":{"$numberInt":"11803"},"sanitizedRegiestrationNumber":"01913484","productName":"TEVA-ALPRAZOLAM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ALPRAZOLAM"],"atcCode":["N05BA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALPRAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfede"},"numbersOfAis":"1","activeIngredientName":["PREDNISOLONE ACETATE"],"dose":["1"],"productID":{"$numberInt":"13946"},"sanitizedRegiestrationNumber":"01916203","productName":"SANDOZ PREDNISOLONE","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["PREDNISOLONE"],"atcCode":["S01BA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfedf"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["160"],"productID":{"$numberInt":"42066"},"sanitizedRegiestrationNumber":"00875996","productName":"TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1985-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee0"},"numbersOfAis":"1","activeIngredientName":["ATENOLOL"],"dose":["50"],"productID":{"$numberInt":"11143"},"sanitizedRegiestrationNumber":"01912062","productName":"TEVA-ATENOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ATENOLOL"],"atcCode":["C07AB03"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATENOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee1"},"numbersOfAis":"1","activeIngredientName":["CLOBETASOL PROPIONATE"],"dose":["0.05"],"productID":{"$numberInt":"13437"},"sanitizedRegiestrationNumber":"01910272","productName":"TEVA-CLOBETASOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CLOBETASOL"],"atcCode":["D07AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOBETASOL PROPIONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee2"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","MAGNESIUM SULFATE","SODIUM PHOSPHATE DIBASIC","POTASSIUM PHOSPHATE MONOBASIC"],"dose":["800","40","20","8.75","6.25"],"productID":{"$numberInt":"10939"},"sanitizedRegiestrationNumber":"00800007","productName":"TIS-U-SOL SOLUTION","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["B05CB10"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Irrigation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["100","100","100","100","100"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee3"},"numbersOfAis":"1","activeIngredientName":["PREDNISOLONE ACETATE"],"dose":["0.12"],"productID":{"$numberInt":"14126"},"sanitizedRegiestrationNumber":"01916181","productName":"SANDOZ PREDNISOLONE","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["PREDNISOLONE"],"atcCode":["S01BA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee4"},"numbersOfAis":"12","activeIngredientName":["VITAMIN D3","PYRIDOXINE HYDROCHLORIDE","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","VITAMIN C","VITAMIN A (VITAMIN A ACETATE)","VITAMIN B2","VITAMIN B12","IODINE (POTASSIUM IODIDE)","IRON (FERROUS FUMARATE)","THIAMINE MONONITRATE","NICOTINAMIDE","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))"],"dose":["400","1","5","75","6000","3","3",".1","15","3","20","125"],"productID":{"$numberInt":"12593"},"sanitizedRegiestrationNumber":"01911236","productName":"MOR-VITES TAB","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN D3","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","MG","MG","UNIT","MG","MCG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee5"},"numbersOfAis":"1","activeIngredientName":["PLANTAGO SEED"],"dose":["3.4"],"productID":{"$numberInt":"11366"},"sanitizedRegiestrationNumber":"01912887","productName":"METAMUCIL PWS 3.4GM/TSP UNFLAVOURED","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ISPAGHULA (PSYLLA SEEDS)"],"atcCode":["A06AC01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PLANTAGO SEED"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee6"},"numbersOfAis":"2","activeIngredientName":["SODIUM CHLORIDE","GENTAMICIN (GENTAMICIN SULFATE)"],"dose":["9","1"],"productID":{"$numberInt":"18660"},"sanitizedRegiestrationNumber":"01913565","productName":"GENTAMICIN SULFATE IN NACL 0.9% INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["GENTAMICIN"],"atcCode":["J01GB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee7"},"numbersOfAis":"2","activeIngredientName":["GENTAMICIN (GENTAMICIN SULFATE)","SODIUM CHLORIDE"],"dose":["1.2","9"],"productID":{"$numberInt":"12668"},"sanitizedRegiestrationNumber":"01913093","productName":"GENTAMICIN SULFATE IN NACL 0.9% INJ","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GENTAMICIN"],"atcCode":["J01GB03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GENTAMICIN (GENTAMICIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee8"},"numbersOfAis":"1","activeIngredientName":["WARFARIN SODIUM"],"dose":["10"],"productID":{"$numberInt":"13418"},"sanitizedRegiestrationNumber":"01918362","productName":"COUMADIN TAB 10MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1957-12-31"],"sanitizedIndication":["WARFARIN"],"atcCode":["B01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WARFARIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfee9"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["2.5"],"productID":{"$numberInt":"11728"},"sanitizedRegiestrationNumber":"01913654","productName":"APO GLYBURIDE TAB 2.5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeea"},"numbersOfAis":"1","activeIngredientName":["CLOZAPINE"],"dose":["25"],"productID":{"$numberInt":"11422"},"sanitizedRegiestrationNumber":"00894737","productName":"CLOZARIL","licenseHolderSponser":"HLS THERAPEUTICS INC","companyCode":[{"$numberInt":"16998"}],"facilityAddress":" 10 Carlson Court, Suite 701 Etobicoke Ontario Canada M9W 6L2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CLOZAPINE"],"atcCode":["N05AH02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOZAPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeeb"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETYLSALICYLIC ACID"],"dose":["2.5","325"],"productID":{"$numberInt":"15109"},"sanitizedRegiestrationNumber":"01916556","productName":"PERCODAN-DEMI","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OXYCODONE AND ACETYLSALICYLIC ACID","OXYCODONE AND ACETYLSALICYLIC ACID"],"atcCode":["N02AJ18","N02AJ18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeec"},"numbersOfAis":"1","activeIngredientName":["CLOXACILLIN SODIUM"],"dose":["2"],"productID":{"$numberInt":"12434"},"sanitizedRegiestrationNumber":"01912410","productName":"CLOXACILLIN SODIUM FOR INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CLOXACILLIN"],"atcCode":["J01CF02"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLOXACILLIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeed"},"numbersOfAis":"1","activeIngredientName":["NALBUPHINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"13963"},"sanitizedRegiestrationNumber":"01913972","productName":"NUBAIN INJECTION 20MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NALBUFINE"],"atcCode":["N02AF02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NALBUPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeee"},"numbersOfAis":"1","activeIngredientName":["WARFARIN SODIUM"],"dose":["2"],"productID":{"$numberInt":"13536"},"sanitizedRegiestrationNumber":"01918338","productName":"COUMADIN TAB 2MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["WARFARIN"],"atcCode":["B01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WARFARIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeef"},"numbersOfAis":"2","activeIngredientName":["CLEMASTINE (CLEMASTINE HYDROGEN FUMARATE)","PHENYLPROPANOLAMINE HYDROCHLORIDE"],"dose":["1","75"],"productID":{"$numberInt":"13521"},"sanitizedRegiestrationNumber":"01906577","productName":"TAVIST-D TABLETS","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PHENYLPROPANOLAMINE, COMBINATIONS","PHENYLPROPANOLAMINE, COMBINATIONS"],"atcCode":["R01BA51","R01BA51"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CLEMASTINE (CLEMASTINE HYDROGEN FUMARATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef0"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"12672"},"sanitizedRegiestrationNumber":"01913468","productName":"NOVO-DOXEPIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef1"},"numbersOfAis":"1","activeIngredientName":["HYDROCODONE BITARTRATE"],"dose":["5"],"productID":{"$numberInt":"13315"},"sanitizedRegiestrationNumber":"01916580","productName":"HYCODAN SYRUP","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCODONE"],"atcCode":["R05DA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCODONE BITARTRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef2"},"numbersOfAis":"1","activeIngredientName":["WARFARIN SODIUM"],"dose":["1"],"productID":{"$numberInt":"12818"},"sanitizedRegiestrationNumber":"01918311","productName":"COUMADIN TAB 1MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1957-12-31"],"sanitizedIndication":["WARFARIN"],"atcCode":["B01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WARFARIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef3"},"numbersOfAis":"1","activeIngredientName":["TRIAZOLAM"],"dose":["0.25"],"productID":{"$numberInt":"13124"},"sanitizedRegiestrationNumber":"01913506","productName":"MYLAN-TRIAZOLAM","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TRIAZOLAM"],"atcCode":["N05CD05"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAZOLAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef4"},"numbersOfAis":"1","activeIngredientName":["CILAZAPRIL (CILAZAPRIL MONOHYDRATE)"],"dose":["5"],"productID":{"$numberInt":"13834"},"sanitizedRegiestrationNumber":"01911481","productName":"INHIBACE","licenseHolderSponser":"CHEPLAPHARM ARZNEIMITTEL GMBH","companyCode":[{"$numberInt":"15812"}],"facilityAddress":" Ziegelhof 24 Greifswald Mecklenburg-Vorpommern Germany 17489","countryOfOrigin":["Germany"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["CILAZAPRIL"],"atcCode":["C09AA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CILAZAPRIL (CILAZAPRIL MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Label (Pharmaceutical)| Package (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef5"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETAMINOPHEN"],"dose":["2.5","325"],"productID":{"$numberInt":"13316"},"sanitizedRegiestrationNumber":"01916491","productName":"PERCOCET-DEMI","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OXYCODONE AND PARACETAMOL","OXYCODONE AND PARACETAMOL"],"atcCode":["N02AJ17","N02AJ17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef6"},"numbersOfAis":"1","activeIngredientName":["NALBUPHINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"13803"},"sanitizedRegiestrationNumber":"01913980","productName":"NUBAIN INJECTION 10MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NALBUFINE"],"atcCode":["N02AF02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NALBUPHINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef7"},"numbersOfAis":"2","activeIngredientName":["DICLOFENAC SODIUM","MISOPROSTOL"],"dose":["50","200"],"productID":{"$numberInt":"13636"},"sanitizedRegiestrationNumber":"01917056","productName":"ARTHROTEC 50","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet (Delayed-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["DICLOFENAC, COMBINATIONS","DICLOFENAC, COMBINATIONS"],"atcCode":["M01AB55","M01AB55"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DICLOFENAC SODIUM","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef8"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"dose":["500"],"productID":{"$numberInt":"15606"},"sanitizedRegiestrationNumber":"00878618","productName":"HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["H02AB09"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfef9"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["10"],"productID":{"$numberInt":"11657"},"sanitizedRegiestrationNumber":"01912437","productName":"BENZAC AC GEL 10%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfefa"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["2.5"],"productID":{"$numberInt":"11780"},"sanitizedRegiestrationNumber":"01913670","productName":"TEVA-GLYBURIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfefb"},"numbersOfAis":"1","activeIngredientName":["OXYMORPHONE HYDROCHLORIDE"],"dose":["1.5"],"productID":{"$numberInt":"14556"},"sanitizedRegiestrationNumber":"01916505","productName":"NUMORPHAN INJECTION 1.5MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NATURAL OPIUM ALKALOIDS"],"atcCode":["N02AA"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfefc"},"numbersOfAis":"6","activeIngredientName":["VITAMIN B2","PYRIDOXINE HYDROCHLORIDE","D-PANTOTHENIC ACID (DEXPANTHENOL)","IRON (FERRIC AMMONIUM CITRATE)","THIAMINE HYDROCHLORIDE","NICOTINAMIDE"],"dose":[".17",".07",".34","1",".1","1"],"productID":{"$numberInt":"42045"},"sanitizedRegiestrationNumber":"01914723","productName":"GERITOL LIQUID","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["VITAMIN B-COMPLEX WITH MINERALS"],"atcCode":["A11EC"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B2","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfefd"},"numbersOfAis":"1","activeIngredientName":["MOCLOBEMIDE"],"dose":["100"],"productID":{"$numberInt":"13096"},"sanitizedRegiestrationNumber":"00899348","productName":"MANERIX TAB 100MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MOCLOBEMIDE"],"atcCode":["N06AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MOCLOBEMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfefe"},"numbersOfAis":"1","activeIngredientName":["HEPARIN SODIUM"],"dose":["100"],"productID":{"$numberInt":"9400"},"sanitizedRegiestrationNumber":"00740578","productName":"HEPALEAN-LOK 100 USP","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEPARIN"],"atcCode":["B01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPARIN SODIUM"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfeff"},"numbersOfAis":"4","activeIngredientName":["OCTISALATE","OCTINOXATE","OXYBENZONE","HOMOSALATE"],"dose":["5","7.5","4","5"],"productID":{"$numberInt":"41930"},"sanitizedRegiestrationNumber":"01915142","productName":"COPPERTONE WATER BABIES SUNBLOCK LOT SPF30","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OCTISALATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff00"},"numbersOfAis":"1","activeIngredientName":["EPSIPRANTEL"],"dose":["12.5"],"productID":{"$numberInt":"12999"},"sanitizedRegiestrationNumber":"01913034","productName":"CESTEX","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["EPSIPRANTEL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff01"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["150"],"productID":{"$numberInt":"12673"},"sanitizedRegiestrationNumber":"01913476","productName":"NOVO-DOXEPIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff02"},"numbersOfAis":"4","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","ACETAMINOPHEN","DOXYLAMINE SUCCINATE","PSEUDOEPHEDRINE HYDROCHLORIDE"],"dose":["30","650","7.5","60"],"productID":{"$numberInt":"13960"},"sanitizedRegiestrationNumber":"01900501","productName":"NITETIME COLD MEDICINE LIQ","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["30","30","30","30"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff03"},"numbersOfAis":"4","activeIngredientName":["AMMONIUM CHLORIDE","PHENYLEPHRINE HYDROCHLORIDE","HYDROCODONE BITARTRATE","PYRILAMINE MALEATE"],"dose":["6","1","0.5","1.25"],"productID":{"$numberInt":"15544"},"sanitizedRegiestrationNumber":"01916521","productName":"HYCOMINE-S","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["AMMONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff04"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"7443"},"sanitizedRegiestrationNumber":"00738832","productName":"NOVO-HYDROXYZIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff05"},"numbersOfAis":"1","activeIngredientName":["AZAPERONE"],"dose":["40"],"productID":{"$numberInt":"9508"},"sanitizedRegiestrationNumber":"00755710","productName":"STRESNIL","licenseHolderSponser":"ELANCO CANADA LIMITED","companyCode":[{"$numberInt":"16571"}],"facilityAddress":"120 150 Research Lane Guelph Ontario Canada N1G 4T2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"pharmaceuticalStd":["PH EUR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AZAPERONE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff06"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETAMINOPHEN"],"dose":["5","325"],"productID":{"$numberInt":"17235"},"sanitizedRegiestrationNumber":"01916548","productName":"ENDOCET","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["OXYCODONE AND PARACETAMOL","OXYCODONE AND PARACETAMOL"],"atcCode":["N02AJ17","N02AJ17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff07"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["5"],"productID":{"$numberInt":"11781"},"sanitizedRegiestrationNumber":"01913689","productName":"TEVA-GLYBURIDE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff08"},"numbersOfAis":"1","activeIngredientName":["MEPIVACAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"12867"},"sanitizedRegiestrationNumber":"01910043","productName":"EQUICAINE","licenseHolderSponser":"ZOETIS CANADA INC","companyCode":[{"$numberInt":"15645"}],"facilityAddress":" 16740 Trans Canada Highway Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MEPIVACAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration","Epidural","Intra-Articular"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff09"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["0.4"],"productID":{"$numberInt":"11225"},"sanitizedRegiestrationNumber":"01911902","productName":"NITRO-DUR 0.4","licenseHolderSponser":"USPHARMA LTD","companyCode":[{"$numberInt":"17456"}],"facilityAddress":" 13900 Nw 57th Court Miami Florida United States 33014","countryOfOrigin":["United States"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0a"},"numbersOfAis":"2","activeIngredientName":["DEXTRAN 70","HYPROMELLOSE"],"dose":["0.1","0.3"],"productID":{"$numberInt":"10032"},"sanitizedRegiestrationNumber":"00743445","productName":"TEARS NATURALE II","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTRAN 70","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["",""],"qunatityUnit":["W/V","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0b"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","SODIUM CHLORIDE"],"dose":["1",".9"],"productID":{"$numberInt":"12589"},"sanitizedRegiestrationNumber":"01909517","productName":"CONTINUOUS EPIDURAL ANESTHESIA TRAY","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Epidural","Block/Infiltration","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["KIT","KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0c"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"12670"},"sanitizedRegiestrationNumber":"01913433","productName":"NOVO-DOXEPIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0d"},"numbersOfAis":"1","activeIngredientName":["ATENOLOL"],"dose":["100"],"productID":{"$numberInt":"11142"},"sanitizedRegiestrationNumber":"01912054","productName":"TEVA-ATENOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ATENOLOL"],"atcCode":["C07AB03"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATENOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0e"},"numbersOfAis":"1","activeIngredientName":["CHLOROXYLENOL"],"dose":[".3"],"productID":{"$numberInt":"11787"},"sanitizedRegiestrationNumber":"01918710","productName":"PUREL ANTIBACTERIAL LOTION SOAP 0.3%","licenseHolderSponser":"GOJO INDUSTRIES, INC.","companyCode":[{"$numberInt":"4264"}],"facilityAddress":"500 One Gojo Plaza Akron Ohio United States 44311","countryOfOrigin":["United States"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLOROXYLENOL"],"atcCode":["D08AE05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLOROXYLENOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff0f"},"numbersOfAis":"4","activeIngredientName":["PYRILAMINE MALEATE","AMMONIUM CHLORIDE","HYDROCODONE BITARTRATE","PHENYLEPHRINE HYDROCHLORIDE"],"dose":["2.5","12","1","2"],"productID":{"$numberInt":"13802"},"sanitizedRegiestrationNumber":"01916564","productName":"HYCOMINE","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PYRILAMINE MALEATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff10"},"numbersOfAis":"1","activeIngredientName":["DOPAMINE HYDROCHLORIDE"],"dose":["40"],"productID":{"$numberInt":"14208"},"sanitizedRegiestrationNumber":"01914014","productName":"INTROPIN INJECTION 40MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["DOPAMINE"],"atcCode":["C01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOPAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff11"},"numbersOfAis":"2","activeIngredientName":["OCTINOXATE","OXYBENZONE"],"dose":["7.5","4"],"productID":{"$numberInt":"42133"},"sanitizedRegiestrationNumber":"01902792","productName":"SUNSEEKERS SUN BLOCKING STICK SPF 15 STK","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OCTINOXATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff12"},"numbersOfAis":"1","activeIngredientName":["SALICYLIC ACID"],"dose":["40"],"productID":{"$numberInt":"41828"},"sanitizedRegiestrationNumber":"00895083","productName":"DR. SCHOLL'S CORN/CALLUS REMOVERS","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Plaster"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["WART AND ANTI-CORN PREPARATIONS"],"atcCode":["D11AF"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALICYLIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff13"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"41933"},"sanitizedRegiestrationNumber":"01919245","productName":"DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Powder","Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff14"},"numbersOfAis":"1","activeIngredientName":["ESTRADIOL"],"dose":["4"],"productID":{"$numberInt":"8174"},"sanitizedRegiestrationNumber":"00756857","productName":"ESTRADERM-50","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Patch (Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["ESTRADIOL"],"atcCode":["G03CA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ESTRADIOL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["STRIP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff15"},"numbersOfAis":"1","activeIngredientName":["FLUVOXAMINE MALEATE"],"dose":["50"],"productID":{"$numberInt":"11752"},"sanitizedRegiestrationNumber":"01919342","productName":"LUVOX","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["FLUVOXAMINE"],"atcCode":["N06AB08"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUVOXAMINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff16"},"numbersOfAis":"1","activeIngredientName":["AURANOFIN"],"dose":["3"],"productID":{"$numberInt":"15902"},"sanitizedRegiestrationNumber":"01916823","productName":"RIDAURA","licenseHolderSponser":"XEDITON PHARMACEUTICALS INC","companyCode":[{"$numberInt":"14115"}],"facilityAddress":" 2000 Argentia Road, Building 4, Suite 495 Mississauga Ontario Canada L5N 1W1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["AURANOFIN"],"atcCode":["M01CB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AURANOFIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff17"},"numbersOfAis":"1","activeIngredientName":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"dose":["150"],"productID":{"$numberInt":"7426"},"sanitizedRegiestrationNumber":"00733059","productName":"APO-RANITIDINE TABLET 150MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1987-12-31"],"sanitizedIndication":["RANITIDINE"],"atcCode":["A02BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["RANITIDINE (RANITIDINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff18"},"numbersOfAis":"1","activeIngredientName":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"dose":["250"],"productID":{"$numberInt":"8167"},"sanitizedRegiestrationNumber":"00741795","productName":"VITAMINE E CREME 250UNIT/ML","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1987-12-31"],"sanitizedIndication":["OTHER EMOLLIENTS AND PROTECTIVES"],"atcCode":["D02AX"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN E (D-ALPHA TOCOPHERYL ACETATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff19"},"numbersOfAis":"1","activeIngredientName":["MUPIROCIN"],"dose":["2"],"productID":{"$numberInt":"15207"},"sanitizedRegiestrationNumber":"01916947","productName":"BACTROBAN","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Approved"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MUPIROCIN"],"atcCode":["D06AX09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MUPIROCIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1a"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41840"},"sanitizedRegiestrationNumber":"01918818","productName":"AVON ROLL-ON LOT INSEPARABLE FOR HER 17.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1b"},"numbersOfAis":"1","activeIngredientName":["WARFARIN SODIUM"],"dose":["5"],"productID":{"$numberInt":"12819"},"sanitizedRegiestrationNumber":"01918354","productName":"COUMADIN TAB 5MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1957-12-31"],"sanitizedIndication":["WARFARIN"],"atcCode":["B01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WARFARIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1c"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":["3.5","7.5"],"productID":{"$numberInt":"42080"},"sanitizedRegiestrationNumber":"01919067","productName":"AVON MOISTURE SHIELD SPF15 CRM","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1d"},"numbersOfAis":"2","activeIngredientName":["TRIMETHOPRIM","SULFADOXINE"],"dose":["40","200"],"productID":{"$numberInt":"11977"},"sanitizedRegiestrationNumber":"01923838","productName":"NOROVET TMPS (INJECTABLE SOLUTION)","licenseHolderSponser":"NORBROOK LABORATORIES LTD.","companyCode":[{"$numberInt":"4720"}],"facilityAddress":" Station Works, Camlough Road Newry, County Down Northern Ireland United Kingdom BT35 6JP","countryOfOrigin":["United Kingdom"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TRIMETHOPRIM","Combination"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1e"},"numbersOfAis":"1","activeIngredientName":["GLYBURIDE"],"dose":["5"],"productID":{"$numberInt":"11727"},"sanitizedRegiestrationNumber":"01913662","productName":"APO GLYBURIDE TAB 5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GLIBENCLAMIDE"],"atcCode":["A10BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLYBURIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff1f"},"numbersOfAis":"2","activeIngredientName":["O-PHENYLPHENOL","CLOROPHENE"],"dose":["9","1"],"productID":{"$numberInt":"12247"},"sanitizedRegiestrationNumber":"01910604","productName":"G-NOL DISINFECTANT SOL","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["O-PHENYLPHENOL","Combination"],"sanitizedRouteOfAdministration":["Disinfectant (Medical Instruments)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff20"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["10"],"productID":{"$numberInt":"11862"},"sanitizedRegiestrationNumber":"01925199","productName":"BENZAC W WASH GEL 10%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff21"},"numbersOfAis":"1","activeIngredientName":["OXYBUTYNIN CHLORIDE"],"dose":["1"],"productID":{"$numberInt":"14021"},"sanitizedRegiestrationNumber":"01924753","productName":"DITROPAN SYRUP 1MG/ML","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OXYBUTYNIN"],"atcCode":["G04BD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYBUTYNIN CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff22"},"numbersOfAis":"1","activeIngredientName":["DEXTROAMPHETAMINE SULFATE"],"dose":["15"],"productID":{"$numberInt":"15210"},"sanitizedRegiestrationNumber":"01924567","productName":"DEXEDRINE SPANSULE SRC 15MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Capsule (Sustained-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXAMFETAMINE"],"atcCode":["N06BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROAMPHETAMINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff23"},"numbersOfAis":"1","activeIngredientName":["NALOXONE HYDROCHLORIDE"],"dose":["0.4"],"productID":{"$numberInt":"13415"},"sanitizedRegiestrationNumber":"01913956","productName":"NARCAN INJECTION 0.4MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["NALOXONE"],"atcCode":["V03AB15"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NALOXONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff24"},"numbersOfAis":"1","activeIngredientName":["AMANTADINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"15546"},"sanitizedRegiestrationNumber":"01913999","productName":"SYMMETREL SYRUP 10MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1973-12-31"],"sanitizedIndication":["AMANTADINE","AMANTADINE"],"atcCode":["N04BB01","N04BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMANTADINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff25"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","ACETIC ACID","CALCIUM CHLORIDE","SODIUM CHLORIDE","DEXTROSE"],"dose":["3.21","8.11","7.74","268.24","89.99"],"productID":{"$numberInt":"9132"},"sanitizedRegiestrationNumber":"00774979","productName":"ACID CONCENTRATE 2121","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G"],"quantityNeedToTake":["","","","",""],"qunatityUnit":["L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff26"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["2"],"productID":{"$numberInt":"11826"},"sanitizedRegiestrationNumber":"01930079","productName":"GERMI STAT GEL 2%","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff27"},"numbersOfAis":"1","activeIngredientName":["SALBUTAMOL (SALBUTAMOL SULFATE)"],"dose":["1"],"productID":{"$numberInt":"13550"},"sanitizedRegiestrationNumber":"01926934","productName":"TEVA-SALBUTAMOL STERINEBS P.F.","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SALBUTAMOL"],"atcCode":["R03AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALBUTAMOL (SALBUTAMOL SULFATE)"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff28"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"9717"},"sanitizedRegiestrationNumber":"00730734","productName":"ACETAMINOPHEN ORAL SOLN 80MG/5ML USP","licenseHolderSponser":"SHOPPERS DRUG MART INC.","companyCode":[{"$numberInt":"5084"}],"facilityAddress":" 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Wholesale (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff29"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN G SODIUM"],"dose":["1000000"],"productID":{"$numberInt":"12394"},"sanitizedRegiestrationNumber":"01930672","productName":"PENICILLIN G SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BENZYLPENICILLIN"],"atcCode":["J01CE01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN G SODIUM"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2a"},"numbersOfAis":"2","activeIngredientName":["GUAIFENESIN","DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["100","15"],"productID":{"$numberInt":"13565"},"sanitizedRegiestrationNumber":"01915533","productName":"GUAITUSSIN DM COUGH FORMULA SYR","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS","OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02","R05FA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GUAIFENESIN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["5","5"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2b"},"numbersOfAis":"1","activeIngredientName":["DOXACURIUM (DOXACURIUM CHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"12834"},"sanitizedRegiestrationNumber":"01924656","productName":"NUROMAX","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXACURIUM CHLORIDE"],"atcCode":["M03AC07"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXACURIUM (DOXACURIUM CHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2c"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["3000000"],"productID":{"$numberInt":"11121"},"sanitizedRegiestrationNumber":"01911988","productName":"ROFERON A STERILE PWS 3M UNIT/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2d"},"numbersOfAis":"1","activeIngredientName":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"dose":["500"],"productID":{"$numberInt":"9170"},"sanitizedRegiestrationNumber":"00768715","productName":"APO-CEPHALEX","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["CEFALEXIN"],"atcCode":["J01DB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CEPHALEXIN (CEPHALEXIN MONOHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2e"},"numbersOfAis":"1","activeIngredientName":["DAUNORUBICIN (DAUNORUBICIN HYDROCHLORIDE)"],"dose":["20"],"productID":{"$numberInt":"13226"},"sanitizedRegiestrationNumber":"01926683","productName":"CERUBIDINE 20MG/VIAL","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1971-12-31"],"sanitizedIndication":["DAUNORUBICIN"],"atcCode":["L01DB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DAUNORUBICIN (DAUNORUBICIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff2f"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["4"],"productID":{"$numberInt":"12713"},"sanitizedRegiestrationNumber":"01930087","productName":"GERMI STAT GEL 4%","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff30"},"numbersOfAis":"1","activeIngredientName":["BISACODYL"],"dose":["10"],"productID":{"$numberInt":"9011"},"sanitizedRegiestrationNumber":"00754595","productName":"APO-BISACODYL SUP 10MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1988-12-31"],"sanitizedIndication":["BISACODYL"],"atcCode":["A06AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BISACODYL"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff31"},"numbersOfAis":"1","activeIngredientName":["BETAXOLOL (BETAXOLOL HYDROCHLORIDE)"],"dose":["0.25"],"productID":{"$numberInt":"15625"},"sanitizedRegiestrationNumber":"01908448","productName":"BETOPTIC S","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["BETAXOLOL"],"atcCode":["S01ED02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAXOLOL (BETAXOLOL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff32"},"numbersOfAis":"1","activeIngredientName":["THIOPROPERAZINE (THIOPROPERAZINE MESYLATE)"],"dose":["10"],"productID":{"$numberInt":"12437"},"sanitizedRegiestrationNumber":"01927639","productName":"MAJEPTIL TAB 10MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1962-12-31"],"sanitizedIndication":["THIOPROPERAZINE"],"atcCode":["N05AB08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOPROPERAZINE (THIOPROPERAZINE MESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff33"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETYLSALICYLIC ACID"],"dose":["5","325"],"productID":{"$numberInt":"15512"},"sanitizedRegiestrationNumber":"01916483","productName":"ENDODAN","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["OXYCODONE AND ACETYLSALICYLIC ACID","OXYCODONE AND ACETYLSALICYLIC ACID"],"atcCode":["N02AJ18","N02AJ18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff34"},"numbersOfAis":"1","activeIngredientName":["DEXTROAMPHETAMINE SULFATE"],"dose":["10"],"productID":{"$numberInt":"15211"},"sanitizedRegiestrationNumber":"01924559","productName":"DEXEDRINE SPANSULE SRC 10MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Capsule (Sustained-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXAMFETAMINE"],"atcCode":["N06BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROAMPHETAMINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff35"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":["2","7"],"productID":{"$numberInt":"41935"},"sanitizedRegiestrationNumber":"01931199","productName":"COPPERTONE SUNSCREEN LOTION SPF 8 DEFEND & GLOW","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1970-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff36"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"11847"},"sanitizedRegiestrationNumber":"01928791","productName":"KOFFEX DM  (SUCROSE FREE)","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff37"},"numbersOfAis":"4","activeIngredientName":["CODEINE PHOSPHATE","PYRILAMINE MALEATE","PHENYLPROPANOLAMINE HYDROCHLORIDE","PHENIRAMINE MALEATE"],"dose":["15","12.5","25","12.5"],"productID":{"$numberInt":"14037"},"sanitizedRegiestrationNumber":"01925954","productName":"TUSSAMINIC C FORTE SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20","R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CODEINE PHOSPHATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff38"},"numbersOfAis":"3","activeIngredientName":["COAL TAR","CHLOROXYLENOL","MENTHOL"],"dose":["7.5","0.5","1.5"],"productID":{"$numberInt":"42043"},"sanitizedRegiestrationNumber":"01931245","productName":"DENOREX MEDICATED SHAMPOO - REGULAR","licenseHolderSponser":"NEOTERIC COSMETICS INC.","companyCode":[{"$numberInt":"8173"}],"facilityAddress":" 4880 Havana St, Suite 400 Denver Colorado United States 80239-0019","countryOfOrigin":["United States"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1970-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["COAL TAR","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["","",""],"qunatityUnit":["W/W","W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff39"},"numbersOfAis":"1","activeIngredientName":["DEXTROAMPHETAMINE SULFATE"],"dose":["5"],"productID":{"$numberInt":"15225"},"sanitizedRegiestrationNumber":"01924516","productName":"DEXEDRINE TABLETS (5MG)","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA I)"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXAMFETAMINE"],"atcCode":["N06BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROAMPHETAMINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3a"},"numbersOfAis":"1","activeIngredientName":["DINOPROSTONE"],"dose":["2"],"productID":{"$numberInt":"11831"},"sanitizedRegiestrationNumber":"01919687","productName":"PROSTIN E2 VAGINAL GEL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DINOPROSTONE"],"atcCode":["G02AD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DINOPROSTONE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["3"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3b"},"numbersOfAis":"3","activeIngredientName":["MICONAZOLE NITRATE","POLYMYXIN B SULFATE","PREDNISOLONE ACETATE"],"dose":["23","0.5293","5"],"productID":{"$numberInt":"10300"},"sanitizedRegiestrationNumber":"00755753","productName":"SUROLAN","licenseHolderSponser":"ELANCO CANADA LIMITED","companyCode":[{"$numberInt":"16571"}],"facilityAddress":"120 150 Research Lane Guelph Ontario Canada N1G 4T2","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MICONAZOLE NITRATE","Combination"],"sanitizedRouteOfAdministration":["Topical","Otic"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3c"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"12451"},"sanitizedRegiestrationNumber":"01934198","productName":"TEVA-PRAZOSIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3d"},"numbersOfAis":"1","activeIngredientName":["WARFARIN SODIUM"],"dose":["2.5"],"productID":{"$numberInt":"13419"},"sanitizedRegiestrationNumber":"01918346","productName":"COUMADIN TAB 2.5MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["WARFARIN"],"atcCode":["B01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["WARFARIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3e"},"numbersOfAis":"1","activeIngredientName":["INTERFERON ALPHA-2A"],"dose":["18000000"],"productID":{"$numberInt":"11123"},"sanitizedRegiestrationNumber":"01912003","productName":"ROFERON A STERILE PWS 18M UNIT/VIAL","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["INTERFERON ALFA-2A"],"atcCode":["L03AB04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INTERFERON ALPHA-2A"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff3f"},"numbersOfAis":"1","activeIngredientName":["PERICIAZINE"],"dose":["10"],"productID":{"$numberInt":"13159"},"sanitizedRegiestrationNumber":"01926756","productName":"NEULEPTIL","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1976-12-31"],"sanitizedIndication":["PERICIAZINE"],"atcCode":["N05AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERICIAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff40"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM CHLOROHYDRATE"],"dose":["17.5"],"productID":{"$numberInt":"41839"},"sanitizedRegiestrationNumber":"01918796","productName":"AVON ROLL-ON LOT INSEPARABLE FOR HIM 17.5%","licenseHolderSponser":"AVON CANADA INC","companyCode":[{"$numberInt":"3685"}],"facilityAddress":" 5500 Trans-Canada Highway Pointe-Claire Quebec Canada H9R 1B6","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM CHLOROHYDRATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff41"},"numbersOfAis":"1","activeIngredientName":["ENALAPRILAT"],"dose":["1.25"],"productID":{"$numberInt":"12650"},"sanitizedRegiestrationNumber":"01923846","productName":"VASOTEC IV","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ENALAPRIL"],"atcCode":["C09AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ENALAPRILAT"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff42"},"numbersOfAis":"1","activeIngredientName":["COAL TAR"],"dose":["1.4"],"productID":{"$numberInt":"42067"},"sanitizedRegiestrationNumber":"01918990","productName":"TEGRIN MEDICATED SHAMPOO - EXTRA CONDITIONING","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COAL TAR"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff43"},"numbersOfAis":"1","activeIngredientName":["FLUVOXAMINE MALEATE"],"dose":["100"],"productID":{"$numberInt":"11751"},"sanitizedRegiestrationNumber":"01919369","productName":"LUVOX","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1997-03-17"],"sanitizedIndication":["FLUVOXAMINE"],"atcCode":["N06AB08"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FLUVOXAMINE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff44"},"numbersOfAis":"3","activeIngredientName":["ALCOHOL ANHYDROUS","O-PHENYLPHENOL","BENZALKONIUM CHLORIDE"],"dose":["70","0.28","0.2"],"productID":{"$numberInt":"12408"},"sanitizedRegiestrationNumber":"01914243","productName":"ULTRA SWIPES DISINFECTANT DISPOSABLE CLOTH","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Pad"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALCOHOL ANHYDROUS","Combination"],"sanitizedRouteOfAdministration":["Disinfectant (Hospital/Hc Facilities)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff45"},"numbersOfAis":"1","activeIngredientName":["PENICILLIN G SODIUM"],"dose":["10000000"],"productID":{"$numberInt":"12395"},"sanitizedRegiestrationNumber":"01930680","productName":"PENICILLIN G SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BENZYLPENICILLIN"],"atcCode":["J01CE01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENICILLIN G SODIUM"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff46"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"12272"},"sanitizedRegiestrationNumber":"01925350","productName":"TARO-SONE","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff47"},"numbersOfAis":"6","activeIngredientName":["SODIUM CHLORIDE","POTASSIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","ACETIC ACID","DEXTROSE"],"dose":["263","6.71","6.24","1.61","10.8","67.54"],"productID":{"$numberInt":"10115"},"sanitizedRegiestrationNumber":"00774944","productName":"ACID CONCENTRATE 2117","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","G","G","G","G","G"],"quantityNeedToTake":["","","","","",""],"qunatityUnit":["L","L","L","L","L","L"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff48"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETYLSALICYLIC ACID"],"dose":["5","325"],"productID":{"$numberInt":"15513"},"sanitizedRegiestrationNumber":"01916572","productName":"PERCODAN","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["OXYCODONE AND ACETYLSALICYLIC ACID","OXYCODONE AND ACETYLSALICYLIC ACID"],"atcCode":["N02AJ18","N02AJ18"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff49"},"numbersOfAis":"1","activeIngredientName":["NYLIDRIN HYDROCHLORIDE"],"dose":["6"],"productID":{"$numberInt":"11970"},"sanitizedRegiestrationNumber":"01926713","productName":"ARLIDIN TABLETS 6MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1955-12-31"],"sanitizedIndication":["BUPHENINE"],"atcCode":["C04AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NYLIDRIN HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4b"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","POVIDONE-IODINE"],"dose":["1","1"],"productID":{"$numberInt":"12598"},"sanitizedRegiestrationNumber":"01924893","productName":"PARACENTESIS TRAY W BOASBERG CATHETER SET","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Subcutaneous","Block/Infiltration","Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["KIT","KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4a"},"numbersOfAis":"1","activeIngredientName":["OXYMORPHONE HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"13902"},"sanitizedRegiestrationNumber":"01916513","productName":"NUMORPHAN SUPPOSITORY 5MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NATURAL OPIUM ALKALOIDS"],"atcCode":["N02AA"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYMORPHONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4c"},"numbersOfAis":"1","activeIngredientName":["PERICIAZINE"],"dose":["5"],"productID":{"$numberInt":"12653"},"sanitizedRegiestrationNumber":"01926780","productName":"NEULEPTIL","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["PERICIAZINE"],"atcCode":["N05AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERICIAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4d"},"numbersOfAis":"1","activeIngredientName":["TRIMEPRAZINE (TRIMEPRAZINE TARTRATE)"],"dose":["2.5"],"productID":{"$numberInt":"12419"},"sanitizedRegiestrationNumber":"01926306","productName":"PANECTYL TAB 2.5MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["ALIMEMAZINE"],"atcCode":["R06AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIMEPRAZINE (TRIMEPRAZINE TARTRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4e"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41877"},"sanitizedRegiestrationNumber":"01935429","productName":"BIG V LADIES STK ANTIPERSP SCENTED 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff4f"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE"],"dose":["0.5"],"productID":{"$numberInt":"12266"},"sanitizedRegiestrationNumber":"01923986","productName":"SOLARCAINE FIRST AID LIDOCAINE SPRAY","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["D04AB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff50"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["5"],"productID":{"$numberInt":"12453"},"sanitizedRegiestrationNumber":"01934228","productName":"TEVA-PRAZOSIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff51"},"numbersOfAis":"1","activeIngredientName":["NITROGLYCERIN"],"dose":["2"],"productID":{"$numberInt":"12220"},"sanitizedRegiestrationNumber":"01926454","productName":"NITROL","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["GLYCERYL TRINITRATE"],"atcCode":["C01DA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NITROGLYCERIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff52"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41858"},"sanitizedRegiestrationNumber":"01935372","productName":"LIFE BRAND WOMENS STK POWDER ANTIPER","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff53"},"numbersOfAis":"3","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","PSEUDOEPHEDRINE HYDROCHLORIDE","CHLORPHENIRAMINE MALEATE"],"dose":["15","30","2"],"productID":{"$numberInt":"12718"},"sanitizedRegiestrationNumber":"01938894","productName":"VICKS PEDIATRIC FORMULA 44M LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS","COMBINATIONS"],"atcCode":["R05DA20","R05DA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["15","15","15"],"qunatityUnit":["ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff54"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"11848"},"sanitizedRegiestrationNumber":"01928783","productName":"KOFFEX DM","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff55"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41837"},"sanitizedRegiestrationNumber":"01931474","productName":"OLD SPICE CLASSIC SPORT ANTI-PER STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff56"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41855"},"sanitizedRegiestrationNumber":"01935534","productName":"PERSONNELLE LADIES ANTIPER STK ALOE SCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff57"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"42142"},"sanitizedRegiestrationNumber":"01935518","productName":"PHARMASAVE STK ANTIPERSP UNSCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff58"},"numbersOfAis":"1","activeIngredientName":["NAPROXEN SODIUM"],"dose":["550"],"productID":{"$numberInt":"14048"},"sanitizedRegiestrationNumber":"01940309","productName":"APO-NAPRO-NA DS","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["NAPROXEN"],"atcCode":["M01AE02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NAPROXEN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff59"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["500"],"productID":{"$numberInt":"22143"},"sanitizedRegiestrationNumber":"01939122","productName":"JAMP ACETAMINOPHEN 500","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["2003-07-02"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5a"},"numbersOfAis":"1","activeIngredientName":["LIOTHYRONINE (LIOTHYRONINE SODIUM)"],"dose":["25"],"productID":{"$numberInt":"15908"},"sanitizedRegiestrationNumber":"01919466","productName":"CYTOMEL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["LIOTHYRONINE SODIUM"],"atcCode":["H03AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIOTHYRONINE (LIOTHYRONINE SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5b"},"numbersOfAis":"1","activeIngredientName":["CHLOROXYLENOL"],"dose":["3"],"productID":{"$numberInt":"19577"},"sanitizedRegiestrationNumber":"01941968","productName":"E 2 SANITIZING HAND SOAP LIQ 3%","licenseHolderSponser":"ZEP MANUFACTURING COMPANY OF CANADA","companyCode":[{"$numberInt":"5477"}],"facilityAddress":" 11627-178 Street Edmonton Alberta Canada T5S 1N6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CHLOROXYLENOL"],"atcCode":["D08AE05"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLOROXYLENOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5c"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN SODIUM)"],"dose":["2"],"productID":{"$numberInt":"12268"},"sanitizedRegiestrationNumber":"01933353","productName":"AMPICILLIN SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN SODIUM)"],"sanitizedRouteOfAdministration":["Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5d"},"numbersOfAis":"2","activeIngredientName":["HYPROMELLOSE","DEXTRAN 70"],"dose":["0.3","0.1"],"productID":{"$numberInt":"13167"},"sanitizedRegiestrationNumber":"01943308","productName":"TEARS NATURALE FREE","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYPROMELLOSE","Combination"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":["",""],"qunatityUnit":["W/V","W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5e"},"numbersOfAis":"1","activeIngredientName":["DIDANOSINE"],"dose":["100"],"productID":{"$numberInt":"12198"},"sanitizedRegiestrationNumber":"01940546","productName":"VIDEX CHEWABLE DISPERSIBLE TAB 100MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DIDANOSINE"],"atcCode":["J05AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIDANOSINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff5f"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"72118"},"sanitizedRegiestrationNumber":"01935712","productName":"METRO ANTIPERSPIRANT STICK SCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-01-01"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff60"},"numbersOfAis":"2","activeIngredientName":["ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE","BENZALKONIUM CHLORIDE"],"dose":["5","5"],"productID":{"$numberInt":"18782"},"sanitizedRegiestrationNumber":"01941054","productName":"ZEP-AMINE A LIQ","licenseHolderSponser":"ZEP MANUFACTURING COMPANY OF CANADA","companyCode":[{"$numberInt":"5477"}],"facilityAddress":" 11627-178 Street Edmonton Alberta Canada T5S 1N6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Disinfectant (Hospital/Hc Facilities)","Disinfectant (Medical Instruments)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff61"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":["1","2"],"productID":{"$numberInt":"42089"},"sanitizedRegiestrationNumber":"01948741","productName":"COPPERTONE SUNTAN LOT SPF-4","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff62"},"numbersOfAis":"1","activeIngredientName":["SODIUM MONOFLUOROPHOSPHATE"],"dose":[".8"],"productID":{"$numberInt":"41978"},"sanitizedRegiestrationNumber":"01942727","productName":"AQUAFRESH MINT TOOTHPASTE (TUBE) 0.8%","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Toothpaste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SODIUM MONOFLUOROPHOSPHATE"],"atcCode":["A01AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM MONOFLUOROPHOSPHATE"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff63"},"numbersOfAis":"3","activeIngredientName":["POLYMYXIN B SULFATE","LIDOCAINE HYDROCHLORIDE","BACITRACIN"],"dose":["10000","50","500"],"productID":{"$numberInt":"10157"},"sanitizedRegiestrationNumber":"00758213","productName":"POLYDERM ANTIBIOTIC OINTMENT","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["BACITRACIN, COMBINATIONS","BACITRACIN, COMBINATIONS"],"atcCode":["D06AX55","D06AX55"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POLYMYXIN B SULFATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","MG","UNIT"],"quantityNeedToTake":["","",""],"qunatityUnit":["G","G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff64"},"numbersOfAis":"1","activeIngredientName":["MIDODRINE HYDROCHLORIDE"],"dose":["5"],"productID":{"$numberInt":"12429"},"sanitizedRegiestrationNumber":"01934406","productName":"AMATINE","licenseHolderSponser":"SHIRE PHARMA CANADA ULC","companyCode":[{"$numberInt":"9504"}],"facilityAddress":" 22 Adelaide St West, Suite 3800 Toronto Ontario Canada M5H 4E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MIDODRINE"],"atcCode":["C01CA17"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MIDODRINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff65"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41945"},"sanitizedRegiestrationNumber":"01950517","productName":"NO NAME LADIES ANTIP 23% SPORT SCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff66"},"numbersOfAis":"2","activeIngredientName":["LIDOCAINE HYDROCHLORIDE","DEXTROSE"],"dose":["5","7.5"],"productID":{"$numberInt":"8400"},"sanitizedRegiestrationNumber":"00775002","productName":"XYLOCAINE - MPF 5% WITH GLUCOSE 7.5%","licenseHolderSponser":"ASTRAZENECA L.P.","companyCode":[{"$numberInt":"9394"}],"facilityAddress":"DCC-1 1800 Concord Pike Wilmington Delaware United States 19850-5437","countryOfOrigin":["United States"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["LIDOCAINE, COMBINATIONS"],"atcCode":["N01BB52"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LIDOCAINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Intraspinal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff67"},"numbersOfAis":"1","activeIngredientName":["TRICLOSAN"],"dose":[".5"],"productID":{"$numberInt":"12189"},"sanitizedRegiestrationNumber":"01933337","productName":"DVM HANDSOAP LIQ 0.5%","licenseHolderSponser":"3M CANADA COMPANY","companyCode":[{"$numberInt":"4550"}],"facilityAddress":" 300 Tartan Dr. London Ontario Canada N5V 4M9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TRICLOSAN"],"atcCode":["D08AE04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRICLOSAN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff68"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"42109"},"sanitizedRegiestrationNumber":"01942573","productName":"TINACTIN PLUS AREOSOL POWDER 1%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Aerosol"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff69"},"numbersOfAis":"1","activeIngredientName":["DIDANOSINE"],"dose":["25"],"productID":{"$numberInt":"12197"},"sanitizedRegiestrationNumber":"01940511","productName":"VIDEX CHEWABLE DISPERSIBLE TAB 25MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DIDANOSINE"],"atcCode":["J05AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIDANOSINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6a"},"numbersOfAis":"2","activeIngredientName":["OXYBENZONE","OCTINOXATE"],"dose":["4.0","7.5"],"productID":{"$numberInt":"41914"},"sanitizedRegiestrationNumber":"01931180","productName":"COPPERTONE SUNSCREEN LOTION SPF 15","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYBENZONE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["",""],"qunatityUnit":["W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6b"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41937"},"sanitizedRegiestrationNumber":"01935593","productName":"LIFE BRAND STK ULTRA ANTIPER UNSCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6c"},"numbersOfAis":"2","activeIngredientName":["CHORIONIC GONADOTROPIN","WATER"],"dose":["10000","10"],"productID":{"$numberInt":"11815"},"sanitizedRegiestrationNumber":"01925679","productName":"PROFASI HP 10000","licenseHolderSponser":"EMD SERONO A DIVISION OF EMD INC CANADA","companyCode":[{"$numberInt":"5181"}],"facilityAddress":" 2695 North Sheridan Way, Suite 200 Mississauga Ontario Canada L5K 2N6","countryOfOrigin":["Canada"],"format":["Kit","Powder For Solution","Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHORIONIC GONADOTROPHIN"],"atcCode":["G03GA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CHORIONIC GONADOTROPIN","Combination"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","ML"],"quantityNeedToTake":["",""],"qunatityUnit":["VIAL","VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6d"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["325"],"productID":{"$numberInt":"22086"},"sanitizedRegiestrationNumber":"01938088","productName":"JAMP ACETAMINOPHEN 325","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["2003-07-02"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6e"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"42143"},"sanitizedRegiestrationNumber":"01935666","productName":"PHARMASAVE STK ULTRA ANTIPER SCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff6f"},"numbersOfAis":"1","activeIngredientName":["DIDANOSINE"],"dose":["4"],"productID":{"$numberInt":"46441"},"sanitizedRegiestrationNumber":"01940635","productName":"VIDEX PEDIATRIC POWDER SOL 4G/BOTT","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1999-07-01"],"sanitizedIndication":["DIDANOSINE"],"atcCode":["J05AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIDANOSINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["BOTTLE"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff70"},"numbersOfAis":"1","activeIngredientName":["SODIUM MONOFLUOROPHOSPHATE"],"dose":[".8"],"productID":{"$numberInt":"41926"},"sanitizedRegiestrationNumber":"01926128","productName":"AQUAFRESH EXTRA BREATH FRESHENING TOOTHPASTE","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Toothpaste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SODIUM MONOFLUOROPHOSPHATE"],"atcCode":["A01AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM MONOFLUOROPHOSPHATE"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff71"},"numbersOfAis":"1","activeIngredientName":["NALOXONE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"13417"},"sanitizedRegiestrationNumber":"01913964","productName":"NARCAN INJECTION 1MG/ML","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["NALOXONE"],"atcCode":["V03AB15"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NALOXONE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff72"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41836"},"sanitizedRegiestrationNumber":"01931288","productName":"OLD SPICE FRESH ANTI-PER STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff73"},"numbersOfAis":"1","activeIngredientName":["DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"12725"},"sanitizedRegiestrationNumber":"01944290","productName":"SOMINEX TABLETS 25MG","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPHENHYDRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff74"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41857"},"sanitizedRegiestrationNumber":"01935631","productName":"LIFE BRAND WOMENS STK SCENTED ANTIPER","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff75"},"numbersOfAis":"1","activeIngredientName":["CHLORPROMAZINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"17004"},"sanitizedRegiestrationNumber":"01933272","productName":"CHLORPROMAZINE HCL INJ 25MG/ML USP","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CHLORPROMAZINE"],"atcCode":["N05AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROMAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff76"},"numbersOfAis":"1","activeIngredientName":["POTASSIUM CITRATE"],"dose":["540"],"productID":{"$numberInt":"46885"},"sanitizedRegiestrationNumber":"01914022","productName":"UROCIT K","licenseHolderSponser":"MISSION PHARMACAL COMPANY","companyCode":[{"$numberInt":"6290"}],"facilityAddress":"1000 10999 Ih 10 West San Antonio Texas United States 78230-1355","countryOfOrigin":["United States"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1995-01-01"],"sanitizedIndication":["POTASSIUM CITRATE"],"atcCode":["A12BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POTASSIUM CITRATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff77"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["12.5"],"productID":{"$numberInt":"11760"},"sanitizedRegiestrationNumber":"01942964","productName":"TEVA-CAPTOPRIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff78"},"numbersOfAis":"1","activeIngredientName":["DOXYLAMINE SUCCINATE"],"dose":["25"],"productID":{"$numberInt":"12744"},"sanitizedRegiestrationNumber":"01946994","productName":"UNISOM-2 TABLETS","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1987-12-31"],"sanitizedIndication":["DOXYLAMINE"],"atcCode":["R06AA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXYLAMINE SUCCINATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff79"},"numbersOfAis":"1","activeIngredientName":["INSULIN SULPHATED BEEF"],"dose":["100"],"productID":{"$numberInt":"14216"},"sanitizedRegiestrationNumber":"01934074","productName":"SULPHATED INSULIN INJ LIQ 100U/ML","licenseHolderSponser":"NOVO NORDISK A/S","companyCode":[{"$numberInt":"4772"}],"facilityAddress":" Novo Alle Bagsvaerd Saone Et Loire Denmark 2880","countryOfOrigin":["Denmark"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["INSULIN (BEEF)"],"atcCode":["A10AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INSULIN SULPHATED BEEF"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7a"},"numbersOfAis":"1","activeIngredientName":["LIOTHYRONINE (LIOTHYRONINE SODIUM)"],"dose":["5"],"productID":{"$numberInt":"15909"},"sanitizedRegiestrationNumber":"01919458","productName":"CYTOMEL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["LIOTHYRONINE SODIUM"],"atcCode":["H03AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIOTHYRONINE (LIOTHYRONINE SODIUM)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7b"},"numbersOfAis":"1","activeIngredientName":["MIDODRINE HYDROCHLORIDE"],"dose":["2.5"],"productID":{"$numberInt":"12428"},"sanitizedRegiestrationNumber":"01934392","productName":"AMATINE","licenseHolderSponser":"SHIRE PHARMA CANADA ULC","companyCode":[{"$numberInt":"9504"}],"facilityAddress":" 22 Adelaide St West, Suite 3800 Toronto Ontario Canada M5H 4E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MIDODRINE"],"atcCode":["C01CA17"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MIDODRINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7c"},"numbersOfAis":"2","activeIngredientName":["GENTAMICIN (GENTAMICIN SULFATE)","SODIUM CHLORIDE"],"dose":["0.8","9"],"productID":{"$numberInt":"12674"},"sanitizedRegiestrationNumber":"01913530","productName":"GENTAMICIN SULFATE IN 0.9% SODIUM CHLORIDE INJECTION","licenseHolderSponser":"HOSPIRA HEALTHCARE ULC","companyCode":[{"$numberInt":"11642"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["GENTAMICIN"],"atcCode":["J01GB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GENTAMICIN (GENTAMICIN SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7d"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["250"],"productID":{"$numberInt":"16954"},"sanitizedRegiestrationNumber":"01934163","productName":"NOVAMOXIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Granules For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7e"},"numbersOfAis":"1","activeIngredientName":["PERICIAZINE"],"dose":["10"],"productID":{"$numberInt":"12425"},"sanitizedRegiestrationNumber":"01926772","productName":"NEULEPTIL","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["PERICIAZINE"],"atcCode":["N05AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERICIAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff7f"},"numbersOfAis":"4","activeIngredientName":["HYDROCODONE BITARTRATE","PHENIRAMINE MALEATE","PYRILAMINE MALEATE","PHENYLPROPANOLAMINE HYDROCHLORIDE"],"dose":["5","12.5","12.5","25"],"productID":{"$numberInt":"13223"},"sanitizedRegiestrationNumber":"01925962","productName":"TUSSAMINIC DH FORTE SYRUP","licenseHolderSponser":"NOVARTIS CONSUMER HEALTH CANADA INC.","companyCode":[{"$numberInt":"7366"}],"facilityAddress":"500 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R05DA20"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HYDROCODONE BITARTRATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff80"},"numbersOfAis":"2","activeIngredientName":["AMILORIDE HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"dose":["5","50"],"productID":{"$numberInt":"12430"},"sanitizedRegiestrationNumber":"01937219","productName":"NOVAMILOR","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS","HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS"],"atcCode":["C03EA01","C03EA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["AMILORIDE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff81"},"numbersOfAis":"1","activeIngredientName":["HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)"],"dose":["40"],"productID":{"$numberInt":"16172"},"sanitizedRegiestrationNumber":"01934023","productName":"RECOMBIVAX HB (ADULT DIALYSIS WITH PRESERVATIVE)","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["HEPATITIS B, PURIFIED ANTIGEN"],"atcCode":["J07BC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff82"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL MALEATE"],"dose":["10"],"productID":{"$numberInt":"12880"},"sanitizedRegiestrationNumber":"01947818","productName":"TEVA-TIMOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["C07AA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff83"},"numbersOfAis":"1","activeIngredientName":["PERICIAZINE"],"dose":["20"],"productID":{"$numberInt":"14767"},"sanitizedRegiestrationNumber":"01926764","productName":"NEULEPTIL","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1976-12-31"],"sanitizedIndication":["PERICIAZINE"],"atcCode":["N05AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PERICIAZINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff84"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["5"],"productID":{"$numberInt":"13311"},"sanitizedRegiestrationNumber":"01925180","productName":"BENZAC W 5 GEL 5%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff85"},"numbersOfAis":"10","activeIngredientName":["VITAMIN B2","VITAMIN B12","VITAMIN D3","CALCIUM D-PANTOTHENATE","NEOMYCIN (NEOMYCIN SULFATE)","NICOTINIC ACID","VITAMIN A","VITAMIN B1","PYRIDOXINE HYDROCHLORIDE","STREPTOMYCIN (STREPTOMYCIN SULFATE)"],"dose":["2.07","0.88","176.7","0.88","19.92","1.47","958.3","0.88","0.075","15.5"],"productID":{"$numberInt":"22007"},"sanitizedRegiestrationNumber":"01936174","productName":"PIG STARTER","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["2004-08-02"],"pharmaceuticalStd":["BP","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["VITAMIN B2","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MCG","UNIT","MG","MG","MG","UNIT","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML","ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff86"},"numbersOfAis":"1","activeIngredientName":["SODIUM MONOFLUOROPHOSPHATE"],"dose":["0.8"],"productID":{"$numberInt":"41977"},"sanitizedRegiestrationNumber":"01942700","productName":"AQUAFRESH ORIGINAL TOOTHPASTE (TUBE)","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Toothpaste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SODIUM MONOFLUOROPHOSPHATE"],"atcCode":["A01AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM MONOFLUOROPHOSPHATE"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff87"},"numbersOfAis":"1","activeIngredientName":["ATENOLOL"],"dose":["50"],"productID":{"$numberInt":"9174"},"sanitizedRegiestrationNumber":"00773689","productName":"APO-ATENOL TAB 50MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["ATENOLOL"],"atcCode":["C07AB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ATENOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff88"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE ACETATE"],"dose":["20"],"productID":{"$numberInt":"18988"},"sanitizedRegiestrationNumber":"01934325","productName":"DEPO-MEDROL (WITH PRESERVATIVE) 20 MG/ML","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1995-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Intrasynovial","Intralesional","Intra-Articular","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff89"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41906"},"sanitizedRegiestrationNumber":"01935496","productName":"OPTION + STK WOMENS ANTIPER UNSCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8a"},"numbersOfAis":"1","activeIngredientName":["SALICYLIC ACID"],"dose":[".5"],"productID":{"$numberInt":"41942"},"sanitizedRegiestrationNumber":"01942646","productName":"COVER GIRL CLARIF BLEMISH CONC LIGHT 0.5%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SALICYLIC ACID PREPARATIONS"],"atcCode":["D02AF"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALICYLIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8b"},"numbersOfAis":"1","activeIngredientName":["SALICYLIC ACID"],"dose":[".5"],"productID":{"$numberInt":"41941"},"sanitizedRegiestrationNumber":"01942611","productName":"COVER GIRL CLARIF BLEMISH CONC FAIR 0.5%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SALICYLIC ACID PREPARATIONS"],"atcCode":["D02AF"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALICYLIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8c"},"numbersOfAis":"1","activeIngredientName":["SIMETHICONE"],"dose":["95"],"productID":{"$numberInt":"13007"},"sanitizedRegiestrationNumber":"01953761","productName":"PHAZYME CAP 95MG","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SILICONES"],"atcCode":["A03AX13"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SIMETHICONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8d"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL MALEATE"],"dose":["5"],"productID":{"$numberInt":"13021"},"sanitizedRegiestrationNumber":"01947796","productName":"TEVA-TIMOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["C07AA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8e"},"numbersOfAis":"1","activeIngredientName":["OXYBUTYNIN CHLORIDE"],"dose":["5"],"productID":{"$numberInt":"14030"},"sanitizedRegiestrationNumber":"01924761","productName":"DITROPAN TABLETS 5MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["OXYBUTYNIN"],"atcCode":["G04BD04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OXYBUTYNIN CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff8f"},"numbersOfAis":"1","activeIngredientName":["INDOMETHACIN"],"dose":["100"],"productID":{"$numberInt":"13558"},"sanitizedRegiestrationNumber":"01934139","productName":"RATIO-INDOMETHACIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["INDOMETACIN"],"atcCode":["M01AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["INDOMETHACIN"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff90"},"numbersOfAis":"1","activeIngredientName":["IODOFORM"],"dose":["5"],"productID":{"$numberInt":"12962"},"sanitizedRegiestrationNumber":"01938312","productName":"IODOFORM NUGAUZE PACKING STRIP 5%","licenseHolderSponser":"JOHNSON & JOHNSON MEDICAL PRODUCTS","companyCode":[{"$numberInt":"4413"}],"facilityAddress":" 200 Whitehall Drive Markham Ontario Canada L3R 0T5","countryOfOrigin":["Canada"],"format":["Dressing"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["IODOFORM"],"atcCode":["D09AA13"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODOFORM"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff91"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"12611"},"sanitizedRegiestrationNumber":"01944436","productName":"TARO SONE ONT","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff92"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"42191"},"sanitizedRegiestrationNumber":"01942581","productName":"TINACTIN PLUS POWDER 1%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff93"},"numbersOfAis":"1","activeIngredientName":["DIMENHYDRINATE"],"dose":["15"],"productID":{"$numberInt":"16428"},"sanitizedRegiestrationNumber":"01957414","productName":"NAUSEATOL","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Tablet (Chewable)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIMENHYDRINATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff94"},"numbersOfAis":"1","activeIngredientName":["FENTANYL"],"dose":["75"],"productID":{"$numberInt":"12658"},"sanitizedRegiestrationNumber":"01937405","productName":"DURAGESIC 75","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Patch"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FENTANYL"],"atcCode":["N02AB03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENTANYL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff95"},"numbersOfAis":"1","activeIngredientName":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"dose":["25"],"productID":{"$numberInt":"12669"},"sanitizedRegiestrationNumber":"01913425","productName":"NOVO-DOXEPIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXEPIN"],"atcCode":["N06AA12"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXEPIN (DOXEPIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff96"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"42130"},"sanitizedRegiestrationNumber":"01935550","productName":"PHARMASAVE STK ANTIPERSP SCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff97"},"numbersOfAis":"1","activeIngredientName":["FENTANYL"],"dose":["50"],"productID":{"$numberInt":"12657"},"sanitizedRegiestrationNumber":"01937391","productName":"DURAGESIC 50","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Patch"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FENTANYL"],"atcCode":["N02AB03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENTANYL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff98"},"numbersOfAis":"1","activeIngredientName":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"dose":["2"],"productID":{"$numberInt":"12452"},"sanitizedRegiestrationNumber":"01934201","productName":"TEVA-PRAZOSIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PRAZOSIN"],"atcCode":["C02CA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAZOSIN (PRAZOSIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff99"},"numbersOfAis":"2","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","PSEUDOEPHEDRINE HYDROCHLORIDE"],"dose":["15","30"],"productID":{"$numberInt":"12719"},"sanitizedRegiestrationNumber":"01938908","productName":"VICKS PEDIATRIC FORMULA 44D LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R05DA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["15","15"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9a"},"numbersOfAis":"2","activeIngredientName":["LORATADINE","PSEUDOEPHEDRINE SULFATE"],"dose":["5","120"],"productID":{"$numberInt":"11974"},"sanitizedRegiestrationNumber":"01945157","productName":"CLARITIN ALLERGY + SINUS","licenseHolderSponser":"BAYER INC","companyCode":[{"$numberInt":"10774"}],"facilityAddress":" 2920 Matheson Blvd East Mississauga Ontario Canada L4W 5R6","countryOfOrigin":["Canada"],"format":["Tablet (Immediate And Extended Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["PSEUDOEPHEDRINE, COMBINATIONS","PSEUDOEPHEDRINE, COMBINATIONS"],"atcCode":["R01BA52","R01BA52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LORATADINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Radiopharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)| Import (Radiopharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9b"},"numbersOfAis":"1","activeIngredientName":["DICLOFENAC SODIUM"],"dose":["0.1"],"productID":{"$numberInt":"11969"},"sanitizedRegiestrationNumber":"01940414","productName":"VOLTAREN OPHTHA","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DICLOFENAC"],"atcCode":["S01BC03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DICLOFENAC SODIUM"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9c"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN SODIUM)"],"dose":["1"],"productID":{"$numberInt":"12267"},"sanitizedRegiestrationNumber":"01933345","productName":"AMPICILLIN SODIUM FOR INJECTION, USP","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN SODIUM)"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9d"},"numbersOfAis":"3","activeIngredientName":["MENTHOL","COAL TAR","CHLOROXYLENOL"],"dose":["1.5","7.5","0.5"],"productID":{"$numberInt":"42042"},"sanitizedRegiestrationNumber":"01942379","productName":"DENOREX MEDICATED SHAMPOO WITH CONDITIONERS","licenseHolderSponser":"NEOTERIC COSMETICS INC.","companyCode":[{"$numberInt":"8173"}],"facilityAddress":" 4880 Havana St, Suite 400 Denver Colorado United States 80239-0019","countryOfOrigin":["United States"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1976-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MENTHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["","",""],"qunatityUnit":["W/W","W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9e"},"numbersOfAis":"2","activeIngredientName":["POLYMYXIN B (POLYMYXIN B SULFATE)","BACITRACIN"],"dose":["10000","500"],"productID":{"$numberInt":"42145"},"sanitizedRegiestrationNumber":"01942921","productName":"POLYTOPIC","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BACITRACIN"],"atcCode":["D06AX05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["POLYMYXIN B (POLYMYXIN B SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT","UNIT"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cff9f"},"numbersOfAis":"4","activeIngredientName":["HOMOSALATE","OCTISALATE","OXYBENZONE","OCTINOXATE"],"dose":["5","5","4","7.5"],"productID":{"$numberInt":"41934"},"sanitizedRegiestrationNumber":"01931164","productName":"COPPERTONE SUNBLOCK LOTION SPF30","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1989-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["HOMOSALATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%","%"],"quantityNeedToTake":["","","",""],"qunatityUnit":["","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa0"},"numbersOfAis":"1","activeIngredientName":["FENTANYL"],"dose":["100"],"productID":{"$numberInt":"12659"},"sanitizedRegiestrationNumber":"01937413","productName":"DURAGESIC 100","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Patch"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FENTANYL"],"atcCode":["N02AB03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENTANYL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa1"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["30"],"productID":{"$numberInt":"12723"},"sanitizedRegiestrationNumber":"01938959","productName":"VICKS CUSTOM CARE DRY COUGH","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["15"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa2"},"numbersOfAis":"2","activeIngredientName":["BENZALKONIUM CHLORIDE","BENZOCAINE"],"dose":["1","180"],"productID":{"$numberInt":"13766"},"sanitizedRegiestrationNumber":"01945726","productName":"TOPICALE GEL PUMP PINA COLADA","licenseHolderSponser":"MEDICAL PRODUCTS LABORATORIES INC.","companyCode":[{"$numberInt":"4642"}],"facilityAddress":" 9990 Global Road Philadelphia Pennsylvania United States 19115","countryOfOrigin":["United States"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["A01AD11"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZALKONIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["G","G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa3"},"numbersOfAis":"1","activeIngredientName":["TRIMEPRAZINE (TRIMEPRAZINE TARTRATE)"],"dose":["5"],"productID":{"$numberInt":"12651"},"sanitizedRegiestrationNumber":"01926292","productName":"PANECTYL TAB 5MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1959-12-31"],"sanitizedIndication":["ALIMEMAZINE"],"atcCode":["R06AD01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIMEPRAZINE (TRIMEPRAZINE TARTRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa4"},"numbersOfAis":"1","activeIngredientName":["GLUTARAL"],"dose":["2"],"productID":{"$numberInt":"11834"},"sanitizedRegiestrationNumber":"01936956","productName":"GLUTACIDE","licenseHolderSponser":"PHARMAX LIMITED","companyCode":[{"$numberInt":"4920"}],"facilityAddress":"509 80 Front St East Toronto Ontario Canada M5E 1T4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1978-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLUTARAL"],"sanitizedRouteOfAdministration":["Disinfectant (Medical Instruments)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa5"},"numbersOfAis":"2","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","GUAIFENESIN"],"dose":["10","100"],"productID":{"$numberInt":"12717"},"sanitizedRegiestrationNumber":"01938886","productName":"VICKS PEDIATRIC FORMULA 44E LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS","OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02","R05FA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["15","15"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa6"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41880"},"sanitizedRegiestrationNumber":"01942603","productName":"SECRET FRESH ADVANT ANTIP SOLID STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa7"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41838"},"sanitizedRegiestrationNumber":"01931261","productName":"OLD SPICE MUSK ANTI-PER STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa8"},"numbersOfAis":"2","activeIngredientName":["OXYCODONE HYDROCHLORIDE","ACETAMINOPHEN"],"dose":["5","325"],"productID":{"$numberInt":"15514"},"sanitizedRegiestrationNumber":"01916475","productName":"PERCOCET","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1977-12-31"],"sanitizedIndication":["OXYCODONE AND PARACETAMOL","OXYCODONE AND PARACETAMOL"],"atcCode":["N02AJ17","N02AJ17"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OXYCODONE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffa9"},"numbersOfAis":"1","activeIngredientName":["VERAPAMIL HYDROCHLORIDE"],"dose":["180"],"productID":{"$numberInt":"15585"},"sanitizedRegiestrationNumber":"01934317","productName":"ISOPTIN SR","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-04-21"],"sanitizedIndication":["VERAPAMIL"],"atcCode":["C08DA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VERAPAMIL HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffaa"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"13005"},"sanitizedRegiestrationNumber":"01944444","productName":"TARO SONE LOT 0.05%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffab"},"numbersOfAis":"1","activeIngredientName":["AMANTADINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"13581"},"sanitizedRegiestrationNumber":"01914006","productName":"SYMMETREL CAPSULES 100MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["AMANTADINE","AMANTADINE"],"atcCode":["N04BB01","N04BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMANTADINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffac"},"numbersOfAis":"1","activeIngredientName":["PENTOBARBITAL SODIUM"],"dose":["100"],"productID":{"$numberInt":"114"},"sanitizedRegiestrationNumber":"00000086","productName":"NEMBUTAL SODIUM CAP 100MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PENTOBARBITAL"],"atcCode":["N05CA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PENTOBARBITAL SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffad"},"numbersOfAis":"1","activeIngredientName":["PAPAIN"],"dose":["30"],"productID":{"$numberInt":"18573"},"sanitizedRegiestrationNumber":"01938711","productName":"PAPAYA ENZYME TAB 30MG","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"sanitizedIndication":["ENZYME PREPARATIONS"],"atcCode":["A09AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PAPAIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffae"},"numbersOfAis":"1","activeIngredientName":["TERCONAZOLE"],"dose":["0.8"],"productID":{"$numberInt":"12684"},"sanitizedRegiestrationNumber":"01934155","productName":"TERAZOL 3 VAGINAL CREAM 0.8%","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TERCONAZOLE"],"atcCode":["G01AG02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TERCONAZOLE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffaf"},"numbersOfAis":"1","activeIngredientName":["BETHANECHOL CHLORIDE"],"dose":["10"],"productID":{"$numberInt":"12746"},"sanitizedRegiestrationNumber":"01947958","productName":"DUVOID TABLETS 10 MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETHANECHOL"],"atcCode":["N07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETHANECHOL CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb0"},"numbersOfAis":"1","activeIngredientName":["BENZOYL PEROXIDE"],"dose":["10"],"productID":{"$numberInt":"13130"},"sanitizedRegiestrationNumber":"01925997","productName":"BENZAC W10 GEL 10% USP","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1980-12-31"],"sanitizedIndication":["BENZOYL PEROXIDE"],"atcCode":["D10AE01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOYL PEROXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb1"},"numbersOfAis":"3","activeIngredientName":["METHOCARBAMOL","ACETYLSALICYLIC ACID","CODEINE PHOSPHATE"],"dose":["400","325","8"],"productID":{"$numberInt":"22274"},"sanitizedRegiestrationNumber":"01941895","productName":"METHOXISAL-C 1/8","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1998-05-19"],"sanitizedIndication":["CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS","CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["N02AA59","N02AA59"],"pharmaceuticalStd":["MFR","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["METHOCARBAMOL","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb2"},"numbersOfAis":"1","activeIngredientName":["COAL TAR"],"dose":["2"],"productID":{"$numberInt":"13129"},"sanitizedRegiestrationNumber":"01921983","productName":"IONIL T PLUS SHAMPOO 2%","licenseHolderSponser":"GALDERMA CANADA INC","companyCode":[{"$numberInt":"4225"}],"facilityAddress":" 55 Commerce Valley Drive West 4th Floor Thornhill Ontario Canada L3T 7V9","countryOfOrigin":["Canada"],"format":["Liquid","Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COAL TAR"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb3"},"numbersOfAis":"1","activeIngredientName":["CALCIUM GLUCONATE"],"dose":["10"],"productID":{"$numberInt":"12619"},"sanitizedRegiestrationNumber":"01949144","productName":"EXCHANGE TRANSFUSION TRAY 10%","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CALCIUM GLUCONATE"],"atcCode":["A12AA03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CALCIUM GLUCONATE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb4"},"numbersOfAis":"1","activeIngredientName":["XYLOMETAZOLINE HYDROCHLORIDE"],"dose":[".1"],"productID":{"$numberInt":"15478"},"sanitizedRegiestrationNumber":"01939998","productName":"DECONGESTANT NASAL SPRAY 0.1%","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Spray"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["XYLOMETAZOLINE"],"atcCode":["R01AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["XYLOMETAZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Nasal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb5"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["4"],"productID":{"$numberInt":"19810"},"sanitizedRegiestrationNumber":"01925202","productName":"SOLUPREP ANTISEPTIC SKIN CLEANSER SPONGE","licenseHolderSponser":"3M CANADA COMPANY","companyCode":[{"$numberInt":"4550"}],"facilityAddress":" 300 Tartan Dr. London Ontario Canada N5V 4M9","countryOfOrigin":["Canada"],"format":["Sponge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1996-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical (Hospital/Hc Facilities)"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb6"},"numbersOfAis":"1","activeIngredientName":["DIDANOSINE"],"dose":["50"],"productID":{"$numberInt":"12242"},"sanitizedRegiestrationNumber":"01940538","productName":"VIDEX CHEWABLE DISPERSIBLE TAB 50MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DIDANOSINE"],"atcCode":["J05AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIDANOSINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb7"},"numbersOfAis":"1","activeIngredientName":["IODINE (POVIDONE-IODINE)"],"dose":["1"],"productID":{"$numberInt":"12615"},"sanitizedRegiestrationNumber":"01945777","productName":"BASIC FOLEY CATH KIT IODOPHOR PVP PAD 1%","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (POVIDONE-IODINE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb8"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41944"},"sanitizedRegiestrationNumber":"01935607","productName":"BIG V LADIES STK A/P 23% PWR SCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffb9"},"numbersOfAis":"4","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE","PSEUDOEPHEDRINE HYDROCHLORIDE","CHLORPHENIRAMINE MALEATE","ACETAMINOPHEN"],"dose":["30","60","4","650"],"productID":{"$numberInt":"12722"},"sanitizedRegiestrationNumber":"01938940","productName":"VICKS FORMULA 44M LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS"],"atcCode":["N02BE51"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG"],"quantityNeedToTake":["20","20","20","20"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffba"},"numbersOfAis":"1","activeIngredientName":["ZIDOVUDINE"],"dose":["100"],"productID":{"$numberInt":"12839"},"sanitizedRegiestrationNumber":"01946323","productName":"APO-ZIDOVUDINE","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ZIDOVUDINE"],"atcCode":["J05AF01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZIDOVUDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffbb"},"numbersOfAis":"1","activeIngredientName":["BENZALKONIUM CHLORIDE"],"dose":[".13"],"productID":{"$numberInt":"12616"},"sanitizedRegiestrationNumber":"01945785","productName":"IRRIGATION TRAY W BENZALKONIUM PAD 1:750","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BENZALKONIUM"],"atcCode":["D08AJ01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZALKONIUM CHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffbc"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"12720"},"sanitizedRegiestrationNumber":"01938916","productName":"VICKS PEDIATRIC FORMULA 44 LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["15"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffbd"},"numbersOfAis":"1","activeIngredientName":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"dose":["0.05"],"productID":{"$numberInt":"13690"},"sanitizedRegiestrationNumber":"01927914","productName":"TEVA-TOPILENE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Lotion"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["BETAMETHASONE"],"atcCode":["D07AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETAMETHASONE (BETAMETHASONE DIPROPIONATE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffbe"},"numbersOfAis":"1","activeIngredientName":["PILOCARPINE HYDROCHLORIDE"],"dose":["0.5"],"productID":{"$numberInt":"256"},"sanitizedRegiestrationNumber":"00000833","productName":"ISOPTO CARPINE 0.5%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PILOCARPINE"],"atcCode":["S01EB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PILOCARPINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffbf"},"numbersOfAis":"2","activeIngredientName":["PSEUDOEPHEDRINE HYDROCHLORIDE","DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["60","30"],"productID":{"$numberInt":"12721"},"sanitizedRegiestrationNumber":"01938932","productName":"VICKS FORMULA 44D LIQ","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS"],"atcCode":["R05DA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["PSEUDOEPHEDRINE HYDROCHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["15","15"],"qunatityUnit":["ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc0"},"numbersOfAis":"1","activeIngredientName":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"dose":["125"],"productID":{"$numberInt":"16955"},"sanitizedRegiestrationNumber":"01934171","productName":"NOVAMOXIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Granules For Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["AMOXICILLIN"],"atcCode":["J01CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMOXICILLIN (AMOXICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc1"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41958"},"sanitizedRegiestrationNumber":"01935690","productName":"SAFEWAY LADIES STK ANTIPER ALOE SCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc2"},"numbersOfAis":"1","activeIngredientName":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"dose":["20"],"productID":{"$numberInt":"12333"},"sanitizedRegiestrationNumber":"01947680","productName":"ACCUPRIL TAB 20MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["QUINAPRIL"],"atcCode":["C09AA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc3"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"42129"},"sanitizedRegiestrationNumber":"01935410","productName":"PHARMASAVE STK ANTIPER FRESH PWR 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc4"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"dose":["22.7"],"productID":{"$numberInt":"41835"},"sanitizedRegiestrationNumber":"01931296","productName":"OLD SPICE ORIGINAL ANTIPER STK 22.7%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLYCINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc5"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE ACETATE"],"dose":["80"],"productID":{"$numberInt":"16276"},"sanitizedRegiestrationNumber":"01934341","productName":"DEPO-MEDROL (WITH PRESERVATIVE) 80 MG/ML","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Intrasynovial","Intramuscular","Intra-Articular","Intralesional"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc6"},"numbersOfAis":"1","activeIngredientName":["PINDOLOL"],"dose":["5"],"productID":{"$numberInt":"9167"},"sanitizedRegiestrationNumber":"00755877","productName":"APO-PINDOL TAB 5MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1988-12-31"],"sanitizedIndication":["PINDOLOL"],"atcCode":["C07AA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINDOLOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc7"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41936"},"sanitizedRegiestrationNumber":"01935445","productName":"OPTION + WOMENS STK ANTIPER ALOE SCENT 23%","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc8"},"numbersOfAis":"3","activeIngredientName":["ACETYLSALICYLIC ACID","CODEINE PHOSPHATE","METHOCARBAMOL"],"dose":["325","16.2","400"],"productID":{"$numberInt":"23354"},"sanitizedRegiestrationNumber":"01966367","productName":"METHOXISAL-C 1/4","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1998-05-19"],"sanitizedIndication":["CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS","CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["N02AA59","N02AA59"],"pharmaceuticalStd":["MFR","USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ACETYLSALICYLIC ACID","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffc9"},"numbersOfAis":"1","activeIngredientName":["ACETAMINOPHEN"],"dose":["80"],"productID":{"$numberInt":"21989"},"sanitizedRegiestrationNumber":"01935275","productName":"ACETAMINOPHEN PEDIATRIC DROPS 80 MG/ML USP","licenseHolderSponser":"JAMP PHARMA CORPORATION","companyCode":[{"$numberInt":"4415"}],"facilityAddress":" 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["2006-01-31"],"sanitizedIndication":["ACETAMINOPHEN (PARACETAMOL)"],"atcCode":["N02BE01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACETAMINOPHEN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffca"},"numbersOfAis":"1","activeIngredientName":["HYDROGEN PEROXIDE"],"dose":["3"],"productID":{"$numberInt":"41925"},"sanitizedRegiestrationNumber":"01947389","productName":"AOSEPT SOLUTION 3%","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS."],"atcCode":["S01XA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROGEN PEROXIDE"],"sanitizedRouteOfAdministration":["Disinfectant (Contact Lens)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffcb"},"numbersOfAis":"1","activeIngredientName":["FUSIDATE SODIUM"],"dose":["250"],"productID":{"$numberInt":"11975"},"sanitizedRegiestrationNumber":"01934252","productName":"FUCIDIN FILM COATED TAB 250MG","licenseHolderSponser":"LEO PHARMA INC","companyCode":[{"$numberInt":"4489"}],"facilityAddress":" 123 Commerce Valley Drive East, Suite 400 Thornhill Ontario Canada L3T 7W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["FUSIDIC ACID"],"atcCode":["J01XC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FUSIDATE SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffcc"},"numbersOfAis":"1","activeIngredientName":["COAL TAR"],"dose":["1.4"],"productID":{"$numberInt":"41972"},"sanitizedRegiestrationNumber":"01918974","productName":"TEGRIN MEDICATED SHAMPOO - HERBAL","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COAL TAR"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffcd"},"numbersOfAis":"1","activeIngredientName":["ACENOCOUMAROL"],"dose":["4"],"productID":{"$numberInt":"1084"},"sanitizedRegiestrationNumber":"00010391","productName":"SINTROM","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1957-12-31"],"sanitizedIndication":["ACENOCOUMAROL"],"atcCode":["B01AA07"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ACENOCOUMAROL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffce"},"numbersOfAis":"1","activeIngredientName":["ISOPROPYL ALCOHOL"],"dose":["99"],"productID":{"$numberInt":"22567"},"sanitizedRegiestrationNumber":"01950169","productName":"ISOPROPYL ALCOHOL USP","licenseHolderSponser":"BIO AGRI MIX LP","companyCode":[{"$numberInt":"3744"}],"facilityAddress":" 11 Ellens Street Mitchell Ontario Canada N0K 1N0","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Approved"],"registrationDate":[null],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ISOPROPYL ALCOHOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["V/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffcf"},"numbersOfAis":"1","activeIngredientName":["CHLORTHALIDONE"],"dose":["50"],"productID":{"$numberInt":"1119"},"sanitizedRegiestrationNumber":"00010413","productName":"HYGROTON 50MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1968-12-31"],"sanitizedIndication":["CHLORTALIDONE"],"atcCode":["C03BA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORTHALIDONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd0"},"numbersOfAis":"1","activeIngredientName":["MENTHOL"],"dose":[".3"],"productID":{"$numberInt":"41985"},"sanitizedRegiestrationNumber":"01955330","productName":"VICKS BLUE THROAT DROPS 0.3%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Lozenge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["R02AA20"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MENTHOL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":["1"],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd1"},"numbersOfAis":"1","activeIngredientName":["CLODRONATE DISODIUM"],"dose":["400"],"productID":{"$numberInt":"16681"},"sanitizedRegiestrationNumber":"01927078","productName":"OSTAC CAP 400MG","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["CLODRONIC ACID"],"atcCode":["M05BA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLODRONATE DISODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd2"},"numbersOfAis":"1","activeIngredientName":["FAMOTIDINE"],"dose":["20"],"productID":{"$numberInt":"13572"},"sanitizedRegiestrationNumber":"01953842","productName":"APO-FAMOTIDINE TAB 20MG USP","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1993-12-31"],"sanitizedIndication":["FAMOTIDINE"],"atcCode":["A02BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FAMOTIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd4"},"numbersOfAis":"1","activeIngredientName":["DIDANOSINE"],"dose":["150"],"productID":{"$numberInt":"12199"},"sanitizedRegiestrationNumber":"01940554","productName":"VIDEX CHEWABLE DISPERSIBLE TAB 150MG","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DIDANOSINE"],"atcCode":["J05AF02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIDANOSINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd3"},"numbersOfAis":"1","activeIngredientName":["PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE)"],"dose":["10"],"productID":{"$numberInt":"12889"},"sanitizedRegiestrationNumber":"01953583","productName":"PHENYLEPHRINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PHENYLEPHRINE"],"atcCode":["C01CA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Subcutaneous","Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd5"},"numbersOfAis":"1","activeIngredientName":["BETHANECHOL CHLORIDE"],"dose":["25"],"productID":{"$numberInt":"12745"},"sanitizedRegiestrationNumber":"01947931","productName":"DUVOID TABLETS 25 MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETHANECHOL"],"atcCode":["N07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETHANECHOL CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd6"},"numbersOfAis":"1","activeIngredientName":["CHLORHEXIDINE GLUCONATE"],"dose":["4"],"productID":{"$numberInt":"13003"},"sanitizedRegiestrationNumber":"01939947","productName":"E-Z SCRUB 747 4%","licenseHolderSponser":"BECTON DICKINSON","companyCode":[{"$numberInt":"3812"}],"facilityAddress":" 1 Becton Drive Franklin Lakes New Jersey United States 07417","countryOfOrigin":["United States"],"format":["Sponge"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CHLORHEXIDINE"],"atcCode":["D08AC02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORHEXIDINE GLUCONATE"],"sanitizedRouteOfAdministration":["Topical (Hospital/Hc Facilities)"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd7"},"numbersOfAis":"2","activeIngredientName":["TESTOSTERONE PROPIONATE","ESTRADIOL BENZOATE"],"dose":["200","20"],"productID":{"$numberInt":"12840"},"sanitizedRegiestrationNumber":"01968327","productName":"COMPONENT E-H IMPLANTS","licenseHolderSponser":"ELANCO CANADA LIMITED","companyCode":[{"$numberInt":"16571"}],"facilityAddress":"120 150 Research Lane Guelph Ontario Canada N1G 4T2","countryOfOrigin":["Canada"],"format":["Implant"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Dormant"],"registrationDate":["1997-04-02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["TESTOSTERONE PROPIONATE","Combination"],"sanitizedRouteOfAdministration":["Subcutaneous"],"className":"Veterinary","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd8"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"12409"},"sanitizedRegiestrationNumber":"01944509","productName":"FOLEY CATHETERIZATION TRAY 10%KIT","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffd9"},"numbersOfAis":"2","activeIngredientName":["OCTINOXATE","ENSULIZOLE"],"dose":["7.5","1"],"productID":{"$numberInt":"41965"},"sanitizedRegiestrationNumber":"01947400","productName":"OIL OF OLAY DAILY UV PROTECTANT MOIST CRM","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION"],"atcCode":["D02BA30"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["OCTINOXATE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["%","%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffda"},"numbersOfAis":"1","activeIngredientName":["FENTANYL"],"dose":["25"],"productID":{"$numberInt":"12656"},"sanitizedRegiestrationNumber":"01937383","productName":"DURAGESIC 25","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Patch"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FENTANYL"],"atcCode":["N02AB03"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FENTANYL"],"sanitizedRouteOfAdministration":["Transdermal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":[""],"qunatityUnit":["HOUR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffdb"},"numbersOfAis":"1","activeIngredientName":["IODINE (POVIDONE-IODINE)"],"dose":["1"],"productID":{"$numberInt":"12614"},"sanitizedRegiestrationNumber":"01945769","productName":"IRRIGATION TRAY W PVP-I PREP PAD 1%","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (POVIDONE-IODINE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffdc"},"numbersOfAis":"1","activeIngredientName":["METHYSERGIDE MALEATE"],"dose":["2"],"productID":{"$numberInt":"422"},"sanitizedRegiestrationNumber":"00027499","productName":"SANSERT","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1962-12-31"],"sanitizedIndication":["METHYSERGIDE"],"atcCode":["N02CA04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYSERGIDE MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffdd"},"numbersOfAis":"1","activeIngredientName":["BISACODYL"],"dose":["5"],"productID":{"$numberInt":"1554"},"sanitizedRegiestrationNumber":"00003867","productName":"DULCOLAX","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["BISACODYL"],"atcCode":["A06AB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BISACODYL"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffde"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["1"],"productID":{"$numberInt":"12728"},"sanitizedRegiestrationNumber":"01949055","productName":"MORPHINE-EPD","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Epidural"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffdf"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["20"],"productID":{"$numberInt":"17002"},"sanitizedRegiestrationNumber":"01947060","productName":"LIDOCAINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"MYLAN PHARMACEUTICALS ULC","companyCode":[{"$numberInt":"13930"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1994-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["N01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Block/Infiltration"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Vaccine)| Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Test (Biological)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe0"},"numbersOfAis":"1","activeIngredientName":["METHYLPREDNISOLONE ACETATE"],"dose":["40"],"productID":{"$numberInt":"16275"},"sanitizedRegiestrationNumber":"01934333","productName":"DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1994-12-31"],"sanitizedIndication":["METHYLPREDNISOLONE"],"atcCode":["H02AB04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPREDNISOLONE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intrasynovial","Intralesional","Intra-Articular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe1"},"numbersOfAis":"2","activeIngredientName":["ALUMINUM HYDROXIDE","MAGNESIUM HYDROXIDE"],"dose":["400","400"],"productID":{"$numberInt":"13389"},"sanitizedRegiestrationNumber":"01945831","productName":"GELUSIL EXTRA STRENGTH TABLETS","licenseHolderSponser":"WELLSPRING PHARMACEUTICAL CANADA CORP","companyCode":[{"$numberInt":"10170"}],"facilityAddress":" 4 Innovation Drive Dundas Ontario Canada L9H 7P3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ORDINARY SALT COMBINATIONS"],"atcCode":["A02AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["ALUMINUM HYDROXIDE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe2"},"numbersOfAis":"1","activeIngredientName":["TETRAHYDROZOLINE HYDROCHLORIDE"],"dose":["0.05"],"productID":{"$numberInt":"42015"},"sanitizedRegiestrationNumber":"01942425","productName":"VISINE ORIGINAL","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Drops"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1960-12-31"],"sanitizedIndication":["TETRYZOLINE"],"atcCode":["S01GA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TETRAHYDROZOLINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe3"},"numbersOfAis":"1","activeIngredientName":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"dose":["4"],"productID":{"$numberInt":"12457"},"sanitizedRegiestrationNumber":"01958119","productName":"CARDURA-4 TAB 4MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXAZOSIN"],"atcCode":["C02CA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe4"},"numbersOfAis":"1","activeIngredientName":["SODIUM DICHLOROISOCYANURATE"],"dose":["5"],"productID":{"$numberInt":"12399"},"sanitizedRegiestrationNumber":"01946404","productName":"PRESEPT DISINFECTANT TABLETS 5G","licenseHolderSponser":"JOHNSON & JOHNSON MEDICAL PRODUCTS","companyCode":[{"$numberInt":"4413"}],"facilityAddress":" 200 Whitehall Drive Markham Ontario Canada L3R 0T5","countryOfOrigin":["Canada"],"format":["Tablet (Effervescent)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SODIUM DICHLOROISOCYANURATE"],"sanitizedRouteOfAdministration":["Disinfectant (Hospital/Hc Facilities)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe5"},"numbersOfAis":"1","activeIngredientName":["PRAMOXINE HYDROCHLORIDE"],"dose":["1"],"productID":{"$numberInt":"12781"},"sanitizedRegiestrationNumber":"01963104","productName":"TRONOTHANE PRAMOXINE HCL CRM 1% USP","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PRAMOCAINE"],"atcCode":["C05AD07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PRAMOXINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Topical","Rectal","Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe6"},"numbersOfAis":"1","activeIngredientName":["SUFENTANIL (SUFENTANIL CITRATE)"],"dose":["50"],"productID":{"$numberInt":"16449"},"sanitizedRegiestrationNumber":"01951319","productName":"SUFENTA INJ 50MCG/ML","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1985-12-31"],"sanitizedIndication":["SUFENTANIL"],"atcCode":["N01AH03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SUFENTANIL (SUFENTANIL CITRATE)"],"sanitizedRouteOfAdministration":["Epidural","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe7"},"numbersOfAis":"1","activeIngredientName":["CLIOQUINOL"],"dose":["3"],"productID":{"$numberInt":"807"},"sanitizedRegiestrationNumber":"00005142","productName":"VIOFORM 3%","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["CLIOQUINOL"],"atcCode":["D08AH30"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CLIOQUINOL"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe8"},"numbersOfAis":"4","activeIngredientName":["GUAIFENESIN","CODEINE PHOSPHATE","ALCOHOL ANHYDROUS","AMMONIUM CHLORIDE"],"dose":["100","10","3","91"],"productID":{"$numberInt":"12623"},"sanitizedRegiestrationNumber":"01951564","productName":"CHERACOL COUGH SYRUP","licenseHolderSponser":"SHIRE PHARMA CANADA ULC","companyCode":[{"$numberInt":"9504"}],"facilityAddress":" 22 Adelaide St West, Suite 3800 Toronto Ontario Canada M5H 4E3","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OPIUM DERIVATIVES AND EXPECTORANTS","OPIUM DERIVATIVES AND EXPECTORANTS"],"atcCode":["R05FA02","R05FA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["GUAIFENESIN","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","%","MG"],"quantityNeedToTake":["5","5","5","5"],"qunatityUnit":["ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffe9"},"numbersOfAis":"2","activeIngredientName":["IMMUNOGLOBULIN (HUMAN)","WATER"],"dose":["5","100"],"productID":{"$numberInt":"12685"},"sanitizedRegiestrationNumber":"01959301","productName":"IVEEGAM IMMUNO 5000MG  (IV)","licenseHolderSponser":"BAXTER AG","companyCode":[{"$numberInt":"9327"}],"facilityAddress":" Industriestrasse 67 Vienna Saone Et Loire Austria 1220","countryOfOrigin":["Austria"],"format":["Kit","Powder For Solution","Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM."],"atcCode":["J06BA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["IMMUNOGLOBULIN (HUMAN)","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","ML"],"quantityNeedToTake":["",""],"qunatityUnit":["VIAL","VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Label (Biological)| Package (Biological)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffea"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE ACETATE"],"dose":["10"],"productID":{"$numberInt":"5575"},"sanitizedRegiestrationNumber":"B00579335","productName":"CORTIFOAM","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":[" Foam"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["A07EA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE ACETATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffeb"},"numbersOfAis":"1","activeIngredientName":["TROPICAMIDE"],"dose":["1"],"productID":{"$numberInt":"780"},"sanitizedRegiestrationNumber":"00001007","productName":"MYDRIACYL","licenseHolderSponser":"ALCON CANADA INC","companyCode":[{"$numberInt":"3594"}],"facilityAddress":" 2665 Meadowpine Blvd Mississauga Ontario Canada L5N 8C7","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1969-12-31"],"sanitizedIndication":["TROPICAMIDE"],"atcCode":["S01FA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TROPICAMIDE"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffec"},"numbersOfAis":"1","activeIngredientName":["TRIAMCINOLONE ACETONIDE"],"dose":[".1"],"productID":{"$numberInt":"13360"},"sanitizedRegiestrationNumber":"01964054","productName":"ORACORT DENTAL PASTE 0.1%","licenseHolderSponser":"TARO PHARMACEUTICALS INC","companyCode":[{"$numberInt":"5241"}],"facilityAddress":" 130 East Drive Brampton Ontario Canada L6T 1C1","countryOfOrigin":["Canada"],"format":["Paste"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TRIAMCINOLONE"],"atcCode":["A01AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TRIAMCINOLONE ACETONIDE"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffed"},"numbersOfAis":"5","activeIngredientName":["SODIUM LACTATE","CALCIUM CHLORIDE","DEXTROSE","SODIUM CHLORIDE","MAGNESIUM CHLORIDE"],"dose":["4.48",".184","25","5.38",".051"],"productID":{"$numberInt":"15612"},"sanitizedRegiestrationNumber":"01965018","productName":"INPERSOL LC WITH DEXTROSE 2.5% LIQ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM LACTATE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffee"},"numbersOfAis":"1","activeIngredientName":["LEUPROLIDE ACETATE"],"dose":["7.5"],"productID":{"$numberInt":"10318"},"sanitizedRegiestrationNumber":"B00836273","productName":"LUPRON DEPOT","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":[" Sustained-Release"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["LEUPRORELIN"],"atcCode":["L02AE02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEUPROLIDE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SYR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffef"},"numbersOfAis":"1","activeIngredientName":["TIMOLOL MALEATE"],"dose":["20"],"productID":{"$numberInt":"12879"},"sanitizedRegiestrationNumber":"01947826","productName":"TEVA-TIMOLOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TIMOLOL"],"atcCode":["C07AA06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TIMOLOL MALEATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff0"},"numbersOfAis":"1","activeIngredientName":["OFLOXACIN"],"dose":["300"],"productID":{"$numberInt":"14527"},"sanitizedRegiestrationNumber":"01968416","productName":"FLOXIN TABLETS 300MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["OFLOXACIN"],"atcCode":["J01MA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OFLOXACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff1"},"numbersOfAis":"1","activeIngredientName":["DIAZEPAM"],"dose":["5"],"productID":{"$numberInt":"3178"},"sanitizedRegiestrationNumber":"00013285","productName":"VALIUM 5 TAB","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Marketed"],"registrationDate":["1978-12-31"],"sanitizedIndication":["DIAZEPAM"],"atcCode":["N05BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIAZEPAM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff2"},"numbersOfAis":"1","activeIngredientName":["MELPHALAN"],"dose":["2"],"productID":{"$numberInt":"1195"},"sanitizedRegiestrationNumber":"00004715","productName":"ALKERAN","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1964-12-31"],"sanitizedIndication":["MELPHALAN"],"atcCode":["L01AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MELPHALAN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff3"},"numbersOfAis":"1","activeIngredientName":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"dose":["40"],"productID":{"$numberInt":"12334"},"sanitizedRegiestrationNumber":"01947699","productName":"ACCUPRIL TAB 40MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["QUINAPRIL"],"atcCode":["C09AA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff4"},"numbersOfAis":"1","activeIngredientName":["SALICYLIC ACID"],"dose":[".5"],"productID":{"$numberInt":"41943"},"sanitizedRegiestrationNumber":"01942654","productName":"COVER GIRL CLARIF BLEMISH CONC MED 0.5%","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["SALICYLIC ACID PREPARATIONS"],"atcCode":["D02AF"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SALICYLIC ACID"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff5"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE"],"dose":["5"],"productID":{"$numberInt":"211"},"sanitizedRegiestrationNumber":"00001961","productName":"XYLOCAINE OINTMENT 5%","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["D04AB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff6"},"numbersOfAis":"1","activeIngredientName":["SULFINPYRAZONE"],"dose":["200"],"productID":{"$numberInt":"1120"},"sanitizedRegiestrationNumber":"00010529","productName":"ANTURAN 200MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["SULFINPYRAZONE"],"atcCode":["M04AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SULFINPYRAZONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff7"},"numbersOfAis":"1","activeIngredientName":["GUAIFENESIN"],"dose":["100"],"productID":{"$numberInt":"12620"},"sanitizedRegiestrationNumber":"01952129","productName":"EXPECTORANT SYRUP (SUCROSE FREE)","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["GUAIFENESIN"],"atcCode":["R05CA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GUAIFENESIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff8"},"numbersOfAis":"1","activeIngredientName":["CHOLESTYRAMINE RESIN"],"dose":["1"],"productID":{"$numberInt":"14057"},"sanitizedRegiestrationNumber":"01966014","productName":"QUESTRAN TAB 1GM","licenseHolderSponser":"BRISTOL-MYERS SQUIBB CANADA","companyCode":[{"$numberInt":"3798"}],"facilityAddress":" 2344 Boul. Alfred-Nobel, Suite 300 Montréal (St-Laurent) Quebec Canada H4S 0A4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["COLESTYRAMINE"],"atcCode":["C10AC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHOLESTYRAMINE RESIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfff9"},"numbersOfAis":"1","activeIngredientName":["QUININE SULFATE"],"dose":["200"],"productID":{"$numberInt":"651"},"sanitizedRegiestrationNumber":"00021008","productName":"TEVA-QUININE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1966-12-31"],"sanitizedIndication":["QUININE"],"atcCode":["P01BC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUININE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfffa"},"numbersOfAis":"1","activeIngredientName":["VALERIAN"],"dose":["500"],"productID":{"$numberInt":"18932"},"sanitizedRegiestrationNumber":"01962302","productName":"NERVATEX TABLETS 500MG","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1995-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VALERIAN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfffb"},"numbersOfAis":"1","activeIngredientName":["VALERIAN"],"dose":["270"],"productID":{"$numberInt":"13880"},"sanitizedRegiestrationNumber":"01951130","productName":"VALERIANE CAP 270MG","licenseHolderSponser":"LABORATOIRE LALCO INC.","companyCode":[{"$numberInt":"4475"}],"facilityAddress":"306 1555 Boulevard De  L'Avenir Laval Quebec Canada H7S 2N5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VALERIAN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["CAP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfffc"},"numbersOfAis":"1","activeIngredientName":["CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)"],"dose":["0.3"],"productID":{"$numberInt":"12953"},"sanitizedRegiestrationNumber":"01945270","productName":"CILOXAN","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["CIPROFLOXACIN"],"atcCode":["S03AA07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Ophthalmic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/V"],"quantityNeedToTake":[""],"qunatityUnit":["W/V"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfffd"},"numbersOfAis":"1","activeIngredientName":["THROMBIN"],"dose":["10000"],"productID":{"$numberInt":"1048"},"sanitizedRegiestrationNumber":"00023108","productName":"THROMBOSTAT 10000UNITS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1954-12-31"],"sanitizedIndication":["THROMBIN"],"atcCode":["B02BC06"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THROMBIN"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":[""],"qunatityUnit":["VIAL"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cfffe"},"numbersOfAis":"3","activeIngredientName":["SODIUM SALICYLATE","SODIUM BENZOATE","SODIUM LAURYL SULFATE"],"dose":["0.2","2","0.25"],"productID":{"$numberInt":"41962"},"sanitizedRegiestrationNumber":"01942506","productName":"PLAX ANTI-PLAQUE DENTAL RINSE","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1988-12-31"],"sanitizedIndication":["VARIOUS"],"atcCode":["A01AD11"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM SALICYLATE","Combination"],"sanitizedRouteOfAdministration":["Dental"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%","%"],"quantityNeedToTake":["","",""],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555cffff"},"numbersOfAis":"5","activeIngredientName":["MAGNESIUM CHLORIDE","SODIUM CHLORIDE","CALCIUM CHLORIDE","DEXTROSE","SODIUM LACTATE"],"dose":[".051","5.38",".184","42.5","4.48"],"productID":{"$numberInt":"15613"},"sanitizedRegiestrationNumber":"01965026","productName":"INPERSOL LC WITH DEXTROSE 4.25% LIQ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MAGNESIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0000"},"numbersOfAis":"1","activeIngredientName":["METHYLPHENIDATE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"800"},"sanitizedRegiestrationNumber":"00005606","productName":"RITALIN 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA III)"],"marketingStatus":["Marketed"],"registrationDate":["1956-12-31"],"sanitizedIndication":["METHYLPHENIDATE"],"atcCode":["N06BA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLPHENIDATE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0001"},"numbersOfAis":"1","activeIngredientName":["PLANTAGO SEED"],"dose":["3.4"],"productID":{"$numberInt":"13282"},"sanitizedRegiestrationNumber":"01968688","productName":"METAMUCIL SUN S PWR ORANGE 3.4GM/12GM","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ISPAGHULA (PSYLLA SEEDS)"],"atcCode":["A06AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PLANTAGO SEED"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["12"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0002"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["100"],"productID":{"$numberInt":"11765"},"sanitizedRegiestrationNumber":"01942999","productName":"TEVA-CAPTOPRIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0003"},"numbersOfAis":"5","activeIngredientName":["SODIUM CITRATE","SODIUM PHOSPHATE MONOBASIC","CITRIC ACID","DEXTROSE","ADENINE"],"dose":["1.66","140","189","2","17.3"],"productID":{"$numberInt":"23039"},"sanitizedRegiestrationNumber":"01960865","productName":"ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Dormant"],"registrationDate":["1996-10-17"],"sanitizedIndication":["BLOOD TRANSFUSION, AUXILIARY PRODUCTS"],"atcCode":["V07AC"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CITRATE","Combination"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G","MG","MG","G","MG"],"quantityNeedToTake":["63","63","63","63","63"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0004"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"317"},"sanitizedRegiestrationNumber":"00024392","productName":"ATARAX CAP 50MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1959-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0005"},"numbersOfAis":"1","activeIngredientName":["METHYLTESTOSTERONE"],"dose":["10"],"productID":{"$numberInt":"13696"},"sanitizedRegiestrationNumber":"00005622","productName":"METANDREN 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["METHYLTESTOSTERONE"],"atcCode":["G03BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYLTESTOSTERONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0006"},"numbersOfAis":"1","activeIngredientName":["OFLOXACIN"],"dose":["400"],"productID":{"$numberInt":"14528"},"sanitizedRegiestrationNumber":"01968408","productName":"FLOXIN TABLETS 400MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1990-12-31"],"sanitizedIndication":["OFLOXACIN"],"atcCode":["J01MA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OFLOXACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0007"},"numbersOfAis":"1","activeIngredientName":["UREA HYDROGEN PEROXIDE"],"dose":["6.5"],"productID":{"$numberInt":"42213"},"sanitizedRegiestrationNumber":"01967959","productName":"MURINE EARWAX REMOVAL SYS-MURINE EAR DPS","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["INDIFFERENT PREPARATIONS"],"atcCode":["S02DC"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["UREA HYDROGEN PEROXIDE"],"sanitizedRouteOfAdministration":["Otic"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0008"},"numbersOfAis":"1","activeIngredientName":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"dose":["2"],"productID":{"$numberInt":"12456"},"sanitizedRegiestrationNumber":"01958097","productName":"CARDURA-2 TAB 2MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXAZOSIN"],"atcCode":["C02CA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0009"},"numbersOfAis":"3","activeIngredientName":["CODEINE PHOSPHATE","METHOCARBAMOL","ACETYLSALICYLIC ACID"],"dose":["32.4","400","325"],"productID":{"$numberInt":"23355"},"sanitizedRegiestrationNumber":"01966375","productName":"METHOXISAL-C 1/2","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1998-05-19"],"sanitizedIndication":["CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS","CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS"],"atcCode":["N02AA59","N02AA59"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["CODEINE PHOSPHATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000a"},"numbersOfAis":"1","activeIngredientName":["GLUCAGON (GLUCAGON HYDROCHLORIDE)"],"dose":["1"],"productID":{"$numberInt":"219"},"sanitizedRegiestrationNumber":"00015377","productName":"GLUCAGON AMPOULE 666 1MG","licenseHolderSponser":"ELI LILLY AND COMPANY LIMITED","companyCode":[{"$numberInt":"4501"}],"facilityAddress":" Lilly Corporate Center, Building 100/328 Indianapolis Indiana United States 46285","countryOfOrigin":["United States"],"format":["Powder For Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule D"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["GLUCAGON"],"atcCode":["H04AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLUCAGON (GLUCAGON HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Intramuscular","Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Biological)| Fabricate (Pharmaceutical)| Label (Biological)| Label (Pharmaceutical)| Package (Biological)| Package (Pharmaceutical)| Test (Biological)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000b"},"numbersOfAis":"1","activeIngredientName":["DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"13277"},"sanitizedRegiestrationNumber":"01957996","productName":"SOMINEX EXTRA STRENGTH CAPLET 50MG","licenseHolderSponser":"GLAXOSMITHKLINE CONSUMER HEALTHCARE INC.","companyCode":[{"$numberInt":"10114"}],"facilityAddress":" 7333 Mississauga Road Mississauga Ontario Canada L5N 6L4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPHENHYDRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000c"},"numbersOfAis":"1","activeIngredientName":["CHLOROQUINE DIPHOSPHATE"],"dose":["250"],"productID":{"$numberInt":"682"},"sanitizedRegiestrationNumber":"00021261","productName":"TEVA-CHLOROQUINE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1968-12-31"],"sanitizedIndication":["CHLOROQUINE"],"atcCode":["P01BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLOROQUINE DIPHOSPHATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000d"},"numbersOfAis":"5","activeIngredientName":["SODIUM CHLORIDE","MAGNESIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","DEXTROSE"],"dose":["5.38",".051","4.48",".184","15"],"productID":{"$numberInt":"15611"},"sanitizedRegiestrationNumber":"01965034","productName":"INPERSOL LC WITH DEXTROSE 1.5% LIQ","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["HEMODIALYTICS, CONCENTRATES"],"atcCode":["B05ZA"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["SODIUM CHLORIDE","Combination"],"sanitizedRouteOfAdministration":["Dialysis"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG","MG","MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML","ML","ML","ML","ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000e"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41946"},"sanitizedRegiestrationNumber":"01955322","productName":"MARVEL WOMEN'S STK ANTI-BABY PWR","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d000f"},"numbersOfAis":"1","activeIngredientName":["PINAVERIUM BROMIDE"],"dose":["50"],"productID":{"$numberInt":"15176"},"sanitizedRegiestrationNumber":"01950592","productName":"DICETEL","licenseHolderSponser":"BGP PHARMA ULC","companyCode":[{"$numberInt":"16524"}],"facilityAddress":" 85 Advance Road Etobicoke Ontario Canada M8Z 2S6","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1993-12-31"],"sanitizedIndication":["PINAVERIUM"],"atcCode":["A03AX04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PINAVERIUM BROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0010"},"numbersOfAis":"1","activeIngredientName":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"dose":["1"],"productID":{"$numberInt":"12455"},"sanitizedRegiestrationNumber":"01958100","productName":"CARDURA-1 TAB 1MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DOXAZOSIN"],"atcCode":["C02CA04"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DOXAZOSIN (DOXAZOSIN MESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0011"},"numbersOfAis":"1","activeIngredientName":["PROPYLTHIOURACIL"],"dose":["50"],"productID":{"$numberInt":"158"},"sanitizedRegiestrationNumber":"00010200","productName":"PROPYL-THYRACIL","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PROPYLTHIOURACIL"],"atcCode":["H03BA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PROPYLTHIOURACIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0012"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["5"],"productID":{"$numberInt":"13079"},"sanitizedRegiestrationNumber":"01964429","productName":"MORPHINE SULFATE INJ 5MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0013"},"numbersOfAis":"1","activeIngredientName":["ORCIPRENALINE SULFATE"],"dose":["20"],"productID":{"$numberInt":"1550"},"sanitizedRegiestrationNumber":"00003891","productName":"ALUPENT TAB 20MG","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ORCIPRENALINE"],"atcCode":["R03CB03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ORCIPRENALINE SULFATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0014"},"numbersOfAis":"1","activeIngredientName":["SENNA"],"dose":["326"],"productID":{"$numberInt":"304"},"sanitizedRegiestrationNumber":"00026042","productName":"SENOKOT GRANULES","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1956-12-31"],"sanitizedIndication":["SENNA GLYCOSIDES"],"atcCode":["A06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SENNA"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["3"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0015"},"numbersOfAis":"1","activeIngredientName":["ZINC OXIDE"],"dose":["15"],"productID":{"$numberInt":"42399"},"sanitizedRegiestrationNumber":"01958895","productName":"JOHNSON'S DIAPER RASH OINTMENT 15%","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Ointment"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["ZINC PRODUCTS"],"atcCode":["D02AB"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ZINC OXIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0016"},"numbersOfAis":"1","activeIngredientName":["QUINIDINE POLYGALACTURONATE"],"dose":["275"],"productID":{"$numberInt":"307"},"sanitizedRegiestrationNumber":"00026131","productName":"CARDIOQUIN TABLETS","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1961-12-31"],"sanitizedIndication":["QUINIDINE"],"atcCode":["C01BA01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINIDINE POLYGALACTURONATE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0017"},"numbersOfAis":"1","activeIngredientName":["LEUPROLIDE ACETATE"],"dose":["7.5"],"productID":{"$numberInt":"10318"},"sanitizedRegiestrationNumber":"B00836273","productName":"LUPRON DEPOT","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":[" Sustained-Release"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1989-12-31"],"sanitizedIndication":["LEUPRORELIN"],"atcCode":["L02AE02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEUPROLIDE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SYR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0018"},"numbersOfAis":"1","activeIngredientName":["PREDNISONE"],"dose":["5"],"productID":{"$numberInt":"507"},"sanitizedRegiestrationNumber":"00021695","productName":"TEVA-PREDNISONE","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1967-12-31"],"sanitizedIndication":["PREDNISONE"],"atcCode":["H02AB07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PREDNISONE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0019"},"numbersOfAis":"1","activeIngredientName":["LEUPROLIDE ACETATE"],"dose":["3.75"],"productID":{"$numberInt":"13443"},"sanitizedRegiestrationNumber":"B00884502","productName":"LUPRON DEPOT","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":[" Sustained-Release"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LEUPRORELIN"],"atcCode":["L02AE02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEUPROLIDE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SYR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001a"},"numbersOfAis":"1","activeIngredientName":["ETHOSUXIMIDE"],"dose":["250"],"productID":{"$numberInt":"771"},"sanitizedRegiestrationNumber":"00022799","productName":"ZARONTIN CAP 250MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1960-12-31"],"sanitizedIndication":["ETHOSUXIMIDE"],"atcCode":["N03AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHOSUXIMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001b"},"numbersOfAis":"1","activeIngredientName":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"dose":["50"],"productID":{"$numberInt":"52046"},"sanitizedRegiestrationNumber":"00027464","productName":"SERENTIL TAB 50MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1997-08-29"],"sanitizedIndication":["MESORIDAZINE"],"atcCode":["N05AC03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001c"},"numbersOfAis":"1","activeIngredientName":["THIOTHIXENE"],"dose":["10"],"productID":{"$numberInt":"783"},"sanitizedRegiestrationNumber":"00024457","productName":"NAVANE CAPSULES 10MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1969-12-31"],"sanitizedIndication":["TIOTIXENE"],"atcCode":["N05AF04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOTHIXENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001d"},"numbersOfAis":"1","activeIngredientName":["CHLORPROPAMIDE"],"dose":["250"],"productID":{"$numberInt":"321"},"sanitizedRegiestrationNumber":"00024716","productName":"DIABINESE TAB 250MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1958-12-31"],"sanitizedIndication":["CHLORPROPAMIDE"],"atcCode":["A10BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CHLORPROPAMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001e"},"numbersOfAis":"1","activeIngredientName":["LEUPROLIDE ACETATE"],"dose":["3.75"],"productID":{"$numberInt":"13443"},"sanitizedRegiestrationNumber":"B00884502","productName":"LUPRON DEPOT","licenseHolderSponser":"ABBVIE CORPORATION","companyCode":[{"$numberInt":"15353"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":[" Sustained-Release"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["LEUPRORELIN"],"atcCode":["L02AE02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LEUPROLIDE ACETATE"],"sanitizedRouteOfAdministration":["Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SYR"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d001f"},"numbersOfAis":"1","activeIngredientName":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"dose":["10"],"productID":{"$numberInt":"1019"},"sanitizedRegiestrationNumber":"00027448","productName":"SERENTIL TAB 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["MESORIDAZINE"],"atcCode":["N05AC03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MESORIDAZINE (MESORIDAZINE BESYLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0020"},"numbersOfAis":"2","activeIngredientName":["LORATADINE","PSEUDOEPHEDRINE SULFATE"],"dose":["5","120"],"productID":{"$numberInt":"12955"},"sanitizedRegiestrationNumber":"01970399","productName":"CHLOR-TRIPOLON ND SRT","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Tablet (Extended-Release)"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["PSEUDOEPHEDRINE, COMBINATIONS","PSEUDOEPHEDRINE, COMBINATIONS"],"atcCode":["R01BA52","R01BA52"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["LORATADINE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0021"},"numbersOfAis":"1","activeIngredientName":["COLCHICINE"],"dose":["0.6"],"productID":{"$numberInt":"113"},"sanitizedRegiestrationNumber":"00000396","productName":"COLCHICINE TAB 0.6MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["COLCHICINE"],"atcCode":["M04AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COLCHICINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0022"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"12621"},"sanitizedRegiestrationNumber":"01952137","productName":"DM SYRUP (SUCROSE FREE)","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0023"},"numbersOfAis":"1","activeIngredientName":["FAMOTIDINE"],"dose":["40"],"productID":{"$numberInt":"13583"},"sanitizedRegiestrationNumber":"01953834","productName":"APO-FAMOTIDINE TAB 40MG USP","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1993-12-31"],"sanitizedIndication":["FAMOTIDINE"],"atcCode":["A02BA03"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FAMOTIDINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0024"},"numbersOfAis":"1","activeIngredientName":["LIDOCAINE HYDROCHLORIDE"],"dose":["100"],"productID":{"$numberInt":"4478"},"sanitizedRegiestrationNumber":"00001937","productName":"XYLOCARD","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1974-12-31"],"sanitizedIndication":["LIDOCAINE"],"atcCode":["C01BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["LIDOCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0025"},"numbersOfAis":"1","activeIngredientName":["GLUTARAL"],"dose":["2"],"productID":{"$numberInt":"12213"},"sanitizedRegiestrationNumber":"01946420","productName":"CIDEX LONG LIFE ACT DIALDEHYDE SOL 2%","licenseHolderSponser":"JOHNSON & JOHNSON MEDICAL PRODUCTS","companyCode":[{"$numberInt":"4413"}],"facilityAddress":" 200 Whitehall Drive Markham Ontario Canada L3R 0T5","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TECHNICAL DISINFECTANTS"],"atcCode":["V07AV"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["GLUTARAL"],"sanitizedRouteOfAdministration":["Disinfectant (Medical Instruments)"],"className":"Disinfectant","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0026"},"numbersOfAis":"1","activeIngredientName":["BETHANECHOL CHLORIDE"],"dose":["50"],"productID":{"$numberInt":"12887"},"sanitizedRegiestrationNumber":"01947923","productName":"DUVOID TABLETS 50 MG","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["BETHANECHOL"],"atcCode":["N07AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BETHANECHOL CHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0027"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN SODIUM"],"dose":["30"],"productID":{"$numberInt":"1036"},"sanitizedRegiestrationNumber":"00022772","productName":"DILANTIN","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN SODIUM"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0028"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41905"},"sanitizedRegiestrationNumber":"01935623","productName":"OPTION + STK MENS ANTIPERSP SCENTED","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0029"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["2"],"productID":{"$numberInt":"13078"},"sanitizedRegiestrationNumber":"01964437","productName":"MORPHINE SULFATE INJ 2MG/ML USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Dormant"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002a"},"numbersOfAis":"1","activeIngredientName":["IPRATROPIUM BROMIDE"],"dose":["250"],"productID":{"$numberInt":"12454"},"sanitizedRegiestrationNumber":"01950681","productName":"ATROVENT UDV SOL INH 250MCG/ML","licenseHolderSponser":"BOEHRINGER INGELHEIM (CANADA) LTD LTEE","companyCode":[{"$numberInt":"3617"}],"facilityAddress":" 5180 South Service Road Burlington Ontario Canada L7L 5H4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["IPRATROPIUM BROMIDE"],"atcCode":["R03BB01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IPRATROPIUM BROMIDE"],"sanitizedRouteOfAdministration":["Inhalation"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002b"},"numbersOfAis":"1","activeIngredientName":["THYROID"],"dose":["60"],"productID":{"$numberInt":"773"},"sanitizedRegiestrationNumber":"00023957","productName":"THYROID TAB 60MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THYROID GLAND PREPARATIONS"],"atcCode":["H03AA05"],"pharmaceuticalStd":["CSD"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THYROID"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002c"},"numbersOfAis":"1","activeIngredientName":["IMIPRAMINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"164"},"sanitizedRegiestrationNumber":"00010464","productName":"TOFRANIL 10MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["IMIPRAMINE"],"atcCode":["N06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IMIPRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002d"},"numbersOfAis":"2","activeIngredientName":["NORGESTIMATE","ETHINYL ESTRADIOL"],"dose":["0.25","0.035"],"productID":{"$numberInt":"12998"},"sanitizedRegiestrationNumber":"01968440","productName":"CYCLEN TABLETS (21 DAY)","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["NORGESTIMATE AND ESTROGEN"],"atcCode":["G03AA11"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NORGESTIMATE","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG","MG"],"quantityNeedToTake":["1"],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002e"},"numbersOfAis":"1","activeIngredientName":["IMIPRAMINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"1099"},"sanitizedRegiestrationNumber":"00010480","productName":"TOFRANIL 50MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1962-12-31"],"sanitizedIndication":["IMIPRAMINE"],"atcCode":["N06AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IMIPRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d002f"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41969"},"sanitizedRegiestrationNumber":"01967827","productName":"MARVEL STICK ULTRA ANTIPERSPIRANT-SCT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0030"},"numbersOfAis":"1","activeIngredientName":["OFLOXACIN"],"dose":["200"],"productID":{"$numberInt":"14531"},"sanitizedRegiestrationNumber":"01968424","productName":"FLOXIN TABLETS 200MG","licenseHolderSponser":"JANSSEN INC","companyCode":[{"$numberInt":"7259"}],"facilityAddress":" 19 Green Belt Drive Toronto Ontario Canada M3C 1L9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["OFLOXACIN"],"atcCode":["J01MA01"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["OFLOXACIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0031"},"numbersOfAis":"1","activeIngredientName":["BUSULFAN"],"dose":["2"],"productID":{"$numberInt":"959"},"sanitizedRegiestrationNumber":"00004618","productName":"MYLERAN","licenseHolderSponser":"ASPEN PHARMACARE CANADA INC.","companyCode":[{"$numberInt":"17065"}],"facilityAddress":" Unit 8, 1155 North Service Road West Oakville Ontario Canada L6M 3E3","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["BUSULFAN"],"atcCode":["L01AB01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BUSULFAN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0032"},"numbersOfAis":"1","activeIngredientName":["BENZOCAINE"],"dose":["5"],"productID":{"$numberInt":"32384"},"sanitizedRegiestrationNumber":"01970267","productName":"JOHNSON AND JOHNSON BURN CRM 5.0%","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Cream"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1997-03-18"],"sanitizedIndication":["BENZOCAINE"],"atcCode":["D04AB04"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["BENZOCAINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0033"},"numbersOfAis":"1","activeIngredientName":["SERTRALINE (SERTRALINE HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"12662"},"sanitizedRegiestrationNumber":"01962817","productName":"ZOLOFT CAP 50MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SERTRALINE"],"atcCode":["N06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SERTRALINE (SERTRALINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0034"},"numbersOfAis":"1","activeIngredientName":["THIOTHIXENE"],"dose":["2"],"productID":{"$numberInt":"785"},"sanitizedRegiestrationNumber":"00024430","productName":"NAVANE CAP 2MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1969-12-31"],"sanitizedIndication":["TIOTIXENE"],"atcCode":["N05AF04"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["THIOTHIXENE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0035"},"numbersOfAis":"1","activeIngredientName":["RESERPINE"],"dose":["0.25"],"productID":{"$numberInt":"803"},"sanitizedRegiestrationNumber":"00005665","productName":"SERPASIL 0.25MG","licenseHolderSponser":"NOVARTIS PHARMACEUTICALS CANADA INC","companyCode":[{"$numberInt":"7277"}],"facilityAddress":" 385 Bouchard Blvd Dorval Quebec Canada H9S 1A9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1954-12-31"],"sanitizedIndication":["RESERPINE"],"atcCode":["C02AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["RESERPINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["TAB"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0036"},"numbersOfAis":"1","activeIngredientName":["VITAMIN D"],"dose":["50000"],"productID":{"$numberInt":"161"},"sanitizedRegiestrationNumber":"00009830","productName":"OSTOFORTE","licenseHolderSponser":"MERCK CANADA INC","companyCode":[{"$numberInt":"12250"}],"facilityAddress":" 16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["ERGOCALCIFEROL"],"atcCode":["A11CC01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["VITAMIN D"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["UNIT"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Distribute (Vaccine)| Wholesale (Biological)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0037"},"numbersOfAis":"1","activeIngredientName":["MERCAPTOPURINE"],"dose":["50"],"productID":{"$numberInt":"960"},"sanitizedRegiestrationNumber":"00004723","productName":"PURINETHOL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1954-12-31"],"sanitizedIndication":["MERCAPTOPURINE"],"atcCode":["L01BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MERCAPTOPURINE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0038"},"numbersOfAis":"1","activeIngredientName":["METHYCLOTHIAZIDE"],"dose":["5"],"productID":{"$numberInt":"222"},"sanitizedRegiestrationNumber":"00000485","productName":"DURETIC 5MG","licenseHolderSponser":"ABBOTT LABORATORIES, LIMITED","companyCode":[{"$numberInt":"3525"}],"facilityAddress":" 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["METHYCLOTHIAZIDE"],"atcCode":["C03AA08"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHYCLOTHIAZIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0039"},"numbersOfAis":"1","activeIngredientName":["DIAZEPAM"],"dose":["10"],"productID":{"$numberInt":"687"},"sanitizedRegiestrationNumber":"00012874","productName":"VALIUM INJ ROCHE 5MG/ML","licenseHolderSponser":"HOFFMANN-LA ROCHE LIMITED","companyCode":[{"$numberInt":"4328"}],"facilityAddress":" 7070 Mississauga Road Mississauga Ontario Canada L5N 5M8","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Targeted (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1968-12-31"],"sanitizedIndication":["DIAZEPAM"],"atcCode":["N05BA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIAZEPAM"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["2"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003b"},"numbersOfAis":"1","activeIngredientName":["PAPAVERINE HYDROCHLORIDE"],"dose":["65"],"productID":{"$numberInt":"160"},"sanitizedRegiestrationNumber":"00009881","productName":"PAPAVERINE HYDROCHLORIDE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PAPAVERINE"],"atcCode":["A03AD01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PAPAVERINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Subcutaneous","Intravenous","Intramuscular"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["2"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003a"},"numbersOfAis":"1","activeIngredientName":["METHIMAZOLE"],"dose":["5"],"productID":{"$numberInt":"9"},"sanitizedRegiestrationNumber":"00015741","productName":"TAPAZOLE 5MG TABLET","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1951-12-31"],"sanitizedIndication":["THIAMAZOLE"],"atcCode":["H03BB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["METHIMAZOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003c"},"numbersOfAis":"1","activeIngredientName":["POVIDONE-IODINE"],"dose":["10"],"productID":{"$numberInt":"12144"},"sanitizedRegiestrationNumber":"01944533","productName":"IRRIGATION TRAY 10% KIT","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["POVIDONE-IODINE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003d"},"numbersOfAis":"1","activeIngredientName":["HYDROCORTISONE ACETATE"],"dose":["10"],"productID":{"$numberInt":"5575"},"sanitizedRegiestrationNumber":"B00579335","productName":"CORTIFOAM","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":[" Foam"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Dormant"],"registrationDate":["1983-12-31"],"sanitizedIndication":["HYDROCORTISONE"],"atcCode":["A07EA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROCORTISONE ACETATE"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":[""],"qunatityUnit":["W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003e"},"numbersOfAis":"1","activeIngredientName":["PHENOBARBITAL"],"dose":["60"],"productID":{"$numberInt":"1150"},"sanitizedRegiestrationNumber":"00023817","productName":"PHENOBARBITAL TAB 60MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PHENOBARBITAL","PHENOBARBITAL"],"atcCode":["N03AA02","N03AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENOBARBITAL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d003f"},"numbersOfAis":"1","activeIngredientName":["HEXETIDINE"],"dose":["0.1"],"productID":{"$numberInt":"13344"},"sanitizedRegiestrationNumber":"01946900","productName":"STERI/SOL LIQUID","licenseHolderSponser":"JOHNSON & JOHNSON INC","companyCode":[{"$numberInt":"4402"}],"facilityAddress":" 88 Mcnabb Street Markham Ontario Canada L3R 5L2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["HEXETIDINE"],"atcCode":["A01AB12"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HEXETIDINE"],"sanitizedRouteOfAdministration":["Buccal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0040"},"numbersOfAis":"1","activeIngredientName":["SENNA"],"dose":["3.5"],"productID":{"$numberInt":"300"},"sanitizedRegiestrationNumber":"00026069","productName":"X PREP POWDER 3.5GM","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1960-12-31"],"sanitizedIndication":["SENNA GLYCOSIDES"],"atcCode":["A06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SENNA"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["21.25"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0041"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN"],"dose":["50"],"productID":{"$numberInt":"1086"},"sanitizedRegiestrationNumber":"00023698","productName":"DILANTIN INFATABS","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1952-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0042"},"numbersOfAis":"1","activeIngredientName":["ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE)"],"dose":["125"],"productID":{"$numberInt":"901"},"sanitizedRegiestrationNumber":"00021172","productName":"NOVO-RYTHRO ESTOLATE SUSPENSION","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1970-12-31"],"sanitizedIndication":["ERYTHROMYCIN"],"atcCode":["J01FA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0043"},"numbersOfAis":"1","activeIngredientName":["PLANTAGO SEED"],"dose":["3.4"],"productID":{"$numberInt":"13307"},"sanitizedRegiestrationNumber":"01968742","productName":"METAMUCIL SUN S PWR ORANGE SUGAR FREE","licenseHolderSponser":"PROCTER & GAMBLE INC","companyCode":[{"$numberInt":"4911"}],"facilityAddress":" 4711 Yonge Street 2nd Floor P.O Box 355 Station A Toronto Ontario Canada M5W 1C5","countryOfOrigin":["Canada"],"format":["Powder"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ISPAGHULA (PSYLLA SEEDS)"],"atcCode":["A06AC01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PLANTAGO SEED"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["G"],"quantityNeedToTake":["5.8"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0044"},"numbersOfAis":"1","activeIngredientName":["MORPHINE SULFATE"],"dose":["0.5"],"productID":{"$numberInt":"12968"},"sanitizedRegiestrationNumber":"01949047","productName":"MORPHINE-EPD","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["MORPHINE"],"atcCode":["N02AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MORPHINE SULFATE"],"sanitizedRouteOfAdministration":["Epidural"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0045"},"numbersOfAis":"1","activeIngredientName":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"dose":["500"],"productID":{"$numberInt":"1124"},"sanitizedRegiestrationNumber":"00020885","productName":"TEVA-AMPICILLIN","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1971-12-31"],"sanitizedIndication":["AMPICILLIN"],"atcCode":["J01CA01"],"pharmaceuticalStd":["BP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["AMPICILLIN (AMPICILLIN TRIHYDRATE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0046"},"numbersOfAis":"1","activeIngredientName":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"dose":["5"],"productID":{"$numberInt":"12331"},"sanitizedRegiestrationNumber":"01947664","productName":"ACCUPRIL 5MG TAB","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["QUINAPRIL"],"atcCode":["C09AA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0047"},"numbersOfAis":"1","activeIngredientName":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"dose":["10"],"productID":{"$numberInt":"12332"},"sanitizedRegiestrationNumber":"01947672","productName":"ACCUPRIL TAB 10MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["QUINAPRIL"],"atcCode":["C09AA06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0048"},"numbersOfAis":"1","activeIngredientName":["MINERAL OIL"],"dose":["100"],"productID":{"$numberInt":"42098"},"sanitizedRegiestrationNumber":"01951718","productName":"NUJOL MINERAL OIL 100%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1993-12-31"],"sanitizedIndication":["LIQUID PARAFFIN"],"atcCode":["A06AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["MINERAL OIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0049"},"numbersOfAis":"1","activeIngredientName":["COCAINE HYDROCHLORIDE"],"dose":["40"],"productID":{"$numberInt":"12625"},"sanitizedRegiestrationNumber":"01962388","productName":"COCAINE HYDROCHLORIDE TOP SOL 40MG/ML","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Narcotic (CDSA I)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["COCAINE"],"atcCode":["R02AD03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["COCAINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004a"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"319"},"sanitizedRegiestrationNumber":"00024376","productName":"ATARAX CAP 10MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1956-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004b"},"numbersOfAis":"1","activeIngredientName":["IODINE (POVIDONE-IODINE)"],"dose":["1"],"productID":{"$numberInt":"12613"},"sanitizedRegiestrationNumber":"01945750","productName":"URETHRAL CATH TRAY W IODPHOR PVP PAD 1%","licenseHolderSponser":"BAXTER CORPORATION","companyCode":[{"$numberInt":"3699"}],"facilityAddress":" 7125 Mississauga Road Mississauga Ontario Canada L5N 0C2","countryOfOrigin":["Canada"],"format":["Liquid"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["POVIDONE-IODINE"],"atcCode":["D08AG02"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["IODINE (POVIDONE-IODINE)"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["KIT"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Wholesale (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004c"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"42011"},"sanitizedRegiestrationNumber":"01950525","productName":"BIG V LADIES ANTI STK 23% UNSCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004d"},"numbersOfAis":"27","activeIngredientName":["NICKEL (NICKEL SULFATE)","COPPER (CUPRIC OXIDE)","VITAMIN A ACETATE","VITAMIN C","THIAMINE MONONITRATE","VITAMIN B12","BIOTIN","D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)","PHOSPHORUS (CALCIUM PHOSPHATE (TRIBASIC))","IRON (FERROUS FUMARATE)","MANGANESE (MANGANESE SULFATE)","CHLORINE (POTASSIUM CHLORIDE)","SELENIUM (SODIUM SELENATE)","ZINC (ZINC OXIDE)","TIN (STANNOUS CHLORIDE)","BETA-CAROTENE","D-ALPHA TOCOPHERYL ACID SUCCINATE","FOLIC ACID","VITAMIN B2","NICOTINAMIDE","PYRIDOXINE HYDROCHLORIDE","VITAMIN D","CALCIUM (CALCIUM PHOSPHATE (TRIBASIC))","IODINE (POTASSIUM IODIDE)","MAGNESIUM (MAGNESIUM OXIDE)","POTASSIUM (POTASSIUM CHLORIDE)","CHROMIUM (CHROMIC CHLORIDE)"],"dose":["5","2","4000","90","1.5","14","30","10","150","9","2.5","72","25","15","10","2000","25",".2","1.7","20","3","400","200",".15","100","80","100"],"productID":{"$numberInt":"15556"},"sanitizedRegiestrationNumber":"01961004","productName":"MULTIVITAMIN-MULTIMINERAL SELECT FORMULA","licenseHolderSponser":"PHARMETICS (2011) INC","companyCode":[{"$numberInt":"4933"}],"facilityAddress":"UNIT 1 30 Concourse Gate Ottawa Ontario Canada K2E 7V7","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1994-12-31"],"sanitizedIndication":["MULTIVITAMINS AND OTHER MINERALS INCL COMBINATIONS"],"atcCode":["A11AA03"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["NICKEL (NICKEL SULFATE)","Combination"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG","MG","UNIT","MG","MG","MCG","MCG","MG","MG","MG","MG","MG","MCG","MG","MCG","UNIT","UNIT","MG","MG","MG","MG","UNIT","MG","MG","MG","MG","MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["","","","","","","","","","","","","","","","","","","","","","","","","","",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Pharmaceutical)| Distribute (Pharmaceutical)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004e"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["25"],"productID":{"$numberInt":"11763"},"sanitizedRegiestrationNumber":"01942972","productName":"TEVA-CAPTOPRIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d004f"},"numbersOfAis":"1","activeIngredientName":["DIPHENHYDRAMINE HYDROCHLORIDE"],"dose":["50"],"productID":{"$numberInt":"12743"},"sanitizedRegiestrationNumber":"01946986","productName":"UNISOM","licenseHolderSponser":"PALADIN LABS INC","companyCode":[{"$numberInt":"8481"}],"facilityAddress":" 100 Blvd Alexis-Nihon, Suite 600 Saint-Laurent Quebec Canada H4M 2P2","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1982-12-31"],"sanitizedIndication":["DIPHENHYDRAMINE"],"atcCode":["R06AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPHENHYDRAMINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Distribute (Biological)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0050"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"41897"},"sanitizedRegiestrationNumber":"01947605","productName":"PERSONNELLE ULTRA ANTIP SPORT STK 22","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0051"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["22"],"productID":{"$numberInt":"42236"},"sanitizedRegiestrationNumber":"01947427","productName":"OPTION + MEN'S ANTIPER STK 22% SPORT SCEN","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0052"},"numbersOfAis":"1","activeIngredientName":["SENNA"],"dose":["652"],"productID":{"$numberInt":"305"},"sanitizedRegiestrationNumber":"00026107","productName":"SENOKOT SUPP","licenseHolderSponser":"PURDUE PHARMA","companyCode":[{"$numberInt":"7054"}],"facilityAddress":" 575 Granite Court Pickering Ontario Canada L1W 3W8","countryOfOrigin":["Canada"],"format":["Suppository"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1964-12-31"],"sanitizedIndication":["SENNA GLYCOSIDES"],"atcCode":["A06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SENNA"],"sanitizedRouteOfAdministration":["Rectal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":[""],"qunatityUnit":["SUP"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0053"},"numbersOfAis":"1","activeIngredientName":["HYDRALAZINE HYDROCHLORIDE"],"dose":["25"],"productID":{"$numberInt":"804"},"sanitizedRegiestrationNumber":"00005533","productName":"APRESOLINE TABLETS, 25MG","licenseHolderSponser":"STERIMAX INC","companyCode":[{"$numberInt":"8892"}],"facilityAddress":" 2770 Portland Drive Oakville Ontario Canada L6H 6R4","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1952-12-31"],"sanitizedIndication":["HYDRALAZINE"],"atcCode":["C02DB02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDRALAZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Label (Pharmaceutical)| Test (Active Pharmaceutical Ingredients)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0054"},"numbersOfAis":"1","activeIngredientName":["SERTRALINE (SERTRALINE HYDROCHLORIDE)"],"dose":["100"],"productID":{"$numberInt":"13392"},"sanitizedRegiestrationNumber":"01962779","productName":"ZOLOFT CAP 100MG","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Capsule"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["SERTRALINE"],"atcCode":["N06AB06"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["SERTRALINE (SERTRALINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0055"},"numbersOfAis":"1","activeIngredientName":["FILGRASTIM"],"dose":["300"],"productID":{"$numberInt":"12474"},"sanitizedRegiestrationNumber":"01968017","productName":"NEUPOGEN","licenseHolderSponser":"AMGEN CANADA INC","companyCode":[{"$numberInt":"3568"}],"facilityAddress":" 6775 Financial Drive, Suite 100 Mississauga Ontario Canada L5N 0A4","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription","Schedule D"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["FILGRASTIM"],"atcCode":["L03AA02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["FILGRASTIM"],"sanitizedRouteOfAdministration":["Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MCG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Biological)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0056"},"numbersOfAis":"1","activeIngredientName":["HYDROXYZINE HYDROCHLORIDE"],"dose":["10"],"productID":{"$numberInt":"316"},"sanitizedRegiestrationNumber":"00024694","productName":"ATARAX SYRUP 2MG/ML","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1956-12-31"],"sanitizedIndication":["HYDROXYZINE"],"atcCode":["N05BB01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["HYDROXYZINE HYDROCHLORIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0057"},"numbersOfAis":"1","activeIngredientName":["PHENYTOIN"],"dose":["125"],"productID":{"$numberInt":"613"},"sanitizedRegiestrationNumber":"00023450","productName":"DILANTIN-125 SUSPENSION","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Suspension"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1953-12-31"],"sanitizedIndication":["PHENYTOIN"],"atcCode":["N03AB02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENYTOIN"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0058"},"numbersOfAis":"1","activeIngredientName":["PHENOBARBITAL"],"dose":["15"],"productID":{"$numberInt":"1112"},"sanitizedRegiestrationNumber":"00023795","productName":"PHENOBARBITAL TAB 15MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Schedule G (CDSA IV)"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1951-12-31"],"sanitizedIndication":["PHENOBARBITAL","PHENOBARBITAL"],"atcCode":["N03AA02","N03AA02"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["PHENOBARBITAL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0059"},"numbersOfAis":"1","activeIngredientName":["TOLNAFTATE"],"dose":["1"],"productID":{"$numberInt":"41971"},"sanitizedRegiestrationNumber":"01918826","productName":"ATHLETE'S FOOT GEL 1%","licenseHolderSponser":"SCHERING-PLOUGH CANADA INC","companyCode":[{"$numberInt":"7016"}],"facilityAddress":" 3535 Route Trans Canada Highway Pointe-Claire Quebec Canada H9R 1B4","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1982-12-31"],"sanitizedIndication":["TOLNAFTATE"],"atcCode":["D01AE18"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["TOLNAFTATE"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Test (Pharmaceutical)| Label (Biological)| Distribute (Pharmaceutical)| Import (Biological)| Import (Active Pharmaceutical Ingredients)| Package (Biological)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005a"},"numbersOfAis":"1","activeIngredientName":["DEXTROMETHORPHAN HYDROBROMIDE"],"dose":["15"],"productID":{"$numberInt":"12788"},"sanitizedRegiestrationNumber":"01928775","productName":"BALMINIL DM  (3MG/ML SUCROSE FREE)","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Syrup"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Marketed"],"registrationDate":["1979-12-31"],"sanitizedIndication":["DEXTROMETHORPHAN"],"atcCode":["R05DA09"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DEXTROMETHORPHAN HYDROBROMIDE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["5"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005b"},"numbersOfAis":"1","activeIngredientName":["DINOPROSTONE"],"dose":["1"],"productID":{"$numberInt":"11830"},"sanitizedRegiestrationNumber":"01919679","productName":"PROSTIN E2 VAGINAL GEL","licenseHolderSponser":"PFIZER CANADA ULC","companyCode":[{"$numberInt":"4908"}],"facilityAddress":" 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["DINOPROSTONE"],"atcCode":["G02AD02"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DINOPROSTONE"],"sanitizedRouteOfAdministration":["Vaginal"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["3"],"qunatityUnit":["G"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Import (Biological)| Distribute (Pharmaceutical)| Distribute (Vaccine)| Distribute (Biological)| Import (Vaccine)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005c"},"numbersOfAis":"1","activeIngredientName":["CAPTOPRIL"],"dose":["50"],"productID":{"$numberInt":"11764"},"sanitizedRegiestrationNumber":"01942980","productName":"TEVA-CAPTOPRIL","licenseHolderSponser":"TEVA CANADA LIMITED","companyCode":[{"$numberInt":"14318"}],"facilityAddress":" 30 Novopharm Court Toronto Ontario Canada M1B 2K9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1991-12-31"],"sanitizedIndication":["CAPTOPRIL"],"atcCode":["C09AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["CAPTOPRIL"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005d"},"numbersOfAis":"1","activeIngredientName":["ETHOPROPAZINE (ETHOPROPAZINE HYDROCHLORIDE)"],"dose":["50"],"productID":{"$numberInt":"12549"},"sanitizedRegiestrationNumber":"01927744","productName":"PARSITAN 50MG","licenseHolderSponser":"ERFA CANADA 2012 INC","companyCode":[{"$numberInt":"9484"}],"facilityAddress":" 8250 Blvd Decarie, Suite 110 Montreal Quebec Canada H4P 2P5","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1952-12-31"],"sanitizedIndication":["PROFENAMINE","PROFENAMINE"],"atcCode":["N04AA05","N04AA05"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ETHOPROPAZINE (ETHOPROPAZINE HYDROCHLORIDE)"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Wholesale (Prescription Drug List, Schedule G, and/or Narcotics or a drug containing cannabis as defined in subsection 2(1) of the Cannabis Act.)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005e"},"numbersOfAis":"1","activeIngredientName":["NEOSTIGMINE METHYLSULFATE"],"dose":["2.5"],"productID":{"$numberInt":"11852"},"sanitizedRegiestrationNumber":"01915436","productName":"NEOSTIGMINE METHYLSULFATE INJECTION USP","licenseHolderSponser":"SANDOZ CANADA INCORPORATED","companyCode":[{"$numberInt":"12027"}],"facilityAddress":" 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6","countryOfOrigin":["Canada"],"format":["Solution"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1991-12-31"],"sanitizedIndication":["NEOSTIGMINE"],"atcCode":["N07AA01"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["NEOSTIGMINE METHYLSULFATE"],"sanitizedRouteOfAdministration":["Intramuscular","Intravenous","Subcutaneous"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":["ML"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d005f"},"numbersOfAis":"2","activeIngredientName":["BENZOCAINE","TETRACAINE HYDROCHLORIDE"],"dose":["18","2"],"productID":{"$numberInt":"13347"},"sanitizedRegiestrationNumber":"01930699","productName":"ZAP TOPICAL ANESTHETIC GEL","licenseHolderSponser":"GERMIPHENE CORPORATION","companyCode":[{"$numberInt":"4231"}],"facilityAddress":" 1379 Colborne Street East Brantford Ontario Canada N3T 5M1","countryOfOrigin":["Canada"],"format":["Gel"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Ethical"],"marketingStatus":["Marketed"],"registrationDate":["1992-12-31"],"sanitizedIndication":["TOPICAL ANESTHETICS, COMBINATIONS"],"atcCode":["D04AB30"],"pharmaceuticalStd":["MFR"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["BENZOCAINE","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%","%"],"quantityNeedToTake":["",""],"qunatityUnit":["",""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Distribute (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0060"},"numbersOfAis":"3","activeIngredientName":["MENTHOL","COAL TAR","CHLOROXYLENOL"],"dose":["1.5","7.5","0.5"],"productID":{"$numberInt":"42099"},"sanitizedRegiestrationNumber":"01931237","productName":"DENOREX MEDICATED SHAMPOO SPRING FRESH","licenseHolderSponser":"NEOTERIC COSMETICS INC.","companyCode":[{"$numberInt":"8173"}],"facilityAddress":" 4880 Havana St, Suite 400 Denver Colorado United States 80239-0019","countryOfOrigin":["United States"],"format":["Shampoo"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Dormant"],"registrationDate":["1993-12-31"],"sanitizedIndication":["TARS"],"atcCode":["D05AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Combination"],"drugCluster":["MENTHOL","Combination"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%W/W"],"quantityNeedToTake":["","",""],"qunatityUnit":["W/W","W/W","W/W"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Fabricate (Pharmaceutical)| Label (Pharmaceutical)| Package (Pharmaceutical)| Test (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0061"},"numbersOfAis":"1","activeIngredientName":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"dose":["23"],"productID":{"$numberInt":"41938"},"sanitizedRegiestrationNumber":"01955314","productName":"MARVEL WOMEN'S STK ANTI-SCENT","licenseHolderSponser":"H.J. SUTTON INDUSTRIES LTD.","companyCode":[{"$numberInt":"5215"}],"facilityAddress":" 8701 Jane Street, Unit C Vaughan Ontario Canada L4K 2M6","countryOfOrigin":["Canada"],"format":["Stick"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["OTC"],"marketingStatus":["Cancelled Post Market"],"registrationDate":["1992-12-31"],"sanitizedIndication":["ANTIHIDROTICS"],"atcCode":["D11AA"],"pharmaceuticalStd":[""],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY"],"sanitizedRouteOfAdministration":["Topical"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["%"],"quantityNeedToTake":[""],"qunatityUnit":["%"],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Import (Pharmaceutical)| Distribute (Pharmaceutical)"}
{"_id":{"$oid":"5e3833368a1cf2b8555d0062"},"numbersOfAis":"1","activeIngredientName":["DIPYRIDAMOLE"],"dose":["25"],"productID":{"$numberInt":"11034"},"sanitizedRegiestrationNumber":"00895644","productName":"APO-DIPYRIDAMOLE-FC TAB 25MG","licenseHolderSponser":"APOTEX INC","companyCode":[{"$numberInt":"3636"}],"facilityAddress":" 150 Signet Drive Toronto Ontario Canada M9L 1T9","countryOfOrigin":["Canada"],"format":["Tablet"],"packagingID":[""],"unit":[""],"type":[""],"packagingInformation":[""],"regulatoryClass":["Prescription"],"marketingStatus":["Marketed"],"registrationDate":["1990-12-31"],"sanitizedIndication":["DIPYRIDAMOLE"],"atcCode":["B01AC07"],"pharmaceuticalStd":["USP"],"regulatoryRoute":["Licensing"],"currentMarket":["Canada"],"nature":["Single"],"drugCluster":["DIPYRIDAMOLE"],"sanitizedRouteOfAdministration":["Oral"],"className":"Human","primaryPackageQuantity":[""],"unitOfDose":["MG"],"quantityNeedToTake":["1"],"qunatityUnit":[""],"gmpCompliance":"Canada GMP","gmpApprovalInformation":"Test (Pharmaceutical)| Import (Active Pharmaceutical Ingredients)| Package (Pharmaceutical)| Test (Biological)| Fabricate (Pharmaceutical)| Label (Pharmaceutical)"}
